. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . "MGC111763" . "MGC26458" . "PERRS" . "regulator of G-protein signaling 9L" . "regulator of G protein signalling 9" . "regulator of G protein signalling 9L" . "RGS9L" . . . . . . . . . . "Ammonium transporter Rh type A" . "CD241" . "RH50A" . "SLC42A1" . . . . . . . . . "CD240CE" . . . . . . . "CD240D" . "DIIIc" . "Rh30a" . "Rh4" . "RhII" . "RhPI" . . . . . . . . . "CSNBAD1" . "OPN2" . "opsin 2, rod pigment" . . . . . . . . . . "GPRK1" . "RK" . . . . . . . . . "receptor-interacting protein kinase 1" . "RIP" . . . . . . . . . . "BCL5" . "BCL6A" . "LAZ3" . "ZBTB27" . . . . . . . . . "GTP-binding protein Roc1" . "MGC125864" . "MGC125865" . "RIBB" . "Ric-like, expressed in many tissues" . "ROC1" . . . . . . . . . . . "CRALBP" . . . . . . . . . . . "NME1" . "RMRPR" . "RRP2" . . . . . . . . . . . . . "RZF" . . . . . . . . . . . "DKFZp686P0776" . "RING-H2 protein RNF-6" . . . . . . . . "Blue-sensitive opsin" . "BOP" . "CBT" . "Color blindness, tritan" . . . . . . . . . . . . "ALL" . "CML" . "D22S662" . "PHL" . . . . . . . . . . . . "BCS" . "Bjornstad syndrome" . "BJS" . "GRACILE syndrome" . "h-BCS" . "Hs.6719" . . . . . . . . "DUTT1" . "FLJ21882" . "SAX3" . . . . . . . . "KIAA1568" . . . . . . . . "ROM" . "TSPAN23" . . . . . . . . . . . . . . . . . . . . . . . . "NR1F3" . "RORG" . "RZRG" . "TOR" . . . . . . . . . "DCDC4A" . "doublecortin domain containing 4A" . "ORP1" . "oxygen-regulated protein 1" . . . . . . . "NM23-H10" . "NME10" . "TBCCD2" . . . . . . . . "PAP-1" . "Pim-1 kinase associated protein" . . . . . . . . . . "all-trans-retinyl-palmitate hydrolase" . "BCO3" . "BCO family, member 3" . "LCA2" . "rd12" . "retinol isomerase" . . . . . . . . . . . . "CORDX1" . . . . . . . . "ribose 5-phosphate epimerase" . . . . . . . . . "DXS648" . "DXS648E" . "FLJ23544" . "L10" . "NOV" . "QM" . . . . . . . . "60S ribosomal protein L11" . "L11" . "uL5" . . . . . . . . "EC45" . "L15" . "RPL10" . "RPLY10" . "RPYL10" . . . . . . . . "60S ribosomal protein L18" . "L18" . . . . . . . . "60S ribosomal protein L21" . "DKFZp686C06101" . "FLJ27458" . "L21" . "MGC104274" . "MGC104275" . "MGC71252" . . . . . . . . "L26" . . . . . . . . "60S ribosomal protein L27" . "L27" . . . . . . . . "L31" . . . . . . . . . "neurotrophin" . . . . . . . "60S ribosomal protein L35" . "L35" . . . . . . . . "eL33" . "GIG33" . "L35A" . . . . . . . . "L5" . "PPP1R135" . "protein phosphatase 1, regulatory subunit 135" . "uL18" . . . . . . . . "MRL3" . . . . . . . . . "H2-Bf" . . . . . . . . . "oligosaccharyltransferase 1 homolog (S. cerevisiae)" . "oligosaccharyltransferase complex subunit (non-catalytic)" . "OST1" . . . . . . . . "MGC88819" . "S10" . . . . . . . . "40S ribosomal protein S14" . "emetine resistance" . "EMTB" . "S14" . . . . . . . . "40S ribosomal protein S15" . "homolog of rat insulinoma" . "insulinoma protein" . "MGC111130" . "RIG" . "S15" . . . . . . . . "S15A" . . . . . . . "MGC72007" . "RPS17L1" . "RPS17L2" . "S17" . . . . . . . . . . . . . . . "DBA" . "Diamond-Blackfan anemia" . "eS19" . "S19" . . . . . . . . . "S20" . "uS10" . . . . . . . . "CP115" . "CP94" . "Filensin" . "LIFL-H" . . . . . . . "eS24" . "S24" . . . . . . . . "40S ribosomal protein S26" . "eS26" . "S26" . . . . . . . . "metallopanstimulin 1" . "MPS-1" . "MPS1" . "S27" . . . . . . . . "40S ribosomal protein S28" . "eS28" . "S28" . . . . . . . . "S29" . "uS14" . . . . . . . . . . "CP47" . "CP49" . "LIFL-L" . "phakinin" . . . . . . . . . . "HU-3" . "RSK" . "RSK2" . . . . . . . . . "eS7" . "S7" . . . . . . . . . "Oncogene RRAS" . "R-Ras" . . . . . . . . "hindsight homolog (drosophila)" . "HNT" . . . . . . . . "biglycan proteoglycan" . "DSPG1" . "SLRR1A" . . . . . . . . "XLRS1" . . . . . . . "CLIP" . "CLIP-170" . "CLIP170" . "CYLN1" . "restin" . . . . . . . . "Neuroendocrine-specific protein-like 1" . "NSP2" . "NSPL1" . "NSP-like protein 1" . . . . . . . . . . . "aml1 oncogene" . "AMLCR1" . "PEBP2A2" . . . . . . . . . "AML3" . "PEBP2A1" . "PEBP2aA1" . . . . . . . . . . . . . . . . . . "PPP1R137" . "protein phosphatase 1, regulatory subunit 137" . "RYR" . . . . . . . . . . . . "ARVC2" . "VTSIP" . . . . . . . . . "PIG4" . "TP53I4" . . . . . . . . "ARSACS" . "DKFZp686B15167" . "DNAJC29" . "KIAA0730" . "PPP1R138" . "protein phosphatase 1, regulatory subunit 138" . "SPAX6" . . . . . . . . . "ARRESTIN" . "arrestin 1" . "rod arrestin" . "RP47" . . . . . . . . "Hsal1" . "ZNF794" . . . . . . . . . . . . . . "Hsal2" . "KIAA0360" . "ZNF795" . . . . . . . . . "AMPH2" . "amphiphysin II" . "SH3P9" . . . . . . . . . . . . . . . "SDH" . . . . . . . . "serine tRNA ligase 1, cytoplasmic" . "SERS" . . . . . . . . "diamine N-acetyltransferase 1" . "SSAT" . . . . . . . . . . . . . . "DENND7A" . "DENN/MADD domain containing 7A" . "MTMR5" . "myotubularin related 5" . . . . . . . . "DESP4" . "ERG25" . . . . . . . "delta(7)-sterol 5(6)-desaturase" . "lathosterol oxidase" . . . . . . . . "ATX1" . "D6S504E" . . . . . . . . "E46L" . "FLJ37990" . . . . . . . . . "ATX2" . "trinucleotide repeat containing 13" . . . . . . . . "ADCAII" . "OPCA3" . "SGF73" . . . . . . . . "NCRNA00003" . "non-protein coding RNA 3" . . . . . . . . "MGC10442" . . . . . . . . . . . . . . "hPN3" . "Nav1.8" . "PN3" . "SNS" . . . . . . . . . . . . . . "NaN" . "Nav1.9" . "SNS-2" . . . . . . . . . . . . . . "GEFSP2" . "HBSCI" . "NAC1" . "Nav1.1" . "SMEI" . . . . . . . . . . . . . . . . . . . . . . . . . . . "HBSCI" . "HBSCII" . "Nav1.2" . . . . . . . . . . . . . . . . . "BS" . "RECQ2" . "RECQL3" . . . . . . . . "Nav1.3" . . . . . . . . . . . . . . . "HYPP" . "Nav1.4" . "SkM1" . . . . . . . . . . "LQT10" . . . . . . . . . . . . . . . "CDCD2" . "CMPD2" . "HB1" . "HB2" . "HBBD" . "HH1" . "ICCD" . "IVF" . "long QT syndrome 3" . "LQT3" . "Nav1.5" . "PFHB1" . "SSS1" . . . . . . . . . . . "CerIII" . "CIAT" . "NaCh6" . "Nav1.6" . "PN4" . . . . . . . . . . . . . . . "ETHA" . "Nav1.7" . "NE-NA" . "NENA" . "PN1" . . . . . . . . . . . . "amiloride-sensitive sodium channel subunit alpha" . "ENaCalpha" . . . . . . . . . "KIAA1592" . . . . . . . . . . "amiloride-sensitive sodium channel subunit beta" . "ENaCbeta" . "Liddle syndrome" . . . . . . . . . . . "amiloride-sensitive sodium channel subunit gamma" . "ENaCgamma" . "SCNEG" . . . . . . . . . . . . . . . . . . . "SCO1L" . . . . . . . . . . . . . . . . . . . . . . . "ARS-interacting multifunctional protein 1" . "EMAP-2" . "EMAP II" . "EMAPII" . "p43" . . . . . . . . "NY-CO-10" . "SDCCAG-10" . . . . . "NY-CO-33" . "TSH1" . . . . . . . . "Bardet-Biedl syndrome 16" . "BBS16" . "CCCAP" . "centrosomal colon cancer autoantigen protein" . "nephrocystin 10" . "NPHP10" . "NY-CO-8" . "Senior-Loken syndrome 7" . "SLSN7" . . . . . . . . . "BMP-1" . "tolloid-like" . . . . . . . . . . . . . "flavoprotein subunit of complex II" . "FP" . "SDHF" . "succinate dehydrogenase [ubiquinone] flavoprotein subunit" . . . . . . . . . . . . . "iron-sulfur subunit of complex II" . "succinate dehydrogenase [ubiquinone] iron-sulfur subunit" . . . . . . . . . . . "CYB560" . "cybL" . "large subunit of cytochrome b" . "succinate dehydrgenase cytochrome b" . "succinate dehydrogenase cytochrome b560 subunit" . . . . . . . . . . . . . "cybS" . "small subunit of cytochrome b" . . . . . . . . . "GDF9B" . . . . . . . . . . . . . . . . . . . . . . . . "CDA-II" . "CDAII" . "HEMPAS" . . . . . . . . "KIAA0079" . . . . . . . . . "KIAA0755" . . . . . . . . "hSBP" . "hSP56" . "LPSB" . "methanethiol oxidase" . . . . . . . . . . . . . . . . . "Coll-1" . "Hsema-I" . "SEMA1" . "Sema III" . "SemD" . . . . . . . . "SemE" . . . . . . . "coll-2" . "Sema-Z2" . . . . . . . "coll-5" . "KIAA0331" . "M-sema H" . "M-SemaK" . . . . . . . . . . "CORD10" . "FLJ12287" . "SemB" . . . . . . . . "semF" . . . . . . . . "VGR1" . . . . . . . . "2PP2A" . "chromatin remodelling factor" . "HLA-DR-associated protein II" . "IGAAD" . "inhibitor of granzyme A-activated DNase" . "IPP2A2" . "PHAPII" . "protein phosphatase type 2A inhibitor" . "TAF-I" . "TAF-IBETA" . "Template-Activating Factor-I" . "Template-Activating Factor-I, chromatin remodelling factor" . . . . . . . . . "Hsh155" . "Prp10" . "PRPF10" . "SAP155" . "SF3b155" . . . . . . . . . . . "ALK3" . "CD292" . . . . . . . . . . "Hsh49" . "SAP49" . "SF3b49" . . . . . . . . "Polypyrimidine tract binding protein associated" . "PPP1R140" . "protein phosphatase 1, regulatory subunit 140" . "PSF" . . . . . . . . "FRP-4" . "frpHE" . "FRPHE" . "FRZB-2" . . . . . . . . . . . "ALK6" . "CDw293" . . . . . . . . . . . "PR264" . "SC-35" . "SC35" . "SFRS2A" . "SR splicing factor 2" . . . . . . . . . . "BMPR3" . "BMPR-II" . "BRK-3" . "T-ALK" . . . . . . . . . "COLEC4" . "SP-A" . "SP-A1" . "surfactant, pulmonary-associated protein A1A" . . . . . . . . "COLEC5" . "SP-A2" . "surfactant, pulmonary-associated protein A2A" . . . . . . . . . "SP-B" . . . . . . . . . . . "BRICD6" . "BRICHOS domain containing 6" . "PSP-C" . "SMDP2" . "SP-C" . . . . . . . . "50kD DAG" . "A2" . "adhalin" . "DMDA2" . "LGMD2D" . "limb girdle muscular dystrophy 2D" . "SCARMD1" . . . . . . . "A3b" . "SGC" . . . . . . . . . "CMD1L" . "DAGD" . "LGMD2F" . . . . . . . . . . . . . "35kD dystrophin-associated glycoprotein" . "A4" . "DAGA4" . "DMDA" . "gamma sarcoglycan" . "limb girdle muscular dystrophy 2C (Duchenne-like muscular dystrophy, autosomal recessive)" . "Maghrebian myopathy (autosomal recessive)" . "MGC130048" . "SCARMD2" . "SCG3" . "TYPE" . . . . . . . . "SPL" . . . . . . . . . "HSS" . "MPS3A" . "mucopolysaccharidosis type IIIA" . "SFMD" . "sulfamidase" . . . . . . . . "HsT19447" . . . . . . "DSHP" . "Duncan's disease" . "EBVS" . "MTCP1" . "SAP" . "XLP" . "XLPD" . . . . . . . . "CRBM" . "RES4-23" . . . . . . . . "deleted in split-hand/foot 1" . "DSS1" . "ECD" . "FLJ42280" . "Shfdg1" . "SHSF1" . . . . . . . . . . . . . . . . . . . . . . . "HHG1" . "MCOPCB5" . "SMMCI" . "TPT" . "TPTPS" . . . . . . . . . . "GCFX" . "PHOG" . "SHOXY" . "SS" . . . . . . . "alpha-glucosidase" . "Alpha-methylglucosidase" . "Oligo-1,6-glucosidase" . "Oligosaccharide alpha-1,6-glucosidase" . . . . . . . . . "ST3Gal III" . . . . . . . . "SIATGM3S" . "ST3GalV" . . . . . . . . . . . "MCPH7" . . . . . . . . . . "bHLHe14" . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . "Six9" . . . . . . . "SKD1B" . "VPS4-2" . . . . . . . . . . . . . . . . "170A" . "DDX13" . "HLP" . "SKI2W" . "SKIV2L1" . . . . . . . . . . . . . . . . . "natural resistance-associated macrophage protein 1" . . . . . . . . . "DCT1" . "DMT1" . . . . . . . . . . "ferroportin 1" . "FPN1" . "HFE4" . "IREG1" . "MTP1" . . . . . . . . . . "BP240" . "BPA" . "CATX-15" . "FLJ13425" . "FLJ21489" . "FLJ30627" . "FLJ32235" . "KIAA0728" . "MACF2" . . . . . . . . "NKCC2" . . . . . . . . . . "basolateral Na-K-Cl symporter" . "BSC" . "BSC2" . "bumetanide-sensitive sodium-(potassium)-chloride cotransporter 1" . "NKCC1" . "PPP1R141" . "protein phosphatase 1, regulatory subunit 141" . . . . . . . . "NCCT" . . . . . . . . . . . . . . . . . . . "MCT" . "MCT1" . . . . . . . . . "MCT7" . "MCT8" . "XPCT" . . . . . . . . . . . . . "BPES1" . . . . . . . . . . "AST" . "ISSD" . "NSD" . "SD" . "SIALIN" . "SLD" . . . . . . . . . "SVAT" . "SVMT" . . . . . . . . . . "VACHT" . . . . . . . . . "THTR1" . . . . . . . . . . "EAAC1" . "EAAT3" . . . . . . . . . . . . . . . . "EAAT2" . "GLT-1" . . . . . . . . . . "EA6" . "EAAT1" . "GLAST" . "glutamate transporter variant EAAT1ex9skip" . . . . . . . . . "alanine/serine/cysteine/threonine transporter" . "ASCT1" . "SATT" . . . . . . . . . "Glvr-2" . "PiT-2" . "Ram-1" . . . . . . . . . . "OATP2A1" . "PGT" . . . . . . . . . "LST-1" . "OATP1B1" . "OATP-C" . . . . . . . . . "OATP1B3" . "OATP8" . . . . . . . . . . "BWR1A" . "ITM" . "TSSC5" . . . . . . . . . "OCTN2" . "SCD" . . . . . . . . . "CSNB1D" . "HsT17412" . "KIAA0702" . "NCKX" . "NCKX1" . "RODX" . . . . . . . . . . "NCKX4" . . . . . . . . . . "CTP" . . . . . . . . . . . . . . . . . . "BRAF1" . . . . . . . . . "OGC" . . . . . . . . . "Aralar" . . . . . . . . . . "ARALAR2" . "CITRIN" . "mitochondrial aspartate glutamate carrier 2" . . . . . . . . . "D13S327" . "ORC1" . "ornithine transporter 1" . . . . . . . . . . . . . . . . . . "T1" . . . . . . . . . . . . "DTDST" . . . . . . . . . "ACSVL4" . "FATP4" . . . . . . . . . "ACSB" . "ACSVL6" . "FACVL3" . "FATP5" . "fatty-acid-Coenzyme A ligase, very long-chain 3" . "FLJ22987" . "VLACSR" . "VLCS-H2" . "VLCSH2" . . . . . . . . . . . . . . . "DYT18" . "DYT9" . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . "BRCA1/BRCA2-containing complex, subunit 1" . "BRCC1" . "Fanconi anemia, complementation group S" . "FANCS" . "PPP1R53" . "protein phosphatase 1, regulatory subunit 53" . "RNF53" . . . . . . . . . . "Na+-phosphate cotransporter type II" . "NAPI-3" . "NPTIIa" . "SLC11" . "sodium/phosphate co-transporter" . "solute carrier family 17 (sodium phosphate), member 2" . . . . . . . . . . . . . . . . "BRCA1/BRCA2-containing complex, subunit 2" . "BRCC2" . "FAD" . "FAD1" . "XRCC11" . . . . . . . . "NAPI-3B" . . . . . . . . . "CMPST" . "hCST" . . . . . . . . . . "UGAT" . "UGT" . "UGT1" . "UGT2" . "UGTL" . . . . . . . . . . . . . . . . . . . . "ATR1" . "CSNU1" . "D2H" . "NBAT" . "RBAT" . . . . . . . . . . . . . . "CD233" . "FR" . "Froese blood group" . "RTA1A" . "SW" . "Swann blood group" . "WR" . "Wright blood group" . . . . . . . . . "hhNMC" . "HNBC1" . "NBC1" . "NBC2" . "pNBC" . . . . . . . . . "D22S675" . "NAGT" . "sodium/glucose cotransporter 1" . . . . . . . . . . . . . . . . . "NIS" . . . . . . . . . "GABATHG" . "GABATR" . "GABA transporter 1" . "GAT1" . . . . . . . . . . . . . . . . . "NET" . "norepinephrine transporter" . . . . . . . . . "DAT" . "dopamine transporter" . . . . . . . . . "glycine transporter 2" . "GLYT2" . . . . . . . . . "creatine transporter" . "CRTR" . "CT1" . . . . . . . . . . "GLYT1" . . . . . . . . . "y+LAT-1" . . . . . . . . . . . . . . . . . "PPP1R143" . "protein phosphatase 1, regulatory subunit 143" . . . . . . . . . . . . . . . . . . "EBP50" . "NHERF" . "NHERF1" . . . . . . . . "KIAA0267" . "NHE6" . . . . . . . . . . "SLUGH" . "SLUGH1" . "SNAIL2" . . . . . . . . . "BAF190" . "brahma homolog" . "BRM" . "hBRM" . "hSNF2a" . "SNF2" . "SNF2LA" . "Sth1p" . "SWI2" . . . . . . . . . . . . "ATP-dependent helicase SMARCA4" . "BAF190" . "brahma protein-like 1" . "BRG1" . "BRM/SWI2-related gene 1" . "FLJ39786" . "global transcription activator homologous sequence" . "homeotic gene regulator" . "hSNF2b" . "mitotic growth and transcription activator" . "nuclear protein GRB1" . "SNF2" . "SNF2-BETA" . "SNF2LB" . "SNF2-like 4" . "sucrose nonfermenting-like 4" . "SWI2" . . . . . . . . . "hISWI" . "hSNF2H" . "ISWI" . . . . . . . . "ATP-driven annealing helicase" . "HARP" . "HepA-related protein" . "HHARP" . . . . . . . . . . . . "BAF47" . "hSNFS" . "Ini1" . "integrase interactor 1" . "malignant rhabdoid tumor suppressor" . "PPP1R144" . "protein phosphatase 1, regulatory subunit 144" . "RDT" . "Sfh1p" . "SNF5" . "Snr1" . "sucrose nonfermenting, yeast, homolog-like 1" . . . . . . . . "BAF170" . "CRACC2" . "Rsc8" . . . . . . . . "BAF60A" . "CRACD1" . "Rsc6p" . . . . . . . . "BAF60B" . "chromatin remodeling complex BAF60B subunit" . "CRACD2" . "mammalian chromatin remodeling complex BRG1-associated factor 60B" . "PRO2451" . "Rsc6p" . "SWI/SNF complex 60 kDa subunit B" . "Swp73-like protein" . . . . . . . . . . "BAF57" . . . . . . . . "B120" . "BAF250" . "BAF250a" . "C10rf4" . "P270" . . . . . . . . . . "DXS423E" . "KIAA0178" . "SB1.8" . "Smcb" . . . . . . . . "DXS1272E" . "XE169" . . . . . . . . . . . . "BCD541" . "gemin-1" . "GEMIN1" . "SMA1" . "SMA2" . "SMA3" . "SMNT" . "TDRD16A" . "tudor domain containing 16A" . . . . . . . . . . . "BCD541" . "GEMIN1" . "SMNC" . "TDRD16B" . "tudor domain containing 16B" . . . . . . . . . . "frizzled family member 11" . "FZD11" . . . . . . . . . . "acid sphingomyelinase" . "ASM" . . . . . . . . . "DFNX4" . . . . . . . "MRSR" . "SPMSY" . "SpS" . . . . . . . . "bA416N4.2" . "dJ1068F16.2" . "resistance to inhibitors of cholinesterase 4 homolog" . "RIC-4" . "RIC4" . "SEC9" . "SNAP-25" . . . . . . . . "CEDNIK" . "SNAP-29" . "soluble 29 kDa NSF attachment protein" . . . . . . . . . . . "α-synuclein" . "alpha-synuclein" . "NACP" . "non A4 component of amyloid precursor" . "PD1" . . . . . . . . "β-synuclein" . . . . . . . . . . "msk" . "myocardial SNF1-like kinase" . . . . . . . . . "COD" . "Sm-B/B'" . "SmB/SmB'" . "snRNP-B" . . . . . . . . "Sm-E" . . . . . . . . . . . . . "HCERN3" . "RT-LI" . "small nuclear ribonucleoprotein N" . "SM-D" . "SMN" . "SM protein N" . "SNRNP-N" . "SNURF-SNRPN" . "tissue-specific splicing protein" . . . . . . . . "dystrophin-associated protein A1, 59kDa, acidic component" . "LQT12" . "pro-TGF-alpha cytoplasmic domain-interacting protein 1" . "TACIP1" . . . . . . . . "IPOA" . . . . . . . . "BASS1" . "Bax antagonist selected in Saccharomyces 1" . "DBP-5" . "FLJ21099" . "FLJ33914" . "KIAA1019" . "negative regulatory element-binding protein" . "NRE-binding protein" . "NREBP" . . . . . . . . "gp250" . "LDLR relative with 11 ligand-binding repeats" . "LR11" . "LRP9" . "SorLA" . "SorLA-1" . . . . . . . . . "GF1" . "HGF" . . . . . . . . . . . . . . . . . . . "DOM" . "dominant megacolon, mouse, human homolog of" . "WS2E" . "WS4" . . . . . . . . "SRY-related HMG-box gene 11" . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . "L-SOX5" . "MGC35153" . . . . . . . . . . . . . "SRA1" . . . . . . . . "CILD28" . "CT140" . "FLJ32920" . "HSD-3.8" . "SP75" . "TPIS" . . . . . . . "cysteine-rich protein" . "secreted protein acidic and rich in cysteine" . . . . . . . . . . "FLJ21439" . "spatacsin" . . . . . . . . . . . . . . . "AD-FSP" . "atlastin" . "FSP1" . . . . . . . . "ADPSP" . "FSP2" . "KIAA1083" . . . . . . . . "CAR" . "paraplegin" . "SPG5C" . . . . . . . . "SPI-B" . . . . . . . . . "PCTT" . "PSTI" . "Spink3" . "TATI" . . . . . . . "HAI-2" . "Kop" . "placental bikunin" . . . . . . . . . "BSPI" . "Early T-lymphocyte activation 1" . "ETA-1" . . . . . . . . "SDR38C1" . "Sepiapterin reductase (L-erythro-7,8-dihydrobiopterin forming)" . "short chain dehydrogenase/reductase family 38C, member 1" . . . . . . . . . . "EL2" . "elliptocytosis 2" . . . . . . . . "alpha-fodrin" . . . . . . . . . "spherocytosis, clinical type I" . . . . . . . . . . . . . . . . "hLCB1" . "HSAN1" . "LCB1" . "SPTI" . . . . . . . . . "hLCB2a" . "KIAA0526" . "LCB2" . "LCB2A" . . . . . . . . . . . . . "A170" . "autophagy receptor p62" . "p60" . "p62" . "p62B" . . . . . . . . "ASV" . "c-src" . . . . . . . . . . "3-oxo-5-alpha-steroid 4-dehydrogenase 2" . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . "TDF" . "testis-determining factor" . . . . . . . . "mtSSB" . "SSBP" . . . . . . . . "translocon-associated protein delta" . "TRAPD" . . . . . . . . "cancer/testis antigen family 5, member 1" . "CT5.1" . . . . . . . "cancer/testis antigen family 5, member 2a" . "CT5.2a" . "HD21" . "HOM-MEL-40" . "MGC119055" . "MGC15364" . "MGC3884" . "sarcoma, synovial, X-chromosome-related 2" . "synovial sarcoma, X breakpoint 2B" . "synovial sarcoma, X breakpoint 2, isoform b" . . . . . . . . . "ATK" . "Bruton's tyrosine kinase" . "PSCTK1" . "XLA" . . . . . . . . . "SYT" . . . . . . . "epithin" . "HAI" . "matriptase" . "MT-SP1" . "SNC19" . "TMPRSS14" . . . . . . . . . "cohesin subunit SA-1" . "SA-1" . "SA1" . "SCC3A" . . . . . . . . . . "SA-2" . "SA2" . "SCC3B" . . . . . . . . . . . . . . . . . "StAR" . "STARD1" . "StAR related lipid transfer (START) domain containing 1" . . . . . . . . . . "ISGF-3" . "STAT91" . "transcription factor ISGF-3 components p91/p84" . . . . . . . . "STAT113" . . . . . . . . . . . . . "APRF" . . . . . . . . . . . . . . . . . . . . . . . . . . . . "D12S1644" . "IL-4-STAT" . . . . . . . . . . . "D11S4896E" . "GOK" . . . . . . . . "LKB1" . "PJS" . "polarization-related protein LKB1" . . . . . . . . . "ARK3" . "AurC" . . . . . . . . . . "Sak" . . . . . . . . . "PEN11B" . "serine/threonine kinase 29" . . . . . . . . "Kinase responsive to stress 2" . "KRS2" . "Mammalian sterile 20-like 1" . "MST1" . "Yeast Ste20-like" . "YSK3" . . . . . . . . . . . . "CFAP247" . "EIEE2" . . . . . . . . . . "ARSC" . "arylsulfatase C" . "steryl-sulfatase" . . . . . . . . "CHIP" . "HSPABP2" . "NY-CO-7" . "SDCCAG7" . "UBOX1" . . . . . . . . . . . . . . . "BTL-II" . "BTN7" . "HSBLMHC1" . . . . . . . . "hsyn16" . "SYN16" . . . . . . . . . "HPC-1" . "p35-1" . . . . . . . . . . . . . . . . . . . . . . "hUNC18" . "MUNC18-1" . "rbSec1" . "syntaxin-binding protein 1" . "UNC18" . . . . . . . . "Hunc18b" . "MUNC18-2" . "UNC18B" . . . . . . . . "succinate--CoA ligase (ADP-forming)" . . . . . . . . . . . . . . . "betaTrCP" . "beta-TrCP1" . "bTrCP" . "bTrCP1" . "FBXW1A" . "Fwd1" . . . . . . . . "HSST2" . . . . . . . . . . . . . . . . . "surfeit locus protein 1" . . . . . . . . "TI-VAMP" . "VAMP-7" . . . . . . . . "BUB1A" . "hBUB1" . . . . . . . . . "Synapsin-1" . . . . . . . . . . . "KIAA1938" . "RASA5" . "SYNGAP" . . . . . . . . "Bub1A" . "BUBR1" . "MAD3L" . "SSK1" . . . . . . . . . . . "inositol polyphosphate-5-phosphatase G" . "INPP5G" . "PARK20" . "phosphoinositide 5-phosphatase" . "synaptic inositol 1,4,5-trisphosphate 5-phosphatase 1" . . . . . . . . . "MRX96" . . . . . . . . "P65" . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . "BUB3L" . . . . . . . . "NKB" . "preprotachykinin-B" . "ZNEUROK1" . . . . . . . . . . . . . . . . "ERIC1" . . . . . . . . "neurokinin beta receptor" . "neurokinin B receptor" . "neuromedin-K receptor" . "NK3" . "NK3R" . "NKR" . "TAC3R" . . . . . . . . . . "17-1A" . "323/A3" . "CD326" . "CO-17A" . "EGP-2" . "EGP34" . "EGP40" . "Ep-CAM" . "ESA" . "GA733-2" . "HEA125" . "KS1/4" . "KSA" . "Ly74" . "MH99" . "MK-1" . "MOC31" . "TACST-1" . "TROP1" . . . . . . . . "HBVES" . "POP1" . "POPDC1" . "popeye domain containing 1" . . . . . . . "EGP-1" . "epithelial glycoprotein-1" . "GA733-1" . "TROP2" . . . . . . . . "SL1" . "TAFI48" . . . . . . . . . "DYT3/TAF1" . "KAT4" . "NSCL2" . "TAFII250" . . . . . . . . . "CIF150" . "TAFII150" . . . . . . . . "TAFII105" . "TATA box binding protein (TBP)-associated factor 4B" . . . . . . . . "TAFII18" . "Transcription initiation factor TFIID subunit 13" . . . . . . . . . "hTAFII68" . "Npl3" . "RBP56" . . . . . . . . "BRF" . "hBRF" . "TFIIIB90" . . . . . . . . "bHLHa17" . "SCL" . . . . . . . . . . . . . . . "TAPA" . "tapasin" . . . . . . . . . "ALS10" . "TDP-43" . . . . . . . . "threonine tRNA ligase 1, cytoplasmic" . . . . . . . . . . . . . . . . "Barth syndrome" . "BTHS" . "G4.5" . "TAZ1" . "transcriptional coactivator with PDZ-binding motif" . "XAP-2" . . . . . . . . . . . . . . . . . "KCS1" . "pac2" . . . . . . . . "alpha-1 antiproteinase, antitrypsin" . "thyroxin-binding globulin" . "thyroxine-binding globulin" . . . . . . . . . "NAK" . . . . . . . . . "DKFZP43N024" . "WBSCR13" . "Williams-Beuren syndrome chromosome region 13" . "WS-betaTRP" . . . . . . . "TFIID" . . . . . . . . . . . . . . . . . . "CATCH22" . . . . . . . . . . . . . . "dj747L4.1" . "TBS 19" . "TPIT" . . . . . . . . . . . . . . . . . . . . . . "TBX3-ISO" . "XHL" . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . "CYP5" . "CYP5A1" . "cytochrome P450, family 5, subfamily A, polypeptide 1" . "THAS" . "TS" . "TXAS" . "TXS" . . . . . . . . . . . . . "FLJ21832" . "PEO" . "PEO1" . "T7 helicase-related protein with intramitochondrial nucleoid localization" . "TWINKLE" . "TWINL" . . . . . . . . . . "19 kDa sarcomeric protein" . "CMD1N" . "T-cap" . "TELE" . "telethonin" . "teneurin C-terminal associated peptide" . . . . . . . . "cancer/testis antigen 111" . "CT111" . "FLJ10540" . . . . . . . . . . . "HNF1" . "LFB1" . . . . . . . . . . "bHLHb20" . "HEB" . "Helix-loop-helix transcription factor 4" . "HsT17266" . "HTF4" . "p64" . . . . . . . . . . . . . . . . "HNF1beta" . "LFB3" . "MODY5" . "VHNF1" . . . . . . . . "AR1" . "SPBP" . "stromelysin-1 platelet-derived growth factor-responsive element binding protein" . . . . . . . . "bHLHb21" . "E2A" . "E2A immunoglobulin enhancer-binding factor E12/E47" . "E47" . "immunoglobulin transcription factor 1" . "ITF1" . "kappa-E2-binding factor" . "MGC129647" . "MGC129648" . "p75" . "transcription factor E2-alpha" . "VDIR" . "VDR interacting repressor" . . . . . . . . . . . . "bHLHb19" . "class B basic helix-loop-helix protein 19" . "E2-2" . "immunoglobulin transcription factor 2" . "ITF2" . "SEF2-1B" . "SL3-3 enhancer factor 2" . . . . . . . . . "AREB6" . "BZP" . "FECD6" . "NIL-2-A" . "ZEB" . "Zfhep" . "Zfhx1a" . . . . . . . . "bHLHd13" . "MAD7" . "MXD7" . . . . . . . . . . . "a3" . "Atp6i" . "ATP6N1C" . "ATP6V0A3" . "OC-116" . "OC116" . "T-cell immune response cDNA 7" . "TIRC7" . . . . . . . . . "TCL1" . . . . . . . . "D22S676" . "D22S750" . "macrocytic anemia" . "TC2" . . . . . . . . "TCS" . "treacle" . . . . . . . . . . . . . "CR" . "CR-1" . "CRIPTO" . "Cripto-1" . . . . . . . . "TDO" . "TPH2" . . . . . . . . . "TEF-1" . "transcriptional enhancer factor 1" . . . . . . . . . . . . . . . . . . "angiopoietin-1 receptor" . "CD202b" . "TIE-2" . "TIE2" . "VMCM1" . . . . . . . . . . . "hTR" . "SCARNA19" . "small Cajal body-specific RNA 19" . "TR" . "TRC3" . . . . . . . . . . . . . "EST2" . "hEST2" . "TCS1" . "TP2" . "TRT" . . . . . . . . "TGC1" . "TSGA3" . . . . . . . . "cancer/testis antigen 113" . "CT113" . . . . . . . "cancer/testis antigen 42" . "CT42" . . . . . . . . "PRO1557" . "PRO2086" . "serotransferrin" . . . . . . . . "AP-2" . . . . . . . . . "AP2-B" . . . . . . . . . . "bHLHe33" . "TFEA" . "transcription factor E family, member A" . . . . . . . . "bHLHe35" . "TCFEB" . . . . . . . . . . . "FLJ36137" . "SPG57" . "TF6" . . . . . . . . "HFE3" . "TFRC2" . . . . . . . . "CD71" . "p90" . "TFR1" . . . . . . . . "AITD3" . "TGN" . . . . . . . . . . . . . . . . . "Camurati-Engelmann disease" . "CED" . "prepro-transforming growth factor beta-1" . "TGFbeta" . . . . . . . . "prepro-transforming growth factor beta-2" . . . . . . . . . . . "prepro-transforming growth factor beta-3" . . . . . . . . . . . . . "BIGH3" . "CDB1" . "CDGG1" . . . . . . . . . . "activin A receptor type II-like kinase, 53kDa" . "ACVRLK4" . "ALK-5" . "ALK5" . "TBR-i" . "TBRI" . . . . . . . . . . . . . "TBR-ii" . "TBRII" . . . . . . . . . "betaglycan" . "betaglycan proteoglycan" . "BGCAN" . . . . . . . . . . . . . . . . . . . . . . . . "K polypeptide epidermal type I, protein-glutamine-gamma-glutamyltransferase" . "LI" . "LI1" . "TGASE" . "TGK" . . . . . . . . "E polypeptide, protein-glutamine-gamma-glutamyltransferase" . "TGE" . . . . . . . "protein-glutamine gamma-glutamyltransferase 5" . "TGMX" . "TGX" . . . . . . . . "DYT5b" . "tyrosine 3-monooxygenase" . . . . . . . . . . "CD141" . . . . . . . . . . . "c-mpl ligand" . "megakaryocyte colony-stimulating factor" . "megakaryocyte growth and development factor" . "megakaryocyte stimulating factor" . "MPLLG" . "MPL ligand" . "myeloproliferative leukemia virus oncogene ligand" . "prepro-thrombopoietin" . "thrombopoietin nirs variant 1" . "TPO" . . . . . . . . "AR7" . "EAR-7.1/EAR-7.2" . "ERBA" . "NR1A1" . "THRA3" . . . . . . . . . "avian erythroblastic leukemia viral (v-erb-a) oncogene homolog 2" . "ERBA-BETA" . "generalized resistance to thyroid hormone" . "GRTH" . "NR1A2" . "oncogene ERBA2" . "THR1" . "THRB1" . "THRB2" . "thyroid hormone receptor beta 1" . . . . . . . . . . "Nucleolysin TIA-1 isoform p40" . "T-cell-restricted intracellular antigen-1" . . . . . . . . "MODY7" . "Tieg3" . . . . . . . "hTIF1" . "RNF82" . "Tif1a" . . . . . . . . . "DDP" . "MTS" . . . . . . . . . . . . . . . . . "TIN2" . . . . . . . . . . . "TTF-1" . "TTF1" . . . . . . . . . . "Friedreich ataxia region gene X104 (tight junction protein ZO-2)" . "X104" . "ZO-2" . "ZO2" . "zona occludens 2" . . . . . . . . . "mitochondrial thymidine kinase" . "SCA31" . . . . . . . . "Wernicke-Korsakoff syndrome" . . . . . . . . . . . . . . . . "CD283" . . . . . . . . . . . . . . . "ARMD10" . "CD284" . "hToll" . "TLR-4" . . . . . . . . . "A15" . "CD231" . "DXS1692E" . "TALLA-1" . . . . . . . . "LAP2" . "LEMD4" . "LEM domain containing 4" . "TP" . . . . . . . . . . . . . . "Membrane-type serine protease 2" . "MT-SP2" . "TMPRSS3" . "Transmembrane serine protease 3" . "Type II membrane serine protease" . . . . . . . . "DIF" . "TNF-alpha" . "TNFSF2" . "TNF superfamily, member 2" . . . . . . . . . . "A20" . "OTUD7C" . . . . . . . . . "aconitate hydratase, mitochondrial" . "ACONM" . "mitochondrial aconitase" . . . . . . . . . . . . . . "CD262" . "DR5" . "KILLER" . "TRAIL-R2" . "TRAILR2" . "TRICK2A" . "TRICKB" . . . . . . . . . . . . . . "CD265" . "FEO" . "RANK" . . . . . . . . . . "OCIF" . "TR1" . . . . . . . . . . . "CD120a" . "TNFAR" . "TNF-R" . "TNF-R55" . "TNFR60" . "TNF-R-I" . . . . . . . . . . "CD120b" . "p75" . "TNFBR" . "TNF-R75" . "TNFR80" . "TNF-R-II" . . . . . . . . . "ACT35" . "CD134" . "OX40" . . . . . . . . . "Bp50" . "p50" . . . . . . . . . . . . "APO-1" . "CD95" . "TNF receptor superfamily member 6" . . . . . . . . . "S152" . "Tp55" . . . . . . . . . "CD254" . "ODF" . "OPGL" . "RANKL" . "TRANCE" . . . . . . . . . "APO3L" . "DR3LG" . "TWEAK" . . . . . . . . "MGC129934" . "MGC129935" . "TL1" . "TL1A" . "TNF ligand-related molecule 1" . "TNF superfamily ligand TL1A" . "Vascular endothelial cell growth inhibitor" . "Vascular endothelial growth inhibitor-192A" . "VEGI" . "VEGI192A" . . . . . . . . . "CD252" . "gp34" . "OX-40L" . . . . . . . . "CD154" . "CD40 antigen ligand" . "CD40L" . "gp39" . "hCD40L" . "hyper-IgM syndrome" . "T-B cell-activating molecule" . "TNF-related activation protein" . "TRAP" . "tumor necrosis factor (ligand) superfamily member 5" . . . . . . . . "CD178" . "FasL" . . . . . . . . "CD27L" . . . . . . . . . . . . . . . . . "DA2B" . "FSSV" . "troponin I fast twitch 2" . "troponin I, fast-twitch skeletal muscle isoform" . . . . . . . . . . "CMH7" . "TNNC1" . . . . . . . . "ANM" . "FLJ98147" . "MGC104241" . "NEM5" . "nemaline myopathy type 5" . "slow skeletal muscle troponin T" . "STNT" . "TNT" . "TNTS" . "troponin T1, skeletal, slow" . . . . . . . . . . . "CMPD2" . . . . . . . . . "AMCD2B" . "DA2B" . "DKFZp779M2348" . "FSSV" . "troponin-T3, skeletal, fast" . . . . . . . . . . . "CAGH45" . "HOPA" . "KIAA0192" . "OKS" . "OPA1" . "TRAP230" . . . . . . . . "GYF2" . "GYF domain containing 2" . "KIAA0642" . . . . . . . "CAG4A" . . . . . . . . . "TNXBS" . "XB" . "XBS" . . . . . . . . . . . . . . . . . . . . . . . . . . . . "ZGRF7" . "zinc finger, GRF-type containing 7" . . . . . . . . . . . . . . . . . . . . . . "LFS1" . "Li-Fraumeni syndrome" . "P53" . . . . . . . . "PALMCOX" . "palmitoyl-CoA oxidase" . . . . . . . . "P73" . . . . . . . . . . . . . . . . . . . . . . . . . . . . . "DA1" . "NEM4" . "nemaline myopathy type 4" . . . . . . . . . . . . . "TRK" . . . . . . . . . . . . . . . . "TPX" . . . . . . . . . "TPPII" . . . . . . . . . . . . . . . . . . . . . . . . . . . "CAP-1" . "CD40bp" . "CRAF1" . "LAP1" . "RNF118" . . . . . . . . "RNF85" . . . . . . . . "T-cell antigen receptor, beta polypeptide, T-cell receptor, beta cluster" . . . . . . "TCRDV1" . . . . . . . . . . . . "alpha,alpha-trehalase" . "alpha,alpha-trehalose glucohydrolase" . "MGC129621" . "TRE" . "TREA" . . . . . . . . . . . "DRN3" . . . . . . . . . . . . "T-cell antigen receptor, gamma polypeptide" . "T-cell rearranging gene, gamma" . "T-cell receptor, gamma cluster" . . . . . . "angioedema, hereditary" . "C1IN" . "C1-INH" . "C1INH" . "C1-inhibitor" . "HAE1" . "HAE2" . "plasma protease C1 inhibitor" . . . . . . . . "prothyroliberin" . . . . . . . . . . . . . . . . "ARHGEF23" . . . . . . . . . . "CEV14" . "GMAP-210" . "GMAP210" . "golgi-microtubule-associated-protein of 210 kDa" . "Trip230" . . . . . . . . "KIAA0045" . . . . . . . . . "16E1BP" . "thyroid receptor interacting protein 13" . . . . . . . . . . . . . . . "Activating Signal Cointegrator-1" . "ASC-1" . "HsT17391" . "ZC2HC5" . "zinc finger, C2HC5-type" . . . . . . . . "DKFZp761F0118" . "FLJ14374" . "KDM3C" . "KIAA1380" . . . . . . . . . "HIFPH2" . "HIF prolyl hydroxylase 2" . "PHD2" . "SM-20" . "ZMYND6" . . . . . . . . . . . . . . . . . "TRP6" . . . . . . . . . . "GC79" . "LGCR" . . . . . . . "PAF400" . "Tra1" . "TR-AP" . . . . . . . . . . "hamartin" . "KIAA0243" . "LAM" . . . . . . . . . . . . . "LAM" . "PPP1R160" . "protein phosphatase 1, regulatory subunit 160" . "tuberin" . . . . . . . . "EF-TS" . "EF-Tsmt" . . . . . . . . . "DKFZp762H1311" . "FLJ22445" . "JBTS15" . . . . . . . . "CILD24" . "FLJ32753" . "Meichroacidin" . "RSP44" . "RSPH10A" . . . . . . . "thyrotropin subunit beta" . . . . . . . . . . . . "LGR3" . . . . . . . . . "cancer/testis antigen 78" . "CT78" . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . "CMH9" . "CMPD4" . "FLJ32040" . "LGMD2J" . "MYLK5" . "TMD" . . . . . . . . . . . . . . . . . . "CTS" . "HsT2651" . . . . . . . . . "rd5" . . . . . . . . . . . . . . . . . . . . . . "EFTu" . "EFTU" . "EF-TuMT" . . . . . . . . . "LCA15" . "TUBL1" . . . . . . . . . . . "bHLHa38" . "BPES2" . "CRS1" . "H-twist" . "Saethre-Chotzen syndrome" . "SCS" . . . . . . . . . . . . . . . . . "JTK1" . . . . . . . . . . . . . "OCA1" . "OCA1A" . "OCAIA" . "oculocutaneous albinism IA" . . . . . . . . . "DAP12" . "DNAX-activation protein 12" . "KARAP" . "killer activating receptor associated protein" . "PLO-SL" . . . . . . . . "b-PROTEIN" . "CATB" . "GP75" . "OCA3" . "TRP" . . . . . . . . . . . . . . . . . . . . . . "FLJ25987" . "MGC8385" . "polyubiquitin B" . . . . . . . . "CFAP124" . "POC20" . "POC20 centriolar protein homolog (Chlamydomonas)" . "UBA1, ubiquitin-activating enzyme E1 homolog (yeast)" . "UBE1X" . . . . . . . . . . . . . . . . . . "HHR6A" . "RAD6A" . "UBC2" . . . . . . . . . . . . . . . . . "UBCH7" . . . . . . . . . . . . . . . . . . . "ANCR" . "Angelman syndrome" . "AS" . "E6-AP" . "FLJ26981" . . . . . . . . "HPAP" . "human purple acid phosphatase" . "tartrate-resistant acid phosphatase" . "TRAP" . . . . . . . . . . . . "GMP1" . "OFC10" . "PIC1" . "SMT3C" . "SMT3H3" . "SUMO-1" . . . . . . . . "Chap1" . "CHAP1/DSK2" . "Dsk2" . "LIC-2" . "N4BP4" . "NEDD4 binding protein 4" . "PLIC-2" . "PLIC2" . "RIHFB2157" . . . . . . . . "NOR-90" . "UBF" . "UBF1" . "UBF2" . . . . . . . . . "PGP9.5" . "ubiquitin thiolesterase" . "Uch-L1" . . . . . . . . . "SLC25A8" . . . . . . . . . . . . . . . . . . . "UGT1A" . . . . . . . . . "Tamm-Horsfall glycoprotein" . "uromucoid" . . . . . . . . "orotate phosphoribosyl transferase and orotidine-5'-decarboxylase" . . . . . . . . . "HRG4" . "POC7" . "POC7A" . "POC7 centriolar protein homolog A (Chlamydomonas)" . . . . . . . . . "HIGM4" . "UDG" . "UNG1" . "UNG2" . "uracil-DNA glycosylase 1, uracil-DNA glycosylase 2" . . . . . . . . . . . . . . "cytochrome b-c1 complex subunit 7" . "QCR7" . "QP-C" . "ubiquinol-cytochrome c reductase, complex III subunit VI" . "UQCR6" . . . . . . . . "QCR2" . "UQCR2" . . . . . . . . "cytochrome b-c1 complex subunit 5" . "RIP1" . "RIS1" . "RISP" . "UQCR5" . . . . . . . . . . . . . . . . "congenital erythropoietic porphyria" . . . . . . . . . "AIE-75" . "harmonin" . "NY-CO-37" . "NY-CO-38" . "PDZ-73" . "PDZ73" . "PDZD7C" . . . . . . . . . . . "RP39" . . . . . . . . . . . . . . . "A2" . "leucine rich repeat containing 76" . "LRRC76" . "nuclear encoded mitochondrial protein" . "YF5" . . . . . . . "Ubl carboxyl-terminal hydrolase 18" . . . . . . . . "TBC1D3 and USP32 fusion" . "TRE17" . "Tre-2" . "Tre2" . "Tre-2 oncogene" . "ubiquitin carboxyl-terminal hydrolase 6" . . . . . . . . . . . . . . . "HumORF8" . "KIAA0055" . "SPG59" . "UBPY" . . . . . . . . . "DFFRX" . "FAF" . "MRX99" . . . . . . . . "DFFRY" . "fat facets-like homolog (Drosophila)" . . . . . . . . . . . . . . . . "VAMP-1" . . . . . . . . . "ALS8" . "VAP-B" . "VAP-C" . . . . . . . . "valine tRNA ligase 1, cytoplasmic" . . . . . . . . . "Metavinculin" . . . . . . . . . . . . . . . "CDC48" . "IBMPFD" . "p97" . "TERA" . "transitional endoplasmic reticulum ATPase" . . . . . . . . "1,25- dihydroxyvitamin D3 receptor" . "NR1I1" . "PPP1R163" . "protein phosphatase 1, regulatory subunit 163" . . . . . . . . . "vascular endothelial growth factor-related protein" . "VRP" . . . . . . . . . . . "VHL1" . . . . . . . . "MGC11251" . "TSP-EAR" . . . . . . . "cytovillin 2" . . . . . . . . . . . . . . . "CARMQ1" . "CHRMQ1" . "VLDLRCH" . . . . . . . . . . . . . . "BEST" . "Best disease" . "BMD" . "RP50" . . . . . . . . "FLJ14848" . . . . . . . . . . . . . . . . . "PPCD1" . "PPD" . . . . . . . . . . . . . . . . . . . "mtTrpRS" . "TrpRS" . "tryptophan tRNA ligase 2, mitochondrial" . . . . . . . . . . "eczema-thrombocytopenia" . "WASP" . "WASPA" . . . . . . . . "WIP" . . . . . . . . "GRAMD6" . "WBP-2" . . . . . . . . . . . . "bHLHd14" . "carbohydrate response element binding protein" . "CHREBP" . "MIO" . "MONDOB" . "WS-bHLH" . . . . . . . . . "TRM82" . "TRM82 tRNA methyltransferase 82 homolog (S. cerevisiae)" . "TRMT82" . . . . . . . . . . . "DIDMOAD" . "WFS" . . . . . . . . "FKHL20" . . . . . . . . . "KMT3G" . "MMSET" . "multiple myeloma SET domain containing protein" . . . . . . . . "NELF-A" . . . . . . . . "CCN6" . "WISP-3" . . . . . . . . . . . . . . . . . "SHFM6" . "WNT-12" . . . . . . . . "MGC131950" . "MGC138321" . "MGC138323" . "WNT-3 proto-oncogene protein" . . . . . . . . . "WNT-4" . . . . . . . . "hWNT5A" . "WNT-5A protein" . . . . . . . . . "proto-oncogene Wnt7a protein" . "Wnt-7a" . . . . . . . . "RECQ3" . "RECQL2" . . . . . . . . . . . . . . . . . "AWT1" . "NPHS4" . "WAGR" . "WIT-2" . . . . . . . . . . . "FOR" . "SDR41C1" . "short chain dehydrogenase/reductase family 41C, member 1" . "WOX1" . . . . . . . . "XO" . "XOR" . . . . . . . . . "Kx" . "Kx antigen" . "McLeod syndrome" . "X1k" . "XKR1" . . . . . . . . "XP1" . "XPAC" . . . . . . . . "RAD4" . "xeroderma pigmentosum group C protein" . "XPCC" . . . . . . . . . . . . . . . . "chromosome region maintenance 1 homolog (yeast)" . "CRM-1" . "CRM1" . "emb" . . . . . . . . . "SLC53A1" . "solute carrier family 53 (phosphate exporter), member 1" . "SYG1" . "X3" . . . . . . . . . . "FANCU" . "RAD51-like" . . . . . . . . . "DNA repair protein XRCC4" . "X-ray repair, complementing defective, repair in Chinese hamster" . . . . . . . . "tyrosine tRNA ligase 1, cytoplasmic" . "tyrRS" . "YRS" . "YTS" . . . . . . . . "YME1L" . . . . . . . . . "14-3-3 epsilon" . "FLJ45465" . . . . . . . . "14-3-3 gamma" . "PPP1R170" . "protein phosphatase 1, regulatory subunit 170" . . . . . . . . . "DELTA" . "INO80 complex subunit S" . "INO80S" . "NF-E1" . "UCRBP" . "Yin and Yang 1 protein" . "YIN-YANG-1" . . . . . . . . "STD" . "tyrosine-protein kinase ZAP-70" . "ZAP-70" . . . . . . . . . . . . . "ZIC" . "ZNF201" . . . . . . . . . . . . . . . "HPE5" . "Zinc finger protein of the cerebellum 2" . . . . . . . . "HTX" . "ZNF203" . . . . . . . . . . "CAAX prenyl protease 1 homolog" . "FACE-1" . "HGPS" . "Hutchinson-Gilford progeria syndrome" . "PRO1" . "STE24" . "Ste24p" . . . . . . . . "pHZ-44" . . . . . . . . . "PLZF" . "promyelocytic leukaemia zinc finger" . . . . . . . . "Cwc24" . "RNF113" . . . . . . . . . . . . . . . "NEM3" . "nemaline myopathy type 3" . . . . . . . . . "Monocytic leukemia zinc finger protein" . "MOZ" . "ZC2HC6A" . . . . . . . . . "CILD26" . "FBB18" . "FLJ20467" . "Kur" . "kurly homolog (zebrafish)" . . . . . . . "C2H2-171" . "RP58" . "TAZ-1" . . . . . . . "B27" . "FALP" . . . . . . . . . . . . "Zfp291" . . . . . . . . . "ACTSA" . . . . . . . . "MGC8941" . "MRX89" . . . . . . . . "CMPX1" . "dJ75N13.1" . "MRX97" . "Zfp711" . "ZNF4" . "ZNF5" . . . . . . . . "HFZ20" . . . . . . . "CNBP1" . "RNF163" . "ZCCHC22" . . . . . . . . . . "hIk-1" . "Hs.54452" . "IKAROS" . "LyF-1" . "PPP1R92" . "protein phosphatase 1, regulatory subunit 92" . . . . . . . . "Aiolos" . . . . . . . . . . . . . . . "ZPA" . . . . . . . . "ZP3-372" . "ZP3-424" . "ZPC" . . . . . . . . . . "ARMD9" . "C3a" . "C3a anaphylatoxin" . "C3b" . "complement component C3a" . "complement component C3b" . "CPAMD1" . "prepro-C3" . . . . . . . . "ADAM-TS10" . . . . . . . . . "KIAA1312" . . . . . . . . "AID" . "ARP2" . "CDA2" . "HIGM2" . . . . . . . . . "RP55" . . . . . . . . "ATP2C1A" . "calcium-transporting ATPase type 2C member 1" . "KIAA1347" . "PMR1" . "secretory pathway Ca2+/Mn2+ ATPase 1" . "SPCA1" . . . . . . . . . "FLJ22597" . . . . . . . . "BCL11A-L" . "BCL11A-S" . "BCL11A-XL" . "CTIP1" . "HBFQTL5" . "ZNF856" . . . . . . . . . . "C4" . "C4A2" . "C4A3" . "C4A4" . "C4A6" . "C4B" . "C4S" . "CO4" . "CPAMD2" . "RG" . . . . . . . . . . . . . . "ACHP" . "FLJ11665" . "ZRS" . . . . . . . . "C4B1" . "C4B3" . "C4F" . "CH" . "CO4" . "CPAMD3" . . . . . . . . "CDLIV" . "JM23" . "SPB1" . "TRM7" . "TRMT7" . "tRNA methyltransferase 7 homolog (S. cerevisiae)" . . . . . . . . . "dual oxidase-like domains 2" . "flavoprotein NADPH oxidase" . "LNOX2" . "NADH/NADPH thyroid oxidase p138-tox" . "NADPH oxidase/peroxidase DUOX2" . "NADPH thyroid oxidase 2" . "nicotinamide adenine dinucleotide phosphate oxidase" . "P138-TOX" . "P138(TOX)" . "THOX2" . . . . . . . . . . . . . . . . "GAC63" . "GRIP1-dependent nuclear receptor coactivator" . "HUEL" . "ZNT9" . . . . . . . . . . . . . . . . . "CS-1" . "FATZ-2" . . . . . . . . . "KDAC8" . "RPD3" . . . . . . . . . "C5a" . "C5a anaphylatoxin" . "C5b" . "CPAMD4" . "prepro-C5" . . . . . . . . "KIAA0188" . "phosphatidate phosphatase LPIN1" . . . . . . . . . "ML4" . "MLIV" . "MST080" . "MSTP080" . "TRPM-L1" . "TRPML1" . . . . . . . . . . "NPHP9" . . . . . . . . . "PDCN" . "SRN1" . . . . . . . . . "H105e3" . "SDR31E1" . "short chain dehydrogenase/reductase family 31E, member 1" . "XAP104" . . . . . . . . . . . . . . . "ACZ" . "aczonin" . "DKFZp779G1236" . "KIAA0559" . . . . . . . "DRES-17" . "H-PRUNE" . "HTCD37" . . . . . . "E3 ubiquitin-protein ligase RLIM" . "LIM domain interacting ring finger protein" . "MGC15161" . "NY-REN-43" . "ring zinc finger protein NY-REN-43antigen" . . . . . . . . "FLJ21044" . "HGPS" . "RBIG1" . . . . . . . . . . "CORD13" . "LCA6" . "RGI1" . . . . . . . . "ACT1" . "CIKS" . "DKFZP586G0522" . . . . . . . . "GLUT10" . . . . . . . . . "Glut9" . "GLUTX" . "urate voltage-driven efflux transporter 1" . "URATv1" . . . . . . . . . . . . . . . . . . . . . . . "UNC93" . . . . . . . . "USP27" . . . . . . . "FLJ10752" . "MEM3" . "PARK17" . . . . . . . . . "FLJ20073" . "KIAA2004" . . . . . . . "FLJ39885" . "KIAA2005" . . . . . . . "DKFZp566F123" . "DPZF" . "ODA-8S" . . . . . . . "DFNB102" . . . . . . . "BOCA" . "KIAA0081" . . . . . . . . . . . . "HP10481" . . . . . . . . "RNX" . . . . . . . . "ATPIB" . "ML-1" . . . . . . . . . . . . . . . . "ATPVA" . "ATPVC" . "KIAA0566" . . . . . . . . . . . . . . . . "ATPIH" . "ATPIS" . "KIAA1021" . "Phospholipid-translocating ATPase" . "Potential phospholipid-transporting ATPase IH" . . . . . . . . . . "SPG" . "WDR10p" . "WDR140" . . . . . . . . . . "Erlin-2" . "NET32" . . . . . . . . . "CAP" . "chromosome-associated protein" . "HUNK1" . "HUNKI" . "MCAP" . . . . . . . . . "Fbx" . "FBX7" . "PARK15" . . . . . . . . . . . . . . . . "FBL4" . "FBL5" . . . . . . . . "BTRC2" . "BTRCP2" . "Fbw11" . "Fbw1b" . "Hos" . "KIAA0696" . . . . . . . . "CG-6" . . . . . . . "FELS" . "fenestrated-endothelial linked structure protein; PV-1 protein" . "gp68" . "PV-1" . "PV1" . . . . . . . "HSA238520" . "KIAA1241" . "KIAA1689" . "TFC5" . "TFIIIB150" . "TFIIIB90" . . . . . . . . "620 kDa actin binding protein" . "ABP620" . "ACF7" . "actin cross-linking factor" . "actin cross-linking family protein 7" . "FLJ45612" . "FLJ46776" . "KIAA0465" . "KIAA1251" . "MACF" . "macrophin 1" . "trabeculin-alpha" . . . . . . . "adracalin" . "aladin" . "Allgrove, triple-A" . . . . . . . . "DKFZp434C2322" . "FLJ42993" . "MGC118899" . "MGC118900" . "TTP" . "vWF-CP" . "VWFCP" . . . . . . . . . . "cadherin-related family member 6" . "CDHR6" . "FIB1" . "FLJ11790" . "KIAA1773" . . . . . . . "FLJ22792" . "POF" . . . . . . . "HsT18816" . . . . . . . . "11 zinc finger transcriptional repressor" . . . . . . . . "HALR" . "Histone-lysine N-methyltransferase 2C" . "KIAA1506" . . . . . . . . . . . . . . . . "cadherin-related family member 23" . "CDHR23" . . . . . . . "CA-II" . "CAII" . "Car2" . . . . . . . . . . . "E-LOX" . "eLOX3" . "Epidermal lipoxygenase-3" . . . . . . . . . "CAIV" . "Car4" . . . . . . . . . "p53 inducible protein" . "PIR121" . . . . . . . . "FLJ14993" . "receptor expressed in lymphoid tissues" . . . . . . . . . "DAND6" . "VBCH" . . . . . . . . "CAV" . "CAVA" . . . . . . . . . "EFGM" . "EGF1" . "GFM" . "mtEF-G1" . . . . . . . . . "KIAA1620" . . . . . . . "Atoh5" . "bHLHa7" . "Math4B" . "ngn3" . . . . . . . . "BCMO" . "FLJ10730" . . . . . . . . "KCC2" . "KIAA1176" . . . . . . . . . . "ASPL" . "ASPS" . "Tether containing UBX domain for GLUT4" . "TUG" . "UBXD9" . "UBX domain protein 9" . "UBXN9" . . . . . . . . . . . . . . . . . . . "CARP" . . . . . . . . . "Caspr2" . "contactin-associated protein-like 2" . "KIAA0868" . "NRXN4" . . . . . . . . . "DR11" . "FLJ10506" . "HH14" . "KIAA1351" . "sensitization to ricin complex subunit 1" . "SRI1" . "WDR15" . . . . . . . . . . . . . . . . . . . . . "CSNB2B" . . . . . . . "DIFF48" . "KIAA0386" . "myogenesis-related and NCAM-associated protein homolog (chicken)" . "MYONAP" . . . . . . . . . "CAGH44" . "CAG repeat protein 44" . "forkhead/winged-helix transcription factor" . "speech and language disorder 1" . "trinucleotide repeat containing 10" . . . . . . . . "FLJ37587" . . . . . . . . "sterolin 1" . "STSL" . . . . . . . . . . "gallbladder disease 4" . "GBD4" . "sterolin 2" . . . . . . . . . . . . . . . . "APCA" . "Cav2.1" . "EA2" . "FHM" . "HPCA" . . . . . . . . . "AIP4" . . . . . . . . "CACNN" . "Cav2.2" . . . . . . . . . "MEGSIN" . . . . . . . . "bHLHa13" . "Math5" . . . . . . . "testis-specific protein" . . . . . . . . . . . "CACH2" . "CACN2" . "Cav1.2" . "LQT8" . "TS" . . . . . . . . . . . "CACH3" . "CACN4" . "Cav1.3" . . . . . . . . . . . "Cav1.4" . "CORDX3" . "CSNB2A" . "CSNBX2" . "JM8" . "JMC8" . "OA2" . . . . . . . . . "CTL4" . "DFNA72" . "FLJ14491" . "NG22" . "TPPT" . . . . . . . . . "Cav3.1" . "NBR13" . . . . . . . . . "Cav3.2" . . . . . . . . . . . . "Cav1.1" . "hypoPP" . . . . . . . . . "KMT8D" . . . . . . . "PFM9" . "PR-domain containing protein 12" . "PR-domain zinc finger protein 12" . . . . . . . . "lncRNA-N3" . . . . . . . . . . "KIAA1675" . "KMT8F" . "MDS1/EVI1-like" . "MEL1" . "MGC166915" . "PFM13" . "PR-domain zinc finger protein 16" . "Transcription factor MEL1" . . . . . . . . "dystonia 23" . "DYT23" . "GENX-3947" . "Transmembrane protein 16C (eight membrane-spanning domains)" . . . . . . . . "CaT1" . . . . . . . "CHT1" . "hCHT" . . . . . . . . . . . . . . . . "CGI-132" . . . . . . . . . "EJM4" . . . . . . . . "HA6116" . "HD4" . "HDAC-4" . "HDAC-A" . "HDACA" . "KIAA0288" . . . . . . . . . "FLJ16239" . "HD6" . "JM21" . "KIAA0901" . "PPP1R90" . "protein phosphatase 1, regulatory subunit 90" . . . . . . . . . "MGC138502" . "MGC138504" . "Stargazin" . . . . . . . . . . . . . . "ANILLIN" . "scra" . "Scraps" . . . . . . . "Gef10" . "KIAA0294" . . . . . . . . "CGTHBA" . "conserved gene telomeric to alpha globin cluster" . "HS-40" . "MARE" . "NPR3" . "RMD11" . . . . . . . "GPI1" . "hGPI1" . . . . . . . . "FLJ34512" . . . . . . . "FLJ12681" . "FLJ22302" . "JFP11" . "TMEM112A" . . . . . . . . . . . . . "FLJ10530" . "HPC2" . "tRNase Z (long form)" . . . . . . . . "JP-2" . . . . . . . "CAGL237" . "HDL2" . "JP-3" . "JP3" . . . . . . . "BASH" . "bca" . "B-cell activation" . "B-cell adapter containing a SH2 domain protein" . "B cell adaptor containing SH2 domain" . "BLNK-s" . "Ly57" . "SLP-65" . "SLP65" . "Src homology [SH2] domain-containing leukocyte protein of 65 kD" . . . . . . . . "KIAA0306" . . . . . . . . "CAC" . "carnitine-acylcarnitine carrier" . "carnitine/acylcarnitine translocase" . . . . . . . . . . . . . "ARA267" . "FLJ22263" . "KMT3B" . . . . . . . . . . . . . . . . "GATD4" . . . . . . . . "GGF2" . "HGF2" . . . "LAG1" . "UOG1" . . . . . . . . . "CMS" . . . . . . . . . . . . "FBRSL2" . "KIAA0442" . . . . . . . . . . . . . . . . "EIEE9" . "KIAA1313" . . . . . . . "EAP1" . "enhanced at puberty 1" . "KIAA1865" . . . . . . . "FLJ22973" . "Pegasus" . . . . . . "HLNX" . "KIAA1260" . "NLGN" . . . . . . . . . . . . . "ASPGX1" . "AUTSX1" . "HNL3" . "KIAA1480" . . . . . . . . . "KIAA1650" . "proline rich synapse associated protein 2" . "prosap2" . "PSAP2" . "shank postsynaptic density protein" . "SPANK-2" . . . . . . . . "CTTNBP1" . "ProSAP1" . "SHANK" . "SPANK-3" . . . . . . . . . "UNC45" . . . . . . . . "basic, SAP and coiled-coil domain" . "BSAC" . "KIAA1438" . "MAL" . "megakaryocytic acute leukemia" . "MKL" . "MRTF-A" . "myocardin-related transcription factor A" . . . . . . . . . . . . . . . . . "complement-c1q tumor necrosis factor-related protein 5" . "CTRP5" . "DKFZp586B0621" . "LORD" . "myonectin" . . . . . . . . "OMI" . "PARK13" . . . . . . . . . . . . . . . . . . . . . . "IRX-2a" . . . . . . . "GKLP" . "HT019" . "MGC78454" . "NKTL" . "P105" . "TAPK" . "TEIF" . "telomerase regulation-associated protein" . "telomerase transcriptional elements-interacting factor" . "teratoma-associated tyrosine kinase" . "TRAP" . . . . . . . . "FAP48" . "FKBPAP" . "GLML" . "GVM" . . . . . . . . . "CARD7" . "CLR17.1" . "DEFCAP" . "DKFZp586O1822" . "KIAA0926" . "NAC" . "nucleotide-binding oligomerization domain, leucine rich repeat and pyrin domain containing 1" . "VAMAS1" . . . . . . . . . "testicular acid phosphatase" . . . . . . . "FLJ20479" . . . . . . . . "homolog of yeast Nop10p" . "MGC70651" . "NOP10P" . . . . . . . . "GPVI" . "platelet glycoprotein VI" . . . . . . . . . . . "CMD1R" . . . . . . . . . "DNC" . "MUP1" . "TPC" . . . . . . . . . . . "cancer/testis antigen 118" . "CT118" . . . . . . . . . "CAMI" . "DD132" . "PHKD" . "phosphorylase kinase subunit delta" . "prepro-calmodulin 1" . . . . . . . . . . . "JBTS14" . . . . . . . "KIAA0249" . . . . . . . . . . "CAMII" . "PHKD" . "phosphorylase kinase subunit delta" . "prepro-calmodulin 2" . . . . . . . . . . . . . . . . . . . . "MRP-S" . "RPMS7" . "RP-S7" . . . . . . . . . "PHKD" . "phosphorylase kinase subunit delta" . "prepro-calmodulin 3" . . . . . . . . . . . . . . . . . . "C3orf5" . "GIBT" . "GK002" . "MRP-S22" . . . . . . . . . . . . "EDDM1" . "epididymal protein 1" . "HE1" . "NP-C2" . . . . . . . . "ALK lymphoma oligomerization partner on chromosome 17" . "ALO17" . "KIAA1554" . "mysterin" . "NET57" . . . . . . . . . "HSAN2" . "PPP1R167" . "protein phosphatase 1, regulatory subunit 167" . . . . . . . . . . . . . . . . . . "CORD15" . "KIAA1775" . "RP65" . . . . . . . "CD369" . "dectin-1" . "hDectin-1" . "SCARE2" . . . . . . . . . . "autoantigen Ro" . "cC1qR" . "CRT" . "FLJ26680" . "RO" . "Sicca syndrome antigen A (autoantigen Ro; calreticulin)" . "SSA" . . . . . . . . "collybistin" . "KIAA0424" . "PEM-2" . . . . . . . . . . . . . "GTL2" . "LINC00023" . "long intergenic non-protein coding RNA 23" . "NCRNA00023" . "non-protein coding RNA 23" . "onco-lncRNA-83" . . . . . . "H1" . "h-vps45" . . . . . . . . "BRPK" . . . . . . . . . "PEP5" . "RNF108" . . . . . . . "IMP2" . . . . . . . . . "ACTSG" . . . . . . . . "amnionless" . . . . . . . . "calcium/calmodulin-dependent protein kinase II alpha-B subunit" . "calcium/calmodulin-dependent protein kinase type II alpha chain" . "CaMK-II alpha subunit" . "CaMKIINalpha" . "CaM-kinase II alpha chain" . "CaM kinase II alpha subunit" . "KIAA0968" . . . . . . . . . "calcium/calmodulin-dependent protein kinase type II beta chain" . "CAM2" . "CAMK2" . "CaM-kinase II beta chain" . "CaM kinase II beta subunit" . "proline rich calmodulin-dependent protein kinase" . . . . . . . . . "FLJ14736" . "JPO1" . . . . . . . . . . . . . . . "KIAA0605" . . . . . . . . "ADAMTSR1" . "FLJ35283" . "punctin" . . . . . . . . . "DKFZP434G232" . "LI2" . . . . . . . . . . . . . . "HUR1" . "mammalian retrotransposon-derived 1" . "Mar1" . "MART1" . "paternally expressed 11" . "PEG11" . "SIRH2" . "Sushi-Ichi retrotransposon homolog 2" . . . . . . . "NEPII" . "NL1" . "NL2" . "SEP" . . . . . . . . "FLJ13335" . "ZFYVE7" . . . . . . . . . "cadherin-related family member 15" . "CDHR15" . . . . . . . . . "NUDR" . "SPN" . "ZMYND5" . . . . . . . . "CD322" . "JAM-B" . "JAMB" . "VE-JAM" . . . . . . . "CANP" . "CANPL1" . "muCANP" . "muCL" . . . . . . . . "CANP3" . "nCL-1" . "p94" . . . . . . . . "ADNIV" . "HTRA3" . "nCL-3" . . . . . . . . "GTC90" . . . . . . . . "FLJ14700" . "GTPBG3" . "MSS1" . "MTGP1" . "THDF1" . . . . . . . . . "KIAA0569" . "SIP-1" . "SIP1" . "SMAD interacting protein 1" . . . . . . . . "MRJ" . . . . . . . . "EDJ" . "ERdj3" . "HEDJ" . . . . . . . . . . . . . . "SHK" . . . . . . . . . . . . . . . "GPI transamidase subunit" . . . . . . . . "CARS1" . "Cysteine tRNA ligase 1, cytoplasmic" . . . . . . . . . . . . . . . "FLJ14744" . . . . . . . . . . . . "one twenty-two" . "OTT" . "OTT1" . . . . . . . . . . . . . . "D2S448" . "D2S448E" . "KIAA0230" . "MG50" . "PRG2" . "PXN" . . . . . . . . . . . . . . . "RGS-PX2" . . . . . . . . . "CAGH39" . "FGS4" . "LIN2" . . . . . . . . . . . . . "FUT12" . "GDP-fucose protein O-fucosyltransferase 1" . "KIAA0180" . "O-Fuc-T" . "O-FUT" . "Peptide-O-fucosyltransferase" . . . . . . . . "MCH4" . . . . . . . . . . "Casp-8" . "FLICE" . "MACH" . "MCH5" . . . . . . . . . . "calmitine" . "calsequestrin 1, fast-twitch, skeletal muscle" . "PDIB1" . . . . . . . . "PDIB2" . . . . . . . . . . . "FHH" . "GPRC2A" . "NSHPT" . "severe neonatal hyperparathyroidism" . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . "LGMD1C" . "LQT9" . "M-caveolin" . "VIP-21" . "VIP21" . . . . . . . . "CALC" . "EFHA3" . "FLJ12684" . . . . . . . . "CDR" . "ETO" . "MTG8" . "ZMYND2" . . . . . . . . "ETO2" . "MTG16" . "MTGR2" . "Myeloid translocation gene 8 and 16b" . "RUNX1T3" . "ZMYND4" . . . . . . . "PEBP2B" . . . . . . . . "corticosteroid binding globulin" . "transcortin" . . . . . . . . . . "c-Cbl" . "oncogene CBL2" . "RNF55" . . . . . . . . "hPrp31" . "NY-BR-99" . "PRP31" . "SNRNP61" . . . . . . . . "KIAA0862" . "SOC-2" . "SOC2" . "SUR-8" . "SUR8" . . . . . . . . . . . . "S2P" . "site-2 protease" . . . . . . . . "P2X2" . . . . . . . . . "DKFZp686K19184" . "FLJ21544" . "FLJ97536" . "FLJ97596" . "FLJ99794" . "LEKTI" . "LETKI" . "lymphoepithelial Kazal-type-related inhibitor" . "NETS" . "NS" . "VAKTI" . . . . . . . . . "KIAA1385" . . . . . . . . . "auxilin" . "KIAA0473" . "PARK19" . . . . . . . . "collagen binding protein 1" . "colligen" . "HSP47" . . . . . . . . "AN" . "DRF3" . "FLJ34705" . "NSDAN" . . . . . . . . . "ANK" . "CPPDD" . "HANK" . "SLC62A1" . . . . . . . . . "BB1" . "hMBOA-7" . "LPIAT" . "LPLAT" . "lysophosphatidylinositol acyltransferase" . "lysophospholipid acyltransferase 7" . . . . . . . . "SEN34" . "SEN34L" . . . . . . . . "tRNA pseudouridine(38-40) synthase" . . . . . . . . "HIP4" . . . . . . . . . . . . . . . . . . . . . . "KIAA1215" . "Loop-tail-associated protein" . "LPP1" . "LTAP" . "MGC119403" . "MGC119404" . "STB1" . "STBM" . "STBM1" . "Strabismus" . "Vang, van gogh-like 2" . . . . . . . . . . . . . . . . . . . . "STB2" . . . . . . . . "CALM" . "CLTH" . . . . . . . . . "protein xylosyltransferase 1" . "PXYLT1" . "XT-I" . . . . . . . . "protein xylosyltransferase 2" . "PXYLT2" . "XT-II" . . . . . . . . . . . . . . . . "P2Y5" . . . . . . . . . "MGC10561" . "Pc class homolog (Drosophila)" . . . . . . . . "JAM-C" . "JAMC" . . . . . . . . . . . . . . . . . . . . "MIX17A" . "MIX17 homolog A" . "N27C7-4" . . . . . . . . . . . "family of interleukin 1-delta" . "FIL1" . "FIL1D" . "FIL1(DELTA)" . "IL-1F5" . "IL1HY1" . "IL1L1" . "IL-1 related protein 3" . "IL1RP3" . "IL36RA" . "interleukin-1 HY1" . "interleukin-1 receptor antagonist homolog 1" . "MGC29840" . . . . . . . . . "KIAA0437" . "SEB" . . . . . . . "GERP" . "glioblastoma expressed ring finger protein" . . . . . . . "BLOC2S1" . "SUTAL" . . . . . . . "HEPC" . "HFE2B" . "LEAP-1" . "LEAP1" . . . . . . . . "NAG" . . . . . . . . "CD32C" . "Fc gamma receptor IIc" . "hFcRII-C" . . . . . . . . . "KLHL6" . "retinitis pigmentosa 42" . "RP42" . "SBBI26" . . . . . . . . "dolichyl-P-Man:Man(6)GlcNAc(2)-PP-dolichol alpha-1,2-mannosyltransferase" . "dolichyl-P-Man:Man(8)GlcNAc(2)-PP-dolichol alpha-1,2-mannosyltransferase" . "dol-P-Man dependent alpha-1,2-mannosyltransferase" . . . . . . . . "BRWD2" . "DCAF14" . "DDB1 and CUL4 associated factor 14" . "FLJ20705" . "ndrp" . . . . . . . . "B3GN-T1" . "BETA3GNTI" . "iGAT" . "iGnT" . "iGNT" . "N-acetyllactosaminide beta-1,3-N-acetylglucosaminyltransferase" . . . . . . . . . . . . . . "cypher" . "KIAA0613" . "oracle" . "PDLIM6" . "ZASP" . "Z-band alternatively spliced PDZ motif protein" . . . . . . . "GP130" . "LRP130" . . . . . . . . "B7323" . . . . . . . "CAM" . . . . . . . "DFNA67" . "KIAA0772" . "ORP-2" . . . . . . . . "ADNP1" . "ADNP homeobox 1" . "KIAA0784" . . . . . . . . . . . "bB379O24.1" . "GATAS" . . . . . . . . . "bA504H3.3" . "CHED" . "HOVO2" . . . . . . . "bA465L10.2" . "NIF-1" . "NRC-interacting factor 1" . . . . . . . . "dJ322G13.2" . "ZBTB23" . . . . . . . "ALRP" . "C-193" . "CARP" . "CVARP" . "MCARP" . . . . . . . . . . "B-cell CLL/lymphoma 1" . "G1/S-specific cyclin D1" . "parathyroid adenomatosis 1" . "U21B31" . . . . . . . . . . . "seipin" . . . . . . . . . . "dJ680N4.3" . "GPR73b" . "GPRg2" . "PKR2" . . . . . . . . . "G1/S-specific cyclin D2" . . . . . . . . "CXXC10" . "Histone-lysine N-methyltransferase 2B" . "HRX2" . "KIAA0304" . "MLL1B" . "MLL2" . "MLL4" . "myeloid/lymphoid or mixed-lineage leukemia (trithorax homolog, Drosophila) 4" . "TRX2" . "WBP7" . . . . . . . "BLOC3S2" . "KIAA1667" . "LE" . . . . . . . . "BIG2" . "Brefeldin A-inhibited guanine nucleotide-exchange protein 2" . . . . . . . . "ANT-1" . "bB152O15.1" . "hPrp6" . "Prp6" . "RP60" . "SNRNP102" . "TOM" . "U5-102K" . . . . . . . . . "Heme-oxidized IRP2 ubiquitin ligase 1" . "HOIL1" . "RBCK2" . "RNF54" . "UBCE7IP3" . "XAP4" . "ZRANB4" . . . . . . . . "HT013" . . . . . . . . "ABHD12A" . "BEM46L2" . "dJ965G21.2" . "DKFZP434P106" . . . . . . . . . . . "bK3184A7.3" . "DKFZP434C013" . "KIAA1088" . "NHL" . "RTEL" . . . . . . . . "FLJ20116" . "KIND1" . "kinderlin" . "kindlin-1" . "UNC112A" . "URP1" . . . . . . . . "FLJ11729" . "Hallervorden-Spatz syndrome" . "HARP" . "HSS" . "PKAN" . . . . . . . . . "dJ842G6.1" . . . . . . . . "CGI-53" . "dJ1028D15.1" . "NGD2" . "NGD5" . . . . . . . . "dJ756N5.1" . "KIAA1512" . "MHC14" . "MYH14" . . . . . . . . "IscS" . "NifS" . . . . . . . . "SCA36" . "spinocerebellar ataxia 36" . . . . . . . . . "KIAA0581" . "phosphoinositide phospholipase C" . "PLC154" . "PLC-I" . . . . . . . . . "FBX1" . "FBXO1" . . . . . . . . . . . . "dJ1112F19.1" . "ZNF797" . . . . . . . . . "AGS5" . "Aicardi-Goutieres syndrome 5" . "HDDC1" . "HD domain containing 1" . "Mg11" . "monocyte protein 5" . "MOP-5" . "SBBI88" . . . . . . . . . "DCDC4B" . "doublecortin domain containing 4B" . . . . . . . "hCaf1z" . . . . . . . . "MGC126442" . "pDP1678" . . . . . . . . . . . . . . . . . . . . . . . "CMT2K" . "CMT4" . . . . . . . . . . . "CMT2R" . "KIAA0517" . "RNF86" . . . . . . . . "bHLHb37" . "bHLH factor Hes7" . . . . . . . . . . . . . . . . "EEC3" . "KET" . "NBP" . "OFC8" . "p51" . "p53CP" . "p63" . "p73H" . "p73L" . "SHFM4" . . . . . . . . . . . . . . . "AOA" . "AOA1" . "EAOH" . "EOAHA" . "FLJ20157" . . . . . . . . "GALNAC-4-ST1" . . . . . . . . "PZI" . "ZPI" . . . . . . . . . . . "RSS" . "SELN" . . . . . . . "dermal papilla derived protein 13" . "DERP13" . "FLJ11808" . "ORF19" . "Russel-Silver syndrome candidate" . "succinate-hydroxymethylglutarate CoA-transferase" . . . . . . . "ORF20" . "tricothiodystrophy, non-photosensitive 1" . "TTDN1" . . . . . . . "CD191" . "CKR-1" . "MIP1aR" . . . . . . . . . "FLJ10111" . "FLJ23501" . "HOIL-1-interacting protein" . "HOIP" . "Paul" . "ZIBRA" . . . . . . . . . . . . . . . "KIAA1635" . "TNRC11L" . "TRALP" . "TRALPUSH" . . . . . . . "FLJ37528" . "WD40-repeat protein upregulated in HCC" . "WDRPUH" . . . . . . . "AF10" . . . . . . . . "alkaline phytoceramidase" . "APHC" . "FLJ11238" . . . . . . . . . . "KEN" . "kendrin" . "KIAA0402" . "PCN" . "PCNTB" . "SCKL4" . "Seckel syndrome 4" . . . . . . . . "DKFZP434G099" . . . . . . . . . "BN-1" . "CD196" . "CKR-L3" . "CMKBR6" . "DCR2" . "DRY-6" . "GPR29" . "GPR-CY4" . . . . . . . . . "particularly interesting new Cys-His protein 2" . "PINCH-2" . "PINCH2" . . . . . . . . "SLC56A4" . . . . . . . "HPR6.6" . . . . . . . . . "BAF53B" . . . . . . . "Dashurin" . "dJ1187M17.3" . "UFBP1" . . . . . . . "dJ852M4.2" . . . . . . . . "dJ967N21.5" . "MGC119522" . "MGC119523" . "MGC12866" . "MGC4816" . "REC" . "REC homolog (Drosophila)" . . . . . . . . . "dJ553F4.4" . "Shax1" . "SNF7-2" . "VPS32B" . . . . . . . . "dJ824F16.3" . . . . . . . . "bA371L19.1" . "hRFT2" . "Hypothetical protein LOC113278" . "RFVT3" . . . . . . . . . "KIAA0098" . . . . . . . . "FLJ23412" . "VNUT" . . . . . . . . "BUD32" . "dJ101A2.2" . "Nori-2p" . "prpk" . . . . . . . . . "bA504H3.4" . "DDK1" . . . . . . . . "COX4-2" . "COX4B" . "COXIV-2" . "cytochrome c oxidase subunit IV-like 2" . "dJ857M17.2" . . . . . . . "DNAJC5A" . "FLJ00118" . "FLJ13070" . . . . . . . . "KMLC" . "MLCK2" . "skeletal muscle myosin light chain kinase" . "skMLCK" . . . . . . . . . "dJ726C3.1" . "testis and spermatogenesis related gene 4" . "TSARG4" . . . . . . . "dJ734P14.3" . "protein-glutamine gamma-glutamyltransferase 6" . "SCA35" . "spinocerebellar ataxia 35" . "TGY" . . . . . . . "Class VI beta-tubulin" . "dJ543J19.4" . . . . . . . . . "YAP65" . . . . . . . . . . . "thiamine transporter 2" . "THTR2" . . . . . . . . . . . . . "iPLA2delta" . "neuropathy target esterase" . "NTE" . "SPG39" . "SWS" . . . . . . . . "CGI-33" . "NifU" . "NIFUC" . . . . . . . "FLJ11429" . "KIAA1113" . "PTC7" . "ret-fused gene 7" . "RFG7" . "TF1G" . "TIF1G" . "TIF1GAMMA" . "TIFGAMMA" . "transcriptional intermediary factor 1 gamma" . . . . . . . . . "BUP1" . . . . . . . . "PETA-3" . "RAPH" . "SFA-1" . "TSPAN24" . . . . . . . . "deafness, autosomal dominant 66" . "DFNA66" . "MGC-24" . "MUC-24" . . . . . . . . . . . . . . . . "11B6" . "BCG1" . "breast cancer associated gene 1" . "HCA10" . "hepatocellular carcinoma associated protein" . "hepatocellular carcinoma-associated protein HCA10" . "JCL-1" . "MAGED" . "MAGE-D2" . "melanoma-associated antigen D2" . "MGC8386" . . . . . . . . "ANKS4A" . "FLJ33924" . "Sans" . . . . . . . . . "CIP98" . "PDZD7B" . "USH2D" . . . . . . . . . "DJ-1" . "DJ1" . "GATD2" . . . . . . . . "cancer/testis antigen 108" . "CT108" . . . . . . . . . "BBS11" . "HT2A" . "TATIP" . . . . . . . . . "KAP1" . "PPP1R157" . "protein phosphatase 1, regulatory subunit 157" . "RNF96" . "TF1B" . "TIF1B" . . . . . . . . . "FLJ22623" . "PASS1" . . . . . . . . . . . . . . . . "bcl10-interacting maguk protein 3" . "BIMP3" . "card-maguk protein 1" . "CARMA1" . . . . . . . . . . . . . . . . . "AGTAVPRL" . "AII" . "AVP" . "CLR1.1" . "Cryopyrin" . "FCAS" . "FCU" . "MWS" . "NALP3" . "nucleotide-binding oligomerization domain, leucine rich repeat and pyrin domain containing 3" . "PYPAF1" . . . . . . . . . "IL-17F" . "ML-1" . "ML1" . . . . . . . . . . . . . "FLJ10466" . "myoclonin-1" . . . . . . . . . . . . . . . . "CLAN" . "CLAN1" . "CLANA" . "CLANB" . "CLANC" . "CLAND" . "CLR2.1" . "ipaf" . "NOD-like receptor C4" . "nucleotide-binding oligomerization domain, leucine rich repeat and CARD domain containing 4" . . . . . . . . . "LAS" . "Lipoyl synthase, mitochondrial" . . . . . . . . . . "BTR1" . "dJ794I6.2" . "FECD4" . "NaBC1" . . . . . . . . "BIMP2" . "CARMA2" . . . . . . . "CD24A" . . . . . . . . . . . . . . . "PRO1280" . "SUFUH" . "SUFUXL" . . . . . . . . "AIM-1" . "OCA4" . . . . . . . . . "CILD6" . "NM23-H8" . "Sperm-specific thioredoxin 2" . "SPTRX2" . . . . . . . "FLJ13541" . "hZIMP10" . "KIAA1224" . "MIZ" . "RP11-519K18.1" . . . . . . . . . . . . . . . . . . . . . . . "FBX14" . "Fbx31" . "FBXO14" . "MGC15419" . . . . . . . . . "BART" . . . . . . . . . . . . . . . "FLJ30744" . "matriptase-2" . . . . . . . . . . "T-cell-specific surface glycoprotein" . . . . . . . . . . . . "bA444G7" . "CDS1" . "CHK2" . "HuCds1" . "PP1425" . . . . . . . . . "disrupted in renal cancer protein 2" . "FLJ14784" . "RCC4" . "renal cell carcinoma 4" . . . . . . . . . "HMSNII" . "KIAA0591" . "KLP" . . . . . . . . "KIAA1601" . "Sarcolemmal-associated protein" . "SLAP" . . . . . . . . "BRIL" . "dispanin subfamily A member 1" . "DSPA1" . "Fragilis4" . "Hrmp1" . . . . . . . "39S ribosomal protein L44, mitochondrial" . "FLJ12701" . "FLJ13990" . . . . . . . . . . "HLGP85" . "LIMP-2" . "LIMPII" . "lysosomal integral membrane protein II" . "lysosome membrane protein 2" . "SR-BII" . . . . . . . . "2610509L04Rik" . "4E-T" . "Clast4" . "FLJ21601" . . . . . . . . "76P" . "FLJ14797" . . . . . . . . "8D6" . "8D6A" . "8D6 antigen" . . . . . . . . . "6C6-Ag" . "BAP31" . "CDM" . "DXS1357E" . . . . . . . . . . . . . . . . . "FOG2" . "hFOG-2" . "ZC2HC11B" . "ZNF89B" . . . . . . . . . . "CILD19" . "Leucine rich testes protein" . "LRTP" . "TSLRP" . . . . . . . "GLOD2" . "glyoxalase domain containing 2" . . . . . . . . . . . . . . . "LSFR1" . "ZNF356" . . . . . . . . . . . . . . . . . . . . . . . "Early B-cell factor associated zinc finger protein" . "Ebfaz" . "hOAZ" . "JBTS19" . "KIAA0760" . "NPHP14" . "OAZ" . "OLF-1/EBF associated zinc finger gene" . "Roaz" . "Zfp104" . . . . . . . . . "CD3H" . "CD3Q" . "T-cell surface glycoprotein CD3 zeta chain" . . . . . . . . . . . "FIHP" . "Paf1/RNA polymerase II complex component" . "parafibromin" . . . . . . . . . . . . . . . . . . . . . . "coenzyme Q8 homolog (yeast)" . "COQ8" . "SCAR9" . . . . . . . . . "FLJ38636" . "PIG7" . "SIMPLE" . "TP53I7" . . . . . . . . "CAPON" . "C-terminal PDZ domain ligand of neuronal nitric oxide synthase" . "KIAA0464" . . . . . . . . . . "ALS11" . "CMT4J" . "dJ249I4.1" . "hSac3" . "SAC3" . . . . . . . . "bHLHe1" . "KIAA0307" . . . . . . . . . . . . "CMT2A2" . "CPRP1" . "KIAA0214" . "MARF" . . . . . . . . . . . . . . . . . . "TACTILE" . . . . . . . . "16.3A5" . "EJ16" . "EJ30" . "EL32" . "G344" . "p18-20" . . . . . . . . "BPEG" . "KIAA1297" . "MGC12676" . "MYLK6" . "SPEGalpha" . "SPEGbeta" . "striated muscle preferentially expressed protein kinase" . . . . . . . . . . . . . . . . . "ABIN-1" . "KIAA0113" . "NAF1" . "Nef-associated factor 1 SNP" . "VAN" . "virion-associated nuclear-shuttling protein" . . . . . . . . . . . "Krp1" . "sarcomeric muscle protein" . "SARCOSIN" . . . . . . . . "C2F" . "Grcc2f" . "NEP1" . . . . . . . . "HCLS1 (and PKD2) associated protein" . "HCLSBP1" . "HS1BP1" . . . . . . . . "calmyrin" . "CIB" . "KIP" . "SIP2-28" . . . . . . . . "LASP2" . "LIM and SH3 protein 2" . "LIM-nebulette" . "LNEBL" . . . . . . . . . . . . . . . "Band_7 23-211 Keo4 (Interim) similar to C.elegans protein C42C1.9" . "Erlin-1" . "KE04" . "SPG62" . . . . . . . . "AMSH" . . . . . . . . "BS69" . . . . . . . . . "Domino homolog 1 (Drosophila)" . "DOMO1" . "EAF1" . "KIAA0309" . "Swi2/Snf2-related ATPase homolog (S. cerevisiae)" . "SWR1" . . . . . . . "FHR-4" . "FHR4" . . . . . . . . . "DOWN16" . "FHR-3" . "FHR3" . "HLF4" . . . . . . . . "B-cell antigen receptor complex-associated protein alpha chain" . "MB-1" . . . . . . . . "ATP/GTPbinding protein" . "hClp1" . "HEAB" . "polyribonucleotide 5'-hydroxyl-kinase" . . . . . . . . "B29" . "B-cell antigen receptor complex-associated protein beta chain" . . . . . . . . . "ACT" . . . . . . . . "HRIHFB2122" . "KIAA1662" . "TAP68" . "Tara" . . . . . . . "EPM1B" . "FLJ31937" . "REST/NRSF interacting LIM domain protein" . "RILP" . . . . . . . . "TAPA-1" . "TSPAN28" . . . . . . . . "AIBP63" . "alpha-integrin-binding protein 63" . "BLOC2S2" . "RU2" . "Ruby-eye protein 2 homolog" . . . . . . . "HRCA1" . "RCA1" . "translocation in renal carcinoma, chromosome 8" . "TRC8" . . . . . . . . "bA421P11.3" . "CBP-interacting protein 3" . "CIP3" . "EAP2" . "OIP2" . "Opa interacting protein 2" . "p9" . "RRP43" . "Rrp43p" . . . . . . . . "CGI-75" . "dimethyladenosine transferase 1, mitochondrial" . "mtTFB" . . . . . . . . . "FBP interacting repressor" . "FIR" . "pyrimidine tract binding splicing factor" . "RoBPI" . "Ro ribonucleoprotein binding protein 1" . "siah binding protein 1" . "SIAHBP1" . . . . . . . . "MGC35570" . "SLC57A1" . . . . . . . . . . "KIAA0066" . "RAB3GAP" . "RAB3GAP130" . "WARBM1" . . . . . . . . "CGI-151" . "KIAA0992" . "SIH002" . . . . . . . . . . . . . . . "CAST2" . "ELKS" . "KIAA1081" . "MGC12974" . . . . . . . . "KIAA0733" . . . . . . . . "KIAA0027" . "LVM" . "MLC" . "VL" . . . . . . . "DKFZP434H2235" . "KIAA1011" . "Nesp2" . "Nesprin-2" . "NUA" . "NUANCE" . "nuclear envelope spectrin repeat-2" . "nucleus and actin connecting element" . "SYNE-2" . . . . . . . . "KIAA0919" . . . . . . . . . . "8B" . "ARCA1" . "CPG2" . "dJ45H2.2" . "Enaptin" . "KIAA0796" . "MYNE1" . "myocyte nuclear envelope protein 1" . "Nesp1" . "Nesprin-1" . "nuclear envelope spectrin repeat-1" . "SCAR8" . "SYNE-1B" . . . . . . . . "KIAA0521" . "MGC15913" . "P114-RhoGEF" . "Rho-specific guanine nucleotide exchange factor p114" . . . . . . . . "APH2" . "KIAA0253" . . . . . . . . . "KIAA0028" . "Leucine tRNA ligase 2, mitochondrial" . "LEURS" . "MGC26121" . "mtLeuRS" . . . . . . . . "homolog of yeast RRP4 (ribosomal RNA processing 4), 3' 5' exoribonuclease (RRP4)" . "hRrp4p" . "p7" . "RRP4" . "Rrp4p" . . . . . . . . . . . . . "Dicer" . "dicer 1, double-stranded RNA-specific endoribonuclease" . "HERNA" . "K12H4.8-LIKE" . "KIAA0928" . . . . . . . . . "CHET9" . "JJAZ1" . "KIAA0160" . . . . . . . . . "importin 12" . "IPO12" . "MTR10A" . "TRN-SR" . "TRN-SR2" . . . . . . . . . . . . . "CDO" . "CDON1" . "cell adhesion molecule-related/down-regulated by oncogenes" . "ORCAM" . . . . . . . . "FLJ16363" . "FLJ32769" . . . . . . . . . . . . . . . . . "CATSPER" . . . . . . . . . "NHE7" . . . . . . . . . "FRAXF" . . . . . . . "AWMS2" . "ZIP4" . . . . . . . . . "CDA-I" . "CDAI" . . . . . . . . . "FIP-2" . "FIP2" . "HIP7" . "HYPL" . "NRP" . "TFIIIA-INTP" . . . . . . . . "BART" . "BART1" . "binder of Arl2" . . . . . . . . . . . . . . . "HU-K4" . . . . . . . . . . "DKFZP434D245" . "KIAA0839" . "RAB3-GAP150" . "SPG69" . . . . . . . . "KIAA1516" . "Nephrosis type 3" . "NPHS3" . "phosphoinositide phospholipase C" . "PLCE" . . . . . . . . . . . . . . . . "cdc14" . "Cdc14A1" . "Cdc14A2" . "DFNB105" . . . . . . . . . "B16.6" . "CDA016" . "CGI-39" . "complex I B16.6 subunit" . "GRIM-19" . "GRIM19" . . . . . . . . "CSS1" . "KIAA0990" . . . . . . . . "ACVR1A" . "ALK2" . "SKR1" . . . . . . . . . . "KIAA0699" . . . . . . . . "FU" . "fused homolog (Drosophila)" . "KIAA1278" . . . . . . . . . . . "Dhr1" . "KIAA1517" . "MGC2695" . "MGC4322" . . . . . . . "hPrp16" . "KIAA0224" . "PRP16" . "PRPF16" . . . . . . . . "CL-K1" . "Collectin K1" . "MGC3279" . . . . . . . . . "CED-12" . "CED12" . "ELMO-2" . "FLJ11656" . "KIAA1834" . . . . . . . . . "CPAH" . . . . . . . . "carboxypeptidase-tubulin" . "CCP1" . "cytosolic carboxypeptidase 1" . "KIAA1035" . "Nna1" . "soluble carboxypeptidase" . "tubulinyl-Tyr carboxypeptidase" . "tyrosine carboxypeptidase" . . . . . . . "DKFZP586M0122" . "FLJ21915" . "RPA1" . "RPO1-4" . . . . . . . . "TC21" . . . . . . "BM032" . "centrosomal P4.1-associated protein" . "CPAP" . "LAP" . "LIP1" . "Sas-4" . "SASS4" . "SCKL4" . . . . . . . . "HKLP2" . "NY-BR-62" . . . . . . . . "SPG71" . "ZFR1" . . . . . . . "KIAA0340" . "Rab3-interacting molecule" . "RIM" . "RIM1" . . . . . . . . . . . "DKFZp586D211" . "hPot1" . . . . . . . . . "APOA-V" . "RAP3" . . . . . . . . . . . . "p53R2" . . . . . . . . . "osterix" . "OSX" . . . . . . . . . "BM-016" . "FLJ31290" . "MGC10753" . "PRO1741" . "Wwp4" . . . . . . . . "biogenesis of lysosomal organelles complex-1, subunit 8" . "BLOC1S8" . "DBND" . "Dysbindin" . "dysbindin-1" . "HPS7" . "My031" . . . . . . . . "hPrp8" . "Prp8" . "PRPC8" . "SNRNP220" . . . . . . . . "ATP(CTP):tRNA nucleotidyltransferase" . "CCA1" . "CCA-adding enzyme" . "CGI-47" . "MtCCA" . . . . . . . . "FLJ38568" . "MRX93" . . . . . . . . "HPRP3" . "Prp3" . "SNRNP90" . . . . . . . . "HPRP4" . "HPRP4P" . "PRP4" . "Prp4p" . "PRP4/STK/WD splicing factor" . "SNRNP60" . "U4/U6 small nuclear ribonucleoprotein Prp4" . . . . . . . . "HTPK1" . "Placental protein 20" . "PP20" . "Thiamine diphosphokinase" . "Thiamine kinase" . "Thiamine pyrophosphokinase 1" . . . . . . . . . "LKRSDH" . "LORSDH" . . . . . . . . "FLJ10147" . "HIPPI" . "MHS4R2" . . . . . . . . "CDC42Hs" . "G25K" . "GTP binding protein, 25kDa" . . . . . . . . "BAF" . . . . . . . . "human CDC45" . . . . . . . . . "B-cell stimulating factor 3" . "BSF-3" . "BSF3" . "CISS2" . "CLC" . "cold-induced sweating syndrome 2" . "NNT-1" . "NNT1" . "novel neurotrophin-1" . "NR6" . . . . . . . . . "DKFZp761P0710" . "FEB4" . "KIAA0686" . "VLGR1" . . . . . . . . "BGL" . "LAB300" . "LBA" . . . . . . . . . . . . . . . . . "CD324" . "E-Cadherin" . "uvomorulin" . . . . . . . . "Gem" . . . . . . . . . . "connexin 47" . "CX46.6" . "CX47" . "SPG44" . . . . . . . . . "ActR-IIB" . . . . . . . . . "CAD11" . "OB" . "OB-Cadherin" . . . . . . . . "CPD" . "Cupidin" . "DFNA68" . "HOMER-2" . "HOMER-2A" . "HOMER-2B" . "Vesl-2" . . . . . . . . . . . . . . . "KIAA0929" . "MINT" . "RBM15C" . "SHARP" . . . . . . . "Morf" . "MOZ2" . "MOZ-related factor" . "qkf" . "querkopf" . "ZC2HC6B" . . . . . . . . . "CD325" . "CDHN" . "N-cadherin" . . . . . . . "activin receptor-like kinase 1" . "ALK1" . "HHT" . "HHT2" . . . . . . . . . "FLJ35755" . "IL-17RD" . "IL17RLM" . "SEF" . . . . . . . . . . . "FLJ20101" . "NDE" . "NUDE" . . . . . . . . . "CDHP" . "PCAD" . "P-cadherin" . . . . . . . . "dJ496H19.1" . "KCP1" . "keratinocyte associated protein 1" . "KRTCAP1" . "PIGPC1" . "THW" . . . . . . . . "ARTEMIS" . "A-SCID" . "FLJ11360" . "PSO2 homolog (S. cerevisiae)" . "SNM1C" . . . . . . . . "CAL" . "dJ94G16.2" . "FIG" . "GOPC1" . "PIST" . . . . . . . . "FLJ11005" . "peptide-N(4)-(N-acetyl-beta-glucosaminyl)asparagine amidase" . "PNG1" . . . . . . . . . "MG61" . "por" . "PORC" . "PPN" . . . . . . . . . "HSPC165" . "HSPC236" . "MOG1" . "MOG1 homolog (S. cerevisiae)" . "RANGNRF" . . . . . . . . "FLJ20450" . "mtSerRS" . "SARS" . "serine tRNA ligase 2, mitochondrial" . "SerRSmt" . "SERS" . "SYS" . . . . . . . . . . . . . . . . "PSK-J3" . . . . . . . . . . . "DAPPER" . "DAPPER1" . "FRODO" . "HDPR1" . "THYEX3" . . . . . . . . . "TMTSP" . . . . . . . "BAFFR" . "CD268" . . . . . . . . . "EDA-A2R" . "EDAA2R" . "TNFRSF27" . "XEDAR" . . . . . . . . . "coenzyme Q1 homolog (yeast)" . "COQ1" . "COQ1A" . "TPT" . . . . . . . . . . . . . . "TREM-2" . "Trem2a" . "Trem2b" . "Trem2c" . . . . . . . . . . . . . . . "MT-TRX" . . . . . . . . "PLSTIRE" . . . . . . . . . . "mixed lineage kinase 7" . "MLK7" . "MLTK" . "MLTKalpha" . "MLTKbeta" . "MRK" . "ZAK" . "ZAK1 homolog, leucine zipper and sterile-alpha motif kinase (Dictyostelium)" . . . . . . . . . . . . . . . "FRSB" . "PheHB" . "phenylalanine tRNA ligase 1, beta, cytoplasmic" . . . . . . . . "FLJ14199" . . . . . . . "cN-III" . "hUMP1" . "lupin" . "p36" . "P5'N-1" . "PN-I" . "POMP" . "PSN1" . "UMPH" . "UMPH1" . . . . . . . . . "CAP20" . "CIP1" . "P21" . "p21CIP1" . "p21Cip1/Waf1" . "SDI1" . "WAF1" . . . . . . . . . "KIP1" . "P27KIP1" . . . . . . . . . "DKFZP434F124" . "IFT54" . "microtubule interacting protein that associates with TRAF3" . "MIP-T3" . "MIPT3" . . . . . . . . "AF5Q31" . "ALL1 fused gene from 5q31" . "MCEF" . . . . . . . . . . . "KIP2" . "P57" . . . . . . . . . "nephrocystin 2" . . . . . . . . "NMNAT" . "PNAT1" . . . . . . . . . . . . . . "ARF" . "CDK4I" . "CMM2" . "INK4" . "INK4a" . "MTS1" . "p14" . "p14ARF" . "p16" . "p16INK4a" . "p19" . "p19Arf" . . . . . . . . . "CDK4I" . "INK4B" . "MTS2" . "P15" . "p15INK4b" . "TP15" . . . . . . . . "Cell wall biogenesis 43 N-terminal homolog (S. cerevisiae)" . "CWH43-N" . "FGF receptor activating protein 1" . "FRAG1" . . . . . . . "INK4C" . "p18" . . . . . . . . "GT198" . "homologous-pairing protein 2 homolog" . "Hop2" . "HUMGT198A" . "TBP-1 interacting protein" . "TBPIP" . . . . . . . . "H+/sugar symporter" . . . . . . . . "CGI-102" . "CGI-102 protein" . "Exosome component Rrp40" . "hRrp-40" . "hRrp40p" . "p10" . "RRP40" . "Rrp40p" . . . . . . . . "androgen-regulated short-chain dehydrogenase/reductase 1" . "ARSDR1" . "MDT1" . "SDR7C1" . "short chain dehydrogenase/reductase family 7C, member 1" . . . . . . . . "NPHP18" . "NY-REN-58" . . . . . . . . "NY-REN-64" . . . . . . . . . "SGC32445" . "SPG72" . "Yip2d" . . . . . . . . . . "beta-1,3-galactosyltransferase-6" . "beta3GalT6" . . . . . . . . "OAT4L" . "RST" . "URAT1" . . . . . . . . . "GON-2" . "KIAA1616" . "LTRPC3" . "melastatin 2" . . . . . . . . . . "FLJ20041" . . . . . . . . . . "CHAK1" . "LTRPC7" . "TRP-PLIK" . . . . . . . . . "CHAK2" . "FLJ22628" . . . . . . . . . "AGAS" . "ARGA" . "NAT7" . . . . . . . . . . . . . "LGMD2I" . "MDC1C" . . . . . . . "C19orf1" . "D19S1177E" . "PER-EC1" . "PEREC1" . "TOM40" . . . . . . . . "FLJ12614" . "NRX" . . . . . . . . "FLJ10814" . . . . . . . "FLJ22583" . "KIAA0197" . . . . . . . "EVIN1" . "LAK-4P" . . . . . . . . . . . . . . . "GCPL1" . "KAE1" . "OSGEP1" . "PRSMG1" . "TCS3" . . . . . . . . . "D6S586E" . . . . . . . . "BAF200" . "DKFZp686G052" . "FLJ30619" . "KIAA1557" . . . . . . . . . "cancer/testis antigen 31" . "CT31" . "PLU-1" . "PPP1R98" . "protein phosphatase 1, regulatory subunit 98" . "RBBP2H1A" . . . . . . . . . . "6A3-5" . "BAF250b" . "DAN15" . "ELD/OSA1" . "KIAA1235" . "p250R" . . . . . . . . . "polycystin-1L1" . "PRO19563" . . . . . . . . . . . . . . "cancer/testis antigen 121" . "CT121" . "EIEE1" . "ISSX" . . . . . . . "alanine aminotransferase 2" . "ALT2" . . . . . . . . . . . . . . . . . . . . . "CMT2C" . "osmosensitive transient receptor potential channel 4" . "OTRPC4" . "TRP12" . "VRL-2" . "VR-OAC" . "VROAC" . . . . . . . . . . "VRL3" . . . . . . . . . "MGC45714" . "VMA12" . "VPH2" . . . . . . . . "Ymer" . . . . . . . . "AFG2" . "ATPase family gene 2 homolog (S. cerevisiae)" . "SPAF" . . . . . . . . "C1q and TNF related 5" . "C1QTNF5" . "FLJ30570" . "membrane-type frizzled-related protein" . "NNO2" . "rd6" . . . . . . . . . . . . . . "HORK3" . "P2Y12" . "SP1999" . . . . . . . . . "DJ402G11.6" . "Gamma-tubulin complex component 6" . "GCP6" . "KIAA1669" . . . . . . . . . . . . . . . . . "DCDC2A" . "KIAA1154" . "NPHP19" . "RU2" . . . . . . . . . . . . "CENP-31" . "centromere protein 31" . "KIAA1823" . "MGC14797" . . . . . . . "BK125H2.1" . . . . . . . . "CD267" . "IGAD2" . "TACI" . . . . . . . . . . "Selenoprotein Z" . "Thioredoxin reductase beta" . "TR" . "TR3" . "TRXR2" . . . . . . . . . . . . . . . "FKBP6" . "FKBP65" . "FLJ20683" . "FLJ22041" . "FLJ23833" . "hFKBP65" . . . . . . . "adipocyte-derived leucine aminopeptidase" . "A-LAP" . "aminopeptidase regulator of TNFR1 shedding" . "ARTS-1" . "ERAAP1" . "KIAA0525" . "PILS-AP" . "puromycin-insensitive leucyl-specific aminopeptidase" . . . . . . . . . . . . . . . "DFNB95" . . . . . . . "HP10122" . . . . . . . . . . . . "KIAA0844" . "Talanin" . "UAN" . . . . . . . "BANK" . "FLJ20706" . . . . . . . "FLJ20733" . "HMCS" . "MOS" . . . . . . . . "CLLD7" . "CLLL7" . "FLJ10716" . . . . . . . . . . . . . . "FLJ10724" . "GUP2" . "MART-2" . "MART2" . "rasp" . "sit" . "ski" . "Skn" . . . . . . . . "CysLT(2)" . "CYSLT2R" . . . . . . . . . "ARMD6" . "CORD11" . "MGC15631" . . . . . . . . . . . . . . . "CRYPTIC" . . . . . . . . "CDG1K" . "HMAT1" . "HMT-1" . "Mat-1" . . . . . . . . . "APT6M8-9" . "ATP6M8-9" . "M8-9" . "prorenin receptor" . "PRR" . "renin receptor" . "RENR" . . . . . . . . . . . "KIAA0978" . . . . . . . . "C(27)-3BETA-HSD" . "SDR11E3" . "short chain dehydrogenase/reductase family 11E, member 3" . . . . . . . . "PDI3" . . . . . . . . . . . "C/EBP-alpha" . . . . . . . . . . . "DYF-2" . "FLJ23127" . "IFT144" . "intraflagellar transport 144 homolog (Chlamydomonas)" . "KIAA1638" . "NPHP13" . "ORF26" . "Oseg6" . "Pwdmp" . . . . . . . . "FLJ20037" . . . . . . . "MGC35334" . "PRVTIRB" . "TICAM-1" . "TIR domain-containing adapter molecule 1" . "TRIF" . . . . . . . . "IL17-RL" . . . . . . . . . . . . . . "IPM200" . "RP56" . . . . . . . . "CRP1" . . . . . . . "HPA2" . "HPR2" . . . . . . . . . . "DKFZp762K2015" . "DKFZP762K2015" . "ETL1" . "KIAA1122" . . . . . . . . . "ADGF" . . . . . . . . "FLJ23184" . "HIF-1" . "HYPB" . "KIAA1732" . "KMT3A" . . . . . . . . . . . "DEP.5" . "KIAA0645" . . . . . . . "CD366" . "FLJ14428" . "T-cell immunoglobulin mucin family member 3" . "Tim-3" . "TIM3" . "TIMD3" . . . . . . . . "F5F8D" . "LMAN1IP" . "SDNSF" . . . . . . . . "AIBP" . "apoA-I binding protein" . "MGC119143" . "MGC119144" . "MGC119145" . "NAD(P)H-hydrate epimerase" . "YJEFN1" . . . . . . "BV8" . "KAL4" . "MIT1" . "PK2" . "protein Bv8 homolog" . . . . . . . . "RNase H1" . . . . . . . "CGI-89" . "DHHC9" . "ZNF379" . "ZNF380" . . . . . . . . "a2" . "ATP6a2" . "ATP6N1D" . "J6B7" . "Stv1" . "TJ6" . "TJ6M" . "TJ6s" . "Vph1" . . . . . . . . . . "LPDLR" . "mPA-PLA1" . "mPA-PLA1alpha" . "phospholipase A(1)" . "PLA1B" . . . . . . . . "bile salt-stimulated lipase" . "BSSL" . "MODY8" . . . . . . . . . "DKFZp781H0392" . "FLJ20315" . "URCC" . . . . . . . . "KIAA0610" . "TAHCCP1" . . . . . . . . "AGS4" . "RNASEHI" . "RNHIA" . "RNHL" . . . . . . . . . . . . . . "CPT1P" . "CPTIC" . "FLJ23809" . . . . . . . "HDCMC04P" . . . . . . . . . . . . . . . "KIF10" . "PPP1R61" . "protein phosphatase 1, regulatory subunit 61" . . . . . . . . "FLJ22422" . "UDG2" . "UNG2" . . . . . . . . . "hcp-1" . "mitosin" . . . . . . . . "Adiponutrin" . "dJ796I17.1" . "FLJ22012" . "iPLA2epsilon" . . . . . . . . . "DKFZp434D0935" . "MGC16714" . "Nek8" . "NERCC" . . . . . . . . . "FLJ32685" . . . . . . . . . . . . . . "FLJ23119" . "KIAA1790" . "RIPK6" . "Roco1" . . . . . . . . . "FLJ25965" . . . . . . . . . "dardarin" . "DKFZp434H2111" . "FLJ45829" . "RIPK7" . "ROCO2" . . . . . . . . . . "COD1" . "DKFZP586E1519" . . . . . . . . . "COD2" . "KIAA1134" . . . . . . . . . . . . . . . "DOR1" . "FLJ22315" . . . . . . . . "FKBP22" . "FLJ20731" . . . . . . . . "BBS19" . "RAYL" . . . . . . . . "ARH" . "ARH2" . "DKFZp586D0624" . "FHCB1" . "FHCB2" . "MGC34705" . . . . . . . . "NIMP" . . . . . . . . . . . . . . . "DKFZP434G145" . . . . . . . "KIAA0225" . "nuclear pore complex protein Nup205" . . . . . . . . "RX" . . . . . . . "FLJ20008" . "KIAA1839" . "RBM40" . "SNRNP65" . "U11/U12 snRNP 65K" . . . . . . . . "Alpha-MPP" . "KIAA0123" . . . . . . . . . . . . "C48" . "centrosomin" . "CEP215" . "FLJ10867" . . . . . . . . "ABS" . "MGC8828" . . . . . . . . "EIF4AIII" . "Fal1" . "KIAA0111" . . . . . . . . . "FLJ16786" . "FLJ38464" . . . . . . . "BPIFF" . "BPI fold containing family F" . . . . . . . . . . . . . . . . . . "DXS707" . "TE2" . . . . . . . . . . . . . . . . . . . . . . "HOZFP" . "ovarian zinc finger protein" . . . . . . "FLJ13568" . "KIAA1354" . . . . . . . . "CILD9" . "DIC2" . "dynein intermediate chain 2" . . . . . . . . "ANUP" . "ARS" . "ArsB" . "ARS component B" . "LY6LS" . "LY6-MT" . "lymphocyte antigen 6-like secreted" . "MDM" . . . . . . . "RASSF4" . . . . . . . . "BBS2L1" . "FLJ10715" . . . . . . . . "NEM7" . "nemaline myopathy type 7" . . . . . . . . "PAT2" . "TRAMD1" . "tramdorin" . . . . . . . . . "DNA segment, single copy, probe pH4 (transforming sequence, thyroid-1" . "H4" . "PTC" . "TPC" . . . . . . . "bA145L22" . "bA145L22.2" . "ZNF698" . . . . . . . "KIAA0461" . "putative protein product of Nbla00003" . "zinc finger protein 280E" . "ZNF280E" . "ZNF635m" . . . . . . . . "ATP12" . "Atp12p" . "LP3663" . "MGC29736" . . . . . . . . "ATP11" . "Atp11p" . "FLJ22351" . . . . . . . . "KIAA0833" . . . . . . . . . . . . . . . "BLOC2S3" . "FLJ22501" . . . . . . . "cancer/testis antigen 17" . "CT17" . "LPDL" . "membrane-associated phospholipase A1 beta" . "mPA-PLA1beta" . "PLA1C" . "PRED5" . . . . . . . . "CGI-65" . "CIA30" . . . . . . . . "FLJ32662" . . . . . . . . . . . . . . . . . . "ABC35" . "ATP-binding cassette sub-family C, member 7" . "CFTR/MRP" . "dJ760C5.1" . "MRP7" . "TNR-CFTR" . . . . . . . . . . "BBF-2 homolog (drosophila)" . "OASIS" . . . . . . . . "dol-P-Man dependent GPI mannosyltransferase" . "DPM:GlcN-(acyl-)PI mannosyltransferase" . "GPI mannosyltransferase 1" . "GPI-MT-I" . . . . . . . . . "KCa4.1" . "KIAA1422" . "Sequence like a calcium-activated K+ channel" . "SLACK" . "Slo2.2" . . . . . . . . "cblA" . . . . . . . . . "helicard" . "Hlcd" . "IDDM19" . "MDA-5" . "MDA5" . "melanoma differentiation-associated gene 5" . . . . . . . . . "LAT1" . "linker for activation of T cells, transmembrane adaptor" . . . . . . . . "FLJ11090" . "SCAN1" . . . . . . . . "CD156c" . "HsT18717" . "kuz" . "MADM" . . . . . . . . . "ACVRIP1" . "AIP1" . "ARIP1" . "KIAA0705" . "MAGI-2" . . . . . . . . "CRL" . "CRL3" . "Glmr" . "GLM-R" . "IL-31RA" . . . . . . . . . . . . . . . . . . "DCR" . "KIDCR" . "SDR20C1" . "short chain dehydrogenase/reductase family 20C, member 1" . . . . . . . . . "AD035" . "Bile acid beta-glucosidase" . "DKFZp762K054" . "KIAA1605" . "Non-lysosomal glucosylceramidase" . . . . . . . . "ATC2" . "CRN" . "Lrp4" . "PRSC" . "TMPRSS10" . . . . . . . . "DIPB" . "MC7" . . . . . . . . "FLJ10337" . "KIAA1437" . "SWELL1" . . . . . . . . "COQ8" . "FLJ12229" . . . . . . . . "FLJ14813" . "greatwall kinase homolog" . "Gwl" . "THC2" . . . . . . . . . "ASP" . "Calmbp1" . "FLJ10517" . "FLJ10549" . . . . . . . . . . . . "dJ506G2.1" . "THO2" . . . . . . . . . . . . "bA430M15.1" . "CanIon" . . . . . . . . . "ASH1" . "ASH1L1" . "huASH1" . "KMT2H" . . . . . . . . . "chorein" . "KIAA0986" . . . . . . . . . "IL-23R" . . . . . . . . . "DKFZp434J1111" . "FLJ13599" . "retinoic acid inducible gene I" . "RIG-1" . "RIG1" . "RIG-I" . "RNA helicase RIG-I" . . . . . . . . . . "KIAA0673" . "nephroretinin" . "POC10" . "POC10 centriolar protein homolog (Chlamydomonas)" . "SLSN4" . . . . . . . . . . "DKFZp586K0717" . "FIP1" . . . . . . . . "CMT4H" . "Frabin" . "FRABP" . "ZFYVE6" . . . . . . . . . "PSA" . . . . . . . . . . . . . . . . . . . . "FLJ20277" . "LGMD2O" . "MGAT1.2" . "protein O-mannose beta-1,2-N-acetylglucosaminyltransferase" . . . . . . . . "KIAA0847" . . . . . . . . . . . . . . . "DKFZp547I1315" . "DKFZp686E01200" . "DKFZp781D1727" . "FLJ38614" . . . . . . . . "KIAA0042" . . . . . . . . . "dJ323M4.1" . "KIAA0790" . "SH3D6A" . . . . . . . . "FLJ14927" . "FLJ22031" . "KIAA1500" . . . . . . . "KIAA1395" . "ZIR1" . . . . . . . . "KIAA1771" . "ZIR2" . . . . . . . . . "FLJ00026" . "FLJ00152" . "FLJ00346" . "ZIR8" . . . . . . . . "FBLN6" . "FIBL-6" . "FIBL6" . "fibulin 6" . . . . . . . "SAS" . "sialic acid synthase" . . . . . . . . "RAP1" . . . . . . . . . . . . . . . "DKFZp564L2423" . "VIP36-like" . "VIPL" . . . . . . . . "ACK" . "ACK1" . "activated Cdc42-associated kinase 1" . "p21cdc42Hs" . . . . . . . . . "KANK" . "KIAA0172" . . . . . . . . . "GROS1" . "growth suppressor 1" . "LEPRECAN" . "MGC117314" . "procollagen-proline 3-dioxygenase" . . . . . . . . "FLJ10718" . "MLAT4" . "procollagen-proline 3-dioxygenase 2" . . . . . . . . "GTX" . "NKX6.1" . "NKX6B" . . . . . . . "ATP:cob(I)alamin adenosyltransferase" . "cblB" . "CFAP23" . "cilia and flagella associated protein 23" . . . . . . . . "bA346C16.3" . "KIAA1028" . . . . . . . . . "CDP2" . "KIAA0293" . . . . . . . "FLJ20052" . . . . . . . . . . . . . . . "DKFZP434K2235" . "KIAA0700" . . . . . . . . "CDG1G" . "dolichyl-P-Man:Man(7)GlcNAc(2)-PP-dolichol alpha-1,6-mannosyltransferase" . "dol-P-Man dependent alpha-1,6-mannosyltransferase" . "ECM39" . . . . . . . . "FLJ10782" . . . . . . . "ARHGAP48" . "KIAA0914" . . . . . . . . "CILD5" . "DKFZp434D0513" . "KIAA1864" . "PPP1R31" . "Protein phosphatase 1, regulatory subunit 31" . . . . . . . "RNA, U12 small nuclear 1" . "RNU12-1" . . . . . "CHETK" . . . . . . . . "Rab escort protein 1" . "REP-1" . . . . . . . . "BLU" . "CILD22" . "DNAAF7" . "dynein axonemal assembly factor 7" . . . . . . . . "FLJ32949" . "SPATA34" . "spermatogenesis associated 34" . . . . . . . "ARHGAP2" . "chimaerin 1" . "Chimerin 1 (GTPase-activating protein, rho, 2)" . "n-chimerin" . "RhoGAP2" . . . . . . . . . "CGI-97" . "FLJ10917" . "SDS" . "SWDS" . . . . . . . "Acetylcholine receptor, muscarinic 3" . . . . . . . . . . . "acetylcholine receptor, nicotinic, alpha 1 (muscle)" . . . . . . . . . "acetylcholine receptor, nicotinic, alpha 2 (neuronal)" . . . . . . . . . "acetylcholine receptor, nicotinic, alpha 4 (neuronal)" . "BFNC" . . . . . . . . . "CD156B" . "cSVP" . . . . . . . . . "acetylcholine receptor, nicotinic, alpha 7 (neuronal)" . . . . . . . . . . "acetylcholine receptor, nicotinic, beta 1 (muscle)" . . . . . . . . "acetylcholine receptor, nicotinic, beta 2 (neuronal)" . . . . . . . . . . . "acetylcholine receptor, nicotinic, delta (muscle)" . . . . . . . . . "CARK" . . . . . . . . . . "acetylcholine receptor, nicotinic, epsilon (muscle)" . "ACHRE" . . . . . . . . . . "acetylcholine receptor, nicotinic, gamma (muscle)" . . . . . . . . . "FLJ16107" . . . . . . . . . . "GCN2" . "KIAA1338" . . . . . . . . "LNIR" . "nectin-4" . "PRR4" . . . . . . . . . "LCA12" . . . . . . . . . "CHS" . . . . . . . "CGI-63" . "ETR1" . "FASN2B" . "mitochondrial 2-enoyl thioester reductase" . "NRBF1" . "nuclear receptor binding factor 1" . . . . . . . . "CGI-92" . . . . . . . "Kv8.2" . . . . . . . . . . "CNK2" . "KIAA0902" . "KSR2" . . . . . . . . "DKFZP434K1772" . . . . . . . . . . . . . . . "DISPA" . "DKFZP434I0428" . "MGC13130" . "MGC16796" . . . . . . . "KIAA1705" . "PA-PLA1" . "Phosphatidic acid-preferring phospholipase A1" . . . . . . . . "C6ST" . "C6ST1" . "chondroitin 6 sulfotransferase 1" . . . . . . . . "SCAN-1" . "SHAPY" . "Soluble Ca-Activated Nucleotidase, isozyme 1" . . . . . . . . . . . . "Dolichyl-phosphate-mannose--protein mannosyltransferase" . "LGMD2N" . . . . . . . . "ARHGAP14" . "KIAA0411" . "MEGAP" . "WRP" . . . . . . . . . "LBN" . "limbin" . . . . . . . . "I-kappa-B kinase" . "IkBKA" . "IKK1" . "IKKA" . "IKK-alpha" . "inhibitor of nuclear factor kappa-B kinase subunit alpha" . "NFKBIKA" . . . . . . . . . . "KIAA1140" . . . . . . . . "RET1" . . . . . . . "CIRHIN" . "FLJ14728" . "KIAA1988" . "NAIC" . "TEX292" . "UTP4, small subunit (SSU) processome component, homolog (yeast)" . . . . . . . . "SIX6OS1" . . . . . "ISA2" . . . . . . . . "CITK" . "CRIK" . "KIAA0949" . "serine/threonine kinase 21" . "STK21" . . . . . . . . . "HUMZD58C02" . "SREC2" . "SREC-II" . . . . . . . . . . . "MRG1" . . . . . . . . "DKFZp586M121" . "gp115" . . . . . . . . "NET37" . . . . . . "PTD009" . "SBDN" . "TRS23" . . . . . . . . . "EIEE3" . "FLJ13044" . "GC1" . "NET44" . . . . . . . . . . . . . . . . "JBTS23" . "Talpid3" . . . . . . . "tubulin polyglutamylase TTLL5" . . . . . . . . . "DAPLE" . "Dvl-associating protein with a high frequency of leucine residues" . "HkRP2" . "SCA40" . "spinocerebellar ataxia 40" . . . . . . . . . "FLJ30273" . "LCA13" . "RP53" . "SDR7C2" . "short chain dehydrogenase/reductase family 7C, member 2" . . . . . . . . "CYC" . "HCS" . . . . . . . . "APC1" . "MCPR" . "TSG24" . . . . . . . . . "FH3" . "NARC-1" . . . . . . . . . "DAND2" . "DRM" . "Gremlin" . "HMPS" . . . . . . . . . . . . . . . "FLJ12827" . . . . . . . . "MGC14793" . . . . . . . . "BBS8" . "RP51" . . . . . . . . "FLJ32864" . . . . . . . . "FLJ38602" . . . . . . . . "CCT" . "FLJ20371" . "MFSD7C" . "SLC49A2" . . . . . . . . "DKFZp434N0820" . "FLJ36164" . "NET54" . . . . . . . . . "GRX5" . "PR01238" . . . . . . . . . "ocular albinism 1" . . . . . . . . . "vesicular glutamate transporter 3" . "VGLUT3" . . . . . . . . . "DUPLIN" . "KIAA1564" . . . . . . . . "CILD10" . "FLJ10563" . "kintoun" . "KTU" . "PF13" . . . . . . . . "CaCC2" . . . . . . . . "FLJ36760" . "FLJ39011" . "MER3" . . . . . . . . "RPA39" . "RPA40" . "RPA5" . "RPAC1" . . . . . . . . "FLJ11320" . "FUCT1" . . . . . . . . . "ClC-1" . "CLC1" . "Thomsen disease, autosomal dominant" . . . . . . . . . . . . . . . . . "B3Glc-T" . "B3GTL" . "beta-1,3-glucosyltransferase" . . . . . . . . . . "ClC-2" . "CLC2" . "EJM6" . . . . . . . . . . "ClC-4" . "CLC4" . . . . . . . . . . "CGI-10" . . . . . . . . "ClC-5" . "CLC5" . "Dent disease" . "DENTS" . "hCIC-K2" . "hClC-K2" . "XLRH" . "XRN" . . . . . . . . . "FLJ33903" . "PPP1R147" . "protein phosphatase 1, regulatory subunit 147" . . . . . . . . . . "CLC-7" . "CLC7" . "OPTA2" . "PPP1R63" . "protein phosphatase 1, regulatory subunit 63" . . . . . . . . . "hClC-Ka" . . . . . . . . . "FLJ12660" . "huInd1" . "IND1" . "iron-sulfur protein required for NADH dehydrogenase" . . . . . . . . . . "hClC-Kb" . . . . . . . . . "KIAA1910" . . . . . . . . "FLJ38680" . "NPTIIc" . . . . . . . . . "CAMP" . "CHAMP" . "chromosome alignment-maintaining phosphoprotein" . . . . . . . . . . . . . . . "SMAP2" . . . . . . . "SDR2E1" . "short chain dehydrogenase/reductase family 2E, member 1" . "TDPGD" . . . . . . . "ILVASC" . "SEMP1" . "senescence-associated epithelial membrane protein 1" . . . . . . . . "HSPC014" . "proteassemblin" . "UMP1" . . . . . . . "CPETRL3" . "OSP-L" . . . . . . . . "DKFZp686D143" . . . . . . . "hSPE-39" . "SPE-39" . "SPE39" . "VIPAR" . "VPS16B" . "VPS33B interacting protein, apical-basolateral polarity regulator" . . . . . . . . . . . . . . "B14.7" . "complex I B14.7 subunit" . . . . . . . . . "complex I NP17.3 subunit" . "ESSS" . "Np15" . "NP17.3" . . . . . . . . "ABHD21" . "ACP33" . "BM-019" . "GL010" . "MAST" . . . . . . . . "FGE" . "UNQ3037" . . . . . . . . "HOMG3" . "hypomagnesemia 3, with hypercalciuria and nephrocalcinosis" . "paracellin-1" . "PCLN1" . . . . . . . . . . . . . . . . . . . . . . "calsperin" . "cancer/testis antigen 93" . "CRT2" . "CT93" . "FLJ25355" . "MGC26577" . . . . . . . . . . . . . . "MGC9850" . "RPA16" . "RPA9" . "RPAC2" . "RPO1-3" . . . . . . . . . . "HSD3" . . . . . . . . . "HUPF3B" . "RENT3B" . "UPF3X" . . . . . . . . . "FLJ11113" . "KIAA1461" . . . . . . . . "FLJ10816" . "FLJ21921" . "RPA135" . "RPA2" . "Rpo1-2" . . . . . . . . "DKFZp586I021" . "MGC7807" . "RNF119" . . . . . . . . . . "CFAP67" . "cilia and flagella associated protein 67" . "FLJ37194" . "NM23-H7" . . . . . . . . . . . . . "BACH1" . "BRCA1/BRCA2-associated helicase 1" . "FANCJ" . "OF" . . . . . . . . "EVIN2" . . . . . . . "FLJ30548" . "RP11-178C10.1" . . . . . . "APOP-1" . "apoptogenic protein 1" . "MGC2562" . . . . . . . "2-hydroxyglutarate dehydrogenase" . "FLJ12618" . . . . . . . . "FLJ11806" . "NY-REN-37" . "UKp68" . . . . . . . . . . . . . . . "Vitamin D 25-hydroxylase" . . . . . . . . . "P450RAI-2" . . . . . . . . . "spastic paraplegia 49" . "SPG49" . . . . . . . . . "bA131P10.1" . . . . . . . . "DS" . "FLJ13102" . "hCIT" . "HDS" . "RP59" . . . . . . . . "D13S1056E" . "hTg737" . "MGC26259" . "polaris homolog" . "Tg737" . . . . . . . "JSX" . "OCA6" . "oculocutaneous albinism 6 (autosomal recessive)" . . . . . . . . . . . . "FLJ20357" . "FLJ20361" . "KIAA1416" . . . . . . . "XAP121" . . . . . . . . . . . . "FLJ35613" . "NHE9" . . . . . . . . . . . . . . . . . . "APC1" . "DKFZp586G0123" . . . . . . . . . "HSA243396" . . . . . . . . . . "bHLHa39" . "Dermo-1" . "DERMO1" . . . . . . . . "histone lysine demethylase PHF8" . "JHDM1F" . "jumonji C domain-containing histone demethylase 1F" . "KDM7B" . "KIAA1111" . "ZNF422" . . . . . . . . . . . "FLJ12387" . . . . . . . . "ARM" . "FLJ12584" . "KIAA1868" . "KU-MEL-1" . . . . . . . "Guanine nucleotide-binding protein subunit beta-4" . "transducin beta chain 4" . . . . . . . . . . . . . . . . "TPP I" . . . . . . . . "FAAP43" . "FLJ10335" . "Pog" . . . . . . . . "BTN1" . "JNCL" . "juvenile neuronal ceroid lipofuscinosis" . . . . . . . "ALFY" . "KIAA0993" . "ZFYVE25" . . . . . . . . "Rabenosyn-5" . . . . . . . . "FYVE-CENT" . "KIAA0321" . "spastizin" . . . . . . . "ANKHZN" . "BTBD23" . "KIAA1255" . "rabankyrin-5" . "RANK-5" . "ZFYVE14" . . . . . . . . . "B-ALPHA-1" . "FLJ25113" . "TUBA3" . "Tubulin, alpha, brain-specific" . . . . . . . . . . . . . . . . . "beta-4" . "CFEOM3" . "CFEOM3A" . "class III beta-tubulin" . . . . . . . . . "bA631M21.2" . "class VIII beta-tubulin" . . . . . . . . . . "beta-5" . "Class IVa beta-tubulin" . . . . . . . . "beta1-tubulin" . "class I beta-tubulin" . "M40" . "MGC16435" . "OK/SW-cl.56" . "Tubb5" . . . . . . . . . . "FLJ20561" . "HsT18960" . "nclf" . . . . . . . . "FLJ22341" . "iRhom2" . "RHBDL5" . "TOCG" . . . . . . . . "FLJ39417" . "TLCD6" . . . . . . . "KIAA0260" . "UGTREL7" . . . . . . . . . "ATP-dependent protease ClpAP (E. coli), proteolytic subunit, human" . . . . . . . "4833431A01Rik" . "FLJ10477" . . . . . . . . "KIAA0062" . "NET34" . "ZIP14" . . . . . . . . "FLJ25785" . . . . . . . . "BIGM103" . . . . . . . . . "KIAA0806" . . . . . . . . . . "BCL-6 coreceptor" . "BCL6 interacting corepressor" . "FLJ20285" . "KIAA1575" . . . . . . . . "Biogenesis of Lysosome-related Organelles complex-1 Subunit 3" . "BLOC-1 subunit 3" . "BLOS3" . "Hermansky-Pudlak syndrome 8" . "HPS8" . . . . . . . . . . . "Hc" . . . . . . . . "CHC22" . "CLH22" . "CLTD" . . . . . . . . "BEND8" . "BEN domain containing 8" . "BTBD30" . "NAC-1" . "NAC1" . . . . . . . . "dJ257A7.2" . "KIAA1733" . . . . . . "DKFZp434N127" . . . . . . . . "alanine tRNA ligase 1, cytoplasmic" . "AlaRS" . "CMT2N" . . . . . . . . . "Anthrax toxin receptor" . "ATR" . "FLJ10601" . "FLJ21776" . "TEM8" . "Tumor endothelial marker 8 precursor" . . . . . . . . "DKFZP564C1278" . "FLJ10989" . "FLJ12189" . "FLJ13447" . "GatA" . "glutamyl-tRNA(Gln) amidotransferase, subunit A" . . . . . . . . . "alanine tRNA ligase 2, mitochondrial" . "bA444E17.1" . "KIAA1270" . . . . . . . . "dJ20C7.5" . . . . . . . . . "KIAA1320" . . . . . . . . "bA22L21.1" . "HRPAP20" . "HSPC125" . "My013" . . . . . . . . "MGC7199" . "NgBR" . "Nogo-B receptor" . "TANGO14" . "transport and golgi organization 14 homolog (Drosophila)" . . . . . . . . "ACKR6" . "atypical chemokine receptor 6" . "NIR1" . "RDGBA3" . . . . . . . . "dJ111C20.1" . "RSP3" . . . . . . . . . "dJ266L20.3" . "FLJ11152" . . . . . . . "CILD12" . "FLJ30845" . . . . . . . "FLJ14917" . . . . . . . . "dJ236A3.1" . "mtPheRS" . "Phenylalanine tRNA ligase 2, mitochondrial" . . . . . . . . "dJ257A7.3" . "FLJ32666" . "TS complex subunit 3" . . . . . . . . "DEHAL1" . "dJ422F24.1" . . . . . . . . . "DNAJC23" . "ERdj2" . "PRO2507" . "SEC63L" . . . . . . . . "DIP-1" . "KIAA1323" . "MIB" . "ZZANK2" . "ZZZ6" . . . . . . . . "QK3" . . . . . . . . "BIF1" . "KIAA0441" . "PATZ2" . "POZ (BTB) and AT hook containing zinc finger 2" . . . . . . . . "DSEPI" . "DS-Epi1" . . . . . . . . "E3 ubiquitin ligase-inducible degrader of the low density lipoprotein receptor" . "IDOL" . "MIR" . . . . . . . . "bA120J8.2" . "DNA repair syndrome trichothiodystrophy group A" . "FLJ30544" . "TFB5" . "TFIIH" . "TTD-A" . "TTDA" . . . . . . . . "MGC13061" . "riplet" . . . . . . . . "bA351K16.3" . "FLJ20627" . "RMD1" . . . . . . . . "FAAH" . "fatty acid hydroxylase" . "FLJ25287" . . . . . . . . "FLJ14594" . "LERN1" . . . . . . . . . "FLJ21016" . "GID7" . "GID complex subunit 7 homolog (S. cerevisiae)" . . . . . . . . . "KIAA0936" . "LCK2" . "MAK-related kinase" . "MGC46090" . "MRK" . "serine/threonine-protein kinase ICK" . . . . . . . . . "bA6B20.2" . "Cbp6" . "cytochrome B protein synthesis 6 homolog (S. cerevisiae)" . "M19" . "MGC14833" . . . . . . . . . "dJ482C21.1" . "lamina-associated polypeptide-emerin-MAN1 domain containing 2" . "LEM2" . "NET25" . . . . . . . . "dJ50J22.1" . "FLJ38755" . . . . . . . "dJ510O8.8" . "MGC33835" . "tetraspan membrane protein of hair cell stereocilia" . "Tmhs" . . . . . . . . "HCA2" . "Hypercalciuria, absorptive, 2" . "RP1-313L4.2" . "SAC" . "SACI" . "Sacy" . "soluble adenylyl cyclase" . . . . . . . . . "FLJ21935" . "FLJ22171" . "MGC3088" . . . . . . . "FLJ21522" . "MGC16817" . . . . . . . . "CDHF13" . "LAH" . . . . . . . . "dJ483K16.1" . "HELO1" . . . . . . . . . "LZ16" . "T13" . . . . . . . . "DMC" . "FLJ20071" . "SMC" . . . . . . . . . "DLDBP" . "E3BP" . "OPDX" . "PDX1" . "proX" . . . . . . . . "DENND7B" . "KIAA1766" . "MTMR13" . "myotubularin related 13" . . . . . . . . "CGI-203" . "ISD11" . . . . . . . . "dJ237I15.1" . . . . . . . . "CGI-58" . "NCIE2" . . . . . . . . "arginine tRNA ligase 2, mitochondrial (putative)" . "DALRD2" . "dJ382I10.6" . "MGC14993" . "MGC23778" . "PRO1992" . . . . . . . . "capillary morphogenesis protein 1" . "CMG-1" . "CMG1" . "FLJ22621" . . . . . . . . . . . "CORS1" . "pharbin" . "PPI5PIV" . . . . . . . . . "dJ955L16.1" . "DNA-binding protein RFX6" . "MGC33442" . . . . . . . . "dJ329L24.3" . "FLJ20170" . "MGC35304" . . . . . . . "cGMP-gated cation channel alpha-1" . "CNG1" . "RCNC1" . "RCNCa" . "RP49" . . . . . . . . . "CILD25" . "dynein, axonemal, assembly factor 4" . "EKN1" . "FLJ37882" . . . . . . . . "MGC14452" . "NPD002" . . . . . . . . "ATG16A" . "FLJ10035" . "WDR30" . . . . . . . . "CNG2" . "FLJ46312" . "OCNC1" . "OCNCa" . "OCNCalpha" . "OCNCALPHA" . . . . . . . . . . "CCNC1" . "CCNCa" . "CNG3" . . . . . . . . "CNGB1B" . "cyclic nucleotide-gated cation channel beta-1" . "GAR1" . "GARP" . "glutamic acid-rich protein" . "RCNC2" . "RCNCb" . "RP45" . . . . . . . . . "DFNA64" . "DIABLO-S" . "FLJ10537" . "FLJ25049" . "second mitochondria-derived activator of caspase" . "SMAC" . . . . . . . . . . . . . . . . . "bA166P24.2" . "bA307F22.3" . "bA74E24.1" . "dJ1018A4.2" . "dJ303F19.1" . "SPAM" . . . . . . . "CILD11" . "dJ412I7.1" . "FLJ37974" . "RSPH6B" . . . . . . . . . "FLJ20069" . "JBTS3" . "Jouberin" . "ORF1" . . . . . . . . "bA204B7.2" . "epilepsy, progressive myoclonus type 2B" . "EPM2B" . "malin" . . . . . . . . "CGI-129" . "dJ68L15.3" . "SLC54A1" . . . . . . . . . . . "FLJ21474" . "KIAA1034" . . . . . . . . "NET-2" . . . . . . . "CLCN7 accessory beta subunit" . "GL" . "HSPC019" . . . . . . . . "LUN" . "TP53BPL" . . . . . . . "bCX105N19.6" . "C6orf37" . "PBLT" . . . . . . . "FLJ34780" . . . . . . "FLJ40906" . "RSPONDIN" . . . . . . . . "DKFZP762N2316" . "KIAA1803" . "Zfp462" . . . . . . . . "CPAMD7" . "DKFZp762L1111" . "FLJ38569" . . . . . . . . "bA514O12.3" . "FLJ10907" . "RNASE6PL" . . . . . . . . "Retina-derived POU-domain factor-1" . "RPF-1" . . . . . . . . "TRIAD3" . "UBCE7IP1" . "ZIN" . . . . . . . . . . . . . . "KIAA0021" . "MCMP" . "MDC9" . "meltrin gamma" . "Mltng" . . . . . . . . . "BRCA1-associated protein required for ATM activation protein 1" . "MGC22916" . . . . . . . . "malcavernin" . "MGC4607" . "OSM" . "osmosensing scaffold for MEKK3" . . . . . . . "F3" . "glycoprotein gP135" . "GP135" . . . . . . . . "IRF-2BP2" . . . . . . . "TAG-1" . "TAX1" . . . . . . . . . "capillary morphogenesis protein 2" . "CMG-2" . "CMG2" . "FLJ31074" . . . . . . . . . . . "Gsh4" . . . . . . . . "COCH-5B2" . . . . . . . "importin alpha 8" . "IPOA8" . . . . . . . . . . . . . "Schmid metaphyseal chondrodysplasia" . . . . . . . . . "FAP163" . "FLJ10300" . . . . . . . . "FLJ10377" . . . . . . . . . "FLJ10842" . . . . . . . . . . . . "CO11A1" . "collagen XI, alpha-1 polypeptide" . "STL2" . . . . . . . . "FLJ11785" . "RINT-1" . . . . . . . . . . "HKE5" . . . . . . . . . . "collagen type XII proteoglycan" . . . . . . . . "ADAM-TS2" . "ADAMTS-3" . "hPCPNI" . "NPI" . "PCINP" . "procollagen I N-proteinase" . "procollagen N-endopeptidase" . . . . . . . . . . . . . . . . . . . . . . . . . . . "BP180" . . . . . . . . "CLN14" . "EPM3" . "FLJ32069" . . . . . . . . "endostatin" . "KNO1" . "KS" . . . . . . . . . . . . . . . . . "OI4" . . . . . . . . . . . . . . . "alpha-2 collagen type I" . "alpha 2(I)-collagen" . "collagen I, alpha-2 polypeptide" . "collagen of skin, tendon and bone, alpha-2 chain" . "type I procollagen" . . . . . . . . "ADAMTS-4" . "KIAA0366" . . . . . . . . . . . . . . . . . . . . . . . . . . . "STL1" . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . "Canstatin" . "Collagen type IV alpha 2" . "DKFZp686I14213" . "FLJ22259" . . . . . . . . . . . "tumstatin" . . . . . . . . . . "CA44" . "collagen of basement membrane, alpha-4 chain" . . . . . . . . . . . . . . . . . "XMEA" . . . . . . . . . . . . . . . "alpha 1 type V collagen" . . . . . . . . "AB collagen" . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . "dentin matrix protein 4" . "DKFZp547D065" . "DMP4" . "G-CK" . "golgi casein kinase" . "IMAGE:4942737" . . . . . . . . . . . . . . . . "collagen VII, alpha-1 polypeptide" . "LC collagen" . . . . . . . . . "FECD1" . "PPCD" . "PPCD2" . . . . . . . . . . . . . . . . . "MED" . . . . . . . . "SPG48" . "zeta" . . . . . . . . "collagen type IX proteoglycan" . "DJ885L7.4.1" . "EDM3" . "FLJ90759" . "IDD" . "MED" . . . . . . . . "CL-L1" . . . . . . . . . . . . . . . . "acetylcholinesterase-associated collagen" . "AChE Q subunit" . "collagenic tail of endplate acetylcholinesterase" . "EAD" . "single strand of homotrimeric collagen-like tail subunit of asymmetric acetylcholinesterase" . . . . . . . . "MED" . "THBS5" . "thrombospondin-5" . . . . . . . . . . . . . . . . "HEP-COP" . "proxenin" . "xenin" . . . . . . . . "beta'-COP" . "betaprime-COP" . "coatomer protein complex subunit beta prime" . . . . . . . . . . "FLJ11273" . "MGC33727" . . . . . . . . . "newborn ovary homeobox-encoding gene" . "OG2" . "Og2x" . . . . . . . "KIAA0593" . "TRAP240" . . . . . . . "Clabp TACO" . "coronin-1" . "HCORO1" . "p57" . . . . . . . . . . "ADAR1" . . . . . . . . "heme O synthase" . "protoheme IX farnesyltransferase, mitochondrial" . . . . . . . . . "CEMCOX2" . . . . . . . . "COX4-1" . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . "COXG" . . . . . . . . . . . . . . . . . . . . . . . . . . "KIAA1851" . "mannose-1-phosphate guanyltransferase beta" . . . . . . . . "CLR19.3" . "Monarch1" . "nucleotide-binding oligomerization domain, leucine rich repeat and pyrin domain containing 12" . "PAN6" . "PYPAF7" . "RNO2" . . . . . . . . . "CLR19.4" . "NOD12" . "nucleotide-binding oligomerization domain, leucine rich repeat and pyrin domain containing 7" . "PAN7" . "PYPAF3" . . . . . . . . "COX" . "COX8-2" . "COX8L" . "VIII" . "VIII-L" . . . . . . . . . "9630046K23Rik" . "hCLP46" . "KDELC family like 1" . "KDELCL1" . "MDS010" . "MDSRP" . "MGC32995" . "Rumi" . . . . . . . . "ferroxidase" . . . . . . . . . "KIAA1025" . "TRAP240L" . . . . . . . . . . "FLJ20695" . . . . . . . . "pancreatic carboxypeptidase A" . . . . . . . . "FLJ11895" . "KIAA1870" . "MGC11337" . . . . . . . . . . "DKFZp434F2322" . . . . . . . . . . . . "c316G12.3" . "CAB56184" . "GlcNAc-phosphotransferase gamma-subunit" . . . . . . . "bA810I22.1" . "cblF" . "FLJ11240" . . . . . . . . "bA59I9.3" . "COQ1B" . . . . . . . . . "NOS1" . "ZC2HC12A" . . . . . . . "bA787I22.1" . "DKFZp434P0714" . . . . . . "carbohydrate deficient glycoprotein syndrome type IV" . "CDGS4" . "D16Ertd36e" . "dol-P-Man dependent alpha-1,3- mannosyltransferase" . "dol-P-Man:Man(5)GlcNAc(2)-PP-Dol alpha-1,3-mannosyltransferase" . "Not56" . "NOT56L" . . . . . . . . "hYP38334" . "MIP-2A" . "SEDT" . "TRS20" . "ZNF547L" . . . . . . . . . . "INDY" . "NACT" . . . . . . . . . "MCT12" . "monocarboxylic acid transporter 12" . . . . . . . . . "ENT3" . "FLJ11160" . . . . . . . . . . "CPX-I" . . . . . . . . . "cadherin-related family member 11" . "CDHF14" . "CDHR11" . "FAT-J" . . . . . . . "AGF" . "angiopoietin-related protein 5" . "ARP5" . . . . . . . "TRM5" . "tRNA (guanine(37)-N1)-methyltransferase" . . . . . . . . "FLJ34198" . "sytXIV" . . . . . . . "Munc13-4" . . . . . . . . "KIAA1032" . "Munc13-1" . . . . . . . "KIND3" . "kindlin-3" . "MGC10966" . "MIG-2" . "MIG2B" . "UNC112C" . "URP2" . . . . . . . . "dolichyl-P-Glc:Man(9)GlcNAc(2)-PP-dolichol alpha- 1->3-glucosyltransferase" . . . . . . . . . "CDG1I" . "CDGIi" . "FLJ14511" . "hALPG2" . "NET38" . . . . . . . . "dolichyl-P-Glc:Glc(1)Man(9)GlcNAc(2)-PP-dolichol alpha- 1->3-glucosyltransferase" . "MGC2840" . . . . . . . . . "3'-5' RNA exonuclease" . "old-35" . "OLD35" . "PNPase" . "Polynucleotide phosphorylase" . . . . . . . . "FAAP250" . . . . . . . . "INrf2" . "kelch-like family member 19" . "KIAA0132" . "KLHL19" . "MGC10630" . "MGC1114" . "MGC20887" . "MGC4407" . "MGC9454" . . . . . . . . . "CYP4AH1" . . . . . . . . . "KIAA1867" . "KIRRE" . "NEPH2" . . . . . . . . . . . . . . . . . "FLJ37433" . "Gwt1" . . . . . . . . "DKFZp434M222" . "FLJ00135" . . . . . . . . "KIAA1858" . . . . . . . "coproporphyria" . "CPX" . "HCP" . . . . . . . . "K-CAP" . "KIAA1283" . "VIP" . . . . . . "FLJ23251" . "UBA5, ubiquitin-activating enzyme E1 homolog (yeast)" . . . . . . . . "carbamoyl-phosphate synthase (ammonia)" . . . . . . . . . . . . "MYOP" . "Sarcomeric protein myopalladin, 145 kDa" . . . . . . . "1700010H15RiK" . "CILD16" . "MGC12435" . . . . . . . "HSCO" . "YF13H12" . . . . . . . . "CPT1-L" . "L-CPT1" . . . . . . . . "AC1" . . . . . . . . . . . . "CPTASE" . . . . . . . . . "KIAA0976" . "Lmnt1" . "Netrin-G1" . "netrin G1f" . . . . . . . . "FLJ20335" . "Slob" . . . . . . . . "FLJ25179" . "p170" . . . . . . . "CEP90" . "progesterone-induced blocking factor 1" . . . . . . . . "C3DR" . "CD21" . "Epstein-Barr virus receptor" . . . . . . . . "DKFZP434C212" . "KIAA1521" . . . . . . . . . . . "C9orf143" . "C9orf145" . "DKFZp686M16108" . "FLJ25461" . "TILRR" . . . . . . . "CDA017" . "OCA7" . "oculocutaneous albinism 7, autosomal recessive" . . . . . . . . "DK1" . "dolichol kinase 1" . "KIAA1094" . . . . . . . . "RAIDD" . "RIP-associated ICH1/CED3-homologous protein with death domain" . . . . . . . . "DKFZP586B0923" . "KBP" . "kinesin binding protein" . "TTC20" . . . . . . . . . . . . . . . "LCA8" . . . . . . . . . "bA119F19.1" . . . . . . . . . . . "bA186O14.3" . . . . . . . . . . . . . . . . . . "CBP" . "KAT3A" . "RTS" . . . . . . . . . . "FLJ22774" . . . . . . . . "KIAA0187" . . . . . . . . "FLJ25162" . . . . . . . . "CMT2Q" . "DKFZP762M115" . "KIAA1630" . "MGC3090" . . . . . . . . "corticoliberin" . "corticotropin-releasing factor" . "CRF" . "CRH1" . . . . . . . . "FLJ14178" . "LINC00048" . "long intergenic non-protein coding RNA 48" . "MIHG1" . "miR-17-92" . "MIRH1" . "NCRNA00048" . "non-protein coding RNA 48" . . . . . . . "AC004542.C22.1" . "KIAA0852" . "ZCW3" . . . . . . . . "FLJ10381" . "FLJ20136" . "KIAA1421" . . . . . . . . . . . . . . . . . "THES" . "thespin" . . . . . . . . . . . . . . . . . "CISS" . "CISS1" . "CLF" . "CLF-1" . "cold-induced sweating syndrome" . . . . . . . . "TIM50L" . . . . . . . . . . "bifunctional UDP-N-acetylglucosamine 2-epimerase/N-acetylmannosamine kinase" . "Uae1" . . . . . . . . . . . . . . . . "FISH" . "five SH3 domains" . "KIAA0418" . . . . . . . . "RE2" . . . . . . . . . . "AC5" . . . . . . . . . "FLJ13859" . "FLJ20535" . "TPARM" . . . . . . "CAB2" . "MGC9753" . "PER1" . "PP1498" . . . . . . . "BBF2H7" . "TCAG_1951439" . . . . . . . . "CRSP130" . "DRIP130" . "Sur2" . . . . . . . . . "bHLHa29" . "p48" . "PTF1-p48" . . . . . . . . . "MGC27091" . . . . . . . . . "CRSP77" . "DRIP80" . "SRB4" . "TRAP80" . . . . . . . . "FAB1" . "KIAA0981" . "MGC40423" . "p235" . "PIKfyve" . "PIP5K" . "ZFYVE29" . "zinc finger, FYVE domain containing 29" . . . . . . . . . . "inverted formin 2" . "MGC13251" . . . . . . . . . "CASP" . "leprecan-like 3" . "LEPREL3" . "P3H5" . "prolyl 3-hydroxylase family member 5 (non-enzymatic)" . . . . . . . . "AC6" . . . . . . . . . "KIAA0545" . "SPAR3" . . . . . . . . "CRD" . "LCA7" . "orthodenticle homeobox 3" . "OTX3" . . . . . . . . "Fanconi anemia, complementation group P" . "FANCP" . "KIAA1784" . "KIAA1987" . . . . . . . . . . . . "HSPB4" . . . . . . . . . . . . "HSPB5" . . . . . . . . . . . "eye lens structural protein" . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . "B17.2" . "complex I B17.2 subunit" . "DAP13" . . . . . . . . . . . . . . . . . . . . "4-aminobutyrate transaminase" . "GABA-T" . "GABAT" . "GABA transaminase" . "gamma-aminobutyrate aminotransferase" . . . . . . . . . . . . . . . . "APPL" . "DCC-interacting protein 13-alpha" . . . . . . . . "adenomatous polyposis coli like" . "APCL" . . . . . . . "ACAM" . "Adipocyte adhesion molecule" . "Adipocyte-specific adhesion molecule" . "ASAM" . "Coxsackie- and adenovirus receptor-like membrane protein" . "FLJ22415" . . . . . . . "DKFZp586I1419" . "TAZ" . . . . . . . . "ADP-ribosylation factor-like tumor suppressor gene 1" . "ARLTS1" . "FLJ33930" . . . . . . . "MGC33864" . . . . . . . . "AF15Q14" . "blinkin, bub-linking kinetochore protein" . "cancer/testis antigen 29" . "CT29" . "D40" . "hKNL-1" . "hSpc105" . "KIAA1570" . "kinetochore null 1 homolog (C. elegans)" . "PPP1R55" . "protein phosphatase 1, regulatory subunit 55" . "Spc7" . . . . . . . . "aldose 1-epimerase" . "aldose mutarotase" . "galactomutarotase" . . . . . . . . . . . . . . "KIAA1001" . . . . . . . . . . . . . . . . . "AGS3" . "Aicardi-Goutieres syndrome 3" . "AYP1" . . . . . . . . . . . . . . . . . . . "B9" . "endothelial precursor protein B9" . "EPPB9" . "MKS9" . "MKSR-1" . . . . . . . . "actin-related protein 4" . "Actl6" . "Arp4" . "Baf53a" . "BAF53A" . "BAF complex 53 kDa subunit" . "BRG1-associated factor" . "INO80 complex subunit K" . "INO80K" . . . . . . . "BCR downstream signaling 1" . "BRDG1" . "STAP-1" . . . . . . . . "BM-011" . "MGC12197" . "SFRS21" . "splicing factor, arginine/serine-rich 21" . "SRrp53" . . . . . . . "CRIM3" . "crossveinless-2" . "Cv2" . . . . . . . "BHC80" . "BM-006" . "KIAA1696" . . . . . . . . . . . . . . . "crystallin, gamma 8" . . . . . . . "BRCC36" . "C6.1A" . "Lys-63-specific deubiquitinase" . . . . . . . . "DFNA40" . "thiomorpholine-carboxylate dehydrogenase" . . . . . . . . "CANP" . . . . . . . . "endoplasmic reticulum intermembrane small protein" . "ERIS" . "Miner1" . "mitoNEET related 1" . "NAF-1" . "nutrient-deprivation autophagy factor-1" . . . . . . . . "CIDE-3" . "FLJ20871" . "Fsp27" . . . . . . . . "CILD21" . "FLJ32660" . "MGC16372" . . . . . . . "HBEBP2" . "HBEBP4" . . . . . . . . "CGI-04" . "FLJ13995" . "mt-TyrRS" . "tyrosine tRNA ligase 2, mitochondrial" . . . . . . . . "CGI-121" . "CGI121" . . . . . . . . "Bcl-2 inhibitor of transcription" . "BIT1" . "CFAP37" . "CGI-147" . "cilia and flagella associated protein 37" . "PTH2" . . . . . . . . . "ASC1p50" . "CGI-18" . "Em:AC022392.3" . . . . . . . . "CGI-77" . "DUBA5" . . . . . . . "CGI-87" . "TTC-15" . . . . . . . . . . . . . . . . "CD115" . "C-FMS" . "CSFR" . . . . . . . . . "alpha-GM-CSF receptor" . "alphaGMR" . "CD116" . . . . . . . . . "beta common cytokine receptor" . "beta-GM-CSF receptor" . "betaGMR" . "CD131" . "IL5RB" . . . . . . . . . . . . "GCSFR" . . . . . . . . . . . . . . . . "D4ST-1" . "HD4ST" . . . . . . . . . . . . . . . "DKFZP434C245" . . . . . . . . "DKFZP434F2021" . "NET17" . . . . . . "ARHGEF44" . "DKFZP434I216" . "puratrophin-1" . . . . . . . . "DKFZP434J046" . "FLJ33298" . . . . . . . . . . "DKFZP564D116" . "JBTS18" . "TECT3" . . . . . . . . "cblC" . "DKFZP564I122" . . . . . . . . "DKFZP564J0863" . . . . . . . "DKFZP564K1964" . . . . . . "CKID" . "CKIdelta" . "HCKID" . . . . . . . . . . . . "CHMP2.5" . "DKFZP564O123" . "VPS2B" . "VPS2 homolog B (S. cerevisiae)" . . . . . . . . "DKFZP566B183" . . . . . . . . "DKFZP586B1621" . "FAD-AMP lyase (cyclizing)" . "NET45" . . . . . . . "DKFZP586P0123" . . . . . . . . . "CENP-36" . "Centromere protein 36" . "DKFZP727C091" . "MSL1v1" . "NSL1" . . . . . . . . "DUP" . "RIS2" . . . . . . . . . "KIP2" . . . . . . . "down regulated by Ctnnb1, a" . "DRCTNNB1A" . "HCC" . "HYCC1" . "hyccin" . . . . . . . "dudlin-2" . "STMP3" . "TSAP6" . . . . . . . . . "CGI-60" . "D2LIC" . "DKFZP564A033" . "LIC3" . . . . . . . . "gamma-adducin" . . . . . . . . "Ckb1" . "Ckb2" . . . . . . . . . "BAP" . "ULG5" . . . . . . . "eps15R" . . . . . . . . "PG-M" . "versican proteoglycan" . . . . . . . . . "bA188C12.1" . "Eu-HMTase1" . "FLJ12879" . "FLJ40292" . "KIAA1876" . "KMT1D" . . . . . . . . . . "Factor H related protein 5" . "FHR-5" . "FHR5" . . . . . . . . "bHLHc8" . "Factor in the germline alpha" . . . . . . . . "FAD1" . "PP591" . . . . . . . . "ALKBH9" . "AlkB homolog 9" . "alpha-ketoglutarate-dependent dioxygenase" . "KIAA1752" . "MGC5149" . . . . . . . . "FLVCR" . "MFSD7B" . "PCA" . "SLC49A1" . . . . . . . . . "FLJ10283" . "GPATC7" . "GPATCH7" . "HSU84971" . "VG5Q" . . . . . . . . "BAM" . "Bamacan" . "bamacan proteoglycan" . "HCAP" . "SMC3L1" . . . . . . . . "AB-DIP" . "FLJ20259" . "VERBRAS" . . . . . . . "FLJ20298" . "GRAMD8B" . "RP11-321G1.1" . . . . . . . . "FLJ22794" . "KIAA1895" . . . . . . . . "cardiac LIM protein" . "CLP" . "CMD1M" . "MLP" . . . . . . . . . . . . . . "CSNB1F" . "Fibronectin type III, immunoglobulin and leucine rich repeat domains 4" . "FIGLER4" . "FLJ44691" . . . . . . . "FLJ46072" . . . . . . . . "fls485" . "ssu-2" . . . . . . . "stefin A" . . . . . . . . . "CST6" . "PME" . "stefin B" . . . . . . . . "GAR17" . . . . . . . "GL004" . . . . . . . "UGRP" . . . . . . . . "CWH41" . "DER7" . "GCS1" . "glucosidase I" . "processing A-glucosidase I" . . . . . . . . "CFAP256" . "GlyBP" . "glycine, glutamate, thienylcyclohexylpiperidine binding protein" . "JBTS25" . "ROC22" . "RP1-286D6.4" . . . . . . . "AD-017" . "FLJ14611" . . . . . . . . . . . . . . . . . . . . . "CSX1" . "NKX2.5" . "NKX4-1" . "tinman paralog (Drosophila)" . . . . . . . . "FLJ35857" . "H326" . . . . . . . "DKFZP564K112" . "HDCMA18P" . "PIP7S" . "P-TEFb-interaction protein for 7SK stability" . . . . . . . . "FLJ32642" . "HCRP1" . "Hepatocellular carcinoma related protein 1" . "SPG53" . . . . . . . . "HCA127" . . . . . . . "endothelial cell LPL transporter" . "GPI-HBP1" . "LOC338328" . . . . . . . . "BARS" . "brefeldin A-ribosylated substrate" . . . . . . . "NPR2" . "NPR2L" . . . . . . . "FCP1" . . . . . . . . "COX25" . "HSPC009" . "MITRAC12" . . . . . . . "HSPC133" . . . . . . "FANCT" . "HSPC150" . . . . . . . . . "CCN2" . "IGFBP8" . . . . . . . . . . "HSPC244" . "JBTS2" . "MGC13379" . . . . . . . . . . . . . . . . "CFAP111" . "COMT2" . . . . . . . . . . . . . "CD" . "CD152" . "CTLA-4" . "GSE" . . . . . . . . . . . "Pip1" . "POT1 and TIN2 organizing protein" . "Ptop" . "TIN2 interacting protein 1" . "Tint1" . "Tpp1" . . . . . . . . "NY-BR-85" . . . . . . . . . "alpha-E-catenin" . "CAP102" . . . . . . . . "FLJ34884" . "gumby" . "ubiquitin thioesterase otulin" . . . . . . . . . . "alpha-T-catenin" . "MGC26194" . "VR22" . . . . . . . . "Methionine tRNA ligase 2, mitochondrial" . "mtMetRS" . "SPAX3" . . . . . . . . "CMT2P" . "E3 ubiquitin-protein ligase LRSAM1" . "FLJ31641" . . . . . . . . . . . . . . . . "armadillo" . "beta-catenin" . . . . . . . . "TAD3" . "tRNA-specific adenosine deaminase 3 homolog (S. cerevisiae)" . . . . . . . . "DHDPS2" . "dihydrodipicolinate synthetase homolog 2 (E. coli)" . "FLJ37472" . "N-acetylneuraminate pyruvate lyase 2 (putative)" . "NPL2" . . . . . . . . "KIAA0384" . "p120" . "p120cas" . "p120ctn" . . . . . . . . "FLJ37327" . "GASP2" . . . . . . . . . "GT24" . "neural plakophilin-related arm-repeat protein" . "neurojungin" . "NPRAP" . . . . . . . . . . . . . "MGC10235" . "TRM9" . "TRMT9A" . "tRNA methyltransferase 9 related" . . . . . . . "CTNS-LSB" . "PQLC4" . "SLC66A4" . . . . . . . . . . . . . . . . . . "GATD5" . . . . . . . . . . "cblD" . "CL25022" . . . . . . . . . . "4-hydroxybenzoate polyprenyltransferase" . "CL640" . "FLJ26072" . . . . . . . . "DJ159A19.3" . "RP1-159A19.1" . . . . . . . . . . "caldecrin" . "CLCR" . "ELA4" . "elastase 4" . . . . . . . . . "DKFZp313M0720" . . . . . . . . "CILD14" . "DKFZp434A128" . "FAP59" . . . . . . . . . . . . . . . "DKFZP434H0115" . . . . . . . . . "dipeptidyl peptidase 1" . "DPP1" . . . . . . . . . "ceroid-lipofuscinosis, neuronal 10" . "CLN10" . . . . . . . . . "DKFZP434K046" . . . . . . . . "CATSF" . "CLN13" . . . . . . . . . "DKFZp434O0527" . "MGC35338" . . . . . . "DKFZp547M236" . "Zinc transporter 8" . "ZnT-10" . "ZNT8" . "ZRC1" . . . . . . . . . "DKFZP547N043" . "DNA damage-targeting VCP (p97) adaptor" . "DVC1" . "Spartan" . "SprT-like domain at the N terminus" . . . . . . . . "ACC-4" . "ACC4" . "ACC-5" . "ACC5" . . . . . . . . . "DKFZP564B1023" . "ZNHIT5" . . . . . . . "DKFZP564B1162" . "FilGAP" . "FLJ33877" . . . . . . . . "3M3" . "DKFZp564K0322" . "PPP1R20" . "protein phosphatase 1, regulatory subunit 20" . . . . . . . . "PKND" . . . . . . . . . "DKFZp586C1924" . "OPA7" . . . . . . . . . "DKFZp686J0811" . . . . . . . "DKFZp761A078" . "FLJ22097" . "SAS-6" . "SAS6" . . . . . . . . "BDP" . "branched-chain α-ketoacid dehydrogenase phosphatase" . "DKFZp761G058" . "hPTMP" . "PP2Ckappa" . "PP2Cm" . "PP2C-type mitochondrial phosphoprotein phosphatase" . "Protein phosphatase 2C kappa" . . . . . . . . "DKFZp761H079" . "JBTS8" . . . . . . . . "DKFZp761L1518" . "FLJ00101" . . . . . . "DKFZp761P1121" . . . . . . . . "DKFZP762D096" . "membrane protein-associated neurodegeneration" . "MGC10922" . "MPAN" . "NBIA4" . "neurodegeneration with brain iron accumulation 4" . . . . . . . "DT1P1A10" . "escortin" . "RP1-112K5.2" . "WGG1" . "WGG motif containing 1" . . . . . . . "FKSG32" . "tRNA pseudouridine(38/39) synthase" . "tRNA-uridine isomerase 3" . . . . . . . . . . "FLJ10140" . "MTO2" . . . . . . . . "FLJ10201" . "FLJ12841" . "FLJ13308" . "KIAA1197" . . . . . . . "gp280" . "IFCR" . "intrinsic factor-cobalamin receptor" . . . . . . . . "bA295P9.4" . "FLJ10210" . "KIAA1294" . . . . . . . . "ArPIKfyve" . "FLJ10305" . . . . . . . . . . . . "FLJ10375" . "MGC47890" . "SCAR10" . . . . . . . . "FLJ10385" . "TCAB1" . "telomerase cajal body protein 1" . "WD-encoding RNA antisense to p53" . . . . . . . . "Akt-phosphorylation enhancer" . "APE" . "FLJ10392" . "Galpha-interacting vesicle-associated protein" . "girders of actin filaments" . "girdin" . "GIV" . "GRDN" . "HkRP1" . . . . . . . "FLJ10486" . "mtPAP" . "SPAX4" . "TENT6" . "TUTase1" . . . . . . . . "bA219P18.1" . "D4Ertd89e" . "FLJ10493" . "TRIC-B" . . . . . . . "FLJ10496" . . . . . . . "Aspartate tRNA ligase 2, mitochondrial" . "FLJ10514" . "mtAspRS" . . . . . . . . "FANCW" . "FLJ10520" . "RNF201" . . . . . . . . . . . . . . . "FLJ10640" . "KIAA1933" . . . . . . . . . . . . . . . . "FLJ10707" . . . . . . . "FLJ10709" . . . . . . . . "FLJ10719" . . . . . . . . "ATP-dependent NAD(P)H-hydrate dehydratase" . "FLJ10769" . "LP3298" . . . . . . . "CASP" . "CDP" . "CDP1" . "CDP/Cut" . "CDP/Cux" . "Clox" . "CUT" . "CUX" . "CUX1 gene Alternatively Spliced Product" . "Cux/CDP" . "golgi integral membrane protein 6" . "GOLIM6" . . . . . . . . "CILD23" . "DKFZP434P1735" . "FLJ10376" . "FLJ10817" . . . . . . . "CCRL1" . "CMKDR1" . "V28" . . . . . . . . . "FLJ10925" . . . . . . . "FLJ10979" . "HCCS1" . . . . . . . . "FLJ10998" . "hDrn1" . . . . . . . "CD184" . "D2S201E" . "fusin" . "HM89" . "HSY3RR" . "LESTR" . "NPY3R" . "NPYR" . "NPYY3R" . . . . . . . . . "FLJ11142" . . . . . . . "FLJ11175" . "FLJ33303" . . . . . . . "FLJ11200" . . . . . . . "FLJ11362" . . . . . . . . "FLJ11457" . "IFT139B" . "JBTS11" . "NPHP12" . "THM1" . . . . . . . . "FLJ11506" . "p34" . . . . . . . "FLJ11712" . . . . . . . "FLJ11752" . "gerodermia osteodysplastica" . "GO" . "NTKL-BP1" . "RAB6-interacting golgin" . . . . . . . . . . . "71-7A" . "JBTS10" . . . . . . . . . . "FLJ11795" . . . . . . . . "FLJ11838" . . . . . . . . . "CG1" . "F18" . . . . . . . . "cysteine tRNA ligase 2, mitochondrial (putative)" . "FLJ12118" . . . . . . . . "FLJ12242" . . . . . . . . . . . . . . . . . "Bst1" . "FLJ12377" . "GPI inositol-deacylase" . "SPG67" . . . . . . . . . "FLJ12525" . . . . . . . . "Cernunnos" . "FLJ12610" . "XLF" . "XRCC4-like factor" . . . . . . . . "FLJ12643" . . . . . . . . . . "FLJ12716" . "foie gras homolog (zebrafish)" . "foigr" . "gry" . "gryzun homolog (Drosophila)" . . . . . . . . . "FLJ12975" . "JBTS24" . "Meckel syndrome, type 8" . "MKS8" . "TECT2" . . . . . . . . "flavocytochrome b-558 alpha polypeptide" . "p22-PHOX" . . . . . . . . "FLJ13063" . . . . . . . . "FLJ13096" . "Woodhouse-Sakati syndrome" . . . . . . . . . "FLJ13110" . "receptor expression enhancing protein 1" . "SPG31" . "Yip2a" . . . . . . . . "FAM42A" . "FLJ13119" . "HsT19294" . "RIA1" . "ribosome assembly 1 homolog (yeast)" . . . . . . . "GP91-PHOX" . "NADPH oxidase 2" . "NOX2" . . . . . . . . . . "FLJ13154" . "HVSL1" . "HVSL motif containing 1" . "Mpn1" . "mutated in poikiloderma with neutropenia protein 1" . "poikiloderma with neutropenia" . "U six biogenesis 1" . . . . . . . "FLJ13220" . . . . . . . "UQCR4" . . . . . . . . "Adenosine 5'-phosphotransferase" . "AK" . . . . . . . . . . . "FLJ13231" . "Hug" . "JBTS17" . . . . . . . "FLJ13305" . . . . . . . . "FLJ13352" . "polyprenol reductase" . "SRD5A2L" . "SRD5A2L1" . . . . . . . . "FLJ13386" . . . . . . . . . . . . "SOM" . . . . . . . . "FLJ13841" . "Zfp750" . . . . . . . . . "KIAA0849" . "ubiquitin specific peptidase like 2" . "USPL2" . . . . . . . . . . "CLIP" . "CLIP-115" . "KIAA0291" . "WSCR3" . "WSCR4" . . . . . . . . . "calcium release-activated calcium modulator 1" . "CRACM1" . "FLJ14466" . . . . . . . . . "FLJ14490" . "sodium-dependent lysophosphatidylcholine symporter 1" . . . . . . . . . "AGO61" . "FLJ14566" . "protein O-mannose beta-1,4-N-acetylglucosaminyltransferase 2" . . . . . . . . "FLJ14600" . "thorase" . . . . . . . . "cholesterol monooxygenase (side-chain-cleaving)" . "P450SCC" . . . . . . . . . . "CPN1" . "FHI" . "P450C11" . "steroid 11-beta-monooxygenase" . . . . . . . . . . "FLJ14888" . "HSPC264" . . . . . . . . "ALDOS" . "CPN2" . "CYP11BL" . "P450aldo" . "P-450C18" . "steroid 11-beta-monooxygenase" . . . . . . . . . . "CPT7" . "P450C17" . "S17AH" . "Steroid 17-alpha-monooxygenase" . . . . . . . . . . . . . . . . . "FLJ20032" . . . . . . . . "DRE1" . "FLJ20059" . . . . . . . . . "ARO" . "ARO1" . "aromatase" . "CPV1" . "CYAR" . "P-450AROM" . . . . . . . . . "FLJ20152" . "JK1" . . . . . . . . . . "CP1B" . . . . . . . . . "FLJ20244" . "TRM1" . . . . . . . . "FLJ20265" . "GPI7" . "GPI ethanolamine phosphate transferase 2" . "LAS21" . . . . . . . . . "FLJ20303" . "Misu" . "Myc-induced SUN-domain-containing protein" . "TRM4" . "tRNA methyltransferase 4 homolog (S. cerevisiae)" . . . . . . . . "castor" . "cst" . "FLJ20321" . "SRG" . "survival related gene" . "zinc finger protein 693" . "ZNF693" . . . . . "FLJ20343" . "MGC19520" . . . . . . . . . "CA21H" . "CAH1" . "CPS1" . "P450c21B" . "Steroid 21-monooxygenase" . . . . . . . . . "CILD18" . "FLJ20397" . "FLJ25564" . "FLJ31671" . "FLJ39381" . . . . . . . "FLJ20421" . "golgi-resident nucleotide phosphatase" . "gPAPP" . "IMPA3" . . . . . . . . "FLJ20432" . "mitochondrial RNase P subunit 1" . "MRPP1" . . . . . . . . "bHLHe81" . "FLJ20449" . "SPATA28" . "spermatogenesis associated 28" . "TEB1" . . . . . . "CP24" . "P450-CC24" . . . . . . . . . "dol-P-Man dependent GPI mannosyltransferase" . "FLJ20477" . "GPI mannosyltransferase 2" . . . . . . . . "FLJ20485" . . . . . "FLJ20487" . "SDH5" . . . . . . . . "FLJ20507" . "FLJ22257" . . . . . . . "FLJ20533" . . . . . . . "FLJ20551" . . . . . . . . "CVG5" . "DNA segment on chromosome X (unique) 9879 expressed sequence" . "DXS9879E" . "DXS9951E" . "ESO3" . "ITBA2" . "Pcc1" . . . . . . . . "cerebrotendinous xanthomatosis" . "CP27" . "CTX" . . . . . . . . . "1alpha(OH)ase" . "25-Hydroxyvitamin D3 1alpha-hydroxylase" . "Calcidiol 1-monooxygenase" . "CYP1" . "P450c1" . "VDDR I" . . . . . . . . . . . "CILD15" . "FAP172" . "FLJ20753" . "FLJ32021" . "KIAA1640" . . . . . . . . "FAP69" . "flagellar protein 69 homolog (Chlamydomonas)" . "FLJ21062" . "hypothetical protein FLJ21062" . . . . . . . "CPA6" . "CYP2A" . . . . . . . . . "FLJ21127" . "JBTS13" . "TECT1" . . . . . . . . "FLJ21128" . "hYjeF_N2-15q23" . "LSM16" . "LSM16 homolog (EDC3, S. cerevisiae)" . "YJEFN2" . . . . . . . . . . . "FANCN" . "Fanconi anemia, complementation group N" . "FLJ21816" . . . . . . . . "CCP5" . "cytosolic carboxypeptidase 5" . "FLJ21839" . . . . . . . . "FLJ21977" . . . . . . . . "AAF132" . "alpha accessory factor 132" . "Conserved telomere capping protein 1" . "Conserved telomere maintenance component 1" . "FLJ22170" . . . . . . . "egg-derived tyrosine phosphatase homolog (Drosophila)" . "FLJ22405" . "FLJ90311" . "hEDTP" . "hJumpy" . . . . . . . . . . "CSPP" . "FLJ22490" . "JBTS21" . . . . . . . "FLJ22531" . "TOPOVIBL" . . . . . . . "bA541N10.2" . "FLJ22559" . . . . . . . . . . . . . . . . . . . . . "ciliogenesis and planar polarity effector 3" . "CPLANE3" . "FLJ22688" . "Fy" . . . . . . . . "FLJ22728" . "SDR10E1" . "short chain dehydrogenase/reductase family 10E, member 1" . . . . . . . . "DKFZp667M1322" . "FLJ13624" . "FLJ22833" . "hSSB2" . "MGC111163" . "Sensor of single-strand DNA complex subunit B2" . "Single-stranded DNA-binding protein 2" . "SOSS-B2" . "SSB2" . . . . . . . . "FLJ22965" . . . . . . . . "FLJ23191" . . . . . . "bA108L7.8" . "FLJ23209" . . . . . . . "FLJ23263" . . . . . . . . . "FLJ23356" . "SGK196" . . . . . . . . . "FLJ23144" . "FLJ23403" . "FLJ34907" . "HsT748" . "HsT771" . . . . . . . . . "asparagine tRNA ligase 2, mitochondrial (putative)" . "FLJ23441" . "SLM5" . . . . . . . . . "CaM KMT" . "CLNMT" . . . . . . . . "FLJ23560" . . . . . . . . . "cancer/testis antigen 122" . "CT122" . "FLJ23577" . "KPL2" . . . . . . "AI2A4" . "amelogenesis imperfecta type IIA4" . "FLJ23657" . . . . . . . "FLJ25410" . . . . . . . . . "FLJ25530" . "GLIALCAM" . "glial cell adhesion molecule" . "hepaCAM" . . . . . . . . "FLJ30296" . . . . . . . "RDC8" . . . . . . . . . "FLJ30532" . "TRIC" . "Tricellulin" . . . . . . . "FLJ30596" . "mitochondrial NAD kinase" . "MNADK" . . . . . . . "FLJ31236" . "Xtrp2" . . . . . . . . . "FLJ31300" . "HMFN0320" . "urocanase 1" . . . . . . . . "FLJ32203" . "RP58" . . . . . . . . "CP51" . "CYPL1" . "LDM" . "P450-14DM" . "P450L1" . . . . . . . . "CCP4" . "cytosolic carboxypeptidase 4" . "FLJ32310" . . . . . . . . "FLJ32440" . "MMS21" . "NSE2" . "zinc finger, MIZ-type containing 7" . "ZMIZ7" . . . . . . . . "cholesterol 7 alpha-monooxygenase" . . . . . . . . . "FLJ32670" . "LH2D1" . . . . . . . . "FLJ32731" . "HGNAT" . . . . . . . . . . . . . . . . . . "FLJ32743" . . . . . . . . "DZIP2" . "FLJ32844" . . . . . . . . . "FLJ32915" . . . . . . . . "CILD20" . "FLJ32926" . . . . . . . . . "FLJ33207" . . . . . . . "FLJ33496" . "KIAA1843" . "UNC-80" . . . . . . . . . "Dok-7" . "FLJ33718" . "FLJ39137" . . . . . . . . "CAMRQ2" . "FLJ33817" . "PPP1R166" . "protein phosphatase 1, regulatory subunit 166" . "SORF-2" . . . . . . . . . . . . . . "CT143" . "FLJ34497" . "PF6" . "RP4-776P7.2" . . . . . . . "FLJ34633" . "RP11-344H11.3" . . . . . . . "FLJ35630" . "FLJ41559" . . . . . . . . "CR" . "CROM" . "TC" . . . . . "FLJ35794" . . . . . . . . . . "156DAG" . "A3a" . "AGRNR" . "alpha-dystroglycan" . "beta-dystroglycan" . "DAG" . "dystrophin-associated glycoprotein-1" . . . . . . . . "bA373N18.2" . "FLJ22944" . "FLJ36006" . . . . . . . . . "FLJ36090" . . . . . . . "FLJ36445" . "Nesp4" . "Nesprin-4" . . . . . . . . . . . . "DAAO" . "DAMOX" . . . . . . . . . "FLJ36928" . "NPHP16" . . . . . . . . "FLJ38663" . "SPG55" . . . . . . . "FAMIN" . "fatty acid metabolism\u0096immunity nexus" . "FLJ38725" . . . . . . . "aspartate tRNA ligase 1, cytoplasmic" . . . . . . . . "FLJ38736" . . . . . . . "DAP6" . . . . . . . . "FLJ39501" . . . . . . . . . . "CAMDI" . "coiled-coil protein associated with myosin II and DISC1" . "FLJ39502" . . . . . . . "SPGY" . . . . . . . "Adenomatous polyposis coli membrane recruitment 1" . "FLJ39827" . "RP11-403E24.2" . "Wilms Tumor on the X" . "WTX" . . . . . . . . "FLJ40629" . "radial fiber and mitotic spindle" . "radmis" . . . . . . . "FLJ90013" . . . . . . . "FLJ90254" . . . . . . . . "FLJ90492" . "SMILE" . . . . . . . . "DBM" . "dopamine beta-monooxygenase" . . . . . . . . . "FLJ90579" . . . . . . . . "FLJ37706" . "RAD26L" . . . . . . . "FLJ14602" . "GL009" . . . . . . . . . "H17" . . . . . . . "FLJ22851" . "HH114" . "MGC11326" . . . . . . . "HSPC138" . "HSPC179" . "OPI10" . . . . . . . . "HSPC196" . "JBTS16" . . . . . . . "FLJ43269" . . . . . . . . "LOC124512" . . . . . . . . . . "dihydrolipoyllysine-residue (2-methylpropanoyl)transferase" . "lipoamide acyltransferase component of branched-chain alpha-keto acid dehydrogenase complex, mitochondrial" . . . . . . . . "DFNB99" . . . . . . . . . . . . . . "IGDCC1" . "immunoglobulin superfamily, DCC subclass, member 1" . "NTN1R1" . . . . . . . . "DNAJA5" . "GS3" . "JJJ1" . "JJJ1 DnaJ domain protein homolog (S. cerevisiae)" . . . . . . . "decorin proteoglycan" . "DSPG2" . "SLRR1B" . . . . . . . . . "ACE1" . "CD143" . "peptidyl-dipeptidase A" . . . . . . . . . "leucine rich repeat containing 16C" . "LRRC16C" . "RGD, leucine-rich repeat, tropomodulin and proline-rich containing protein" . . . . . . . . "p150 glued homolog (Drosophila)" . . . . . . . . . "DBCN" . "DC" . "doublecortex" . "LISX" . "SCLH" . "XLIS" . . . . . . . . "DDBB" . "DDB p48 subunit" . "FLJ34321" . "UV-damaged DNA-binding protein 2" . "UV-DDB2" . "xeroderma pigmentosum group E protein" . "XPE" . . . . . . . . "AADC" . "aromatic L-amino acid decarboxylase" . . . . . . . . . "EFO2" . . . . . . . . . . "Bardet-Biedl syndrome 21" . "BBS21" . "cone-rod dystrophy 16" . "CORD16" . "FLJ30600" . "RP64" . . . . . . . "C/EBP zeta" . "CHOP" . "CHOP10" . "GADD153" . . . . . . . . "malonyl-CoA synthetase" . . . . . . . . "advanced glycation end-product receptor 1" . "GATD6" . "KIAA0115" . "oligosaccharyltransferase subunit 48" . "OST" . "OST48" . "WBP1" . . . . . . . . . "FLJ12734" . "Iron-sulfur cluster assembly factor for biotin synthase- and aconitase-like mitochondrial proteins, with a mass of 57kDa" . . . . . . . . . "BHD" . "MGC17998" . "MGC23445" . . . . . . . "TKT" . . . . . . . . . . . "GDD1" . . . . . . . . "DKFZp313B2333" . "DKFZp313D0829" . "glycoprotein, synaptic 2-like" . "GPSN2L" . "SRD5A2L2" . "TERL" . . . . . . . "CHL1" . "CHL1-like helicase homolog (S. cerevisiae)" . "CHLR1" . "KRG2" . "WABS" . . . . . . . . "DKFZp686C1178" . "FLJ36866" . . . . . . . . . . . . . . . . "DBX" . "DDX14" . "HLP2" . . . . . . . . "RCK" . . . . . . . . "SEN54" . "SEN54L" . . . . . . . . "D6S231E" . . . . . . . . . . "CMD1I" . "CSM1" . "CSM2" . "intermediate filament protein" . . . . . . . . "adipsin" . "ADN" . . . . . . . . . "bA100C15.3" . "bHLHe80" . "NOHLH" . "SPATA27" . "spermatogenesis associated 27" . "TEB2" . . . . . . . . . "Hartnup disease" . . . . . . . . . . "ERIS" . "FLJ38577" . "MITA" . "MPYS" . "NET23" . "stimulator of interferon genes" . "STING" . . . . . . . . . . . "BOM" . "FLJ13782" . . . . . . . . . "ichthyin" . "ICHYN" . . . . . . . . . . "BBS15" . "ciliogenesis and planar polarity effector 5" . "CPLANE5" . "fritz" . "hFrtz" . . . . . . . "FLJ33839" . . . . . . . . "APP3" . "ICP55" . "Intermediate Cleaving Peptidase 55" . "NPHPL1" . . . . . . . . . "FLJ20796" . "MZM1L" . . . . . . . . "B17.2L" . "mimitin" . "MMTN" . "Myc-induced mitochondrial protein" . . . . . . . . "bA348N5.3" . "BBIP10" . "BBS18" . . . . . . . "ICERE-1" . "inversely correlated with estrogen receptor expression" . . . . . . . "MGC10744" . . . . . . . . "ccp1" . "FLJ30131" . "MGC12981" . . . . . . . "MGC13040" . . . . . . . . "MGC14126" . . . . . . . . "MGC14156" . . . . . . "MGC14288" . . . . . . . . "HSPC302" . "MGC16169" . . . . . . . . "MGC19780" . . . . . . . . . . . . . "bA216B9.3" . "DIC5" . "FAP133" . "MGC20486" . . . . . . . . "ADRARL1" . . . . . . . . . "MGC20983" . . . . . . . . . . . . . "DENNL72" . "MGC23980" . . . . . . . "BLAP18" . "MGC24665" . . . . . . . . "D2HGD" . "FLJ42195" . "MGC25181" . . . . . . . . "fSAP35" . "functional spliceosome-associated protein 35" . "MGC2655" . . . . . . . . . . . "JBTS6" . "Meckelin" . "MGC26979" . "NPHP11" . . . . . . . . "MGC27034" . "TRM10" . . . . . . . . "MGC2776" . "SEN2" . "SEN2L" . . . . . . . . "MGC2793" . . . . . . . . . . . . . . "ARGP1" . "DGAT" . . . . . . . . . . "MGC3032" . . . . . . . . . . "DKFZp586G1919" . "LUMA" . "MGC3222" . . . . . . . . "MGC33302" . . . . . . . "CaM-IP4" . "MGC33630" . . . . . . "MGC33662" . . . . . . . "AER61" . "AER61 glycosyltransferase" . "FLJ33770" . . . . . . . . "DAGK6" . "DGK" . . . . . . . . "DKFZp686F0372" . "MGC34713" . . . . . . . "MGC35097" . . . . . . . "MGC35212" . . . . . . . "DNAAF6" . "dynein axonemal assembly factor 6" . "MGC35261" . "NYSAR97" . "sarcoma antigen NY-SAR-97" . "TWISTER" . . . . . . . . "MGC35555" . . . . . . . . . "dGK" . . . . . . . . . . "MGC39558" . . . . . . . . "Delta(24)-sterol reductase" . "KIAA0018" . "seladin-1" . . . . . . . . . . . . . . . "MGC40042" . "SPATA38" . "spermatogenesis associated 38" . . . . . . . . . . . . . . . "MGC40214" . . . . . . . . "MGC4093" . "MKS10" . "MKSR-2" . . . . . . . . . "FLJ36974" . "MGC42174" . . . . . . . . "HHG-3" . "MGC35145" . . . . . . . . "hIscA" . "ISA1" . "MGC4276" . . . . . . . . "Eros" . "FLJ90469" . "MGC4368" . . . . . . . . . . . . . . . "NADH-cytochrome b5 reductase 3" . . . . . . . . "MGC50831" . . . . . . . "MGC54289" . "PRO180" . "RP5-1180E21.1" . "WWFQ154" . . . . . . . . "hDIA1" . "LFHL1" . . . . . . . . "DIA" . "DIA2" . "POF" . "POF2" . . . . . . . . "Fbx38" . "FLJ13962" . "MOKA" . "SP329" . . . . . . . . . . "ACID1" . "ARC92" . "DKFZp434K0512" . "TCBAP0758" . . . . . . . . . "bA108K14.6" . "cancer/testis antigen 76" . "CT76" . . . . . . . . . "DKFZp434L1319" . "FLJ11203" . "FLJ12597" . "FLJ13354" . "FLJ13648" . "IDN3" . "Scc2" . "sister chromatid cohesion 2 homolog (yeast)" . . . . . . . . "DKFZp564K142" . "IAP" . "MRX95" . "oligosaccharyltransferase 3 homolog B (S. cerevisiae)" . "OST3B" . "SLC58A1" . . . . . . . . . . . . "inner nuclear membrane protein Man1" . "MAN1" . . . . . . . . . . . . . . . "J domain protein 1" . "JDP1" . . . . . . . "JM1" . . . . . . . . . "Cbf5" . "dyskerin" . "H/ACA ribonucleoprotein complex subunit 4" . "NAP57" . "NOLA4" . "XAP101" . . . . . . . . . "JM5" . "NBIA5" . "neurodegeneration with brain iron accumulation 5" . "WIPI4" . . . . . . . . . "DKFZp761K2222" . "TIP27" . "ZNF802" . . . . . . . . "DKK-1" . "SK" . . . . . . . . "K6IRS1" . "KRT6IRS" . "KRT6IRS1" . . . . . . . . . . "K6IRS4" . "KRT5C" . "KRT6IRS4" . . . . . . . . . "KIAA0036" . "nephrocystin-5" . "NPHP5" . "SLSN5" . . . . . . . . "CAP-D3" . "FLJ42888" . "hCAP-D3" . "hcp-6" . "hHCP-6" . "KIAA0056" . . . . . "KIAA0089" . . . . . . . . . . . . . . "KIAA0095" . "nuclear pore complex protein Nup93" . . . . . . . . . "ED1R" . "ED5" . "EDA1R" . "EDA3" . "Edar" . . . . . . . . . "dihydrolipoyllysine-residue acetyltransferase" . "E2" . "E2 component of pyruvate dehydrogenase complex" . "PDC-E2" . . . . . . . . . . . . . . . "KIAA0186" . "PSF1" . . . . . . . . . . . . . . . "strumpellin" . . . . . . . "CAMOS" . "KIAA0211" . . . . . . . . "DLDH" . "E3" . "E3 component of pyruvate dehydrogenase complex, 2-oxo-glutarate complex, branched chain keto acid dehydrogenase complex" . . . . . . . . "rubicon" . "rundataxin" . . . . . . . . "KIAA0233" . . . . . . . . "CFAP81" . "cilia and flagella associated protein 81" . "DLC1" . . . . . . . "KIAA0316" . . . . . . . "discs large homolog 1" . "dJ1061C18.1.1" . "DLGH1" . "hdlg" . "presynaptic protein SAP97" . "SAP-97" . "SAP97" . "synapse-associated protein 97" . . . . . . . . "KIAA0356" . . . . . . . . . . . "3H11Ag" . "Bardet-Biedl syndrome 14" . "BBS14" . "cancer/testis antigen 87" . "CT87" . "FLJ13615" . "JBTS5" . "Joubert syndrome 5" . "KIAA0373" . "LCA10" . "Meckel syndrome, type 4" . "MKS4" . "nephrocystin-6" . "NPHP6" . "POC3" . "POC3 centriolar protein homolog (Chlamydomonas)" . "rd16" . "SLSN6" . . . . . . . . . . "cytokinesis and spindle organization A" . "CYTSA" . "KIAA0376" . . . . . . . . "KIAA1232" . "MRX90" . "NE-Dlg" . "NEDLG" . "neuroendocrine-dlg" . "PPP1R82" . "protein phosphatase 1, regulatory subunit 82" . "SAP-102" . "SAP102" . . . . . . . . "CFAP160" . "KIAA0433" . "VIP2" . . . . . . . "FLJ10387" . "FLJ34502" . "RP11-506B15.1" . "seizure threshold 2 homolog A (mouse)" . "seizure threshold 2 homolog B (mouse)" . "SZT2A" . "SZT2B" . . . . . . . . "DustyPK" . "KIAA0472" . "RIP5" . . . . . . . . . . . "BRAG1" . "brefeldin A resistant Arf-guanine nucleotide exchange factor 1" . "IQ-ArfGEF" . "KIAA0522" . . . . . . . "JBTS26" . "KATNIP" . . . . . . . . . . "gs114" . "KIAA0590" . . . . . . . . "BHC110" . "KIAA0601" . "LSD1" . "Lysine-specific histone demethylase 1A" . . . . . . . . . . . . . . . "Delta1" . "FA1" . "pG2" . "Pref-1" . "ZOG" . . . . . . . . "FLJ13621" . . . . . . . . . . . . . . . . . . . . . . . "FSHD2" . "KIAA0650" . . . . . . . "KIAA0657" . . . . . . . . "hCLK2" . "KIAA0683" . "TEL2" . . . . . . . . "SCDO1" . . . . . . . "Lem4" . "LEMD7" . "LEM domain containing 7" . . . . . . . . . "GEF720" . "KIAA0720" . "synectin-binding guanine exchange factor" . "Syx" . "Tech" . . . . . . . . "KIAA0725" . "SPG54" . . . . . . . . . . . . . . . . "MNR" . "moonraker" . "OFD1 and FOPNL interacting protein" . "OFIP" . . . . . . . . "ARF-GEP100" . "BRAG2" . "brefeldin A-resistant ARF-GEF2" . "GEP100" . "KIAA0763" . . . . . . . "Dihydrolipoyllysine-residue succinyltransferase" . . . . . "KIAA0842" . . . . . . . . . . . . . . . . . . . . . . . . "CORS3" . "fantom homolog" . "FTM" . "JBTS7" . "KIAA1005" . "Meckel syndrome, type 5" . "MKS5" . "NPHP8" . "PPP1R134" . "protein phosphatase 1, regulatory subunit 134" . . . . . . . . . . . . . . . . . . . . . . . "KIAA1023" . . . . . . . . "strumpellin and WASH-interacting protein" . "SWIP" . . . . . . . "BP1" . "DLX8" . . . . . . . . "KIAA1052" . "NPHP15" . . . . . . . . . "KIAA1074" . . . . . . . . . . . . . . "KIAA1093" . . . . . . . . . . . . . . . . . . . . . . . . . . . "DFNA65" . "KIAA1171" . "skywalker homolog (Drosophila)" . "TBC/LysM-associated domain containing 6" . "TLDC6" . . . . . . . . "MGC45441" . . . . . . "ERGIC-32" . "ERGIC32" . "KIAA1181" . "NET24" . . . . . . . . "KIAA1202" . . . . . . . "CDGAP" . . . . . . . . "FLJ20831" . . . . . . . . . "IFT121" . "IFTA1" . "KIAA1336" . "MGC33196" . . . . . . . . . . "JBTS9" . "KIAA1345" . "Meckel syndrome, type 6" . "MKS6" . . . . . . . . "FLJ10159" . . . . . . . "FLJ14314" . "KIAA1361" . "MAP3K16" . "MARKK" . "PSK2" . "TAO1" . . . . . . . . . . "KIAA1374" . . . . . . . . . . . . . . . "KIAA1441" . . . . . . . . "LIM15" . . . . . . . . . . . . "BMD" . "DXS142" . "DXS164" . "DXS206" . "DXS230" . "DXS239" . "DXS268" . "DXS269" . "DXS270" . "DXS272" . "muscular dystrophy, Duchenne and Becker types" . . . . . . . . . "asterless" . "KIAA0912" . "MCPH9" . "SCKL5" . . . . . . . . "KIAA1518" . . . . . . . . . . . . . . . "KIAA1577" . . . . . . . "KIAA1613" . "PPP1R142" . "protein phosphatase 1, regulatory subunit 142" . . . . . . . . . . . . . . . "hEPG5" . . . . . . . "DM1PK" . "DMK" . "DM protein kinase" . "dystrophia myotonica 1" . "MDPK" . "MT-PK" . "myotonic dystrophy associated protein kinase" . "Myotonin-protein kinase" . "myotonin protein kinase A" . "thymopoietin homolog" . . . . . . . . . "CT154" . "DM domain expressed in testis 1" . "DMT1" . . . . . . . . . . . . . "KIAA1724" . "SELI" . "SEPI" . . . . . . . . . "DFNA71" . "KIAA0856" . "rabconnectin 3" . "RC3" . . . . . . . "KIAA0083" . . . . . . . . "KIAA1915" . . . . . . . . . "DNAHC1" . "HDHC7" . "HL-11" . "HL11" . "XLHSRF-1" . . . . . . . "Glutamate tRNA ligase 2, mitochondrial" . "KIAA1970" . "MSE1" . "mtGlnRS" . . . . . . . . "KIAA1972" . . . . . . . "FLJ32345" . "FLJ32767" . "KIAA1977" . . . . . . . "FLJ30681" . "KIAA1983" . . . . . . . "CMT4C" . "KIAA1985" . . . . . . . "CILD7" . "DNAHBL" . "Dnahc11" . "DNHBL" . "DPL11" . "dynein, ciliary, heavy chain 11" . "dynein, heavy chain beta-like" . . . . . . . . "KIDLIA" . "MRX98" . "XLMR-related protein, neurite extension" . "XPN" . . . . . . . "collectrin" . "NX17" . . . . . . "nephrocystin-7" . "NPHP7" . . . . . . . . "FLJ13142" . "lamina associated polypeptide 1B" . "LAP1B" . . . . . . . "DNEL2" . "FLJ40457" . . . . . . "FLJ22386" . . . . . . . . "LGN" . "Pins" . . . . . . . . . . . . . . "ankyrin repeat-rich membrane-spanning protein" . "ARMS" . . . . . . . . "CILD3" . "Dnahc5" . "dynein heavy chain 5" . "HL1" . "KTGNR" . "PCD" . . . . . . . "C10" . "gene rich cluster C10 gene" . "GRCC10" . . . . . . . . "C21" . "DC42" . "FLJ12894" . "IRA1" . "TBLR1" . . . . . . . . . "KIAA0596" . "NPHP20" . . . . . . . . . . "Dnahc9" . "DNAL1" . "DYH9" . "HL-20" . "HL20" . "KIAA0357" . . . . . . "CILD1" . "DIC1" . "PCD" . . . . . . . . "NELIN" . "nexilin" . . . . . . . "dJ327J16" . "PIG27" . . . . . . . . . . . . . . . . "MGC12290" . "MGC13378" . . . . . . . . . . . . . . . "complex III subunit 8" . "QCR8" . "QP-C" . "ubiquinol-cytochrome c reductase, complex III subunit VII" . "UQCR7" . . . . . . . . "IFI1" . "LRG-47" . "LRG47" . . . . . . . . "DNAS1L3" . "DNase gamma" . "LSD" . . . . . . . . . . . . "IDDM20" . "LNK" . "lymphocyte adaptor protein" . . . . . . . . . . "CMT2O" . "DHC1" . "Dnchc1" . "HL-3" . "p22" . . . . . . . . "[acyl-carrier-protein] S-malonyltransferase" . "fabD" . "FASN2C" . "MCT" . "MCT1" . "MT" . "NET62" . . . . . . . . . . "DHC1b" . "DHC2" . "DYH1B" . "hdhc11" . . . . . . . . "KIAA1780" . . . . . . . "exophilin-3" . "l(1)-3Rk" . "l1Rk3" . "ln" . "Slac-2a" . . . . . . . "bHLHc6" . "SCDO2" . . . . . . . . "FMT1" . . . . . . . . "FLJ32173" . "MGC16028" . . . . . . . . . "KIAA1208" . "MGC4170" . . . . . . . . "MAGP2" . "microfibril-associated glycoprotein-2" . "MP25" . . . . . . . . "FLJ10504" . "LST005" . "misato" . "MST" . . . . . . . "Magmas" . "mitochondria associated protein involved in granulocyte macrophage colony stimulating factor signal transduction" . "Tim16" . "TIMM16" . . . . . . . . "EFG2" . "EF-G2mt" . "FLJ21661" . . . . . . . . "MFTC" . . . . . . . . . "FLJ10326" . "isoleucine tRNA ligase 2, mitochondrial" . . . . . . . . . . . . . . . . . "DRP1" . "DVLP" . "DYMPLE" . "HDYNIV" . "VPS1" . . . . . . . . . . . "CMT2M" . "CMTDI1" . "CMTDIB" . "cytoskeletal protein" . "DI-CMTB" . "DYN2" . "dynamin II" . "DYNII" . . . . . . . . . "CXXC9" . "MCMT" . . . . . . . . . . . . . . . . . . "ENDAP" . "Endosomal adaptor protein" . "MAPBPIP" . "MAPKSP1 adaptor protein" . "MAPKSP1AP" . "Mitogen activated protein binding protein interacting protein" . "p14" . "Ragulator2" . . . . . . . . . . . . . . . . "5'-(N(7)-methyl 5'-triphosphoguanosine)-[mRNA] diphosphatase" . "HINT-5" . "HINT5" . "HSL1" . "HSPC015" . . . . . . . . "FLJ10631" . . . . . . . . . . . . . "CHL" . "NRLN1" . . . . . . . . "hnifU" . "IscU" . "ISU2" . . . . . . . . "KIAA0209" . . . . . . . . "KIAA0299" . "MOCA" . "PBP" . . . . . . . . . "nuclear pore complex protein Nup107" . "NUP84" . . . . . . . . . "2P1" . "DKFZP564J0123" . "E3-3" . "MGC10527" . . . . . . . . "DKFZp434O192" . "FAM22H" . "nuclear protein in testis" . "NUT" . . . . . . . . "FLJ22618" . "MGC5585" . . . . . . . "CoASY" . "DPCK" . "NBP" . "PPAT" . . . . . . . . "NYD-SP12" . . . . . . . "NYD-SP14" . . . . . . "CFAP250" . "CILD27" . "DRC2" . "FAP250" . "FLJ35732" . "NYD-SP28" . . . . . . . . "B17" . "C2TA" . "DKFZP434M035" . . . . . . . "FLJ22489" . "Ocular development associated gene" . "ODAG" . "RG083M05.2" . . . . . . . . "KIAA1455" . "Ten-M3" . . . . . . "KIAA1302" . "Ten-M4" . . . . . . . . "KIAA1042" . "MILT1" . "milton homolog 1 (Drosophila)" . "OGT(O Glc NAc transferase) interacting protein 106 KDa" . "OIP106" . "O-linked N-acetylglucosamine transferase interacting protein 106" . . . . . . . . "RDHS" . "SDR-O" . . . . . . . . . "ALG7" . "CDG-Ij" . "D11S366" . "DGPT" . "GlcNAc-1-P transferase 1" . "GPT" . "UDP-N-acetylglucosamine--dolichyl-phosphate N-acetylglucosaminephosphotransferase 1" . . . . . . . . . "Tangier disease" . "TGD" . . . . . . . . . "B1" . "parathyroid hormone responsive B1 gene" . "PTHB1" . . . . . . . . "FLJ10209" . "KIAA1175" . . . . . . . . "p101" . "P101-PI3K" . . . . . . . . . "ovarian tumor suppressor candidate 1" . "OVCA1" . . . . . . . . "CDGIE" . "DPM synthase complex, catalytic subunit" . "MPDS" . . . . . . . . "BAF180" . "PB1" . . . . . . . . . "DPM synthase complex subunit" . "MGC111193" . "MGC21559" . . . . . . . . . "AAVR" . "AAV receptor" . "KIAA1837" . . . . . . . . . . . . . "hRPC155" . "RPC1" . "RPC155" . . . . . . . . "deleted in polyposis 1-like 1" . "DP1L1" . "FLJ25383" . "polyposis locus protein 1-like 1" . "Yip2f" . . . . . . . . "DPM synthase complex subunit" . "MGC125904" . "MGC125905" . "MGC34275" . . . . . . . . . "PEN2" . . . . . . . . . "DPL1" . "DPPX" . . . . . . . "processing of precursors 1" . . . . . . . . . "DPD" . . . . . . . . . "DHPase" . . . . . . . . . . . . "CMT2L" . "E2IG1" . "H11" . "HSP22" . "HspB8" . . . . . . . . "LYK5" . "NY-BR-96" . "STE20-like pseudokinase" . "Stlk" . "STRAD" . . . . . . . . . "MRT2" . . . . . . . . . . . . . . . . "PARG1" . . . . . . . . "DKFZP564D166" . "FLJ10215" . "FLJ11824" . "KIAA1148" . "KIAA1636" . "rolling pebbles homolog B (Drosophila)" . "rols" . "ROLSA" . . . . . . . . "CLN12" . "HSA9947" . . . . . . . . . "CDG1N" . "congenital disorder of glycosylation 1N" . . . . . . . . "D15Ertd747e" . "FLJ11856" . "GPCR41" . "hRFT3" . "PAR1" . "RFVT2" . . . . . . . . . "FLJ10060" . "GPCR42" . "hRFT1" . "PAR2" . "RFVT1" . "Riboflavin transporter 1" . . . . . . . . . . . . "KIAA0436" . . . . . . . . "FLJ20241" . "Freud-1" . "mental retardation, nonsyndromic, autosomal recessive, 3" . "MRT3" . . . . . . . . . . . . . . . "Magnesium uptake/transporter TUSC3" . "MagT2" . "MGC13453" . "MRT7" . "N33" . "oligosaccharyltransferase 3 homolog A (S. cerevisiae)" . "OST3A" . "SLC58A2" . . . . . . . . . . . . . . . . . "PDXPO" . . . . . . . . . "P5CR2" . . . . . . . . "FLJ45744" . "PERRS" . "R9AP" . "RGS9" . . . . . . . . "B37" . . . . . . . . "KIAA0678" . "RME8" . . . . . . . . . "FLJ10388" . "RPC2" . . . . . . . . "KIAA1665" . "RPC8" . . . . . . . . "CDHF2" . . . . . . . . "NEM8" . "nemaline myopathy type 8" . "Sarcosynapsin" . "SRYP" . . . . . . . "ARHGEF36" . "KIAA1010" . "scaffold protein TUBA" . "Tuba" . . . . . . . "CDHF3" . "DSC" . "DSC1" . "DSC2" . . . . . . . . . . . "BBS20" . "NPHP17" . "osm-1" . "SLB" . "wim" . "wimple homolog" . . . . . . . . "ACLP" . "adipocyte enhancer binding protein 1" . "aortic carboxypeptidase-like protein" . . . . . . . . . "FLJ30542" . "SH2B" . "SH2-B homolog" . . . . . . . . "FLJ38979" . . . . . . . "DCRC" . "DSRC" . "phosphatidylinositol-n-acetylglucosaminyltranferase subunit" . . . . . . . . . . . "CDHF4" . . . . . . . . "FLJ36139" . "FLJ40069" . "PCD" . "PF22" . . . . . . . . . . . . . . . "JBTS12" . . . . . . . . . . . "CDHF5" . . . . . . . . . . . . . "dispanin subfamily B member 3" . "DKFZp547J199" . "DSPB3" . "EKD1" . "FICCA" . "FLJ25513" . "IFITMD1" . "Interferon induced transmembrane protein domain containing 1" . "PKC" . . . . . . . "HCP1" . "heme carrier protein 1" . "MGC9564" . "PCFT" . "proton-coupled folate transporter" . . . . . . . . . "mitochondrial import inner membrane translocase subunit TIM14" . "Pam18" . "Tim14" . "TIMM14" . . . . . . . . . . . . . . . . . . "DPI" . "DPII" . "KPPS2" . "PPKS2" . . . . . . . . "CILD13" . "FLJ25330" . "ODA7" . "outer row dynein assembly 7 homolog (Chlamydomonas)" . "swt" . . . . . . . . . . . "DMP3" . . . . . . . . "MARCH-VI" . "RNF176" . "TEB4" . . . . . . . "DIB1" . "DIM1" . "HsT161" . "similar to S. pombe dim1+" . "SNRNP15" . "U5-15kD" . . . . . . . . "DKFZp727A071" . "proline tRNA ligase 2, mitochondrial (putative)" . . . . . . . "FLJ39787" . "skeletrophin" . "ZZZ5" . . . . . . . . "SLAC2-B" . "synaptotagmin-like homologue lacking C2 domains b" . . . . . . . "D18S892E" . "DRP3" . "DTN" . "DTN-1" . "DTN-2" . "DTN-3" . "dystrophin-related protein 3" . . . . . . . . . "O-phosphoseryl-tRNA(Sec) selenium transferase" . "SLA" . "SLA/LP" . "soluble liver antigen/liver pancreas antigen" . . . . . . . . "Dolichyl-diphosphooligosaccharide--protein glycosyltransferase subunit STT3B" . "dolichyl-diphosphooligosaccharide protein glycotransferase" . "FLJ90106" . "SIMP" . "source of immunodominant MHC associated peptides" . "STT3-B" . . . . . . . . "FLJ12541" . "retinol binding protein 4 receptor" . . . . . . . . "ANKCLB" . "ankyrin-repeat containing bacterial clp fusion" . "FLJ13152" . "HSP78" . "SKD3" . "suppressor of potassium transport defect 3" . . . . . . . . . "SRPUL" . . . . . . . "GPATC5" . "GPATCH5" . "G patch domain containing 5" . "Spp2" . "T54" . . . . . . . "TA-WDRP" . "UTP21" . . . . . . . . "radial spoke 16 homolog A (Chlamydomonas)" . "RSPH16A" . "TSARG6" . . . . . . . . "FLJ25765" . . . . . . . "MKP-3" . "PYST1" . . . . . . . . "FLJ12528" . "threonine tRNA ligase 2, mitochondrial" . . . . . . . . "GDT1" . "TMPT27" . "TPA regulated locus" . "TPARL" . . . . . . . . "IFT139A" . "STI2" . . . . . . . "ring finger protein 206" . "RNF206" . "TRIP" . . . . . . . . "KIAA0551" . . . . . . . . . "FLJ14502" . "kinastrin" . "kinetochore-localized astrin-binding protein" . "SKAP" . "small kinetochore-associated protein" . "TRAF4AF1" . "TRAF4 associated factor 1" . . . . . . . . . . . . "P66beta" . "Transcription repressor p66 beta component of the MeCP1 complex" . . . . . . . . "TERE1" . "transitional epithelia response protein" . . . . . . . . "KIAA0092" . "Translokin" . "TSP57" . . . . . . . . . . . . . . . "ATGL" . "desnutrin" . "FP17548" . "iPLA2zeta" . "TTS-2.2" . . . . . . . . . . . "bA506K6.1" . "class IIb beta-tubulin" . "DKFZp566F223" . "MGC8685" . . . . . . . . . . . . "IKBKBBP" . "KIAA1882" . "MRT13" . "NIBP" . "T1" . "TRAPP 120 kDa subunit" . "TRS120" . "tularik gene 1" . . . . . . . . "FLJ14923" . "TUWD12" . . . . . . . . . . . . . . . . . . . . . . "116 kDa U5 small nuclear ribonucleoprotein component" . "SNRNP116" . "Snrp116" . "Snu114" . "U5-116KD" . "U5 snRNP specific protein, 116 kD" . . . . . . . . "bad response to refrigeration 2 homolog (S. cerevisiae)" . "BRR2" . "HELIC2" . "KIAA0788" . "U5-200KD" . "U5 snRNP specific protein, 200 KD" . . . . . . . . "KIAA0208" . . . . . . . . . "CDG1S" . "FLJ23018" . "MDS031" . "N-acetylglucosaminyldiphosphodolichol N-acetylglucosaminyltransferase" . "TDRD13" . "Tudor domain containing 13" . "YGL047W" . . . . . . . . "HT007" . . . . . . . . "bA792D24.4" . "DAPIT" . "Diabetes Associated Protein in Insulin-sensitive Tissues" . "MGC14697" . . . . . . "Ib772" . "KIAA0312" . "UREB1" . . . . . . . . . . . . "KIAA1449" . "P80" . "SPG60" . . . . . . . . . . . . . . . . . "WINS1" . . . . . . . "XT3" . "Xtrp3" . . . . . . . . . "minibrain-related kinase" . "MIRK" . . . . . . . . . "HCCA2" . "YAP" . "YY1AP" . . . . . . . . "FLJ20980" . "ZFH4" . . . . . . . "SBP2" . "Sec insertion sequence-binding protein 2" . "Selenocysteine insertion sequence-binding protein 2" . . . . . . . . . . . "FER1L1" . "fer-1-like family member 1" . . . . . . . . "BSN2" . "FLJ20043" . . . . . . . "DQ2" . "torsin A" . . . . . . . . . . . "C18orf6" . "FLJ13687" . . . . . . . "LEFTA" . "LEFTYA" . "transforming growth factor, beta-4 (endometrial bleeding-associated factor; LEFTY A)" . . . . . . . . . "3-beta-hydroxysteroid-delta-8,delta-7-isomerase" . "CHO2" . "Chondrodysplasia punctata-2, X-linked dominant (Happle syndrome)" . "CPX" . "CPXD" . "sterol 8-isomerase" . . . . . . . . "CSNB1E" . . . . . . . . . . . . . . . . . . . . . . . . . "Damage induced neuronal endopeptidase" . "DINE" . "XCE" . . . . . . . "Gliostatin" . . . . . . . . "SCEH" . "short chain enoyl-CoA hydratase" . . . . . . . . "hsa-mir-140" . . . . . . . . . . . . "hsa-mir-184" . . . . . . . . "ED1-A1" . "ED1-A2" . "EDA1" . "EDA-A1" . "EDA-A2" . "HED" . "XHED" . "XLHED" . . . . . . . . "hsa-mir-204" . . . . . . "SPAX5" . . . . . . . . "hsa-mir-96" . . . . . . "PPP1R88" . "protein phosphatase 1, regulatory subunit 88" . . . . . . . . "AGR16" . "Gpcr13" . "H218" . . . . . . . . . "FLJ39458" . . . . . . "ET1" . . . . . . . . . . "ET3" . . . . . . . . . "ET-A" . "ETA-R" . "hET-AR" . . . . . . . . . . "FETA" . . . . . . . . . . "ETB" . . . . . . . . . "HPH1" . "RAE28" . . . . . . . . "HEED" . "WAIT-1" . "WD protein associating with integrin cytoplasmic tails 1" . . . . . . . . . "ASRG" . "glycosylasparaginase" . "N(4)-(beta-N-acetylglucosaminyl)-L-asparaginase" . . . . . . . . . . . . . . . . "KIAA0540" . . . . . . . . . "EEF1AL" . "HS1" . . . . . . . . . "DFNA4B" . . . . . . . . . . "aggrecan proteoglycan" . "CSPGCP" . . . . . . . . "EEF-2" . "Polypeptidyl-tRNA translocase" . . . . . . . . . "FBLN3" . "fibulin 3" . "MTLV" . "S1-5" . . . . . . . . . "FBLN4" . "fibulin 4" . "UPH1" . . . . . . . . "glycogen debranching enzyme" . "glycogen storage disease type III" . . . . . . . . "CSDD2" . "FLJ16517" . . . . . . . . "Elk-L" . "LERK2" . . . . . . . . . "Pro-epidermal growth factor" . . . . . . . . "SPG29" . . . "FLJ22365" . "HBV pre s2 binding protein 1" . "SBP1" . . . . . . . . . "ERBB1" . "erb-b2 receptor tyrosine kinase 1" . "erythroblastic leukemia viral (v-erb-b) oncogene homolog (avian)" . . . . . . . . . . . "Krox-20 homolog, Drosophila" . . . . . . . . . . . . . . . "CDG1P" . "GDP-Man:Man(3)GlcNAc(2)-PP-dolichol alpha-1,2-mannosyltransferase" . "KIAA0266" . . . . . . . . . . . . . . . . "eIF-1A" . "eIF-4C" . . . . . . . . "FLJ16069" . "SPG66" . . . . . . . . "RP36" . . . . . . . "PEK" . "PERK" . . . . . . . . . . . . . "EIF-2B" . "EIF2BA" . "EIF-2Balpha" . . . . . . . . . . . . "EIF2B" . "EIF-2Bbeta" . . . . . . . . . . . . "EIF-2B" . "EIF2Bgamma" . . . . . . . . "LPAAT-beta" . "lysophosphatidic acid acyltransferase-beta" . "lysophosphatidic acid acyltransferase, beta" . . . . . . . . . . . . "DKFZP586J0119" . "EIF-2B" . "EIF2B" . "EIF2Bdelta" . . . . . . . . . . . . "EIF-2B" . "EIF2Bepsilon" . . . . . . . . "LIN-41" . "LIN41" . . . . . "EIF2" . "EIF2gamma" . "eukaryotic translation initiation factor 2G" . . . . . . . . "ARMD8" . "LOC387715" . . . . . . . . . . . . . . . . . . . "CILD17" . "FLJ13094" . "FLJ34211" . "PR46b" . . . . . . . . . . "HBII-52" . . . . . . . "HBII-85" . "PET1" . . . . . "ADAP-S" . "ADAS" . "ADHAPS" . "ADPS" . "ALDHPSY" . . . . . . . . "EIF4E1" . . . . . . . . . . . . . . . . "CSX2" . "NKX4-2" . "tinman paralog (Drosophila)" . . . . . . . . . "U8" . . . . . "p220" . "PARK18" . . . . . . . . . "AGRIN" . . . . . . . . . "HLE" . "HNE" . "leukocyte elastase" . "medullasin" . "NE" . "neutrophil elastase" . . . . . . . . . "RSTI689" . "UNQ689" . . . . . . . . "ELFR" . "MEF" . . . . . . . . . "IFPS" . . . . . . . . . . . "supravalvular aortic stenosis" . "SVAS" . "tropoelastin" . "WBS" . "Williams-Beuren syndrome" . "WS" . . . . . . . . . "FLJ44060" . . . . . . . "ELP79" . "EMAP" . "HuEMAP" . . . . . . . . "LEMD5" . "LEM domain containing 5" . "STA" . . . . . . . . "XMP" . . . . . . . "CD312" . . . . . . . . . "alpha-1 antiproteinase, antitrypsin" . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . "FLJ12343" . "MGC20625" . "MGC21482" . "MGC26740" . . . . . . . . . . . "CD105" . "END" . "HHT1" . . . . . . . . . "beta-enolase" . "muscle enriched enolase" . . . . . . . . . . . . . . . . "PC-1" . "PCA1" . . . . . . . . "Pat1a" . . . . . . . "ATPDase" . "NTPDase-1" . "SPG64" . . . . . . . . . . "ECAT1" . "ES cell associated transcript 1" . . . . . . . . "AG2S" . "AGTR1A" . "AT1" . "AT1B" . "AT2R1" . "AT2R1A" . "AT2R1B" . "HAT1R" . . . . . . . . . "MIC13" . "P117" . "QIL1" . . . . . . . "FAP221" . "flagellar associated protein 221 homolog (Chlamydomonas)" . "PCDP1" . "primary ciliary dyskinesia 1 homolog (mouse)" . . . . . . "T-box brain2" . "TBR2" . . . . . . . "histone acetyltransferase p300" . "KAT3B" . "p300" . . . . . . . . . . . "bHLHe73" . "HIF-1 alpha-like factor" . "HIF2A" . "HLF" . "MOP2" . "PASD2" . . . . . . . . . "TMEM226" . "transmembrane protein 226" . . . . . . "4.1R" . . . . . . . . . "4.1N" . "KIAA0338" . . . . . . . . "dJ70A9.1" . "FLJ25791" . "FLJ42177" . "MGC26954" . . . . . . . "Erythrocyte surface protein band 4.2" . "MGC116735" . "MGC116737" . "PA" . . . . . . . "FLJ27524" . "MGC52110" . "Pet191" . . . . . . . "DFNB101" . . . . . . "LYRM8" . "LYR motif containing 8" . . . . . . . . . . . . . . . . . . . "skeletal muscle and kidney enriched inositol phosphatase" . "SKIP" . . . . . . . . . "Hek8" . . . . . . . . . "AT2" . "MRX88" . . . . . . . . . "Hek5" . "Tyro5" . . . . . . . . . . "Tyro11" . . . . . . . . . "ABC-C" . "EST111653" . "LBM180" . . . . . . . . . . . "RNU4ATAC1" . "U4atac" . . . . . . . . . . . . . "LD" . "LDE" . . . . . . . . "EP" . . . . . . . . . . . . . . . . "AGT" . "AGT1" . "AGXT1" . "glycolicaciduria" . "L-alanine: glyoxylate aminotransferase 1" . "oxalosis I" . "PH1" . "primary hyperoxaluria type 1" . "serine:pyruvate aminotransferase" . "SPT" . . . . . . . . . . . . . . . "HERA-B" . . . . . . . . "CD340" . "HER-2" . "HER2" . "human epidermal growth factor receptor 2" . "NEU" . "neuro/glioblastoma derived oncogene homolog" . . . . . . . . "HER3" . "human epidermal growth factor receptor 3" . . . . . . . . . "ALS19" . "HER4" . "human epidermal growth factor receptor 4" . . . . . . . . . . "RAD10" . . . . . . . . . . . "EM9" . "excision repair cross-complementing rodent repair deficiency, complementation group 2 protein" . "MAG" . "MGC102762" . "MGC126218" . "MGC126219" . "TFIIH" . "TFIIH basal transcription factor complex helicase XPB subunit" . . . . . . . . . . "BTF2" . "GTF2H" . "RAD25" . "TFIIH" . "xeroderma pigmentosum group B complementing" . "XPB" . . . . . . . . . . . "FANCQ" . "RAD1" . "xeroderma pigmentosum, complementation group F" . . . . . . . . . . "Cockayne syndrome" . . . . . . . . . . . "FLJ34931" . "RP54" . . . . . . . . . . . . "ARMD5" . "Cockayne syndrome B protein" . "CSB" . "RAD26" . . . . . . . . "UNQ655" . . . . . . . . . "CSA" . . . . . . . . "SAHH" . . . . . . . . . . . . "PE-2" . "PE2" . . . . . . . . . "erg-3" . "p55" . "TMPRSS2-ERG prostate cancer specific" . "transcriptional regulator ERG (transforming protein ERG)" . "v-ets erythroblastosis virus E26 oncogene like" . . . . . . . . "E2 receptor alpha" . "Era" . "ER-alpha" . "estrogen receptor alpha" . "NR3A1" . "nuclear receptor subfamily 3 group A member 1" . "oestrogen receptor alpha" . . . . . . . . . "Erb" . "ER beta" . "ER-beta" . "estrogen receptor beta" . "NR3A2" . "nuclear receptor subfamily 3 group A member 2" . "oestrogen receptor beta" . . . . . . . . . "ERR2" . "ERRb" . "ERRbeta" . "NR3B2" . . . . . . . . . . "EMA" . "GA2" . "glutaric aciduria II" . "MADD" . . . . . . . . . . . . . . . . . "ETFQO" . . . . . . . . "Avian erythroblastosis virus E26 (v-ets) oncogene homolog-1" . "ETS-1" . "ets protein" . "FLJ10768" . . . . . . . . "bHLHe76" . . . . . . . . . "ER81" . . . . . . . . "E1A enhancer binding protein" . "E1A-F" . "E1AF" . "PEA3" . . . . . . . . . . . . . . "TEL" . "TEL oncogene" . . . . . . . . "EVA" . . . . . . . "DWF-1" . . . . . . . . . . "KMT8E" . "MDS1-EVI1" . "PRDM3" . "PR domain 3" . . . . . . . . "A2HS" . "FETUA" . "fetuin A" . "HSGA" . . . . . . . . . . . "ARMD2" . "CORD3" . "FFM" . "Stargardt disease" . . . . . . . . . . . . . "EWS" . . . . . . . . . . "bHLHa9" . "BHLHF42" . "Fingerin" . . . . . . . . . "Glucuronosyl-N-acetylglucosaminyl-proteoglycan 4-alpha-N- acetylglucosaminyltransferase" . "N-acetylglucosaminyl-proteoglycan 4-beta-glucuronosyltransferase" . "ttv" . . . . . . . . . . "Glucuronosyl-N-acetylglucosaminyl-proteoglycan 4-alpha-N- acetylglucosaminyltransferase" . "N-acetylglucosaminyl-proteoglycan 4-beta-glucuronosyltransferase" . "SOTV" . . . . . . . . "botv" . "glucuronyl-galactosyl-proteoglycan 4-alpha-N-acetylglucosaminyltransferase" . "REGR" . "REG receptor" . . . . . . . . . . . . . . . . . . . . . . . . . "ENX-1" . "EZH1" . "KMT6" . "KMT6A" . . . . . . . . . . . . . . . . . "FXI" . "plasma thromboplastin antecedent" . . . . . . . . . . . . . . . . . . . . . . . . . . "FXIIIB" . . . . . . . . . . "prepro-coagulation factor II" . . . . . . . . . . . . . . . . . . . . . . . "eptacog alfa" . "factor VII" . "FVII coagulation protein" . . . . . . . . . . . . "DXS1253E" . "Factor VIIIF8B" . "FVIII" . "HEMA" . "hemophilia A" . . . . . . . . . . . . "Christmas disease" . "Factor IX" . "FIX" . "hemophilia B" . "plasma thromboplastic component" . . . . . . . . . . "ACS4" . "LACS4" . "lignoceroyl-CoA synthase" . . . . . . . . . "Fas-associating death domain-containing protein" . "Fas-associating protein with death domain" . "GIG3" . "Growth-inhibiting gene 3 protein" . "Mediator of receptor-induced toxicity" . "MORT1" . . . . . . . . "fumarylacetoacetase" . . . . . . . . . "FAC1" . "NURF301" . . . . . . . . "FAA" . "FA-H" . "FAH" . . . . . . . . . "FAAP95" . "FAB" . "FLJ34064" . . . . . . . . "FA3" . "FAC" . . . . . . . . "FAD" . "FA-D2" . . . . . . . . "FAE" . . . . . . . . "FAF" . . . . . . . . "DNA repair protein XRCC9" . "FAG" . "X-ray repair, complementing defective, in Chinese hamster, 9" . "X-ray repair complementing defective repair in Chinese hamster cells 9" . . . . . . . . . . . . . "ARA9" . "FKBP16" . "XAP2" . . . . . . . . "cadherin-related family member 9" . "CDHF8" . "CDHR9" . "HFAT2" . "MEGF1" . . . . . . . . . . . . . . "EST90625" . . . . . . . . . . "FBLN" . . . . . . . . . . . "ARMD3" . "DANCE" . "EVEC" . "UP50" . . . . . . . . . . . . . . . . . . "asprosin" . "Marfan syndrome" . "MASS" . "OCTD" . "SGS" . . . . . . . . . "DA9" . "fibrillin 5" . . . . . . . . . . . . . . . . "APS1" . "autoimmune polyendocrinopathy candidiasis ectodermal dystrophy" . "PGA1" . . . . . . . . "CD32" . "CD32B" . "Fc gamma receptor IIb" . . . . . . . . "CD16" . "CD16a" . "Fc gamma receptor IIIa" . . . . . . . . . . . . . . . . . "CD16" . "CD16b" . "Fc gamma receptor IIIb" . . . . . . . . . . . . . "LGMD2M" . . . . . . . "FCNH" . "HAKA1" . "Hakata antigen" . . . . . . . . . . . . . . . "farnesyl pyrophosphate synthetase, dimethylallyltranstransferase, geranyltranstransferase" . . . . . . . . . . "ADR" . "adrenodoxin-NADP(+) reductase" . "adrenodoxin reductase" . . . . . . . "protoporphyria" . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . "ZFYVE3" . . . . . . . . . . . . . . . . "FHF1" . "fibroblast growth factor 12B" . "fibroblast growth factor FGF-12b" . "fibroblast growth factor homologous factor 1" . "myocyte-activating factor" . . . . . . . . . . . . "FHF4" . "SCA27" . . . . . . . . . . . . . . . . "FGF-13" . . . . . . . . . . . . . . . . . . . . . . . . . "HBGF-3" . "INT-2 proto-oncogene protein" . "murine mammary tumor virus integration site 2, mouse" . "oncogene INT2" . "V-INT2 murine mammary tumor virus integration site oncogene homolog" . . . . . . . . . . . . . . . . . . . . . . . . "AIGF" . "androgen-induced growth factor" . . . . . . . . "glia-activating factor" . . . . . . . . . . . . . . . . . . . . . . . . . . . "BFGFR" . "CD331" . "CEK" . "FLG" . "H2" . "H3" . "H4" . "H5" . "N-SAM" . "Pfeiffer syndrome" . . . . . . . . . . . . . . . . . . . . . "CD332" . "CEK3" . "Crouzon syndrome" . "ECT1" . "K-SAM" . "Pfeiffer syndrome" . "TK14" . "TK25" . . . . . . . . . . . . . . . . . . . . . . "CD333" . "CEK2" . "JTK4" . . . . . . . . . . . . . . . . . . . . . "fumarase" . . . . . . . . "AP3Aase" . "bis(5'-adenosyl)-triphosphatase" . "FRA3B" . . . . . . . . . . . . "bA535K18.1" . "FHL1B" . "FLH1A" . "Four-and-a-half LIM domains 1" . "KYO-T" . "LIM protein SLIMMER" . "MGC111107" . "SLIM1" . "XMPMA" . . . . . . . . "DRAL" . "SLIM3" . . . . . . . . "FGFIBP" . . . . . . . . . . "ATPIC" . "PFIC" . . . . . . . . . . "killin" . . . . . . . . . . . . . . "hCG_1645727" . "NEM6" . "nemaline myopathy type 6" . . . . . . . . . . . . . . "ALYE870" . "FLJ22167" . "JBTS20" . "MKS11" . "PRO1886" . . . . . . . . . "4-diphosphocytidyl-2C-methyl-D-erythritol synthase homolog (Arabidopsis)" . "D-ribitol-5-phosphate cytidylyltransferase" . "hCG_1745121" . "IspD" . "Nip" . "Notch1-induced protein" . . . . . . . . . . . . . . . . . . . . . "EWSR2" . "SIC-1" . . . . . . . . "FLI" . "Fli1" . "FLIL" . "MGC39265" . . . . . . . . . . . . . . . . . . "ABP-280" . "actin binding protein 280" . "alpha filamin" . . . . . . . . . . . . "ABP-278" . "actin binding protein 278" . "beta filamin" . "FH1" . "TABP" . "TAP" . . . . . . . . . . . "ABP-280" . "ABPL" . "actin binding protein 280" . "gamma filamin" . . . . . . . . "MGC21624" . "SPG68" . . . . . . . . . . . . . . . "vascular endothelial growth factor receptor 1" . "vascular permeability factor receptor" . "VEGFR1" . . . . . . . . . . . . . . . . "CD135" . "FLK2" . "STK1" . . . . . . . . . . . "PCL" . "VEGFR3" . . . . . . . . . . "Dimethylaniline monooxygenase [N-oxide-forming] 3" . "FMOII" . . . . . . . . . . . . "FMRP" . "FRAXA" . "MGC87458" . . . . . . . "FRAXE" . . . . . . . . . . . "CIG" . "Cold-insoluble globulin" . "FINC" . "GFND2" . "LETS" . "Migration-stimulating factor" . "MSF" . . . . . . . . "folate receptor alpha" . . . . . . . . "AP-1" . "c-fos" . . . . . . . . . "AKAP120-like protein" . "AKAP350" . "AKAP450" . "AKAP9-BRAF fusion protein" . "A-kinase anchoring protein 450" . "A-kinase anchor protein, 350kDa" . "centrosome- and golgi-localized protein kinase N-associated protein" . "CG-NAP" . "HYPERION" . "KIAA0803" . "LQT11" . "MU-RMS-40.16A" . "PPP1R45" . "PRKA9" . "protein kinase A anchoring protein 9" . "protein phosphatase 1, regulatory subunit 45" . "YOTIAO" . . . . . . . . . "ABCX" . . . . . . . . . . . . . "ARA" . "FREAC3" . "IGDA" . "IHG1" . . . . . . . . "mesenchyme forkhead 1" . "MFH-1" . . . . . . . . "Genesis" . "HFH2" . . . . . . . . . . . "HFKH4" . "thyroid transcription factor 2" . "TTF-2" . . . . . . . . . . "FREAC8" . . . . . . . "FREAC1" . . . . . . . . . "BF1" . "brain factor 1" . "HBF-3" . "HFK1" . "HFK2" . "HFK3" . "QIN" . . . . . . . . . . . . "FAST1" . . . . . . . . . "FREAC6" . . . . . . . "HFH-4" . "HFH4" . . . . . . . "FKH1" . . . . . . . . . . "12CC4" . "fork head-related protein like B" . "glutamine-rich factor 1" . "hFKH1B" . "HSPC215" . "PAX5/FOXP1 fusion protein" . "QRF1" . . . . . . . . "FMLP" . "FPR" . . . . . . . . . "BABP" . "DD" . "DD2" . "dihydrodiol dehydrogenase 2; bile acid binding protein; 3-alpha hydroxysteroid dehydrogenase, type III" . "HAKRD" . "MCDR2" . . . . . . . . "3-alpha-HSD" . "C11" . "CDR" . "chlordecone reductase; 3-alpha hydroxysteroid dehydrogenase, type I; dihydrodiol dehydrogenase 4" . "DD4" . "HAKRA" . "MGC22581" . . . . . . . . "delta 4-3-ketosteroid-5-beta-reductase" . . . . . . . . "KIR2.6" . "TTPP2" . . . . . . . . . "AKT" . "PKB" . "PRKBA" . "protein kinase B" . "RAC" . . . . . . . . . . . . . . . . . . . "PKBG" . "PRKBG" . "protein kinase B, gamma" . "RAC-gamma" . . . . . . . . . . . "dJ576K7.1 (FK506 binding protein 12-rapamycin associated protein 1)" . "FK506 binding protein 12-rapamycin associated protein 2" . "FKBP12-rapamycin complex-associated protein 1" . "FKBP-rapamycin associated protein" . "FLJ44809" . "mammalian target of rapamycin" . "RAFT1" . "rapamycin and FKBP12 target 1" . "rapamycin associated protein FRAP2" . "rapamycin target protein" . "RAPT1" . . . . . . . . . . . . . . . . . "CyaY" . "FA" . "FARR" . "X25" . . . . . . . . "FRG1A" . "FSG1" . . . . . . . . "ALADH" . "PBGS" . "porphobilinogen synthase" . . . . . . . . "RFSN" . "RP30" . . . . . . . "follitropin, beta chain" . . . . . . . . . . "FSHRO" . "LGR1" . . . . . . . . . . . . . . . . "apoferritin" . "FHC" . "FTH" . "PIG15" . "placenta immunoregulatory factor" . "PLIF" . "proliferation-inducing protein 15" . . . . . . . . . "sideroblastic/hypochromic anemia" . . . . . . . . . . . . "ferritin L-chain" . "ferritin light polypeptide-like 3" . "ferritin L subunit" . "L apoferritin" . "MGC71996" . "NBIA3" . "neurodegeneration with brain iron accumulation 3" . . . . . . . . . . . . . . . . . . . . . . "CSRP2BP" . . . . . . "IDAS" . "MCI" . "multicilin" . . . . . . . . "α-L-fucosidase 1" . "a-L-fucosidase 1" . "tissue fucosidase" . . . . . . . . . . . . . "FUS1" . "heterogeneous nuclear ribonucleoprotein P2" . "hnRNP-P2" . "HNRNPP2" . "TLS" . "translocated in liposarcoma" . . . . . . . . . "3-dehydrosphinganine reductase" . "DHSR" . "SDR35C1" . "short chain dehydrogenase/reductase family 35C, member 1" . . . . . . . . . "MGC12372" . . . . . . . . . "ADAP" . "adhesion and degranulation promoting adaptor protein" . "FYB-120/130" . "SLAP-130" . . . . . . . "FALDH" . "fatty aldehyde dehydrogenase" . . . . . . . . . . . . . . . . . . . "CD344" . . . . . . . . . . . . . . "DKFZP434E2135" . "HFZ5" . . . . . . . . . "Hfz6" . . . . . . . . . "IFI15" . "UCRP" . . . . . . . . "G6PC1" . "glycogen storage disease type I, von Gierke disease" . "GSD1a" . . . . . . . . . "G6PD1" . . . . . . . . "GSD1b" . "GSD1c" . "GSD1d" . . . . . . . . . . "glycogen storage disease type II" . "Pompe disease" . . . . . . . . . "Delta-1-pyrroline-5-carboxylate dehydrogenase" . "L-glutamate gamma-semialdehyde dehydrogenase" . "P5CDh" . . . . . . . . . . "EJM5" . "GABA(A) receptor, alpha 1" . . . . . . . . . "GABA(A) receptor, alpha 2" . . . . . . . . "GABA(A) receptor, alpha 3" . . . . . . . . . "GABA(A) receptor, alpha 5" . . . . . . . . . "GABA(A) receptor, beta 2" . . . . . . . . . . . "GABA(A) receptor, beta 3" . . . . . . . . . . . "GABA(A) receptor, delta" . . . . . . . . . . . . "GABA(A) receptor, gamma 2" . . . . . . . . . "SSADH" . "SSDH" . "succinate-semialdehyde dehydrogenase" . . . . . . . . . . . . . . . . . "RALDH3" . "Retinaldehyde dehydrogenase 3" . . . . . . . . "ABC20" . "CD243" . "GP170" . "Multidrug resistance protein 1" . "P-gp" . . . . . . . . . . . "Krabbe disease" . . . . . . . . . "SDR1E1" . "short chain dehydrogenase/reductase family 1E, member 1" . "UDP-glucose 4-epimerase" . . . . . . . . "beta1-4GalNAc-T" . "GD2 synthase, GM2 synthase" . . . . . . . . . . . . . . . "GALNAC6S" . "GAS" . "Morquio syndrome" . "mucopolysaccharidosis type IVA" . . . . . . . . . "GalNAc-T3" . "HFTC" . "HHS" . "polypeptide GalNAc transferase 3" . . . . . . . . . . . . . . . "PIG2" . "TP53I2" . . . . . . . . "GAN1" . "kelch-like family member 16" . "KLHL16" . . . . . . . . "G2AN" . "GIIA" . "GluII" . "KIAA0088" . "neutral alpha-glucosidase AB" . . . . . . . . . . . . . . . . "DSMAV" . "glycine tRNA ligase" . "GlyRS" . "SMAD1" . . . . . . . . . . . . . "Growth arrest-specific gene-1" . . . . . . . . "DRC4" . . . . . . . . . . . . . . . "ERYF1" . "GATA-1" . "NF-E1" . "NFE1" . "nuclear factor, erythroid 1" . . . . . . . . . . . "NFE1B" . . . . . . . . . "HDR" . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . "AGAT" . "L-arginine:glycine amidinotransferase" . . . . . . . . . . . . . . . . "GBA1" . . . . . . . . . . . . . . . . . . . . . . . "Andersen disease" . "glycogen branching enzyme" . "glycogen storage disease type IV" . . . . . . . . "ACAD5" . . . . . . . . "GGR" . . . . . . . . . . "dopa-responsive dystonia" . "DYT5a" . "GTPCH1" . . . . . . . . . . "hexokinase 4" . "HK4" . . . . . . . . . . "hGCMb" . . . . . . . . "bA360O19.2" . "bA421M1.1" . "IGNT" . "Ii blood group" . "NAGCT1" . "ULG3" . "unassigned linkage group 3" . . . . . . . . . . "COD5" . "cone dystrophy 5 (X-linked)" . "OPN1MW1" . . . . . . . . . . . "lipoic acid-containing protein" . . . . . . . . . . . . . . . . . . "BMP-9" . "BMP9" . . . . . . . . . . . . . . . . . . . . . . . . "BMP14" . "cartilage-derived morphogenetic protein-1" . "CDMP1" . . . . . . . . . . "BMP13" . "KFS" . "KFS1" . . . . . . . . . . . . . . . . . . . . . "FLJ41411" . "mental retardation, X-linked 41" . "mental retardation, X-linked 48" . "OPHN2" . "RABGDIA" . "rab GDP-dissociation inhibitor, alpha" . "XAP-4" . . . . . . . . . "astrocyte-derived trophic factor" . "ATF1" . "ATF2" . "glial cell line derived neurotrophic factor" . "glial derived neurotrophic factor" . "HFB1-GDNF" . . . . . . . . . "FLJ45472" . "intermediate filament protein" . . . . . . . . "ALR" . "ERV1" . "ERV1 homolog (S. cerevisiae)" . "FAD-linked sulfhydryl oxidase ALR" . "HERV1" . "HPO1" . "HPO2" . "HSS" . . . . . . . . "GFI-1" . "GFI1A" . . . . . . . . . "ZNF163B" . . . . . . . . "GFA" . "GFAT" . "GFAT1" . . . . . . . . . . "peptidyl-glutamate 4-carboxylase" . "vitamin K-dependent gamma-carboxylase" . "VKCFD1" . . . . . . . . . "CD224" . "D22S672" . "D22S732" . . . . . . . . . . . "GH" . "GH-N" . "GHN" . "hGH-N" . "pituitary growth hormone" . "somatotropin" . . . . . . . . . "GHBP" . "growth hormone binding protein" . . . . . . . . . . . . . . . . . . . . . . . . . "IF" . "IFMH" . "INF" . "TCN3" . . . . . . . . . . . . . . "connexin 43" . "CX43" . "oculodentodigital dysplasia (syndactyly type III)" . "ODD" . "ODOD" . "SDTY3" . . . . . . . . . . . "connexin 46" . "CX46" . . . . . . . . . . "connexin 40" . "CX40" . . . . . . . . . . . . . . "CD246" . . . . . . . . . . . . . . "connexin 50" . "CX50" . . . . . . . . . . "Charcot-Marie-Tooth neuropathy, X-linked" . "connexin 32" . "CX32" . . . . . . . . . . . . . . . "connexin 26" . "CX26" . "NSRD1" . . . . . . . . . . . . "connexin 31" . "CX31" . . . . . . . . . "connexin 30.3" . "CX30.3" . . . . . . . . . . . . "connexin 30" . "CX30" . "EDH" . "HED" . . . . . . . . . . "GK1" . "GKD" . . . . . . . . "KIAA0328" . . . . . . . . "GALA" . . . . . . . . . . . "EBP" . . . . . . . . . . "ABC16" . "ABC member 16, MDR/TAP subfamily" . "PFIC-2" . "PGY4" . "SPGP" . . . . . . . . . . . . . . "12R-LOX" . . . . . . . . . . "GCS" . . . . . . . . . . "GCSP" . "glycine cleavage system protein P" . "glycine dehydrogenase" . "NKH" . . . . . . . . . . "hGLE1" . . . . . . . . . . . . . . . . . . . . . . . . . . . "HPE9" . "tax helper protein 1" . "tax helper protein 2" . "tax-responsive element-2 holding protein" . "THP1" . "THP2" . . . . . . . . . . . . . . "ACLS" . "DNA-binding protein" . "oncogene GLI3" . "PAP-A" . "PAPA" . "PAPA1" . "PAPB" . "PPDIV" . "zinc finger protein GLI3" . . . . . . . . "stiff person syndrome" . . . . . . . . . . . . . . . . . . "GLS1" . "KIAA0838" . . . . . . . . "GDH" . . . . . . . . "glutamine synthetase" . . . . . . . . "cerebroside sulfate activator protein" . "SAP-3" . "sphingolipid activator protein 3" . . . . . . . . . . . . . . . . "FBH" . "FBH2" . "FHH2" . . . . . . . . . . . . . . . . "87U6" . "Guanine nucleotide-binding protein G(k) subunit alpha" . . . . . . . . . . . . . . . . "G-ALPHA-o" . . . . . . . . . . . . . "tissue non-specific alkaline phosphatase" . "TNALP" . "TNAP" . "TNSALP" . . . . . . . . . . . "G-ALPHA-q" . "GAQ" . . . . . . . . . . . . . . . . . . "GNASXL" . "G protein subunit alpha S" . "GPSA" . "NESP" . "NESP55" . "SCG6" . "secretogranin VI" . "SgVI" . . . . . . . . "CSNBAD3" . . . . . . . . . "ACHM4" . . . . . . . . "guanine nucleotide-binding protein G(I)/G(S)/G(T) subunit beta-1" . "transducin beta chain 1" . . . . . . . . "LINC-HELLP" . "Long intergenic non-protein coding RNA associated with HELLP syndrome" . . . . . "D6S114E" . "PSF1" . "RING4" . . . . . . . . . "Guanine nucleotide-binding protein G(I)/G(S)/G(T) subunit beta-3" . "transducin beta chain 3" . . . . . . . . "GB5" . "Guanine nucleotide-binding protein subunit beta-5" . "Transducin beta chain 5" . . . . . . . . . . . . . . "DAP-AT" . "DAPAT" . "DHAPAT" . "dihydroxyacetone phosphate acyltransferase" . "glycerone-phosphate O-acyltransferase" . . . . . . . . "progonadoliberin-1" . . . . . . . . "LHRHR" . . . . . . . . . "N-acetylglucosamine-6-sulfatase" . "Sanfilippo disease IIID" . . . . . . . . "golgi integral membrane protein 5" . "golgin-84" . "GOLIM5" . "ret-II" . "rfg5" . . . . . . . . "Bos1" . "GS27" . . . . . . . . . . . "CD42b" . "GPIbalpha" . "platelet glycoprotein Ib alpha chain" . . . . . . . . . . "Alsin" . . . . . . . . . . . "CD42c" . "GPIbbeta" . "platelet glycoprotein Ib beta chain" . . . . . . . . "CD42a" . "GPIX" . "platelet glycoprotein IX" . . . . . . . . "GAA1" . "GPI transamidase subunit" . "hGAA1" . . . . . . . . "DGSX" . "glypican proteoglycan 3" . "OCI-5" . "SGB" . "SGBS" . "SGBS1" . . . . . . . . . . "glypican proteoglycan 4" . "K-glypican" . . . . . . . . "glypican proteoglycan 6" . . . . . . . . . . . . . . . "AMF" . "NLK" . . . . . . . . . "AOA2" . "KIAA0625" . "Sen1" . . . . . . . . "glycoprotein NMB" . "glycoprotein nmb-like protein" . "glycoprotein nonmetastatic melanoma protein B" . "hematopoietic growth factor inducible neurokinin-1" . "HGFIN" . "NMB" . "osteoactivin" . "transmembrane glycoprotein" . . . . . . . . "LPA4" . "P2RY9" . "P2Y5-LIKE" . "P2Y9" . . . . . . . . . . . . . . . . . . . . . . . "D6S217E" . "PSF2" . "RING11" . . . . . . . . . "GABABR2" . "GPRC3B" . "HG20" . . . . . . . . . . . . "FPP" . "KIAA1788" . "PFM" . . . . . . . . "AXOR12" . "HOT7T175" . . . . . . . . . . "TM7LN4" . "TM7XN1" . . . . . . . . "EDDM6" . "epididymal protein 6" . "HE6" . "TM7LN2" . . . . . . . . "OGR1" . . . . . . . . . "P504S" . "RACE" . . . . . . . . "enamel matrix protein" . . . . . . . . "MRT14" . "TER" . "very-long-chain enoyl-CoA reductase" . . . . . . . . "MCSP" . "PHGPx" . "phospholipid hydroperoxidase" . . . . . . . . . . . . . . "PH2" . "primary hyperoxaluria type 2" . . . . . . . . "GluA3" . "GLURC" . "MRX94" . . . . . . . . . "GluD2" . "GluR-delta-2" . . . . . . . . "GluK2" . "MRT6" . . . . . . . . . . "GluN1" . . . . . . . . . . . . . "GluN2A" . . . . . . . . . . . "GluN2B" . . . . . . . . . "EB11" . "GluN2D" . "N-methyl-d-aspartate receptor subunit 2D" . "NR2D" . . . . . . . . . . "GPRC1A" . "mGlu1" . "MGLUR1" . "PPP1R85" . "protein phosphatase 1, regulatory subunit 85" . . . . . . . . . "CSNB1B" . "GPRC1F" . "mGlu6" . "MGLUR6" . . . . . . . . . . . "GBD1" . "MDR2" . "PFIC-3" . . . . . . . . . . . . "CLN11" . "PCDGF" . "PGRN" . "progranulin" . . . . . . . . . . . . . . "amelogenesis imperfecta 1" . . . . . . . . "amyloidosis, Finnish type" . "DKFZp313L0718" . . . . . . . . "glutathione S-reductase" . . . . . . . . . . . . . . . . . . . . . "MIS" . . . . . . . . "FE" . "TF2E2" . "TFIIE-B" . "TFIIE beta subunit" . "Transcription initiation factor IIE subunit beta" . . . . . . . . "BAP-135" . "BTKAP1" . "DIWS" . "IB291" . "SPIN" . "TFII-I" . . . . . . . . "MISR2" . "MISRII" . "Muellerian inhibiting substance type II receptor" . . . . . . . . . "BEN" . "binding factor for early enhancer" . "Cream1" . "GTF3" . "MusTRD1" . "RBAP2" . "WBSCR12" . . . . . . . . . . "COD3" . "cone dystrophy 3" . "CORD14" . "dJ139D8.6" . "GCAP" . "GCAP1" . . . . . . . . "GCAP2" . "RP48" . . . . . . . . . . . . . . . . "GC-SA3" . . . . . . . . . . . "heat stable enterotoxin receptor" . "STAR" . "STA receptor" . . . . . . . . . . . "CYGD" . "LCA1" . "retGC" . "RETGC-1" . "retinal guanylate cyclase 1" . "rod outer segment membrane guanylate cyclase" . "ROS-GC1" . . . . . . . . . "AMPD isoform M" . "MAD" . "MADA" . "skeletal muscle AMPD" . . . . . . . . . . . . . . . . "glycogenin glucosyltransferase" . . . . . . . . . "AMPD isoform L" . "SPG63" . . . . . . . . "CD236" . "CD236R" . "Ge" . "GPC" . "GYPD" . . . . . . . . "GSY" . . . . . . . . . . . . . . . "erythrocyte-specific AMP deaminase" . . . . . . . . . . . . . "ASM" . "ASM1" . "D11S813E" . "LINC00008" . "long intergenic non-protein coding RNA 8" . "MIR675HG" . "MIR675 host gene" . "NCRNA00008" . "non-protein coding RNA 8" . . . . . . . . "GCST" . "glycine cleavage system protein T" . "NKH" . . . . . . . . "macroH2A1.2" . . . . . . . "6-phosphogluconolactonase" . "GDH/6PGL endoplasmic bifunctional protein" . . . . . . . . . . . . . "factor VII activating protein" . "FSAP" . "HABP" . "HGFAL" . "PHBP" . "plasma hyaluronan binding protein" . . . . . . . "HADH1" . "SCHAD" . . . . . . . . . . . . . . . . "ATP-binding cassette half-transporter" . "EST45597" . "MTABC3" . "umat" . . . . . . . . . . . "17b-HSD10" . "ABAD" . "AB-binding alcohol dehydrogenase" . "CAMR" . "ERAB" . "MHBD" . "mitochondrial RNase P subunit 2" . "MRPP2" . "SDR5C1" . "short chain dehydrogenase/reductase family 5C, member 1" . "type 10 17beta-hydroxysteroid dehydrogenase" . "type 10 17b-HSD" . . . . . . . . . . "gastrin-binding protein" . "GBP" . "LCEH" . "LCHAD" . "long-chain 2-enoyl-CoA hydratase" . "long-chain-3-hydroxyacyl-CoA dehydrogenase" . "mitochondrial trifunctional protein, alpha subunit" . "MTPA" . . . . . . . . "mitochondrial trifunctional protein, beta subunit" . "MTPB" . . . . . . . . . . . . . . . "bHLHa26" . "dHand" . "Hed" . "Thing2" . . . . . . . . "HisRS" . "Histidine tRNA ligase 1, cytoplasmic" . "Jo-1 antigen" . . . . . . . . "HARSR" . "histidine tRNA ligase 2, mitochondrial (putative)" . "HO3" . . . . . . . . . . . "HBA-T3" . . . . . . . . . . . "HBA-T2" . . . . . . . . . . . . . . . . . . . . . . . . . "beta-globin" . "CD113t-C" . . . . . . . . . . . . . . . . . . "HBG-T2" . . . . . . . . . . "HBG-T1" . . . . . . . . "CCHL" . "cytochrome c heme-lyase" . . . . . . . . "CFF" . "HCF-1" . "HCF1" . "MGC70925" . "PPP1R89" . "protein phosphatase 1, regulatory subunit 89" . "VCAF" . "VP16-accessory protein" . . . . . . . . "RAA1" . "ribonuclease A family member 5" . "RNASE5" . . . . . . . . . "BCNG-1" . "HAC-2" . . . . . . . . . . "orexin" . "OX" . "PPOX" . "prepro-orexin" . . . . . . . . "Ang1" . "KIAA0003" . . . . . . . . . "IT15" . . . . . . . . . . . . . . . . "LSH" . "Nbla10143" . "PASG" . "proliferation-associated SNF2-like protein" . "SMARCA6" . "SWI/SNF2-related, matrix-associated, actin-dependent regulator of chromatin, subfamily A, member 6" . . . . . . . . "p532" . "p619" . . . . . . . . "D15F37S1" . "jdf2" . "p528" . . . . . . . . . . . . "ANF" . "RPX" . . . . . . . . . . . "beta-hexosaminidase subunit alpha" . "GM2 gangliosidosis" . "Tay Sachs disease" . . . . . . . . . . "beta-hexosaminidase subunit beta" . . . . . . . . "bHLHb32" . "HERP1" . "HESR2" . . . . . . . . . . . . . . . "age-related maculopathy susceptibility 1" . "ARMD4" . "ARMS1" . "beta-1H" . "FHL1" . "H factor 2 (complement)" . "HUS" . . . . . . . . . . . . "high Fe" . "HLA-H" . . . . . . . . "haemojuvelin" . "hemojuvelin" . "HFE2A" . "HJV" . "JH" . "repulsive guidance molecule c" . "RGMC" . . . . . . . . . . "CFHL" . "FHR1" . "H36-1" . "H36-2" . . . . . . . . "FHR2" . . . . . . . . "HGO" . "homogentisate oxidase" . . . . . . . . "fibroblast-derived tumor cytotoxic factor" . "F-TCF" . "hepatopoietin A" . "HGFB" . "HPTA" . "lung fibroblast-derived mitogen" . "scatter factor" . "SF" . . . . . . . . "ASAT" . "Atm1p" . "EST140535" . . . . . . . . . . . . . . . . "ILAS1-AS1" . . . . "ZBTB29" . "ZNF901" . . . . . . . . "PKCI-1" . . . . . . . "DGCR1" . "DiGeorge critical region gene 1" . "TUP1" . . . . . . . . "angiopoietin 5" . . . . . . . . "c-myc intron binding protein 1" . "HIV-EP2" . "MBP-2" . "MIBP1" . "Schnurri-2" . "ZAS2" . "ZNF40B" . . . . . . . . . . . . . . . . "SPH1" . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . "CELIAC1" . . . . . . . . . . . . . . . . "CELIAC1" . "IDDM1" . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . "ankyrin-3, node of Ranvier" . "ankyrin-G" . . . . . . . . . "ANKK2" . "DIK" . "PKC-delta-interacting protein kinase" . "PKK" . "Protein kinase C-associated kinase" . "RIP4" . . . . . . . . . "HCS" . . . . . . . . "MGC33822" . . . . . . . "HB24" . . . . . . . "HB9" . "HOXHB9" . "SCRA1" . . . . . . . . . . . . . . . . . . . . . . "HL" . "hydroxymethylglutaricaciduria" . "hydroxymethylglutaryl-CoA lyase" . . . . . . . . . . . . . . . . . . . . "BABL" . "LIPO" . . . . . . . . . "bK286B10" . "HO-1" . . . . . . . . . "H6" . "NKX5-3" . . . . . . . . . . . . . . . . "HNF4" . "NR2A1" . . . . . . . . . . . . . . . . . "ALS20" . "hnRNP-A1" . "hnRNPA1" . . . . . . . . . . . . . . . "JKTBP" . "laAUF1" . . . . . . . . "hnRNPH" . . . . . . . . . "CSBP" . "transformation upregulated nuclear protein" . "TUNP" . . . . . . . . "FLJ30202" . "FLJ37978" . "SAF-A" . "scaffold attachment factor A" . . . . . . . . "Homeo box-11 (T-cell leukemia-3 associated breakpoint, homologous to Drosophila Notch)" . "homeo box 11 (T-cell lymphoma 3-associated breakpoint)" . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . "4-HPPD" . "4HPPD" . "GLOD3" . "glyoxalase domain containing 3" . . . . . . . . . . . "15-hydroxyprostaglandin dehydrogenase (NAD(+))" . "SDR36C1" . "short chain dehydrogenase/reductase family 36C, member 1" . . . . . . . . . . "HGPRT" . "Lesch-Nyhan syndrome" . . . . . . . . "BLOC3S1" . . . . . . . . . . "AU" . . . . . . . . . . . . . . . . . . . . "histidine-proline rich glycoprotein" . "HPRG" . "HRGP" . "thrombophilia due to elevated HRG" . . . . . . . . "GS-X" . . . . . . . . . . . . . . . . . "SDR26C1" . "short chain dehydrogenase/reductase family 26C, member 1" . . . . . . . . . "SDR9C3" . "short chain dehydrogenase/reductase family 9C, member 3" . . . . . . . . . "SDR12C2" . "short chain dehydrogenase/reductase family 12C, member 2" . . . . . . . . . "17beta-estradiol dehydrogenase type IV" . "17-beta-HSD IV" . "17-beta-hydroxysteroid dehydrogenase 4" . "3-alpha,7-alpha,12-alpha-trihydroxy-5-beta-cholest-24-enoyl-CoA hydratase" . "beta-hydroxyacyl dehydrogenase" . "beta-keto-reductase" . "D-3-hydroxyacyl-CoA dehydratase" . "D-bifunctional protein, peroxisomal" . "DBP" . "MFE-2" . "peroxisomal multifunctional protein 2" . "SDR8C1" . "short chain dehydrogenase/reductase family 8C, member 1" . . . . . . . . "SDR11E2" . "short chain dehydrogenase/reductase family 11E, member 2" . . . . . . . . . . . . . . . . . "CMT2T" . "HSPF3" . . . . . . . . "75 kDa glucose-regulated protein" . "GRP75" . "mortalin" . "mortalin2" . "mot-2" . "mthsp75" . "PBP74" . "Stress-70 protein, mitochondrial" . . . . . . . . . "CMT2F" . "Hs.76067" . "Hsp25" . "HSP27" . "HSP28" . . . . . . . . "HSPL27" . . . . . . . . "GROEL" . "HSP60" . . . . . . . . "Hsp40" . "radial spoke 16 homolog B (Chlamydomonas)" . "RSPH16B" . "Sis1" . . . . . . . . . . "perlecan" . "perlecan proteoglycan" . "PRCAN" . . . . . . . . "5-HT1A" . . . . . . . . . "hexabrachion (tenascin)" . "MGC167029" . "TN" . . . . . . . . "FUS2" . "HYAL-1" . "LUCA1" . "NAT6" . . . . . . . . "LuCa-2" . "LUCA2" . "lysosomal hyaluronidase" . "PH-20 homolog" . . . . . . . . . "NCRNA00020" . "non-protein coding RNA 20" . . . . . . "IARS1" . "ILRS" . "isoleucine tRNA ligase 1, cytoplasmic" . . . . . . . . . . "BLAU" . "CD" . "CLR16.3" . "NLRC2" . "NLR family, CARD domain containing 2" . "NOD-like receptor C2" . "nucleotide-binding oligomerization domain, leucine rich repeat and CARD domain containing 2" . "PSORAS1" . . . . . . . . . "activation-inducible lymphocyte immunomediatory molecule" . "AILIM" . "CD278" . . . . . . . . . "ICSBP" . "IRF-8" . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . "H-IDH alpha" . "isocitrate dehydrogenase (NAD+) alpha chain" . "isocitrate dehydrogenase [NAD] subunit alpha, mitochondrial" . "isocitric dehydrogenase" . "NAD(H)-specific isocitrate dehydrogenase alpha subunit" . "NAD+-specific ICDH" . . . . . . . . "RP46" . . . . . . . . . "Hunter syndrome" . . . . . . . . . . "MPS1" . . . . . . . . . . . . . . . . . . "C3b-INA" . "C3b-inactivator" . "FI" . "KAF" . "Konglutinogen-activating factor" . . . . . . . . "cMRP" . "DJS" . "MRP2" . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . "CD119" . . . . . . . . . . . "AF-1" . . . . . . . . . "PC4" . "TIS7" . . . . . . . "alpha 4" . . . . . . . . "IGF" . "IGF1A" . "IGF-I" . "IGFI" . "somatomedin C" . . . . . . . . "CD221" . "IGFIR" . "IGFR" . "JTK13" . "MGC18216" . . . . . . . . . . . . . "FLJ44734" . "IGF-II" . "preptin" . "somatomedin A" . . . . . . . . "ALS" . . . . . . . . "FSTL2" . "IGFBP-7" . "MAC25" . "PSF" . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . "cardiac transcription factor 1" . "CATF1" . "CMT2S" . "HCSA" . "HMN6" . "SMARD1" . "SMUBP2" . "ZFAND7" . "zinc finger, AN1-type domain 7" . . . . . . . "AP105A" . "BAM22" . . . . . . . . . . . . "AP19" . "AP-1 complex subunit sigma-1A" . "clathrin assembly protein complex 1 sigma-1A small chain" . "clathrin-associated/assembly/adaptor protein, small 1 (19kD)" . "clathrin coat assembly protein AP19" . "golgi adaptor HA1/AP1 adaptin sigma-1A subunit" . "HA1 19 kDa subunit" . "SIGMA1A" . "sigma1A-adaptin" . "sigma1A subunit of AP-1 clathrin adaptor complex" . "WUGSC:H_DJ0747G18.2" . . . . . . . . . . "SIGMA1B" . . . . . . . . "AP-2 mu 2 chain" . "AP50" . "clathrin adaptor complex AP2, mu subunit" . "clathrin assembly protein complex 2 medium chain" . "clathrin-associated/assembly/adaptor protein, medium 1" . "clathrin coat adaptor protein AP50" . "HA2 50 kDA subunit" . "mu2" . "plasma membrane adaptor AP-2 50kDA protein" . . . . . . . . . . . . . "FBH3" . "FBHOk" . . . . . . . . "ADTB3A" . "HPS2" . . . . . . . . "NAPTB" . . . . . . . "ADTD" . . . . . . . "HCAK1" . . . . . . . . "CBF1" . "IGKJRB" . "KBF2" . "RBP-J" . "RBPJK" . "SUH" . "Suppressor of hairless homolog (Drosophila)" . . . . . . . . "AP-4 complex subunit beta-1" . "BETA-4" . "beta 4 subunit of AP-4" . . . . . . . . "AP-4-EPSILON" . "SPG51" . . . . . . . . "adaptor-related protein complex AP-4 mu4 subunit" . "AP-4 adapter complex mu subunit" . "MU-4" . "mu-adaptin-related protein-2" . "MU-ARP2" . "mu subunit of AP-4" . "SPG50" . . . . . . . . "AP47B" . "CLA20" . "SPG52" . . . . . . . . . "EST349056" . "MLP1" . "MRP6" . "URG7" . . . . . . . . . . . . . . . "DP2" . "DP2.5" . "DP3" . "PPP1R46" . "protein phosphatase 1, regulatory subunit 46" . . . . . . . . "14.1" . "CD179B" . "IGL5" . "IGVPB" . "lambda 5" . . . . . . . . "apoptosis inhibitor 2" . "c-IAP2" . "cIAP2" . "hiap-1" . "inhibitor of apoptosis protein 1" . "MALT2" . "mammalian IAP homolog C" . "MIHC" . "RNF49" . "TNFR2-TRAF signaling complex protein" . . . . . . . . . "hILP" . "IAP-like protein 1" . "ILP-1" . . . . . . . . . "IGCD1" . "IGDC1" . "INHBP" . "KIAA0364" . "MGC75490" . "PGSF2" . . . . . . . "EWI-3" . "MGC117164" . "V8" . . . . . . . . "BDA1" . "HHG2" . . . . . . . . "elongator acetyltransferase complex subunit 1" . "IKAP" . "IKI3" . "TOT1" . . . . . . . . "IKK2" . "IKKB" . "IKK-beta" . "NFKBIKB" . . . . . . . . . . . . "FIP-3" . "FIP3" . "Fip3p" . "IKK-gamma" . "NEMO" . "ZC2HC9" . . . . . . . . . . "CSIF" . "cytokine synthesis inhibitory factor" . "IL-10" . "IL10A" . "T-cell growth inhibitory factor" . "TGIF" . . . . . . . . "CD210" . "CD210a" . "CDW210A" . "HIL-10R" . . . . . . . . . "CDW210B" . "CRF2-4" . "IL-10R2" . . . . . . . . . . . . . . . . . . "CLMF" . "cytotoxic lymphocyte maturation factor 1, p35" . "IL-12A" . "IL-12, subunit p35" . "IL35 subunit" . "interleukin-12 alpha chain" . "interleukin 12, p35" . "natural killer cell stimulatory factor 1, 35 kD subunit" . "NF cell stimulatory factor chain 1" . "NFSK" . "p35" . . . . . . . . . "CLMF" . "CLMF2" . "cytotoxic lymphocyte maturation factor 2, p40" . "IL-12B" . "IL12, subunit p40" . "interleukin-12 beta chain" . "interleukin 12, p40" . "natural killer cell stimulatory factor-2" . "natural killer cell stimulatory factor, 40 kD subunit" . "NKSF" . . . . . . . . . "CD212" . . . . . . . . . "CD217" . "CDw217" . "hIL-17R" . "IL-17RA" . . . . . . . . . "IL1R8" . "OPHN4" . "TIGIRR-2" . . . . . . . . . . . . . . "ABC36" . "HHF1" . "HI" . "MRP8" . "PHHI" . "sulfonylurea receptor (hyperinsulinemia)" . "SUR1" . "TNDM2" . . . . . . . . . "ICIL-1RA" . "IL1F3" . "IL1RA" . "IL-1RN" . "interleukin-1 receptor antagonist protein" . "intracellular interleukin-1 receptor antagonist" . "IRAP" . "MGC10430" . . . . . . . . "IL-21" . "Za11" . . . . . . . "CD360" . . . . . . . . . . "CD25" . . . . . . . . . . "CD122" . . . . . . . . . . . . . . . . . . "CD132" . . . . . . . . . . "BSF2" . "HGF" . "HSF" . "IL-6" . "interferon, beta 2" . . . . . . . . . . . . . . . "IL-7" . . . . . . . . . "CD127" . "IL7RA" . . . . . . . . . "CD182" . "CMKAR2" . . . . . . . . . . . . . . . . . . . "LCA11" . "sWSS2608" . . . . . . . . . "GP147" . "IPM150" . . . . . . . . . . . . . "growth inhibitor ING1" . "growth inhibitory protein ING1" . "inhibitor of growth 1" . "p24ING1c" . "p33" . "p33ING1" . "p33ING1b" . "p47" . "p47ING1a" . "tumor suppressor ING1" . . . . . . . . . . . . . . . . . . . . . . . "51C protein" . "phosphatidylinositol 3,4,5-trisphosphate 5-phosphatase 2" . "SH2 domain-containing inositol 5'-phosphatase 2" . "SHIP2" . . . . . . . . . . . . . . . . . . . . "CD220" . . . . . . . . . . . . . . . . . . . . . "CMD1O" . "sulfonylurea receptor 2" . "SUR2" . . . . . . . . . "AIID" . "DIETER" . "JM2" . "PIDX" . "SCURFIN" . "XPID" . . . . . . . . . . "IDX-1" . "MODY4" . "PDX-1" . "somatostatin transcription factor 1" . "STF-1" . . . . . . . . . . . . . . . . . . "IRAK" . "pelle" . . . . . . . . . . . . . . . . . . . . . . . . . . . "OFC6" . "VWS1" . . . . . . . . . . . . . . . "Isl-1" . "ISLET1" . . . . . . . . "alpha 2 subunit of VLA-2 receptor" . "CD49b" . . . . . . . . . . . "CD41" . "CD41B" . "platelet glycoprotein IIb of IIb/IIIa complex" . "PPP1R93" . "protein phosphatase 1, regulatory subunit 93" . . . . . . . . . "alpha 3 subunit of VLA-3 receptor" . "antigen CD49C" . "CD49c" . "GAP-B3" . "VCA-2" . "VLA3a" . . . . . . . . . . . . . . . . . . . . . "CD49f" . . . . . . . . . . . . . . . . . . . . . . . . . . "CD11b" . "complement component 3 receptor 3 subunit" . "MAC-1" . . . . . . . . . "complement component 3 receptor 3 and 4 subunit" . "LFA-1" . "MAC-1" . . . . . . . . . . . "antigen CD61" . "CD61" . "GPIIIa" . "platelet glycoprotein IIIa" . . . . . . . . . . . . . "CD104" . . . . . . . . . . . . . . . . . . . "EMT" . "LYK" . "PSCTK2" . . . . . . . . . "dolichyl-diphosphooligosaccharide protein glycotransferase" . "MGC9042" . "STT3-A" . "TMC" . . . . . . . . "BRICD2A" . "BRICHOS domain containing 2A" . "E25A" . . . . . . . . . "BRI" . "BRI2" . "BRICD2B" . "BRICHOS domain containing 2B" . "E25B" . "E3-16" . . . . . . . . "dJ794I6.3" . "HLC14-06-P" . "nucleoside-triphosphate diphosphatase" . . . . . . . . . . "ACV" . "Insp3r1" . "IP3R1" . "PPP1R94" . "protein phosphatase 1, regulatory subunit 94" . . . . . . . . . "CFAP48" . "cilia and flagella associated protein 48" . "IP3R2" . . . . . . . . . "ACAD2" . . . . . . . . . . "AHD" . "AWS" . "CD339" . "HJ1" . . . . . . . . . . . . . . . "JAK1A" . "JTK3" . . . . . . . . . . . "JTK10" . . . . . . . . . "JAK-3" . "JAK3_HUMAN" . "JAKL" . "leukocyte Janus kinase" . "L-JAK" . "LJAK" . "tyrosine-protein kinase JAK3" . . . . . . . . . . . . . . "jerky" . "JH8" . . . . . . . . . . . "adrenoleukodystrophy" . "ALDP" . "AMN" . . . . . . . . . . . . . "DP3" . "DPIII" . "PDGB" . "PKGB" . . . . . . . . . . . . . . "peptidase nexin-II" . . . . . . . . "Adhesion molecule-like, X-linked" . "anosmin-1" . "KALIG-1" . "Kallmann syndrome interval gene 1" . "WAP four-disulfide core domain 19" . "WFDC19" . . . . . . . . . "KARS1" . "KARS2" . "lysine tRNA ligase" . . . . . . . . . . . . . . . . . . "HUK1" . "Kv1.1" . "MBK1" . "RBK1" . . . . . . . . . . "HK4" . "Kv1.2" . . . . . . . . . "HK2" . "HPCN1" . "Kv1.5" . . . . . . . . . "AKR6A5" . "HKvbeta2.1" . "HKvbeta2.2" . "KCNA2B" . . . . . . . . "Kv2.1" . . . . . . . . . "Kv3.1" . . . . . . . . . "Kv3.3" . . . . . . . . . . "KSHIVB" . "Kv4.3" . . . . . . . . . . . "ISK" . "JLNS2" . "LQT5" . "minK" . . . . . . . . . . . . . . . . . "LQT6" . "MiRP1" . . . . . . . . . "HOKPP" . "MiRP2" . . . . . . . . . "eag" . "eag1" . "h-eag" . "Kv10.1" . . . . . . . . . . "erg1" . "HERG" . "Kv11.1" . . . . . . . . . "ATP-sensitive inward rectifier potassium channel 1" . "Kir1.1" . "ROMK1" . . . . . . . . . . "Kir1.2" . "Kir4.1" . . . . . . . . . . . . . . . . "ATP-sensitive inward rectifier potassium channel 11" . "BIR" . "Kir6.2" . . . . . . . . . . "Kir1.4" . "Kir7.1" . "LCA16" . . . . . . . . . . "IRK1" . "Kir2.1" . "LQT7" . . . . . . . . . . . . "CIR" . "GIRK4" . "G protein-activated inward rectifier potassium channel 4" . "KATP1" . "Kir3.4" . "LQT13" . . . . . . . . . "BIR1" . "GIRK2" . "hiGIRK2" . "KATP2" . "Kir3.2" . . . . . . . . . . "Kir6.1" . . . . . . . . . . . . . . . . "K2p3.1" . "TASK" . "TASK-1" . . . . . . . . . "K2p9.1" . "TASK-3" . "TASK3" . . . . . . . . . "big potassium channel alpha subunit" . "BK channel alpha subunit" . "KCa1.1" . "maxiK channel" . "mSLO1" . . . . . . . . . "hSK3" . "KCa2.3" . "SKCA3" . "small conductance calcium-activated potassium channel 3" . . . . . . . . . . "hIKCa1" . "hKCa4" . "hSK4" . "IK" . "intermediate conductance calcium-activated potassium channel" . "KCa3.1" . "small conductance calcium-activated potassium channel 4" . . . . . . . . . . . . "Jervell and Lange-Nielsen syndrome 1" . "JLNS1" . "KCNA8" . "Kv7.1" . "KVLQT1" . "LQT1" . . . . . . . . . . "KCNQ1 antisense RNA 2 (non-protein coding)" . "KCNQ1-AS2" . "KCNQ1 overlapping transcript 1 (non-protein coding)" . "KvDMR1" . "KvLQT1-AS" . "LIT1" . "NCRNA00012" . "non-protein coding RNA 12" . . . . . . . . . . "BFNC" . "ENB1" . "HNSPC" . "KCNA11" . "Kv7.2" . . . . . . . . . . . "Kv7.3" . . . . . . . . . "Kv7.4" . . . . . . . . . "Kv7.5" . . . . . . . . . . . . . "CD309" . "fetal liver kinase 1" . "FLK1" . "vascular endothelial growth factor receptor 2" . "VEGFR" . "VEGFR2" . . . . . . . . . "keratocan proteoglycan" . "SLRR2B" . . . . . . . . "fructokinase" . . . . . . . . "SPAX2" . "SPG58" . . . . . . . . . "D12S1889" . "MY050" . "NKHC" . . . . . . . . "kisspeptin" . "prepro-kisspeptin" . . . . . . . . . . . . . . . . . . . . . . . . . . "CD117" . "C-Kit" . "mast/stem cell growth factor receptor Kit" . "SCFR" . . . . . . . . . . . . . "DFNA69" . "familial progressive hyperpigmentation 2" . "FPH2" . "Kitl" . "KL-1" . "mast cell growth factor" . "SCF" . "SF" . "SLF" . "steel factor" . "stem cell factor" . . . . . . . . . . . . . . . . . . "EKLF" . "erythroid Kruppel-like factor" . . . . . . . . . . . . . . . "KIAA1129" . . . . . . . . "EMSP" . "EMSP1" . "enamel matrix serine proteinase 1" . "KLK-L1" . "PSTS" . . . . . . . . "Fletcher factor" . . . . . . . . . "NKG2-F" . . . . . . . . "alpha-2-thiol proteinase inhibitor" . "BK" . "bradykinin" . . . . . . . . "Eg5" . "HKSP" . "TRIP5" . . . . . . . . . . . . . . . . . "Kid" . "OBP-1" . "OBP-2" . . . . . . . . "MKLP-1" . "MKLP1" . . . . . . . . "2E4" . . . . . . . . . . . . . . . . . "KRAS1" . . . . . . . . . . . . . . . . . . . . . . . . . "KRT1A" . . . . . . . . . . . "CK10" . "cytokeratin 10" . "epidermolytic hyperkeratosis" . "K10" . . . . . . . . "K12" . "Meesmann corneal dystrophy" . . . . . . . . "CK13" . "cytokeratin 13" . "K13" . "keratin, type I cytoskeletal 13" . "MGC161462" . "MGC3781" . . . . . . . . . . . . . . "epidermolysis bullosa simplex, Dowling-Meara, Koebner" . . . . . . . . . . "focal non-epidermolytic palmoplantar keratoderma" . "NEPPK" . . . . . . . . . . . . . . . . "epidermal ichthyosis bullosa of Siemens" . "KRTE" . . . . . . . . "CK3" . "cytokeratin 3" . "K3" . "keratin, type II cytoskeletal 3" . . . . . . . . "CK4" . "cytokeratin 4" . "K4" . "keratin, type II cytoskeletal 4" . . . . . . . . . . . . . "KRT5A" . . . . . . . . "CK6C" . "CK6D" . "K6C" . "K6D" . . . . . . . . . . . . . . . "CK-9" . "cytokeratin 9" . "epidermolytic palmoplantar keratoderma" . "EPPK" . "K9" . "type I cytoskeletal 9" . . . . . . . . . . . "AIS" . "HUMARA" . "Kennedy disease" . "NR3C4" . "SMAX1" . "testicular feminization" . . . . . . . . . "hard keratin type II 1" . "Hb-1" . . . . . . . . . "hard keratin type II" . "Hb-3" . . . . . . . . "hard keratin type II" . "Hb-5" . . . . . . . . "hard keratin type II 6" . "Hb6" . "MNX" . . . . . . . . . "L-kynurenine hydrolase" . . . . . . . . . . . "CD171" . "neural cell adhesion molecule L1" . . . . . . . . . . . . . . . "congenital muscular dystrophy" . "merosin" . . . . . . . . . . "BM600-150kDa" . "epiligrin" . "kalinin-165kDa" . "nicein-150kDa" . . . . . . . . "LAMA3" . . . . . . . . . . . . . . . . . . . . . . . "laminin S" . "NPHS5" . . . . . . . . . . "BM600-125kDa" . "kalinin-140kDa" . "nicein-125kDa" . . . . . . . . . "BM600-100kDa" . "kalinin-105kDa" . "nicein-100kDa" . . . . . . . . "DKFZp434E202" . . . . . . . . "CD107b" . . . . . . . . "37LRP" . "LRP" . "p40" . "SA" . . . . . . . . . . "KIAA0609" . "like-acetylglucosaminyltransferase" . . . . . . . . "FLJ10595" . "FLJ21788" . "HSPC192" . "LARS1" . "leucine tRNA ligase 1, cytoplasmic" . "LEUS" . "RNTLS" . . . . . . . . . . "DHCR14B" . "TDRD18" . "tudor domain containing 18" . . . . . . . . . "phosphatidylcholine--sterol O-acyltransferase" . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . "KIAA1381" . . . . . . . . . . . . . . . . "familial hypercholesterolemia" . "LDLCQ2" . . . . . . . . . . . . . . . "CD295" . "OBR" . . . . . . . . . "Mdm38 homolog (yeast)" . "SLC55A1" . . . . . . . . . "SCDO3" . . . . . . . . "EPITEMPIN" . "ETL1" . "IB1099" . . . . . . . . "CGB4" . "hLHB" . "interstitial cell stimulating hormone, beta chain" . "LSH-B" . "luteinizing hormone beta subunit" . "lutropin, beta chain" . . . . . . . . . . . "LCGR" . "LGR2" . "LHR" . "ULG5" . . . . . . . . . "LIM-1" . "LIM1" . . . . . . . . . . . . . . "CD118" . . . . . . . . . . . "DNA joinase" . "DNA repair enzyme" . "polydeoxyribonucleotide synthase [ATP] 4" . "polynucleotide ligase" . "sealase" . . . . . . . . "MP17" . "MP19" . . . . . . . "LIMK" . . . . . . . . . . . "CESD" . "LAL" . "lysosomal acid lipase" . "sterol esterase" . "Wolman disease" . . . . . . . . "HL" . "HTGL" . "Triacylglycerol lipase" . . . . . . . . "HSL" . . . . . . . . . "endoplasmic reticulum-golgi intermediate compartment protein 53" . "ERGIC-53" . "ERGIC53" . "FMFD1" . "gp58" . "MCFD1" . "MR60" . . . . . . . . . . . . . . . . . . . . . . . . . . . "HGPS" . "MADA" . "mandibuloacral dysplasia type A" . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . "RHOM1" . "TTG1" . . . . . . . . "1D" . "64kD" . "D1" . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . "protein-lysine 6-oxidase" . . . . . . . . . "LOL" . "LOXL" . . . . . . . . . . . . . . . "Rho12" . "RhoA" . "RHOH12" . . . . . . . . . . "LCA14" . "phosphatidylcholine--retinol O-acyltransferase" . . . . . . . . . "APOER" . "CD91" . "LRP" . "LRP1A" . "transforming growth factor-β receptor type V" . . . . . . . . "DBS" . "gp330" . "Megalin" . . . . . . . . . . "CLSS" . "LRP-4" . "MEGF7" . "SOST2" . . . . . . . . . . . . . . . . . "BMND1" . "EVR4" . "HBM" . "LR3" . "OPS" . "OPTA1" . "VBCH2" . . . . . . . . . "ADCAD2" . . . . . . . . "HBP44" . . . . . . . . . . "OSC" . "Oxidosqualene-lanosterol cyclase" . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . "FLJ46318" . "FLJ90018" . "LTBP-4" . "LTBP-4L" . . . . . . . . "renal amyloidosis" . . . . . . . . "BBS17" . . . . . . . . . . . "BTBD29" . "LZTR-1" . . . . . . . . . . . . . . "FANCV" . "MAD2B" . "mitotic arrest deficient homolog-like 2" . "polymerase (DNA-directed), zeta 2, accessory subunit" . "POLZ2" . "REV7" . . . . . . . . . . . . "JV18-1" . "MADR2" . . . . . . . . . "HsT17436" . "JV15-2" . . . . . . . . . . . . "DPC4" . . . . . . . . . "HsT17432" . . . . . . . . "SMAD8" . "SMAD8/9" . . . . . . . . . . . "c-MAF" . . . . . . . "sialic acid binding Ig-like lectin 4A" . "SIGLEC-4A" . "SIGLEC4A" . "S-MAG" . . . . . . . . "RHOGDI" . . . . . . . . . . . . "nM15" . . . . . . . . "dJ417M14.2" . "RP62" . . . . . . . . . . "MALT1 protease" . "paracaspase 1" . "PCASP1" . . . . . . . . . . "Alpha 1,2-mannosidase" . "Endoplasmic reticulum alpha-mannosidase 1" . "endoplasmic Reticulum Class I alpha-mannosidase" . "Endoplasmic reticulum mannosyl-oligosaccharide 1,2-alpha-mannosidase 1" . "ER alpha 1,2-mannosidase" . "ERManI" . "Man9GlcNAc2-specific processing alpha-mannosidase" . "MANA-ER" . "MRT15" . . . . . . . . . "LAMAN" . . . . . . . . "beta-mannosidase A" . . . . . . . . . . . . . . . . "MAP5" . "PPP1R102" . "protein phosphatase 1, regulatory subunit 102" . . . . . . . . "MAPKK1" . "MEK1" . . . . . . . . . . "MEK2" . . . . . . . . . . "MAPKKK1" . "MEKK" . . . . . . . . . "FTDCR1B" . "HS" . "HSNIK" . "NIK" . "serine/threonine protein-kinase" . . . . . . . . . "apoptosis signal regulating kinase 2" . "ASK2" . "MAPKKK6" . "MEKK6" . . . . . . . . . . "MEKK7" . "TGF-beta activated kinase 1" . . . . . . . . . "alpha-PIX" . "alphaPIX" . "Cool-2" . "Cool2" . "KIAA0006" . "PAK-interacting exchange factor, alpha" . "Rac/Cdc42 guanine exchange factor (GEF) 6" . "rho guanine nucleotide exchange factor 6" . . . . . . . . "RhoH" . "TTF" . . . . . . . . "ERK" . "ERK2" . "MAPK2" . "p41mapk" . . . . . . . . . "JNK3" . "p493F12" . "p54bSAPK" . . . . . . . . . "3pK" . "3PK" . "MAPKAP3" . . . . . . . . . "APC-binding protein EB1" . "EB1" . "EB2" . "RP1" . . . . . . . . . . . . . . . "FLJ31424" . "FTDP-17" . "G protein beta1/gamma2 subunit-interacting factor 1" . "MGC138549" . "microtubule-associated protein tau, isoform 4" . "MSTD" . "MTBT1" . "MTBT2" . "PPND" . "PPP1R103" . "protein phosphatase 1, regulatory subunit 103" . "tau" . . . . . . . . . . "CMT2U" . "methionine tRNA ligase 1, cytoplasmic" . "MetRS" . "SPG70" . . . . . . . . "EST352188" . "P70R" . "PMP69" . . . . . . . . "C4/C2 activating component of Ra-reactive factor" . "MASP" . . . . . . . . . . . . . . . "MAT" . "MATA1" . "S-adenosylmethionine synthetase" . "SAMS" . "SAMS1" . . . . . . . . "MATA2" . "MATII" . "SAMS2" . . . . . . . . . "EDM5" . "HOA" . . . . . . . . . "KIAA0723" . "MGC9105" . "VCPDM" . . . . . . . . "bHLHd4" . "bHLHd5" . "bHLHd6" . "bHLHd7" . "bHLHd8" . . . . . . . . "CFEOM2" . "PMX2A" . . . . . . . . . "alpha melanocyte stimulating hormone receptor" . "MSH-R" . . . . . . . . . "ACTHR" . "adrenocorticotropic hormone receptor" . . . . . . . . . "MC3" . . . . . . . . . . . . . . . . . "MCCA" . "methylcrotonoyl-CoA carboxylase alpha" . . . . . . . . "MCCB" . "methylcrotonoyl-CoA carboxylase beta" . . . . . . . . . . . . . . . "BM28" . "cdc19" . "D3S3194" . "DFNA70" . "KIAA0030" . "mitotin" . . . . . . . . "CDC54" . "DNA replication licensing factor MCM4" . "hCdc21" . "MGC33310" . "P1-Cdc21" . . . . . . . . "Mis5" . "MIS5 homolog (S.pombe)" . . . . . . . . . "ARFL3" . . . . . . . . . "MGC26544" . "TLX" . "TRA2.10" . . . . . . . . "BRCT-repeat inhibitor of TERT expression 1" . "BRIT1" . "FLJ12847" . . . . . . . . . . . . . . . . . "HDM2" . "MGC5370" . . . . . . . . . "AIP1" . "ARMER" . "KIAA0069" . "SPG61" . . . . . . . . . . . . . . . . . . . . . . "RSRFC4" . "RSRFC9" . . . . . . . . . . . . . . . . . . "FMF" . "marenostrin" . "TRIM20" . . . . . . . . "HsT18361" . "MRG1" . . . . . . . . . . . . . "menin" . . . . . . . . "MOX1" . . . . . . . . "c-Eyk" . "mer" . "RP38" . "Tyro12" . . . . . . . . . . . . . . "DFNB97" . "hepatocyte growth factor receptor" . "HGFR" . "RCCP2" . . . . . . . . . "GNT-II" . . . . . . . . . . "methylated-DNA--protein-cysteine methyltransferase" . . . . . . . . . . . . . . "C2TA" . "NLRA" . "NLR family, acid domain containing" . "nucleotide-binding oligomerization domain, leucine rich repeat and acid domain containing" . . . . . . . . . "FXY2" . "MRX101" . "RNF60" . "TRIM1" . . . . . . . . "GIF" . "glycosylation-inhibiting factor" . "phenylpyruvate tautomerase" . . . . . . . . "MIPP" . . . . . . . . . . . . . "AQP0" . "aquaporin 0" . "LIM1" . "MP26" . . . . . . . . . "MIP" . . . . . . . . . . . . . "bHLHe32" . "homolog of mouse microphthalmia" . "MI" . . . . . . . . . . "ATX3" . "JOS" . . . . . . . . . . . . . . . . "MGC88288" . "RNF63" . "ZFP127" . "zinc finger protein 127" . . . . . . . . . . . "BBS13" . "FLJ20345" . "POC12" . "POC12 centriolar protein homolog (Chlamydomonas)" . . . . . . . . . . "FCC2" . "HNPCC" . "HNPCC2" . . . . . . . . . . . . . . . . . . . . "ALL-1" . "CXXC7" . "Histone-lysine N-methyltransferase 2A" . "HRX" . "HTRX1" . "MLL1A" . "TRX1" . . . . . . . . . . "ALR" . "CAGL114" . "histone-lysine N-methyltransferase 2D" . "MLL4" . . . . . . . . . "AF-4" . "AF4" . . . . . . . . "AF-9" . "AF9" . "YEATS3" . . . . . . . . . . . "metachromatic leucodystrophy" . . . . . . . . "CSNB1C" . "LTRPC1" . . . . . . . . . . . . . . . . . "hMCD" . "MCD" . . . . . . . . . . . . "CALLA" . "CD10" . "enkephalinase" . "NEP" . "neprilysin" . "neutral endopeptidase" . . . . . . . . . "interstitial collagenase" . . . . . . . . . . . . "CLG3" . "collagenase 3" . . . . . . . . . "Membrane type 1 metalloprotease" . "MT1-MMP" . . . . . . . . . "RASI-1" . . . . . . . . . "TBE-1" . . . . . . . . . "enamelysin" . . . . . . . . . . . . . . . . . . . . . . "malonate-semialdehyde dehydrogenase (acetylating)" . . . . . . . . "MGCR1" . "MGCR1-PEN" . "probable tumor suppressor protein MN1" . . . . . . . "MOCOD" . . . . . . . . "MOCO1" . "MOCS2A" . "MOCS2B" . "molybdopterin synthase catalytic subunit" . "molybdopterin synthase large subunit" . "molybdopterin synthase small subunit" . . . . . . . . "BTN6" . "BTNL11" . . . . . . . "chondrodysplasia punctata 1" . . . . . . . . "CDGIf" . "Lec35" . "PQLC5" . "SL15" . "SLC66A5" . . . . . . . . . "MUPP1" . . . . . . . . "mannose-6-phosphate isomerase" . . . . . . . . . . . . . "CD110" . "THPOR" . "TPOR" . . . . . . . . . . . . . . . . . "glomerulosclerosis" . "SYM1" . . . . . . . . . . . . . . "CMT2I" . "CMT2J" . "HMSNIB" . . . . . . . "M-RAs" . "R-RAS3" . "RRAS3" . . . . . . . "ATLD" . "AT-like disease" . . . . . . . . . . . . . . "B1" . "Bp35" . "MS4A2" . . . . . . . . . "AF17q25" . "KIAA0991" . "MSF1" . "Ov/Br septin" . "PNUTL4" . "SeptD1" . . . . . . . . . "DNA mismatch repair protein Msh2" . "HNPCC" . "HNPCC1" . . . . . . . . "Divergent upstream protein" . "DUP" . "Mismatch repair protein 1" . "MRP1" . . . . . . . . "G7" . . . . . . . . . . . . . . . . . . "AC" . "ACDase" . "acid ceramidase" . "acylsphingosine deacylase" . "FLJ21558" . "PHP32" . . . . . . . . . "beta-microseminoprotein" . "IGBF" . "MSP" . "MSPB" . "PN44" . "PRPS" . "PSP" . "PSP57" . "PSP-94" . "PSP94" . . . . . . . . . . . . . . . "CD204" . "SCARA1" . "SR-A" . "SR-AI" . "SR-AII" . "SR-AIII" . . . . . . . . "MSP" . "NF15S2" . . . . . . . . "ASH1" . "bHLHa46" . "HASH1" . . . . . . . . . . . . . "HYD1" . "OFC5" . . . . . . . . . "craniosynostosis, type 2" . "CRS2" . "FPP" . "HOX8" . "MSH" . "PFM" . . . . . . . . "c86fus" . "MSAP" . "S-methyl-5'-thioadenosine phosphorylase" . . . . . . . . . . . . . . . "ATP6" . "ATPase-6" . "mitochondrially encoded ATP synthase membrane subunit a" . "Su6m" . . . . . . . . . . . "A6L" . "ATP8" . "mitochondrially encoded ATP synthase membrane subunit A6L" . . . . . . . . . . . . . "COI" . "COX1" . . . . . . . . . "CO2" . "COX2" . . . . . . . . . . . "CO3" . "COIII" . "COX3" . . . . . . . . . . "COB" . "CYTB" . "UQCR3" . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . "KIAA1073" . "phosphatidylinositol-3-phosphatase" . "phosphoinositide-3-phosphatase" . . . . . . . . . . . "complex I ND1 subunit" . "NAD1" . "NADH-ubiquinone oxidoreductase chain 1" . "ND1" . . . . . . . . . . "complex I ND2 subunit" . "NAD2" . "NADH-ubiquinone oxidoreductase chain 2" . "ND2" . . . . . . . . . . "complex I ND3 subunit" . "NAD3" . "NADH-ubiquinone oxidoreductase chain 3" . "ND3" . . . . . . . . . . . . "complex I ND4 subunit" . "NAD4" . "NADH-ubiquinone oxidoreductase chain 4" . "ND4" . . . . . . . . "complex I ND4L subunit" . "NAD4L" . "NADH-ubiquinone oxidoreductase chain 4L" . "ND4L" . . . . . . . . . . . "complex I ND5 subunit" . "NAD5" . "NADH-ubiquinone oxidoreductase chain 5" . "ND5" . . . . . . . . . . . "complex I ND6 subunit" . "NAD6" . "NADH-ubiquinone oxidoreductase chain 6" . "ND6" . . . . . . . . . "ABL" . . . . . . . . "cblG" . "Methionine synthase" . . . . . . . . . . . . . . . . . "12S" . "mitochondrial open-reading-frame of the twelve S rRNA type-c" . "MOTS-c" . . . . . . . "16S" . "formyl-humanin" . "HN" . "humanin" . . . . . . . . "cblE" . "Methionine synthase reductase" . . . . . . . . . . "trnE" . . . . . . . "trnF" . . . . . . "trnG" . . . . . . . . . "trnH" . . . . . . "trnI" . . . . . . . . . "trnK" . . . . . . . . . . . . "TRNL1" . . . . . . "TRNL2" . . . . . . "trnN" . . . . . . "trnP" . . . . . . . "trnQ" . . . . . . . . . . "TRNS1" . . . . . . . . "RP8" . "TRNS2" . . . . . . "trnT" . . . . . . "trnV" . . . . . . . "trnW" . . . . . . . . . . "ADMCKD" . "ADMCKD1" . "CD227" . "MCD" . "MCKD" . "PEM" . . . . . . . . . "MG1" . . . . . . . . "KIAA0898" . "POB1" . "RING-B-box-coiled-coil protein" . "TEF3" . . . . . . . . . . . . . . . . . . "MCM" . . . . . . . . "MYH" . . . . . . . . "diphosphomevalonate decarboxylase" . "mevalonate pyrophosphate decarboxylase" . "MPD" . . . . . . . . . . . . "LH receptor mRNA-binding protein" . "LRBP" . "mevalonic aciduria" . "MK" . . . . . . . . . . . . . . . . . . "c-myb" . . . . . . . . . . . . . . . . . . . "FHC" . "MYBP-C" . . . . . . . . . . . "bHLHe39" . "c-Myc" . "MYCC" . . . . . . . . . . . "bHLHe37" . "MYCNOT" . "N-myc" . . . . . . . . . . . . . . . . "bHLHc4" . "herculin" . "MRF4" . "muscle-specific regulatory factor 4" . . . . . . . . . . . . "SMHC" . "SMMHC" . . . . . . . . . "ACY2" . "aminoacylase 2" . "ASP" . "Canavan disease" . . . . . . . . . "MYH2A" . "MYHas8" . "MyHC-2A" . "MyHC-IIa" . "MYHSA2" . . . . . . . . . . . . . "HEMHC" . "muscle embryonic myosin heavy chain 3" . "MYHC-EMB" . "MYHSE1" . "myosin, skeletal, heavy chain, embryonic 1" . "SMHCE" . . . . . . . . . . . "cardiomyopathy, hypertrophic 1" . . . . . . . . . . . . . . . "CMD1S" . . . . . . . . . "MyHC-peri" . "MyHC-pn" . . . . . . . . . . "EPSTS" . "FTNS" . "MHA" . "NMHC-II-A" . "NMMHCA" . "nonmuscle myosin heavy chain II-A" . . . . . . . . "BAH" . "CASQ2BP1" . "HAAH" . "humbug" . "JCTN" . "junctate" . "junctin" . . . . . . . . . . . . . . . "cardiac ventricular myosin light chain 2" . "CMH10" . . . . . . . . "CMH8" . "MLC1SB" . "MLC1V" . "VLC1" . . . . . . . . "ALC1" . "AMLC" . "GT1" . "myosin, atrial/fetal muscle, light chain" . "PRO1957" . . . . . . . . . "CTLN1" . . . . . . . . . "MLCK" . "MLCK1" . "MYLK1" . "smMLCK" . "smooth muscle myosin light chain kinase" . . . . . . . . . . . . . . . . . . . . . "myr2" . . . . . . . . "HuncM-IC" . "MGC104638" . "MYO1C" . "myosin-IC" . . . . . . . . . . . . . . . . . "GS1" . "MYO5" . "myosin heavy chain 12" . "myosin, heavy polypeptide kinase" . "myosin V" . "myoxin" . "MYR12" . . . . . . . . . . "KIAA1119" . . . . . . . . . . "KIAA0389" . . . . . . . . . . . "NSRD2" . . . . . . . . "FLJ11061" . "FLJ13244" . "MGC71859" . . . . . . . . . "JOAG1" . "juvenile-onset open-angle glaucoma 1" . "TIGR" . "trabecular meshwork inducible glucocorticoid response protein" . . . . . . . "bHLHc1" . "myoblast determination protein 1" . "MYOD" . "PUM" . . . . . . . . . . "KIAA1106" . "neural zinc finger transcription factor 1" . "NZF1" . "ZC2H2C2" . "ZC2HC4B" . . . . . . . "EGR1 binding protein 2" . "MADER" . . . . . . . . . . "alpha-galactosidase B" . "D22S674" . . . . . . . . "NAG" . "Sanfilippo disease IIIB" . . . . . . . . . . "NLRB1" . "NLR family, BIR domain containing 1" . "nucleotide-binding oligomerization domain, leucine rich repeat and BIR domain containing 1" . . . . . . . . . . "ATV" . "AT-V1" . "AT-V2" . . . . . . . . . "chronic granulomatous disease, autosomal 1" . "NADPH oxidase organizer 2" . "NCF1A" . "NOXO2" . "p47phox" . "SH3PXD1A" . . . . . . . . "chronic granulomatous disease, autosomal 2" . "NADPH oxidase activator 2" . "NOXA2" . "p67phox" . . . . . . . . . "neutrophil NADPH oxidase factor 4" . "p40phox" . "SH3PXD4" . . . . . . . . "ARA70" . "DKFZp762E1112" . "ELE1" . "PTC3" . "RET-activating gene ELE1" . "RFG" . . . . . . . . . . "HsT16328" . "Prader-Willi syndrome chromosome region" . "PWCR" . . . . . . . . . . . . "norrin" . . . . . . . . "DRG1" . "NDR1" . "RTP" . "TDD5" . . . . . . . . "[Heparan sulfate]-glucosamine N-sulfotransferase 1" . "heparan sulfate/heparin GlcNAc N-deacetylase/GlcN N-sulfotransferase 1" . "N-Deacetylase-N-sulfotransferase 1" . "NST1" . . . . . . . . "CI-MWFE" . "complex I MWFE subunit" . "MWFE" . "NADH:ubiquinone oxidoreductase (complex 1)" . "type I dehydrogenase" . . . . . . . . "CI-42k" . "complex I 42kDa subunit" . . . . . . . . . "B8" . "complex I B8 subunit" . . . . . . . . "CI-9k" . "complex I 9kDa subunit" . "COXFA4" . "cytochrome c oxidase subunit FA4" . "MLRQ" . "NADH-ubiquinone oxidoreductase MLRQ subunit" . . . . . . . . "B14" . "CI-B14" . "complex I B14 subunit" . "LYRM6" . "NADHB14" . . . . . . . . "CI-39k" . "Complex I 39kDa subunit" . "COQ11" . "SDR22E1" . "Short chain dehydrogenase/reductase family 22E, member 1" . . . . . . . . "complex I PDSW subunit" . "PDSW" . . . . . . . . "B12" . "Complex I B12 subunit" . . . . . . . . . . "c-ABL" . "JTK7" . "p150" . . . . . . . . . "ASHI" . "CI-ASHI" . "complex I ASHI subunit" . . . . . . . . "B22" . "Complex I B22 subunit" . "LYRM3" . "UQOR22" . . . . . . . . . "CI-75k" . "complex I 75kDa subunit" . "NADH-ubiquinone oxidoreductase 75 kDa subunit, mitochondrial" . . . . . . . . . . . "CI-49" . "complex I 49kDa subunit" . "NADH dehydrogenase [ubiquinone] iron-sulfur protein 2, mitochondrial" . . . . . . . . . "CI-30" . "complex I 30kDa subunit" . "NADH dehydrogenase [ubiquinone] iron-sulfur protein 3, mitochondrial" . . . . . . . . . "AQDQ" . "CI-18" . "complex I 18kDa subunit" . . . . . . . . "CI-13kA" . "complex I 13kDa subunit A" . "NADH dehydrogenase [ubiquinone] iron-sulfur protein 6, mitochondrial" . . . . . . . . . "CI-20" . "complex I 20kDa subunit" . "FLJ45860" . "FLJ46880" . "NADH dehydrogenase [ubiquinone] iron-sulfur protein 7, mitochondrial" . "PSST" . . . . . . . . . "CI-23k" . "complex I 23kDa subunit" . "NADH dehydrogenase [ubiquinone] iron-sulfur protein 8, mitochondrial" . "TYKY" . . . . . . . . . "CI-51K" . "complex I 51kDa subunit" . "NADH dehydrogenase [ubiquinone] flavoprotein 1, mitochondrial" . . . . . . . . . "CI-24k" . "complex I 24kDa subunit" . "NADH dehydrogenase [ubiquinone] flavoprotein 2, mitochondrial" . . . . . . . . . . . . . "NEB177D" . "nemaline myopathy type 2" . . . . . . . . "KIAA0439" . "NEDD4-2" . "RSP5" . . . . . . . . . . . . . . . . "CMT1F" . "CMT2E" . "NF68" . "NFL" . "PPP1R110" . "protein phosphatase 1, regulatory subunit 110" . . . . . . . . . . "KIAA1901" . "NY-REN-55" . . . . . . . . . "HsPK 21" . "NEK2A" . "NLK1" . "PPP1R111" . "protein phosphatase 1, regulatory subunit 111" . "RP67" . . . . . . . . . . . . . . . . . . "antithrombin (aa 375-432)" . "antithrombin III" . "ATIII" . "coding sequence signal peptide antithrombin part 1" . "MGC22579" . "signal peptide antithrombin part 1" . . . . . . . . . "BETA2" . "beta-cell E-box transactivator 2" . "BHF-1" . "bHLHa3" . "MODY6" . "NeuroD" . "neurogenic helix-loop-helix protein NEUROD" . . . . . . . . "bHLHa1" . "NDRF" . . . . . . . . . . . "neurofibromatosis" . "von Recklinghausen disease" . "Watson disease" . . . . . . . . . . "ACN" . "BANF" . "Merlin" . "moesin-ezrin-radixin like" . "SCH" . "schwannomin" . . . . . . . . "KIAA0827" . "NF-AT5" . "NFATL1" . "NFATZ" . "OREBP" . "TONEBP" . "tonicity-responsive enhancer binding protein" . . . . . . . . "KIAA1439" . "NFI-L" . . . . . . . . . . "CCAAT-binding transcription factor" . "NF1A" . . . . . . . . "KBF1" . "NF-kappaB" . "NFkappaB" . "NF-kB1" . "NFKB-p50" . "Nuclear factor NF-kappa-B p105 subunit" . "p105" . "p50" . . . . . . . . . "LYT-10" . "NF-kB2" . "p105" . "p49/p100" . "p52" . . . . . . . . . . . "IkappaBalpha" . "IKBA" . "MAD-3" . "NF-kappa-B inhibitor alpha" . . . . . . . . "BNIP-H" . "Cayman ataxia" . "caytaxin" . . . . . . . . "IKBR" . . . . . . . . . . . . . . . . . . . . . "entactin" . . . . . . "TREB36" . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . "ARC" . "CARD2" . "MYP" . "NOP30" . . . . . . . . . "NMT55" . "non-Pou domain-containing octamer (ATGCAAAT) binding protein" . "NRB54" . "Nuclear RNA-binding protein, 54-kD" . "P54" . "P54NRB" . "PPP1R114" . "protein phosphatase 1, regulatory subunit 114" . . . . . . . . "nNOS" . . . . . . . . . "AD-005" . "CDC39" . "KIAA1007" . "NOT1H" . . . . . . . "CDC36" . "NOT2H" . . . . . . . "KIAA0691" . "LENG2" . "NOT3H" . "NOT3 (negative regulator of transcription 3, yeast) homolog" . . . . . . . . . . . . . . . . . . . . . . . . . . . . "CASIL" . . . . . . . . . "PUNP" . . . . . . . . . . . . . "SLC65A1" . . . . . . . . . "SLC65A2" . . . . . . . . . . . . "JBTS4" . "SLSN1" . . . . . . . . . . . . "CFAP31" . "cilia and flagella associated protein 31" . "FLJ30691" . "FLJ36696" . "KIAA2000" . "Meckel syndrome, type 7" . "MKS7" . "NPH3" . "SLSN3" . . . . . . . . . "CNF" . "NPHN" . . . . . . . . . . . . . . "B23" . "NPM" . "nucleolar phosphoprotein B23" . "Nucleophosmin/nucleoplasmin family, member 1" . "Numatrin" . . . . . . . . . "activating transcription factor 6 alpha" . "ATF6A" . . . . . . . . . . . . . . . . . "ANPb" . "guanylate cyclase 2B" . "GUCY2B" . . . . . . . . . "AICARFT" . "IMPCHASE" . "phosphoribosylaminoimidazolecarboxamide formyltransferase/IMP cyclohydrolase" . "PURH" . . . . . . . . . . . "TEL1" . "TEL1, telomere maintenance 1, homolog (S. cerevisiae)" . "TELO1" . . . . . . . . . . . . "AHCH" . "DAX1" . . . . . . . . . . "bile acid receptor" . "farnesoid X receptor" . "FXR" . "HRR-1" . "HRR1" . "RIP14" . . . . . . . . . . "PNR" . "rd7" . "RP37" . . . . . . . . . "COUPTF1" . "COUP-TFI" . "EAR-3" . "SVP44" . "TCFCOUP1" . . . . . . . . . . . "COUPTF2" . "COUPTFB" . "COUP-TFII" . "NF-E3" . "SVP40" . . . . . . . . . "glucocorticoid receptor" . "GR" . . . . . . . . . "MR" . . . . . . . . . "CHN" . "CSMF" . "MINOR" . "NOR1" . . . . . . . . . . . . . . . "AD4BP" . "ELP" . "FTZ1" . "hSF-1" . "SF-1" . "SF1" . "steroidogenic factor 1" . . . . . . . . . . . . . . . "N-ras" . . . . . . . . . . "sodium-potassium ATPase catalytic subunit alpha-1" . "sodium/potassium-transporting ATPase subunit alpha-1" . "sodium pump subunit alpha-1" . . . . . . . . . "D14S46E" . "NRL-MAF" . "RP27" . . . . . . . "NTN" . "prepro-neurturin" . . . . . . . . . "Hs.22998" . "KIAA0578" . . . . . . . . . "FHM2" . "sodium-potassium ATPase catalytic subunit alpha-2" . "sodium/potassium-transporting ATPase subunit alpha-2" . "sodium pump subunit alpha-2" . . . . . . . . . "Caspr" . "CNTNAP" . "neurexin 4" . "p190" . . . . . . . . . . "sodium-potassium ATPase catalytic subunit alpha-3" . "sodium/potassium-transporting ATPase subunit alpha-3" . "sodium pump subunit alpha-3" . . . . . . . . . "CALJA" . "CD73" . "eN" . "eNT" . . . . . . . . . "cN-II" . "GMP" . "PNT5" . "purine 5' nucleotidase" . "SPG65" . . . . . . . . . "GLC1O" . "Neurotrophic factor 4" . "NT-4/5" . . . . . . . . "NTH1" . "OCTS3" . . . . . . . . "Netrin-1" . "NTN1L" . . . . . . . . . . . "high affinity nerve growth factor receptor" . "MTC" . "TRK" . "TRKA" . . . . . . . . . . . "BDNF/NT-3 growth factors receptor" . "TRKB" . . . . . . . . . . . "TRKC" . . . . . . . . . . . . . . . . "KIAA0791" . "N155" . . . . . . . . . "CAIN" . "CAN" . "CAN protein, putative oncogene" . "D9S46E" . "N214" . "nuclear pore complex protein Nup214" . . . . . . . . "DKFZp547L134" . "FLJ20822" . "FLJ43869" . "IBSN" . "MGC841" . "nuclear pore glycoprotein p62" . "p62" . "SNDI" . . . . . . . . "MGC8530" . . . . . . . "FLJ43346" . . . . . . . "CLRP" . "CSNB1A" . . . . . . . . "IFI-4" . "OIASI" . . . . . . . . "gyrate atrophy" . "HOGA" . "Ornithine aminotransferase" . "ornithine aminotransferase precursor" . . . . . . . . . . . . "BEY" . "BEY1" . "BEY2" . "EYCL" . "melanocyte-specific transporter protein" . "P-protein" . . . . . . . . "phosphatase 1, regulatory subunit 115" . "PPP1R115" . "tight junction protein occludin TM4 minus" . . . . . . . . . "OCRL1" . . . . . . . . . "ODC" . . . . . . . . "TEN-M1" . . . . . . . "calcium pump 1" . "sarcoplasmic/endoplasmic reticulum calcium ATPase 1" . "SERCA1" . . . . . . . . . "E1k" . . . . . . . . "8-hydroxyguanine DNA glycosylase" . "HMMH" . "HOGG1" . "MUTM" . "OGG1 type 1d" . "OGG1 type 1e" . "OGG1 type 1g" . "OGG1 type 1h" . "OGH1" . . . . . . . . . . "calcium pump 2" . "sarcoplasmic/endoplasmic reticulum calcium ATPase 2" . "SERCA2" . . . . . . . . . . "Dynamin-like 120 kDa protein, mitochondrial" . "dynamin-like guanosine triphosphatase" . "FLJ12460" . "KIAA0567" . "MGM1" . "mitochondrial dynamin-like GTPase" . "NPG" . "NTG" . . . . . . . . . . . "FLJ22187" . "MGA3" . . . . . . . "ARHGAP41" . "OPN1" . . . . . . . . "5-Opase" . "OPLA" . . . . . . . . . "SR-BP1" . . . . . . . . "plasma membrane Ca2+ pump 2" . "plasma membrane calcium-transporting ATPase 2" . "PMCA2" . . . . . . . . . . "CFAP39" . "cilia and flagella associated protein 39" . "Plasma membrane calcium-transporting ATPase 3" . "PMCA3" . . . . . . . . . "ATP6A" . "gastric H,K-ATPase alpha subunit" . "H(+)-K(+)-ATPase alpha subunit" . "proton pump" . . . . . . . . . "ATP5A" . "hATP1" . "OMR" . "ORM" . . . . . . . . . . . . . . . . . . . . . . "HSORC1" . "origin recognition complex 1" . "origin recognition complex, subunit 1, S. cerevisiae, homolog-like" . "PARC1" . "replication control protein 1" . . . . . . . . "HsORC4" . "Orc4p" . . . . . . . . "Oncostatin-M-specific receptor subunit beta" . "OSMRB" . . . . . . . . . . . . . . . . "DFNB6" . "FER1L2" . "fer-1-like family member 2" . . . . . . . "FLJ46346" . "mlemp" . "OTGN" . . . . . . . . "VA68" . "Vma1" . . . . . . . . . . . . . . . . . . . "SCOT" . "Succinyl-CoA:3-ketoacid-CoA transferase" . . . . . . . . "MGC20089" . "P2X7" . . . . . . . . . "Renal tubular acidosis with deafness" . "RTA1B" . "VATB" . "Vma2" . . . . . . . . . "P2Y11" . . . . . . . . . "C-P4Halpha(II)" . . . . . . "collagen prolyl 4-hydroxylase beta" . "DSI" . "GIT" . "P4Hbeta" . "PDI" . "PDIA1" . "PO4HB" . "PROHB" . "protein disulfide isomerase-associated 1" . "protein disulfide isomerase family A, member 1" . . . . . . . . "HPS9" . . . . . . . . . . "HO57" . "VATB" . "Vma2" . . . . . . . . . "PAB2" . . . . . . . . . . . "LIS1" . "lissencephaly-1" . "NudF" . "PAFAH" . . . . . . . . "ATP6E2" . "P31" . "Vma4" . . . . . . . . . . . . . "PH" . "phenylalanine 4-monooxygenase" . . . . . . . . . "PAI" . "plasminogen activator inhibitor, type I" . . . . . . . . "bPAK" . "hPAK3" . . . . . . . . . . "adenosine 5'-phosphosulfate kinase" . "adenylyl-sulfate kinase" . "ATPSK2" . "bifunctional 3'-phosphoadenosine 5'-phosphosulfate synthase 2" . "sulfate adenylyltransferase" . . . . . . . . "AR-JP" . "E3 ubiquitin ligase" . "PARK2" . "parkin" . "PDJ" . . . . . . . . . . "DAN" . "deadenylation nuclease" . . . . . . . . . . . . . . . . . . . . . . . . . "HUP2" . . . . . . . . "MODY9" . . . . . . . . . "B-cell lineage specific activator" . "BSAP" . . . . . . . . . . . . . . . . . . . . . "AN" . "aniridia, keratitis" . "D11S812E" . "WAGR" . . . . . . . . "Hup1" . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . "PCB" . . . . . . . . . "dimerizing cofactor for HNF1" . "PCD" . "Pterin-4a-carbinolamine dehydratase (dimerization cofactor of hepatic nuclear factor 1-alpha)" . "pterin-4-alpha carbinolamine dehydratase" . . . . . . . . . . . . . . . . . . . . . . . . "VE-cadherin-2" . . . . . . "a4" . "RDRTA2" . "RTADR" . "Stv1" . "Vph1" . "VPP2" . . . . . . . . . . . . "copper pump 1" . "copper-transporting ATPase 1" . . . . . . . . . "copper pump 2" . "copper-transporting ATPase 2" . "Wilson disease" . . . . . . . . . "PEPCK-C" . . . . . . . . "PEPCK" . "PEPCK2" . . . . . . . . "PTC4" . . . . . . . . . . . . . . . "FLJ12549" . "NUP75" . . . . . . . "CHMP1" . "KIAA0047" . "Vps46A" . . . . . . . . "neuroendocrine convertase 1" . "PC1" . "PC3" . "prohormone convertase 1" . "prohormone convertase 3" . "proprotein convertase 1" . "SPC3" . . . . . . . . . . "CT" . "CTPCT" . . . . . . . . . "CD279" . "hSLE1" . "PD-1" . "PD1" . . . . . . . . . "TFAR15" . . . . . . . . . . . "AIF" . "CMTX4" . . . . . . . . . "cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A" . . . . . . . . . "Dual 3',5'-cyclic-AMP and -GMP phosphodiesterase 11A" . . . . . . . . . "Hcam3" . . . . . . . . . . . . . . "CGI-PDE" . "cGMP-inhibited 3',5'-cyclic phosphodiesterase A" . . . . . . . . . "26g turgor protein homolog" . "alpha-AASA dehydrogenase" . "alpha-aminoadipic semialdehyde dehydrogenase" . "antiquitin 1" . "delta1-piperideine-6-carboxylate dehydrogenease" . "EPD" . "P6c dehydrogenase" . "PDE" . . . . . . . . . . "cAMP-specific 3',5'-cyclic phosphodiesterase 4D" . "Phosphodiesterase E3 dunce homolog (Drosophila)" . . . . . . . . . "Rod cGMP-specific 3',5'-cyclic phosphodiesterase subunit alpha" . "RP43" . . . . . . . . . . "congenital stationary night blindness 3, autosomal dominant" . "CSNB3" . "CSNBAD2" . "rd1" . "rod cGMP-specific 3',5'-cyclic phosphodiesterase subunit beta" . "RP40" . . . . . . . . . . "ACHM5" . "COD4" . "Cone cGMP-specific 3',5'-cyclic phosphodiesterase subunit alpha" . "PDEA2" . . . . . . . . "JBTS22" . "retinal rod rhodopsin-sensitive cGMP 3',5'-cyclic phosphodiesterase subunit delta" . . . . . . . . . "RP57" . . . . . . . . . "retinal cone rhodopsin-sensitive cGMP 3',5'-cyclic phosphodiesterase subunit gamma" . . . . . . . . . "High affinity cAMP-specific and IBMX-insensitive 3',5'-cyclic phosphodiesterase 8B" . . . . . . . . . "isobutyryl-CoA dehydrogenase" . . . . . . . . . . . "becaplermin" . "oncogene SIS" . "SSV" . . . . . . . . . . . . "CD140a" . "GAS9" . "PDGFR2" . . . . . . . . . . . . . . . . "CD140b" . "JTK12" . "PDGFR1" . . . . . . . . . "PRLTS" . . . . . . . . "pyruvate dehydrogenase E1 component subunit alpha, somatic form, mitochondrial" . . . . . . . . "PDHE1B" . . . . . . . . . . . . . . . . . . . "PDS" . "pendrin" . . . . . . . . . "ADCA" . "beta-neoendorphin" . "dynorphin" . "leu-enkephalin" . "leumorphin" . "neoendorphin-dynorphin-enkephalin prepropeptide" . "PENKB" . "preproenkephalin B" . "rimorphin" . . . . . . . . . "alpha-2 antiplasmin" . "EPC-1" . "PIG35" . "pigment epithelium-derived factor" . "proliferation-inducing protein 35" . . . . . . . . "FRP1" . "MEC1" . "MEC1, mitosis entry checkpoint 1, homolog (S. cerevisiae)" . "SCKL" . "SCKL1" . . . . . . . . . "prolidase" . "Xaa-Pro dipeptidase" . . . . . . . . "KIAA0347" . . . . . . . . . . . . . . . . . . . . . . . . . . . "RNF69" . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . "PAF-2" . "PXAAA1" . . . . . . . . "PTS2R" . "RD" . "Refsum disease" . . . . . . . . . . . . . . . . "RAD54 homolog (S. cerevisiae)" . "XH2" . "XNP" . . . . . . . . "PFK-1" . "PPP1R122" . "protein phosphatase 1, regulatory subunit 122" . . . . . . . . . . . . . . . "PGAM-M" . . . . . . . . . . . "UNC104" . . . . . . . . . . . . . . . . . . . . . . "acetylglucosamine phosphomutase" . "AGM1" . "DKFZP434B187" . "PAGM" . "phosphoacetylglucosamine mutase" . . . . . . . . . . . . . . . "HPDR1" . "HYP1" . "PEX" . "XLH" . . . . . . . . "D-3-phosphoglycerate dehydrogenase" . "PDG" . "PGDH" . "SERA" . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . "PAHX" . "PHYH1" . "phytanoyl-CoA dioxygenase" . "RD" . "Refsum disease" . . . . . . . . . . "A1A" . "A1AT" . "AAT" . "alpha-1-antitrypsin" . "alpha1AT" . "PI1" . "protease inhibitor 1 (anti-elastase), alpha-1-antitrypsin" . . . . . . . . "neuroserpin" . . . . . . . "ADH" . "antidiuretic hormone" . "copeptin" . "diabetes insipidus" . "neurohypophyseal" . "neurophysin II" . "prepro-arginine-vasopressin-neurophysin II" . "prepro-AVP-NP II" . . . . . . . . "CAP" . "cytoplasmic antiproteinase" . "PTI" . . . . . . . . "CAP2" . "cytoplasmic antiproteinase 2" . . . . . . . . . . . . "GPI3" . "paroxysmal nocturnal hemoglobinuria" . "phosphatidylinositol N-acetylglucosaminyltransferase" . . . . . . . . "phosphatidylinositol N-acetylglucosaminyltransferase" . . . . . . . . . "N-acetylglucosaminylphosphatidylinositol deacetylase" . . . . . . . . . "MCD4" . "MDC4" . "PIG-N" . . . . . . . . "PI3K-C2alpha" . . . . . . . . . . . . . . . . . "PI3K" . . . . . . . . . . "p110D" . "phosphatidylinositol 3-kinase, catalytic, delta polypeptide" . "phosphoinositide-3-kinase C" . . . . . . . . . . . "GRB1" . "p85" . "p85-ALPHA" . "phosphoinositide-3-kinase regulatory subunit alpha" . . . . . . . . . . "nephrogenic diabetes insipidus" . "V2R" . . . . . . . . . . "p85" . "P85B" . "phosphoinositide-3-kinase regulatory subunit beta" . . . . . . . . . "phosphatidylinositol 4-kinase III alpha" . "pi4K230" . "PI4K-ALPHA" . . . . . . . . . "KIAA0589" . "LCCS3" . "PIP5Kgamma" . . . . . . . . . "PIP5KIIA" . "PIP5KIIalpha" . . . . . . . . . . . . . . "ACAD1" . "MCAD" . "MCADH" . "medium-chain acyl-CoA dehydrogenase" . . . . . . . . . . . "POTX" . "PTX1" . . . . . . . . . . . . . . "ARP1" . "Brx1" . "IGDS" . "Otlx2" . "RS" . . . . . . . . . . . . . . . . "PBP" . "Pc-1" . "polycystin 1" . "transient receptor potential cation channel, subfamily P, member 1" . "TRPP1" . . . . . . . . "Pc-2" . "PC2" . "PKD4" . "transient receptor potential cation channel, subfamily P, member 2" . "TRPP2" . . . . . . . . . . "ARPKD" . "FCYT" . "fibrocystin" . "fibrocystin/polyductin complex" . "FPC" . "polyductin" . "tigmin" . . . . . . . . . . . . . . . "B6P" . "ectodermal dysplasia/skin fragility syndrome" . . . . . . . . . . . . . . . . . . . . "cPLA2-alpha" . . . . . . . . . . . . . . . . . . "iPLA2" . "iPLA2beta" . "NBIA2" . "Neurodegeneration with brain iron accumulation 2" . "PARK14" . "PNPLA9" . . . . . . . . . "PPP1R49" . "protein phosphatase 1, regulatory subunit 49" . . . . . . . . "DOA1" . "DOA1 homolog (S. cerevisiae)" . "FLJ11281" . "FLJ12699" . "PLA2P" . "PLAP" . . . . . . "ZNF912" . . . . . . . . "LOT1" . "ZAC" . . . . . . . . . . . "axil" . "conductin" . "DKFZp781B0869" . "MGC126582" . . . . . . . . . . . . . . . . . "UPA" . "URK" . . . . . . . . . . . . . . . . . . . . . . . . . "1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase delta-1" . . . . . . . . . . . . . . . . . . . . . . "PCN" . "PLTN" . . . . . . . . . . . . . . . . . "A2AP" . "AAP" . "alpha-2-antiplasmin" . "ALPHA-2-PI" . "alpha-2-plasmin inhibitor" . "API" . . . . . . . . . . . . . . . . "CMD1P" . . . . . . . . "LH1" . "lysyl hydroxlase 1" . . . . . . . . "LH2" . "lysyl hydroxlase 2" . "procollagen-lysine 5-dioxygenase" . . . . . . . . "LH3" . "Lysyl hydroxlase 3" . . . . . . . . . . . . . . "GPM6C" . "Pelizaeus-Merzbacher disease" . . . . . . . "I-plastin" . "Plastin-1" . . . . . . . "T-plastin" . . . . . . . "ACAD3" . "SCAD" . . . . . . . . . "KIAA0620" . . . . . . . . "MYL" . "RNF71" . "TRIM19" . . . . . . . . "CDG1a" . "CDGS" . "mannose-6-phosphate isomerase" . "phosphomannose isomerase 1" . "PMI" . "PMI1" . . . . . . . . "FABP8" . "M-FABP" . "MP2" . . . . . . . . . . . . . . "GAS3" . "HNPP" . "Sp110" . . . . . . . . "MPPB" . "MPPP52" . . . . . . . "MLH2" . . . . . . . . "H_DJ0042M02.9" . "HNPCC4" . "MLH4" . . . . . . . . "p5" . "p6" . "PM/Scl-75" . "polymyositis/scleroderma autoantigen 1 (75kD)" . "RRP45" . "Rrp45p" . . . . . . . . "HUMPMKI" . "PMK" . "PMKA" . . . . . . . . . "PHOX1" . . . . . . . . . . "NBPhox" . "Phox2b" . . . . . . . . . . . . . . . "BRP17" . "DKFZp564N1362" . "DYT8" . "FKSG19" . "FPD1" . "KIAA1184" . "KIPP1184" . "MGC31943" . "MR-1" . "MR-1S" . "myofibrillogenesis regulator 1" . "PDC" . "PKND1" . "TAHCCP2" . . . . . . . . . . "PNK" . . . . . . . . . . . . . . . . . "Gp200" . "PC" . "PCLP" . . . . . . . . . "p180" . . . . . . . . . "CDC2" . "CDC2 homolog (S. cerevisiae)" . . . . . . . . . . "DNA polymerase epsilon catalytic subunit A" . "POLE1" . . . . . . . . . . . . . . . "POLG1" . "POLGA" . . . . . . . . "HP55" . "MTPOLB" . . . . . . . . "RAD30A" . "XP-V" . . . . . . . . "ACAD7" . "SBCAD" . . . . . . . . "ACTH" . "adrenocorticotropic hormone" . "adrenocorticotropin" . "alpha-melanocyte stimulating hormone" . "beta-endorphin" . "beta-lipotropin" . "beta-melanocyte stimulating hormone" . "CLIP" . "LPH" . "MSH" . "NPP" . "opiomelanocortin prepropeptide" . "POC" . . . . . . . . . . . . . "dolichyl-phosphate-mannose-protein mannosyltransferase" . "LGMD2K" . . . . . . . . "arylesterase 1" . "ESA" . "esterase A" . . . . . . . . . "arylesterase 2" . "paraoxonase nirs" . . . . . . . . . "arylesterase 3" . . . . . . . . . . "CYPOR" . "FLJ26468" . "NADPH--hemoprotein reductase" . . . . . . . . . . "GHF-1" . "growth hormone factor 1" . "PIT-1" . "pituitary transcript factor 1" . "POU1F1a" . . . . . . . "BOB1" . "OBF1" . . . . . . . . . "brain-4" . "BRN4" . "DFNX2" . "Octamer-binding transcription factor 9" . "OTF9" . . . . . . . "BRN3C" . . . . . . . . . . . . "NR1C3" . "PPARG1" . "PPARG2" . "PPARgamma" . . . . . . . . . "PGC1" . "PGC1A" . "PGC-1alpha" . "PPARgamma coactivator 1alpha" . . . . . . . . "galactosylgalactosylxylosylprotein 3-beta-glucuronosyltransferase 3" . "GlcAT-I" . "glucuronosyltransferase I" . . . . . . . . "beta4Gal-T1" . . . . . . . . . "carboxypeptidase C" . "carboxypeptidase-L" . "carboxypeptidase Y-like kininase" . "deamidase" . "lysosomal carboxypeptidase A" . "lysosomal protective protein" . "urinary kininase" . . . . . . . . . . . "B" . "cyclophilin B" . "CYPB" . "CYP-S1" . "OI9" . "peptidyl-prolyl cis-trans isomerase B" . "PPIase" . "rotamase B" . "S-cyclophilin" . "SCYLP" . . . . . . . . "PP2CB" . "PP2CBETA" . "PPC2BETAX" . "protein phosphatase 2C, beta isoform" . . . . . . . . "PP2C-DELTA" . "protein phosphatase 2C, delta isoform" . "wild-type p53-induced phosphatase 1" . "Wip1" . . . . . . . . . "PDH" . "PDP" . "PPM2A" . "protein phosphatase, Mg2+/Mn2+ dependent 2A" . . . . . . . . "PPO" . . . . . . . . "PP-1B" . "PP1B" . "PP1beta" . . . . . . . . "ACAD6" . "LCACD" . "VLCAD" . . . . . . . . "PP2AA" . "PP2A-Aalpha" . "PR65A" . "protein phosphatase 2, 65kDa regulatory subunit A" . "protein phosphatase 2A, regulatory subunit A, alpha isoform" . "protein phosphatase 2A structural subunit A, alpha isoform" . . . . . . . . "B55beta" . "PP2A subunit B isoform beta" . "PR52B" . "PR55-BETA" . . . . . . . . "beta4Gal-T7" . "galactosyltransferase I" . "XGALT-1" . . . . . . . . "B56D" . "B56delta" . . . . . . . . . . "calcineurin A alpha" . "CNA1" . "PPP2B" . "protein phosphatase 2B, catalytic subunit, alpha isoform" . . . . . . . . "ceroid-lipofuscinosis, neuronal 1, infantile" . "CLN1" . "INCL" . . . . . . . . "BAT" . "glycine N-choloyltransferase" . . . . . . . . . . . . . . . . . . "RCCP1" . . . . . . . . "PFM2" . . . . . . . . "KMT8C" . "PRISM" . . . . . . . "deafness, neurosensory, autosomal recessive, 61" . "DFNB61" . . . . . . . . . . "HPLH2" . "P1" . "Perforin" . "perforin 1 (preforming protein)" . "PFP" . . . . . . . . "articular superficial zone protein" . "bG174L6.2" . "bG174L6.2 (MSF: megakaryocyte stimulating factor )" . "camptodactyly, arthropathy, coxa vara, pericarditis syndrome" . "FLJ32635" . "HAPO" . "Jacobs camptodactyly-arthropathy-pericarditis syndrome" . "JCAP" . "lubricin" . "megakaryocyte stimulating factor" . "MSF" . "SZP" . . . . . . . . "PKACa" . . . . . . . . . "PKACg" . . . . . . . . . . . "AAKG" . "AAKG2" . "AMPK gamma2" . "CMH6" . "H91620p" . "WPWS" . . . . . . . . . . . . . . "Carney complex type 1" . "CNC1" . . . . . . . . . . . . . . . . . "dJ1039K5" . "MGC15204" . . . . . . . . . . . . . . . . . . . "BAG family molecular chaperone regulator 3" . . . . . . . . "acetoacetyl Coenzyme A thiolase" . "THIL" . . . . . . . . . "MGC57564" . "PKCC" . "PKC-gamma" . . . . . . . . . "PKCM" . "PKC-mu" . "PKD" . . . . . . . . . "advanced glycation end-product receptor 2" . "GIIB" . "glucosidase 2 subunit beta" . "glucosidase II beta subunit" . "hepatocystin" . "VASAP-60" . . . . . . . . "PKC2" . . . . . . "DNA-dependent protein kinase" . "DNA-dependent protein kinase catalytic subunit" . "DNAPK" . "DNAPKc" . "DNA-PKC" . "DNA-PKcs" . "DNPK1" . "p350" . "p460" . "XRCC7" . . . . . . . . . "PGK" . "PKG" . "PKG1" . . . . . . . . . "DYT16" . "HSD14" . "PACT" . "protein activator of the interferon-induced protein kinase" . "RAX" . . . . . . . . "endoplasmic reticulum DNA J domain-containing protein 6" . "ERdj6" . "HP58" . "interferon-induced, double-stranded RNA-activated protein kinase inhibitor" . "P58" . "P58IPK" . "protein kinase inhibitor of 58 kDa" . . . . . . . . . . . . . . . . . . . . . . . "AltPrP" . "CD230" . "Creutzfeldt-Jakob disease" . "fatal familial insomnia" . "Gerstmann-Strausler-Scheinker syndrome" . "p27-30" . "PRP" . . . . . . . . . "prepro-protein C" . . . . . . . . . "CCD41" . "CD201" . "EPCR" . . . . . . . . "HSPOX2" . "PIG6" . "PRODH1" . "PRODH2" . "proline oxidase" . "TP53I6" . . . . . . . . . . . "AC133" . "CD133" . "CORD12" . "RP41" . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . "PZ" . . . . . . . . "PRPH1" . . . . . . . . . . . . . "CMTX5" . "DFNX1" . "PRS I" . "ribose-phosphate diphosphokinase 1" . . . . . . . . . . . . . . . . . . . . "ARMD7" . "HtrA" . "IGFBP5-protease" . . . . . . . . "BSSP-3" . "motopsin" . "MRT1" . "neurotrypsin" . . . . . . . . "hLON" . "LonHS" . "PIM1" . . . . . . . . "TRY2" . "trypsin 2" . . . . . . . . . "enteropeptidase" . "ENTK" . "MGC133046" . "proenterokinase" . . . . . . . "ACPA" . "AGP7" . "C-ANCA" . "MBT" . "myeloblastin" . "P29" . "PR-3" . "serine proteinase, neutrophil" . "Wegener granulomatosis autoantigen" . . . . . . . . . . . . . . "variant Gaucher disease and variant metachromatic leukodystrophy" . . . . . . . . . . . . . "FAD" . "PS1" . "S182" . . . . . . . . . . "AD3L" . "PS2" . "STM2" . . . . . . . . . . . . . . . "hucep-6" . "KIAA0272" . "ubiquitin carboxy-terminal hydrolase" . "UCHL2" . . . . . . . . . "NKX3.2" . "NKX3B" . . . . . . . . . . . . . . "beta5i" . "D6S216E" . "PSMB5i" . "RING10" . . . . . . . . . . "p55" . "Rpn5" . . . . . . . . . . . . . . . "CD2 antigen-binding protein 1" . "CD2BP1" . "CD2BP1L" . "CD2BP1S" . "CD2 cytoplasmic tail-binding protein" . "H-PIP" . "PAPAS" . "PEST phosphatase-interacting protein 1" . "PSTPIP" . . . . . . . . . . . . . . . . "BCNS" . . . . . . . . . . . . . . . . "KIAA0024" . "PSS1" . "PSSA" . . . . . . . . . . . . . . . . . . . . . . . . . "MMAC1" . "mutated in multiple advanced cancers 1" . "PTEN1" . "TEP1" . . . . . . . . . . "AT-1" . "AT1" . . . . . . . . . "CYP8A1" . "cytochrome P450, family 8, subfamily A, polypeptide 1" . "PGIS" . "prostacyclin synthase" . . . . . . . . . "parathormone" . "parathyrin" . "parathyroid hormone 1" . "preproparathyroid hormone" . "prepro-PTH" . "PTH1" . . . . . . . . "HHM" . "osteostatin" . "parathyroid hormone-like hormone preproprotein" . "parathyroid hormone-related protein preproprotein" . "PLP" . "PTHR" . "PTHRP" . . . . . . . . . . . . . . . . . . . . "transcription factor WSTF" . "Williams-Beuren syndrome chromosome region 10" . "Williams-Beuren syndrome chromosome region 9" . "WSTF" . . . . . . . . . "CAP" . "cementum attachment protein" . "Very-long-chain (3R)-3-hydroxyacyl-CoA dehydratase 1" . . . . . . . . . . . "BPTP3" . "PTP2C" . "SHP-2" . "SHP2" . "SH-PTP2" . . . . . . . . "PEZ" . . . . . . . . . . . "TCELLPTP" . "TC-PTP" . "TCPTP" . . . . . . . . . . . . . "Lyp" . "Lyp1" . "Lyp2" . . . . . . . . . "PTPH1" . . . . . . . . "GP180" . "LCA" . "T200" . . . . . . . . . "FLJ23590" . . . . . . . . . . . . . . . . "GLEPP1" . "NPHS6" . "osteoclastic transmembrane protein-tyrosine phosphatase" . "PTP-oc" . "PTP-U2" . "PTPU2" . . . . . . . . . . "phosphatidylinositol phosphatase PTPRQ" . . . . . . . . . . . . . . . . "cavin-1" . "CGL4" . "congenital generalized lipodystrophy 4" . . . . . . . . "PTPS" . . . . . . . . . . . . . . . . "PUR1" . "PUR-ALPHA" . "PURALPHA" . . . . . . . . . . . "CD111" . "CLPED1" . "HIgR" . "nectin" . "OFC7" . "PRR" . "PRR1" . "PVRR1" . "SK-12" . . . . . . . . "DKFZp762I194" . . . . . . . . . . "D1S2223E" . "HK33" . "housekeeping gene, 33kD" . "PMP1" . "PMPI" . "PXMP1" . . . . . . . . . . "PAF-1" . "peroxin 2" . "PMP35" . "RNF72" . "Zellweger syndrome" . "ZWS3" . . . . . . . . . . . "peroxisomal import receptor 5" . "peroxisomal targeting signal 1 receptor" . "PTS1R" . . . . . . . . . . "P5C" . . . . . . . . . . . . "P5CS" . . . . . . . . "glycogen phosphorylase, liver form" . "glycogen storage disease type VI" . "Hers disease" . . . . . . . . "glycogen phosphorylase, muscle form" . "glycogen storage disease type V" . "McArdle syndrome" . "myophosphorylase" . . . . . . . . . "glutamine tRNA ligase" . . . . . . . . "6,7-dihydropteridine reductase" . "DHPR" . "PKU2" . "SDR33C1" . "short chain dehydrogenase/reductase family 33C, member 1" . . . . . . . . "YL8" . . . . . . . . "GS2" . "HsT18676" . "RAB27" . "RAM" . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . "p21-Rac1" . "Rac-1" . "TC-25" . . . . . . . . "EN-7" . . . . . . . . "hHR21" . "KIAA0078" . "kleisin" . "SCC1" . "sister chromatid cohesion 1" . . . . . . . . . "hRad50" . "RAD50-2" . . . . . . . . . . "BRCA1/BRCA2-containing complex, subunit 5" . "BRCC5" . "FANCR" . "HsRad51" . "HsT16930" . . . . . . . . . "FANCO" . "RAD51L2" . . . . . . . . "DNA repair protein RAD51 homolog 4" . "HsTRAD" . "R51H3" . "Recombination repair protein" . "Trad" . . . . . . . . "hHR54" . "hRAD54" . "RAD54A" . . . . . . . . . . "c-Raf" . "CRAF" . "C-Raf proto-oncogene, serine/threonine kinase" . "Raf-1" . . . . . . . . . . . . "MGC43321" . "recombination activating protein 1" . "RING finger protein 74" . "RNF74" . "V(D)J recombination-activating protein 1" . . . . . . . . . . . . . . . . . . . "DKFZP434A139" . "KIAA1820" . "MGC12824" . "SMS" . . . . . . . . "E1" . . . . . . . . . . . "ADANE" . "nucleoporin 358" . "NUP358" . . . . . . . . . . "CMS1D" . "CMS1E" . "rapsyn" . "RNF205" . . . . . . . "NR1B1" . "RAR" . . . . . . . . . "HAP" . "NR1B2" . "RRB2" . . . . . . . . . . . . "maple syrup urine disease" . "MSU" . . . . . . . . "arginine tRNA ligase 1, cytoplasmic" . "DALRD1" . . . . . . . . . "capillary malformation-arteriovenous malformation" . "CM-AVM" . "GAP" . "p120" . "p120GAP" . "p120RASGAP" . "p120 RAS GTPase activating protein" . . . . . . . . "GAP1M" . . . . . . . . "calcium- and diacylglycerol-regulated guanine nucleotide exchange factor II" . "CalDAG-GEFII" . "RASGRP" . . . . . . . . . "calcium- and diacylglycerol-regulated guanine nucleotide exchange factor I" . "CALDAG-GEFI" . . . . . . . . . . . "2-oxoisovalerate dehydrogenase subunit beta, mitochondrial" . "maple syrup urine disease" . . . . . . . . . . . . "PPP1R130" . "prepro-retinoblastoma-associated protein" . "protein phosphatase 1, regulatory subunit 130" . "RB" . . . . . . . . . "COM1" . "CTBP-interacting protein" . "CtIP" . "RIM" . . . . . . . . "DXS8237E" . "GPATC9" . "GPATCH9" . "KIAA0122" . "S1-1" . "ZRANB5" . . . . . . . . "CARD-containing apoptotic signaling protein" . "CARD containing molecule enhancing NF-kB" . "CARD-containing proapoptotic protein" . "CARD-like apoptotic protein" . "CARMEN" . "caspase-recruiting domain-containing protein" . "c-E10" . "CIPER" . "CLAP" . "mE10" . . . . . . . . "BOV-1A" . "BOV-1B" . "BOV-1C" . "RBM8B" . "Y14" . "ZNRP" . . . . . . . . . . "Bcl-2" . "PPP1R50" . "protein phosphatase 1, regulatory subunit 50" . . . . . . . . . "YRRM1" . "YRRM2" . . . . . . . . "D10S64" . "D10S65" . "D10S66" . "interstitial retinol-binding protein 3" . "RP66" . . . . . . . . . . . . . . . . . . . . . "COD5" . "cone dystrophy 5 (X-linked)" . . . . . . . . . . "HSD17B9" . "SDR9C5" . "short chain dehydrogenase/reductase family 9C, member 5" . . . . . . . . . . . . . . . . "CACD2" . "rd2" . "retinal peripherin" . "TSPAN22" . . . . . . . . . . . . . . . . "RecQ4" . . . . . . . . "p65" . . . . . . . . . "PRO1598" . "RL" . . . . . . . . . . . . . . . . . "BAF45d" . "ubi-d4" . . . . . . . . . "ARG" . "ARP" . "DNB1" . "KIAA0458" . . . . . . . . . "neuron-restrictive silencer factor" . "NRSF" . "XBR" . . . . . . . . . . . . . . . . . "cadherin-related family member 16" . "CDHF12" . "CDHR16" . "PTC" . "rearranged during transfection" . "RET51" . "RET receptor tyrosine kinase" . . . . . . . . . "polymerase, DNA, zeta" . "POLZ" . "REV3" . . . . . . . . "A1" . "MHCBFB" . "PO-GA" . "RFC140" . . . . . . . "A1" . "activator 1" . "RFC40" . . . . . . . . "RNF76" . . . . . . . . . . . . . . . "ANKRA1" . "ankyrin repeat-containing regulatory factor X-associated protein" . "BLS" . "DNA-binding protein RFXANK" . "F14150_1" . "MGC138628" . "regulatory factor X subunit B" . "RFX-B" . "RFX-Bdelta4" . . . . . . . . . . . . . "RGR-opsin" . "RP44" . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . "ABeta amyloidosis, Dutch type" . . . "ACys amyloidosis" . . . "Hypoplastic amelogenesis imperfecta" . . . "Hypocalcified amelogenesis imperfecta" . . . "Hypomaturation amelogenesis imperfecta" . . . "Hypomaturation-hypoplastic amelogenesis imperfecta with taurodontism" . . . "Autosomal dominant intermediate Charcot-Marie-Tooth disease type B" . . . "Autosomal dominant intermediate Charcot-Marie-Tooth disease type C" . . . "Autosomal dominant intermediate Charcot-Marie-Tooth disease type D" . . . "Hereditary angioedema type 1" . . . "Hereditary angioedema type 2" . . . "F12-related hereditary angioedema with normal C1Inh" . . . "Renin-angiotensin-aldosterone system-blocker-induced angioedema" . . . "Semantic dementia" . . . "Progressive non-fluent aphasia" . . . "Neuroendocrine tumor of stomach" . . . "Carcinoid syndrome" . . . "2q37 microdeletion syndrome" . . . "Porphyria due to ALA dehydratase deficiency" . . . "FRAXE intellectual disability" . . . "FRAXF syndrome" . . . "Bathing suit ichthyosis" . . . "Autosomal dominant spastic paraplegia type 3" . . . "Autosomal dominant spastic paraplegia type 4" . . . "Autosomal recessive spastic paraplegia type 5A" . . . "Autosomal dominant spastic paraplegia type 6" . . . "Autosomal dominant spastic paraplegia type 8" . . . "Autosomal dominant spastic paraplegia type 10" . . . "Autosomal dominant spastic paraplegia type 12" . . . "Autosomal dominant spastic paraplegia type 13" . . . "Autosomal recessive spastic paraplegia type 14" . . . "Autosomal recessive spastic paraplegia type 15" . . . "X-linked spastic paraplegia type 16" . . . "Autosomal dominant spastic paraplegia type 17" . . . "Autosomal dominant spastic paraplegia type 19" . . . "Ataxia-telangiectasia" . . . "Autosomal recessive spastic paraplegia type 20" . . . "Autosomal recessive spastic paraplegia type 21" . . . "Autosomal recessive spastic paraplegia type 23" . . . "Autosomal recessive spastic paraplegia type 24" . . . "Autosomal recessive spastic paraplegia type 25" . . . "Autosomal recessive spastic paraplegia type 26" . . . "Autosomal recessive spastic paraplegia type 27" . . . "Autosomal recessive spastic paraplegia type 28" . . . "Autosomal dominant spastic paraplegia type 29" . . . "Autosomal spastic paraplegia type 30" . . . "Autosomal dominant spastic paraplegia type 31" . . . "Romano-Ward syndrome" . . . "Cleft hard palate" . . . "Transaldolase deficiency" . . . "Female restricted epilepsy with intellectual disability" . . . "Familial hypofibrinogenemia" . . . "Autosomal dominant epilepsy with auditory features" . . . "Familial hypocalciuric hypercalcemia type 2" . . . "Familial hypocalciuric hypercalcemia type 3" . . . "Situs inversus totalis" . . . "Congenital stromal corneal dystrophy" . . . "Bilateral frontoparietal polymicrogyria" . . . "X-linked Charcot-Marie-Tooth disease type 1" . . . "X-linked Charcot-Marie-Tooth disease type 4" . . . "Charcot-Marie-Tooth disease type 1A" . . . "Charcot-Marie-Tooth disease type 1B" . . . "Charcot-Marie-Tooth disease type 1C" . . . "Charcot-Marie-Tooth disease type 1D" . . . "Charcot-Marie-Tooth disease type 1F" . . . "X-linked hyper-IgM syndrome" . . . "Hyper-IgM syndrome type 2" . . . "Hyper-IgM syndrome type 3" . . . "Hyper-IgM syndrome type 5" . . . "Autosomal recessive Charcot-Marie-Tooth disease with hoarseness" . . . "Autosomal dominant palmoplantar keratoderma and congenital alopecia" . . . "Charcot-Marie-Tooth disease type 2B2" . . . "Charcot-Marie-Tooth disease type 2H" . . . "Spinocerebellar ataxia type 23" . . . "Spinocerebellar ataxia type 28" . . . "Spinocerebellar ataxia type 20" . . . "Spinocerebellar ataxia type 25" . . . "Spinocerebellar ataxia type 26" . . . "Autosomal recessive dopa-responsive dystonia" . . . "Familial isolated congenital asplenia" . . . "X-linked Alport syndrome-diffuse leiomyomatosis" . . . "Dentatorubral pallidoluysian atrophy" . . . "Early-onset autosomal dominant Alzheimer disease" . . . "Acute myeloid leukemia with t(8;21)(q22;q22) translocation" . . . "Enamel-renal syndrome" . . . "Congenital sodium diarrhea" . . . "Trehalase deficiency" . . . "Tropical pancreatitis" . . . "Myopathic intestinal pseudoobstruction" . . . "Metaphyseal anadysplasia" . . . "Leber hereditary optic neuropathy" . . . "Mosaic variegated aneuploidy syndrome" . . . "Vein of Galen aneurysmal malformation" . . . "Blue rubber bleb nevus" . . . "Tufted angioma" . . . "Aniridia-cerebellar ataxia-intellectual disability syndrome" . . . "NON RARE IN EUROPE: Autism" . . . "Ankyloblepharon-ectodermal defects-cleft lip/palate syndrome" . . . "BOR syndrome" . . . "Microlissencephaly" . . . "Bannayan-Riley-Ruvalcaba syndrome" . . . "Microphthalmia with limb anomalies" . . . "Bardet-Biedl syndrome" . . . "Aplasia cutis congenita" . . . "Barth syndrome" . . . "Arnold-Chiari malformation type II" . . . "Neurogenic arthrogryposis multiplex congenita" . . . "Infantile-onset X-linked spinal muscular atrophy" . . . "Distal arthrogryposis type 1" . . . "Sheldon-Hall syndrome" . . . "Kuskokwim syndrome" . . . "Arthrogryposis-oculomotor limitation-electroretinal anomalies syndrome" . . . "Progressive pseudorheumatoid arthropathy of childhood" . . . "Congenital contractural arachnodactyly" . . . "NON RARE IN EUROPE: Asperger syndrome" . . . "Ataxia-oculomotor apraxia type 1" . . . "Autosomal recessive cerebelloparenchymal disorder type 3" . . . "Cerebellar ataxia-areflexia-pes cavus-optic atrophy-sensorineural hearing loss syndrome" . . . "Cerebellar ataxia-hypogonadism syndrome" . . . "X-linked progressive cerebellar ataxia" . . . "Beh\u00E7et disease" . . . "Ataxia-hypogonadism-choroidal dystrophy syndrome" . . . "Infantile-onset spinocerebellar ataxia" . . . "Lethal ataxia with deafness and optic atrophy" . . . "Beta-mannosidosis" . . . "Atelosteogenesis type I" . . . "TMEM70-related mitochondrial encephalo-cardio-myopathy" . . . "Congenital atransferrinemia" . . . "Beta-sarcoglycan-related limb-girdle muscular dystrophy R4" . . . "Burn-McKeown syndrome" . . . "Autosomal dominant optic atrophy plus syndrome" . . . "Autosomal dominant congenital benign spinal muscular atrophy" . . . "Baller-Gerold syndrome" . . . "Bamforth-Lazarus syndrome" . . . "Congenital intrauterine infection-like syndrome" . . . "Birt-Hogg-Dub\u00E9 syndrome" . . . "Barber-Say syndrome" . . . "NON RARE IN EUROPE: Barrett esophagus" . . . "Bartsocas-Papas syndrome" . . . "Bj\u00F6rnstad syndrome" . . . "Best vitelliform macular dystrophy" . . . "Blackfan-Diamond anemia" . . . "Bloom syndrome" . . . "Boomerang dysplasia" . . . "Bowen-Conradi syndrome" . . . "Aym\u00E9-Gripp syndrome" . . . "Brachydactyly-elbow wrist dysplasia syndrome" . . . "Brachydactyly-arterial hypertension syndrome" . . . "Borjeson-Forssman-Lehmann syndrome" . . . "Branchio-oculo-facial syndrome" . . . "Branchioskeletogenital syndrome" . . . "Autosomal dominant popliteal pterygium syndrome" . . . "Buschke-Ollendorff syndrome" . . . "C syndrome" . . . "Medullary sponge kidney" . . . "Brugada syndrome" . . . "Caffey disease" . . . "Budd-Chiari syndrome" . . . "Camurati-Engelmann disease" . . . "Butyrylcholinesterase deficiency" . . . "Partial atrioventricular septal defect" . . . "Familial prostate cancer" . . . "Familial pancreatic carcinoma" . . . "Chronic mucocutaneous candidiasis" . . . "Heart defect-tongue hamartoma-polysyndactyly syndrome" . . . "Chronic beryllium disease" . . . "Cardiofaciocutaneous syndrome" . . . "Atrial standstill" . . . "Mitochondrial DNA-related cardiomyopathy and hearing loss" . . . "Beta-ketothiolase deficiency" . . . "Carey-Fineman-Ziter syndrome" . . . "Carney complex" . . . "Congenital cataract-hypertrophic cardiomyopathy-mitochondrial myopathy syndrome" . . . "Cerebral autosomal dominant arteriopathy-subcortical infarcts-leukoencephalopathy" . . . "Legius syndrome" . . . "Segmental outgrowth-lipomatosis-arteriovenous malformation-epidermal nevus syndrome" . . . "Glycogen storage disease due to muscle and heart glycogen synthase deficiency" . . . "Overgrowth-macrocephaly-facial dysmorphism syndrome" . . . "Hypomyelinating leukodystrophy-ataxia-hypodontia-hypomyelination syndrome" . . . "Capillary malformation-arteriovenous malformation" . . . "Histiocytoid cardiomyopathy" . . . "Spondyloepiphyseal dysplasia with metatarsal shortening" . . . "Hepatoencephalopathy due to combined oxidative phosphorylation defect type 1" . . . "Neurological conditions associated with aminoacylase 1 deficiency" . . . "Lethal congenital contracture syndrome type 2" . . . "Lethal congenital contracture syndrome type 3" . . . "Cataract-microcornea syndrome" . . . "X-linked intellectual disability-cerebellar hypoplasia syndrome" . . . "Frank-Ter Haar syndrome" . . . "Auriculocondylar syndrome" . . . "Male infertility due to large-headed multiflagellar polyploid spermatozoa" . . . "Leukoencephalopathy with brain stem and spinal cord involvement-high lactate syndrome" . . . "Isolated optic nerve hypoplasia/aplasia" . . . "Hypotonia with lactic acidemia and hyperammonemia" . . . "Cataract-intellectual disability-hypogonadism syndrome" . . . "Catel-Manzke syndrome" . . . "CHARGE syndrome" . . . "X-linked cerebral adrenoleukodystrophy" . . . "Adrenomyeloneuropathy" . . . "Cerebrocostomandibular syndrome" . . . "Encephalopathy due to prosaposin deficiency" . . . "Hypomyelination with atrophy of basal ganglia and cerebellum" . . . "Autosomal recessive bestrophinopathy" . . . "SERKAL syndrome" . . . "Microphthalmia with brain and digit anomalies" . . . "17q11.2 microduplication syndrome" . . . "Autosomal recessive spastic paraplegia type 39" . . . "Autosomal recessive ataxia due to ubiquinone deficiency" . . . "Hemochromatosis type 4" . . . "NON RARE IN EUROPE: Hemochromatosis type 1" . . . "Cerebrofaciothoracic dysplasia" . . . "Neuropathy with hearing impairment" . . . "Charcot-Marie-Tooth disease type 4J" . . . "Distal hereditary motor neuropathy type 2" . . . "Distal hereditary motor neuropathy type 5" . . . "Distal hereditary motor neuropathy, Jerash type" . . . "X-linked distal spinal muscular atrophy type 3" . . . "Mutilating hereditary sensory neuropathy with spastic paraplegia" . . . "X-linked hereditary sensory and autonomic neuropathy with deafness" . . . "Distal hereditary motor neuropathy type 7" . . . "CHILD syndrome" . . . "6-pyruvoyl-tetrahydropterin synthase deficiency" . . . "CHAND syndrome" . . . "Primary intraosseous venous malformation" . . . "Autosomal dominant slowed nerve conduction velocity" . . . "Hyperlipidemia due to hepatic triacylglycerol lipase deficiency" . . . "Brachydactyly type B2" . . . "Stapes ankylosis with broad thumbs and toes" . . . "Titin-related limb-girdle muscular dystrophy R10" . . . "Benign familial neonatal-infantile seizures" . . . "Short stature due to primary acid-labile subunit deficiency" . . . "CLOVES syndrome" . . . "Syndactyly-telecanthus-anogenital and renal malformations syndrome" . . . "Autosomal dominant macrothrombocytopenia" . . . "Bilateral microtia-deafness-cleft palate syndrome" . . . "Palmoplantar keratoderma, Nagashima type" . . . "Saldino-Mainzer syndrome" . . . "Campomelic dysplasia" . . . "External auditory canal aplasia/hypoplasia" . . . "Uncombable hair syndrome" . . . "Tessier number 4 facial cleft" . . . "Tessier number 7 facial cleft" . . . "Cleft lip and alveolus" . . . "Tarsal-carpal coalition syndrome" . . . "Familial calcium pyrophosphate deposition" . . . "Chondrodysplasia-disorder of sex development syndrome" . . . "Desbuquois syndrome" . . . "Greenberg dysplasia" . . . "Otospondylomegaepiphyseal dysplasia" . . . "Benign hereditary chorea" . . . "Xq21 microdeletion syndrome" . . . "Parathyroid carcinoma" . . . "Lynch syndrome" . . . "CINCA syndrome" . . . "Cleidocranial dysplasia" . . . "Joubert syndrome with hepatic defect" . . . "CODAS syndrome" . . . "Hereditary breast and ovarian cancer syndrome" . . . "Isolated complex III deficiency" . . . "Coffin-Siris syndrome" . . . "COFS syndrome" . . . "Differentiated thyroid carcinoma" . . . "Uveal coloboma-cleft lip and palate-intellectual disability" . . . "Renal coloboma syndrome" . . . "Atrial septal defect-atrioventricular conduction defects syndrome" . . . "Carbamoyl-phosphate synthetase 1 deficiency" . . . "NON RARE IN EUROPE: Ventricular septal defect" . . . "Lethal congenital contracture syndrome type 1" . . . "Corneal dystrophy-perceptive deafness syndrome" . . . "Vici syndrome" . . . "Corpus callosum agenesis-neuronopathy syndrome" . . . "X-linked complicated corpus callosum dysgenesis" . . . "Abetalipoproteinemia" . . . "Adrenocortical carcinoma" . . . "Autosomal recessive Robinow syndrome" . . . "Coxopodopatellar syndrome" . . . "Nasopharyngeal carcinoma" . . . "Craniodiaphyseal dysplasia" . . . "Cranioectodermal dysplasia" . . . "Hypertrichotic osteochondrodysplasia, Cantu type" . . . "SPECC1L-related hypertelorism syndrome" . . . "Craniofrontonasal dysplasia" . . . "Craniometaphyseal dysplasia" . . . "Cranio-osteoarthropathy" . . . "Craniofacial-deafness-hand syndrome" . . . "Jackson-Weiss syndrome" . . . "Craniosynostosis, Boston type" . . . "Crisponi syndrome" . . . "Familial isolated dilated cardiomyopathy" . . . "Currarino syndrome" . . . "Curry-Jones syndrome" . . . "Cutis gyrata-acanthosis nigricans-craniosynostosis syndrome" . . . "Cutis marmorata telangiectatica congenita" . . . "Submucosal cleft palate" . . . "NON RARE IN EUROPE: Familial isolated hypertrophic cardiomyopathy" . . . "Fatal infantile cytochrome C oxidase deficiency" . . . "Spondyloepimetaphyseal dysplasia, matrilin-3 type" . . . "X-linked intellectual disability-Dandy-Walker malformation-basal ganglia disease-seizures syndrome" . . . "Carnitine palmitoyl transferase 1A deficiency" . . . "Knobloch syndrome" . . . "Hereditary hypophosphatemic rickets with hypercalciuria" . . . "Common variable immunodeficiency" . . . "Hypotrichosis with juvenile macular degeneration" . . . "Congenital or early infantile CACH syndrome" . . . "Late infantile CACH syndrome" . . . "Juvenile or adult CACH syndrome" . . . "Situs ambiguus" . . . "Epithelioid hemangioendothelioma" . . . "Hereditary mixed polyposis syndrome" . . . "Serrated polyposis syndrome" . . . "Mesoaxial synostotic syndactyly with phalangeal reduction" . . . "Cold-induced sweating syndrome" . . . "Neuroferritinopathy" . . . "Pterin-4 alpha-carbinolamine dehydratase deficiency" . . . "Huntington disease-like 1" . . . "Combined immunodeficiency with granulomatosis" . . . "ANE syndrome" . . . "Oculoauricular syndrome, Schorderet type" . . . "SLC39A13-related spondylodysplastic Ehlers-Danlos syndrome" . . . "Congenital muscular dystrophy due to LMNA mutation" . . . "Sea-blue histiocytosis" . . . "Ectodermal dysplasia-skin fragility syndrome" . . . "Localized dystrophic epidermolysis bullosa, acral form" . . . "Localized dystrophic epidermolysis bullosa, nails only" . . . "Epidermolysis bullosa simplex with circinate migratory erythema" . . . "Epidermolysis bullosa simplex with pyloric atresia" . . . "Lethal acantholytic erosive disorder" . . . "Typical urticaria pigmentosa" . . . "Plaque-form urticaria pigmentosa" . . . "Nodular urticaria pigmentosa" . . . "Smoldering systemic mastocytosis" . . . "Isolated bone marrow mastocytosis" . . . "Monosomy 13q14" . . . "Systemic primary carnitine deficiency" . . . "Distal monosomy 15q" . . . "Carnitine-acylcarnitine translocase deficiency" . . . "Achondroplasia" . . . "1p36 deletion syndrome" . . . "2q24 microdeletion syndrome" . . . "Deletion 5q35" . . . "Cataract-glaucoma syndrome" . . . "Hb Bart's hydrops fetalis" . . . "Maffucci syndrome" . . . "Spondyloepiphyseal dysplasia, Nishimura type" . . . "CNTNAP2-related developmental and epileptic encephalopathy" . . . "Leukoencephalopathy-dystonia-motor neuropathy syndrome" . . . "Hypotonia-cystinuria syndrome" . . . "2p21 microdeletion syndrome" . . . "Action myoclonus-renal failure syndrome" . . . "Alveolar soft tissue sarcoma" . . . "Benign familial mesial temporal lobe epilepsy" . . . "Rolandic epilepsy-speech dyspraxia syndrome" . . . "Rolandic epilepsy-paroxysmal exercise-induced dystonia-writer's cramp syndrome" . . . "Peripheral demyelinating neuropathy-central dysmyelinating leukodystrophy-Waardenburg syndrome-Hirschsprung disease" . . . "Limbic encephalitis with LGI1 antibodies" . . . "Pustulosis palmaris et plantaris" . . . "Acrodermatitis continua of Hallopeau" . . . "X-linked intellectual disability, Najm type" . . . "X-linked intellectual disability, Nascimento type" . . . "X-linked dominant chondrodysplasia, Chassaing-Lacombe type" . . . "X-linked intellectual disability, Van Esch type" . . . "Hyperekplexia-epilepsy syndrome" . . . "Hereditary hyperferritinemia-cataract syndrome" . . . "Partial chromosome Y deletion" . . . "Familial advanced sleep-phase syndrome" . . . "NON RARE IN EUROPE: Dementia with Lewy body" . . . "Familial mesial temporal lobe epilepsy with febrile seizures" . . . "Absence of fingerprints-congenital milia syndrome" . . . "Exercise-induced hyperinsulinism" . . . "Multiple epiphyseal dysplasia due to collagen 9 anomaly" . . . "Multiple epiphyseal dysplasia, Beighton type" . . . "Multiple epiphyseal dysplasia, Al-Gazali type" . . . "Brachydactyly-short stature-retinitis pigmentosa syndrome" . . . "Pontocerebellar hypoplasia type 4" . . . "Pontocerebellar hypoplasia type 6" . . . "Von Willebrand disease type 1" . . . "Von Willebrand disease type 2A" . . . "Von Willebrand disease type 2B" . . . "Von Willebrand disease type 2M" . . . "Von Willebrand disease type 2N" . . . "Von Willebrand disease type 3" . . . "Autosomal dominant otospondylomegaepiphyseal dysplasia" . . . "FASTKD2-related infantile mitochondrial encephalomyopathy" . . . "Intellectual disability, Birk-Barel type" . . . "Isolated osteopoikilosis" . . . "Dentinogenesis imperfecta type 2" . . . "Dentinogenesis imperfecta type 3" . . . "Odontochondrodysplasia" . . . "Familial sick sinus syndrome" . . . "Porokeratotic eccrine ostial and dermal duct nevus" . . . "Restrictive dermopathy" . . . "Hot water reflex epilepsy" . . . "Wolcott-Rallison syndrome" . . . "Dihydropyrimidine dehydrogenase deficiency" . . . "Ch\u00E9diak-Higashi syndrome" . . . "Spondyloepimetaphyseal dysplasia, Genevi\u00E8ve type" . . . "46,XY disorder of sex development-adrenal insufficiency due to CYP11A1 deficiency" . . . "46,XY gonadal dysgenesis-motor and sensory neuropathy syndrome" . . . "Fatal mitochondrial disease due to combined oxidative phosphorylation defect type 3" . . . "H syndrome" . . . "Native American myopathy" . . . "Hereditary cryohydrocytosis with reduced stomatin" . . . "Hereditary North American Indian childhood cirrhosis" . . . "Hyperandrogenism due to cortisone reductase deficiency" . . . "Sudden infant death-dysgenesis of the testes syndrome" . . . "Brain demyelination due to methionine adenosyltransferase deficiency" . . . "Congenital enteropathy due to enteropeptidase deficiency" . . . "Seborrhea-like dermatitis with psoriasiform elements" . . . "Congenital deficiency in alpha-fetoprotein" . . . "Hereditary persistence of alpha-fetoprotein" . . . "Familial scaphocephaly syndrome, McGillivray type" . . . "Autosomal thrombocytopenia with normal platelets" . . . "Heart-hand syndrome, Slovenian type" . . . "Primary peritoneal carcinoma" . . . "Chronic eosinophilic leukemia" . . . "Myeloid/lymphoid neoplasm associated with PDGFRA rearrangement" . . . "Myeloid/lymphoid neoplasm associated with PDGFRB rearrangement" . . . "Myeloid/lymphoid neoplasm associated with FGFR1 rearrangement" . . . "Cernunnos-XLF deficiency" . . . "Combined immunodeficiency due to CD3gamma deficiency" . . . "Susceptibility to respiratory infections associated with CD8alpha chain mutation" . . . "Severe combined immunodeficiency due to FOXN1 deficiency" . . . "Immunodeficiency due to CD25 deficiency" . . . "Recurrent infection due to specific granule deficiency" . . . "Immunodeficiency due to a classical component pathway complement deficiency" . . . "Immunodeficiency due to a late component of complement deficiency" . . . "T-B+ severe combined immunodeficiency due to IL-7Ralpha deficiency" . . . "T-B+ severe combined immunodeficiency due to CD45 deficiency" . . . "T-B+ severe combined immunodeficiency due to CD3delta/CD3epsilon/CD3zeta" . . . "Autosomal recessive centronuclear myopathy" . . . "Autosomal dominant centronuclear myopathy" . . . "Primary CD59 deficiency" . . . "Recurrent Neisseria infections due to factor D deficiency" . . . "Idiopathic central precocious puberty" . . . "Severe hemophilia B" . . . "Moderate hemophilia B" . . . "Mild hemophilia B" . . . "Severe hemophilia A" . . . "Moderate hemophilia A" . . . "Mild hemophilia A" . . . "Blue cone monochromatism" . . . "Woolly hair" . . . "17p11.2 microduplication syndrome" . . . "Severe congenital nemaline myopathy" . . . "Intermediate nemaline myopathy" . . . "Typical nemaline myopathy" . . . "Childhood-onset nemaline myopathy" . . . "Muscle filaminopathy" . . . "X-linked spastic paraplegia type 34" . . . "Autosomal dominant spastic paraplegia type 37" . . . "Autosomal dominant spastic paraplegia type 38" . . . "Autosomal recessive spastic paraplegia type 32" . . . "Autosomal recessive spastic paraplegia type 35" . . . "Lissencephaly due to TUBA1A mutation" . . . "Metabolic myopathy due to lactate transporter defect" . . . "Parkinsonian-pyramidal syndrome" . . . "Diffuse panbronchiolitis" . . . "Microcephaly-polymicrogyria-corpus callosum agenesis syndrome" . . . "Short stature-delayed bone age due to thyroid hormone metabolism deficiency" . . . "Male infertility due to globozoospermia" . . . "White sponge nevus" . . . "6q16 microdeletion syndrome" . . . "Polyneuropathy-hearing loss-ataxia-retinitis pigmentosa-cataract syndrome" . . . "MEDNIK syndrome" . . . "Autosomal dominant spastic paraplegia type 42" . . . "Spondyloepimetaphyseal dysplasia, aggrecan type" . . . "Renal pseudohypoaldosteronism type 1" . . . "Generalized pseudohypoaldosteronism type 1" . . . "Cap myopathy" . . . "Primary sclerosing cholangitis" . . . "22q11.2 duplication syndrome" . . . "Metaphyseal chondrodysplasia, Schmid type" . . . "Cartilage-hair hypoplasia" . . . "Proximal Xq28 duplication syndrome" . . . "Familial dysautonomia" . . . "Dysequilibrium syndrome" . . . "45,X/46,XY mixed gonadal dysgenesis" . . . "Dyskeratosis congenita" . . . "Temtamy syndrome" . . . "Prader-Willi syndrome due to paternal deletion of 15q11q13 type 1" . . . "Prader-Willi syndrome due to paternal deletion of 15q11q13 type 2" . . . "Prader-Willi syndrome due to translocation" . . . "Prader-Willi syndrome due to imprinting mutation" . . . "Bleeding disorder in hemophilia A carriers without FVIII deficiency" . . . "Bleeding disorder in hemophilia B carriers without FIX deficiency" . . . "Moderate multiminicore disease with hand involvement" . . . "Dysosteosclerosis" . . . "Reticulate acropigmentation of Kitamura" . . . "\u00C5land Islands eye disease" . . . "UV-sensitive syndrome" . . . "Inflammatory myofibroblastic tumor" . . . "Aromatase excess syndrome" . . . "Smith-McCort dysplasia" . . . "Syndromic microphthalmia type 5" . . . "Osteosclerosis-developmental delay-craniosynostosis syndrome" . . . "Osteopetrosis-hypogammaglobulinemia syndrome" . . . "Hemorrhagic disease due to alpha-1-antitrypsin Pittsburgh mutation" . . . "Distal myopathy with anterior tibial onset" . . . "X-linked myopathy with postural muscle atrophy" . . . "Hereditary myopathy with early respiratory failure" . . . "Autosomal dominant non-syndromic intellectual disability" . . . "Brain calcification, Rajab type" . . . "Perry syndrome" . . . "Acrofacial dysostosis, Rodr\u00EDguez type" . . . "Chordoma" . . . "Obesity due to leptin receptor gene deficiency" . . . "Autosomal dominant spondylocostal dysostosis" . . . "Birdshot chorioretinopathy" . . . "Fatal infantile lactic acidosis with methylmalonic aciduria" . . . "Isolated congenital breast hypoplasia/aplasia" . . . "Ghosal hematodiaphyseal dysplasia" . . . "Focal facial dermal dysplasia type III" . . . "Choroideremia" . . . "Autosomal dominant hypohidrotic ectodermal dysplasia" . . . "X-linked hypohidrotic ectodermal dysplasia" . . . "MYH9-related disease" . . . "Lowry-Wood syndrome" . . . "Frontometaphyseal dysplasia" . . . "Acromelic frontonasal dysplasia" . . . "Schimke immuno-osseous dysplasia" . . . "Lethal osteosclerotic bone dysplasia" . . . "Recurrent infections associated with rare immunoglobulin isotypes deficiency" . . . "Hermansky-Pudlak syndrome with neutropenia" . . . "Neutrophil immunodeficiency syndrome" . . . "Bacterial susceptibility due to TLR signaling pathway deficiency" . . . "Renal agenesis, bilateral" . . . "Cherubism" . . . "Spondyloenchondrodysplasia" . . . "Spondyloperipheral dysplasia-short ulna syndrome" . . . "Thanatophoric dysplasia type 1" . . . "Dyssegmental dysplasia, Silverman-Handmaker type" . . . "Primary biliary cholangitis" . . . "Progressive cone dystrophy" . . . "Cone rod dystrophy" . . . "Jalili syndrome" . . . "TRIM32-related limb-girdle muscular dystrophy R8" . . . "Melorheostosis with osteopoikilosis" . . . "Ebstein malformation of the tricuspid valve" . . . "Isolated ectopia lentis" . . . "Cushing syndrome due to macronodular adrenal hyperplasia" . . . "Primary pigmented nodular adrenocortical disease" . . . "Familial isolated hypoparathyroidism due to impaired PTH secretion" . . . "EEC syndrome" . . . "EEM syndrome" . . . "Arthrochalasia Ehlers-Danlos syndrome" . . . "Hidrotic ectodermal dysplasia" . . . "Kyphoscoliotic Ehlers-Danlos syndrome due to lysyl hydroxylase 1 deficiency" . . . "Dermatosparaxis Ehlers-Danlos syndrome" . . . "Coats disease" . . . "Coffin-Lowry syndrome" . . . "Herpes simplex virus encephalitis" . . . "Mitochondrial DNA depletion syndrome, encephalomyopathic form with methylmalonic aciduria" . . . "Early infantile epileptic encephalopathy" . . . "Early myoclonic encephalopathy" . . . "Cohen syndrome" . . . "Juvenile absence epilepsy" . . . "Myoclonic-astatic epilepsy" . . . "Rolandic epilepsy" . . . "Amelocerebrohypohidrotic syndrome" . . . "Progressive epilepsy-intellectual disability syndrome, Finnish type" . . . "Benign familial neonatal epilepsy" . . . "Spinocerebellar ataxia type 34" . . . "Bilateral striopallidodentate calcinosis" . . . "Gollop-Wolfgang complex" . . . "Occipital horn syndrome" . . . "Pulmonary capillary hemangiomatosis" . . . "Corticosteroid-binding globulin deficiency" . . . "Hereditary hypercarotenemia and vitamin A deficiency" . . . "Congenital isolated ACTH deficiency" . . . "Isolated cleft lip" . . . "Cleft lip/palate" . . . "15q13.3 microdeletion syndrome" . . . "Isolated autosomal dominant hypomagnesemia, Glaudemans type" . . . "Congenital myopathy, Paradas type" . . . "Endocrine-cerebro-osteodysplasia syndrome" . . . "Pancreatic insufficiency-anemia-hyperostosis syndrome" . . . "Muscular dystrophy, Selcen type" . . . "EAST syndrome" . . . "Thiamine-responsive encephalopathy" . . . "Adult-onset dystonia-parkinsonism" . . . "Cerebral autosomal recessive arteriopathy-subcortical infarcts-leukoencephalopathy" . . . "Blepharo-cheilo-odontic syndrome" . . . "Cornelia de Lange syndrome" . . . "Immunodeficiency with factor I anomaly" . . . "Immunodeficiency with factor H anomaly" . . . "Cowden syndrome" . . . "Congenital fiber-type disproportion myopathy" . . . "Fibrochondrogenesis" . . . "Hereditary gingival fibromatosis" . . . "Gingival fibromatosis-hypertrichosis syndrome" . . . "Juvenile hyaline fibromatosis" . . . "Fibrosarcoma" . . . "Idiopathic pulmonary fibrosis" . . . "Scalp-ear-nipple syndrome" . . . "Floating-Harbor syndrome" . . . "Cole-Carpenter syndrome" . . . "Fraser syndrome" . . . "Freeman-Sheldon syndrome" . . . "Essential fructosuria" . . . "Fryns syndrome" . . . "Infantile Krabbe disease" . . . "Late-infantile/juvenile Krabbe disease" . . . "Adult Krabbe disease" . . . "Symptomatic form of muscular dystrophy of Duchenne and Becker in female carriers" . . . "Anoctamin-5-related limb-girdle muscular dystrophy R12" . . . "Fukutin-related limb-girdle muscular dystrophy R13" . . . "POMT2-related limb-girdle muscular dystrophy R14" . . . "POMGNT1-related limb-girdle muscular dystrophy R15" . . . "Autosomal recessive lower motor neuron disease with childhood onset" . . . "Adult polyglucosan body disease" . . . "Isolated asymptomatic elevation of creatine phosphokinase" . . . "Galloway-Mowat syndrome" . . . "Gamma-aminobutyric acid transaminase deficiency" . . . "GAPO syndrome" . . . "NON RARE IN EUROPE: Crohn disease" . . . "Gaucher disease-ophthalmoplegia-cardiovascular calcification syndrome" . . . "Narcolepsy type 1" . . . "Geroderma osteodysplastica" . . . "Crouzon disease" . . . "Bilateral parasagittal parieto-occipital polymicrogyria" . . . "Bilateral generalized polymicrogyria" . . . "Glaucoma-ectopia lentis-microspherophakia-stiff joints-short stature syndrome" . . . "Spinocerebellar ataxia type 29" . . . "Fanconi-Bickel syndrome" . . . "Glycogen storage disease due to hepatic glycogen synthase deficiency" . . . "Focal dermal hypoplasia" . . . "Autosomal dominant adult-onset proximal spinal muscular atrophy" . . . "DYNC1H1-related autosomal dominant childhood-onset proximal spinal muscular atrophy" . . . "Severe neonatal-onset encephalopathy with microcephaly" . . . "Gorlin-Chaudhry-Moss syndrome" . . . "Autosomal dominant rhegmatogenous retinal detachment" . . . "NON RARE IN EUROPE: Congenital isolated thyroxine-binding globulin deficiency" . . . "Acromesomelic dysplasia, Grebe type" . . . "Hypercholesterolemia due to cholesterol 7alpha-hydroxylase deficiency" . . . "Brain-lung-thyroid syndrome" . . . "Childhood apraxia of speech" . . . "Extraskeletal myxoid chondrosarcoma" . . . "Cone dystrophy with supernormal rod response" . . . "Autosomal recessive spastic paraplegia type 18" . . . "Episodic ataxia type 6" . . . "IRIDA syndrome" . . . "3-hydroxy-3-methylglutaric aciduria" . . . "Intermediate osteopetrosis" . . . "Sterile multifocal osteomyelitis with periostitis and pustulosis" . . . "Congenital alveolar capillary dysplasia" . . . "Urocanic aciduria" . . . "Inherited congenital spastic tetraplegia" . . . "Lethal polymalformative syndrome, Boissel type" . . . "Adult hepatocellular carcinoma" . . . "Congenital lethal myopathy, Compton-North type" . . . "GTP cyclohydrolase I deficiency" . . . "Macrocephaly-intellectual disability-autism syndrome" . . . "Dystonia 16" . . . "Spinocerebellar ataxia type 30" . . . "Episodic ataxia type 5" . . . "Hip dysplasia, Beukes type" . . . "Hartnup disease" . . . "Hartsfield syndrome" . . . "Hawkinsinuria" . . . "Familial cylindromatosis" . . . "Kaposiform hemangioendothelioma" . . . "Solitary fibrous tumor/hemangiopericytoma" . . . "Isolated hemihyperplasia" . . . "Cystathioninuria" . . . "Alternating hemiplegia of childhood" . . . "Hemoglobin C disease" . . . "Hemoglobin E disease" . . . "Adenocarcinoma of ovary" . . . "Hereditary site-specific ovarian cancer syndrome" . . . "Hennekam syndrome" . . . "Endometrial stromal sarcoma" . . . "46,XX ovotesticular disorder of sex development" . . . "Congenital diaphragmatic hernia" . . . "Donnai-Barrow syndrome" . . . "Lissencephaly type 1 due to doublecortin gene mutation" . . . "Hirschsprung disease-ganglioneuroblastoma syndrome" . . . "Histidinemia" . . . "Congenital stationary night blindness" . . . "Holoprosencephaly" . . . "Isolated congenitally uncorrected transposition of the great arteries" . . . "Congenitally uncorrected transposition of the great arteries with cardiac malformation" . . . "Osteogenesis imperfecta type 1" . . . "Osteogenesis imperfecta type 2" . . . "Osteogenesis imperfecta type 3" . . . "Osteogenesis imperfecta type 4" . . . "Osteogenesis imperfecta type 5" . . . "Classic pantothenate kinase-associated neurodegeneration" . . . "Atypical pantothenate kinase-associated neurodegeneration" . . . "Niemann-Pick disease type C, severe perinatal form" . . . "Niemann-Pick disease type C, severe early infantile neurologic onset" . . . "Niemann-Pick disease type C, late infantile neurologic onset" . . . "Niemann-Pick disease type C, juvenile neurologic onset" . . . "Niemann-Pick disease type C, adult neurologic onset" . . . "Methylcobalamin deficiency type cblE" . . . "Spinocerebellar ataxia type 31" . . . "NON RARE IN EUROPE: Obesity due to MC3R deficiency" . . . "Autosomal recessive intermediate Charcot-Marie-Tooth disease type A" . . . "Isolated congenital digital clubbing" . . . "Mucopolysaccharidosis type 2, severe form" . . . "Mucopolysaccharidosis type 2, attenuated form" . . . "Methylcobalamin deficiency type cblG" . . . "BNAR syndrome" . . . "REN-related autosomal dominant tubulointerstitial kidney disease" . . . "RIN2 syndrome" . . . "Acute infantile liver failure due to synthesis defect of mtDNA-encoded proteins" . . . "Microduplication Xp11.22p11.23 syndrome" . . . "Neurodegenerative syndrome due to cerebral folate transport deficiency" . . . "17p13.3 microduplication syndrome" . . . "Combined immunodeficiency due to DOCK8 deficiency" . . . "Progressive polyneuropathy with bilateral striatal necrosis" . . . "Hereditary hypotrichosis with recurrent skin vesicles" . . . "Hereditary thrombophilia due to congenital histidine-rich (poly-L) glycoprotein deficiency" . . . "Neonatal acute respiratory distress due to SP-B deficiency" . . . "Chronic respiratory distress with surfactant metabolism deficiency" . . . "Sensorineural deafness with dilated cardiomyopathy" . . . "Infantile systemic hyalinosis" . . . "Hydranencephaly" . . . "Isolated Dandy-Walker malformation" . . . "Hydrocephalus with stenosis of the aqueduct of Sylvius" . . . "Hydrolethalus" . . . "Darier disease" . . . "Dicarboxylic aminoaciduria" . . . "Familial primary hypomagnesemia with hypercalciuria and nephrocalcinosis with severe ocular involvement" . . . "Idiopathic hypercalciuria" . . . "Palmoplantar keratoderma-esophageal carcinoma syndrome" . . . "Epidermolytic palmoplantar keratoderma" . . . "Delta-sarcoglycan-related limb-girdle muscular dystrophy R6" . . . "Xeroderma pigmentosum-Cockayne syndrome complex" . . . "Palmoplantar keratoderma-deafness syndrome" . . . "Semilobar holoprosencephaly" . . . "Diffuse cutaneous systemic sclerosis" . . . "Hyperlysinemia" . . . "Limited cutaneous systemic sclerosis" . . . "Limited systemic sclerosis" . . . "Quebec platelet disorder" . . . "Bleeding diathesis due to thromboxane synthesis deficiency" . . . "Laron syndrome with immunodeficiency" . . . "Joubert syndrome with ocular defect" . . . "Joubert syndrome with renal defect" . . . "Maternal phenylketonuria" . . . "Denys-Drash syndrome" . . . "Rothmund-Thomson syndrome type 1" . . . "Rothmund-Thomson syndrome type 2" . . . "Hereditary fibrosing poikiloderma-tendon contractures-myopathy-pulmonary fibrosis syndrome" . . . "Poikiloderma with neutropenia" . . . "Familial cerebral cavernous malformation" . . . "Fowler vasculopaty" . . . "Combined immunodeficiency with faciooculoskeletal anomalies" . . . "Cutis laxa with severe pulmonary, gastrointestinal and urinary anomalies" . . . "Hypertryptophanemia" . . . "NON RARE IN EUROPE: Hypodontia" . . . "Hypodontia-dysplasia of nails syndrome" . . . "Dilated cardiomyopathy-hypergonadotropic hypogonadism syndrome" . . . "Hypoparathyroidism-sensorineural deafness-renal disease syndrome" . . . "Familial isolated hypoparathyroidism due to agenesis of parathyroid gland" . . . "Nephrogenic diabetes insipidus" . . . "Megacystis-microcolon-intestinal hypoperistalsis syndrome" . . . "Hypoplastic left heart syndrome" . . . "Hyposmia-nasal and ocular hypoplasia-hypogonadotropic hypogonadism syndrome" . . . "Hemochromatosis type 3" . . . "Familial infantile bilateral striatal necrosis" . . . "Foveal hypoplasia-presenile cataract syndrome" . . . "Pontocerebellar hypoplasia type 1" . . . "Pancreatic hypoplasia-diabetes-congenital heart disease syndrome" . . . "Maternally-inherited diabetes and deafness" . . . "Hypothyroidism due to deficient transcription factors involved in pituitary development or function" . . . "Genetic transient congenital hypothyroidism" . . . "ICF syndrome" . . . "Dihydropteridine reductase deficiency" . . . "Ichthyosis follicularis-alopecia-photophobia syndrome" . . . "Multiple system atrophy, cerebellar type" . . . "Hereditary breast cancer" . . . "Fundus albipunctatus" . . . "Autosomal recessive optic atrophy, OPA7 type" . . . "Idiopathic CD4 lymphocytopenia" . . . "Severe combined immunodeficiency due to CORO1A deficiency" . . . "Progressive sensorineural hearing loss-hypertrophic cardiomyopathy syndrome" . . . "Idiopathic ventricular fibrillation, non Brugada type" . . . "Autosomal dominant striatal neurodegeneration" . . . "Autosomal dominant Charcot-Marie-Tooth disease type 2N" . . . "Autosomal dominant Charcot-Marie-Tooth disease type 2M" . . . "Carnitine palmitoyl transferase II deficiency, myopathic form" . . . "Carnitine palmitoyl transferase II deficiency, severe infantile form" . . . "Carnitine palmitoyl transferase II deficiency, neonatal form" . . . "CLN1 disease" . . . "CLN10 disease" . . . "CLN4A disease" . . . "CLN4B disease" . . . "CLN3 disease" . . . "CLN2 disease" . . . "CLN8 disease" . . . "CLN5 disease" . . . "CLN6 disease" . . . "CLN7 disease" . . . "Charcot-Marie-Tooth disease type 2B5" . . . "5q14.3 microdeletion syndrome" . . . "Spondylo-megaepiphyseal-metaphyseal dysplasia" . . . "Frontonasal dysplasia-alopecia-genital anomalies syndrome" . . . "2q23.1 microdeletion syndrome" . . . "Polyvalvular heart disease syndrome" . . . "5q35 microduplication syndrome" . . . "Monocytopenia with susceptibility to infections" . . . "Syndromic multisystem autoimmune disease due to Itch deficiency" . . . "Neuronal intranuclear inclusion disease" . . . "Microvillus inclusion disease" . . . "Insulin-resistance syndrome type A" . . . "Familial aortic dissection" . . . "Succinic semialdehyde dehydrogenase deficiency" . . . "Multiple intestinal atresia" . . . "Congenital short bowel syndrome" . . . "IVIC syndrome" . . . "Classical-like Ehlers-Danlos syndrome type 1" . . . "Cardiac-valvular Ehlers-Danlos syndrome" . . . "Ehlers-Danlos/osteogenesis imperfecta syndrome" . . . "Jacobsen syndrome" . . . "Pachyonychia congenita" . . . "Dopamine beta-hydroxylase deficiency" . . . "Familial generalized lentiginosis" . . . "Familial rhabdoid tumor" . . . "Beckwith-Wiedemann syndrome due to imprinting defect of 11p15" . . . "Beckwith-Wiedemann syndrome due to CDKN1C mutation" . . . "Beckwith-Wiedemann syndrome due to 11p15 microdeletion" . . . "Silver-Russell syndrome due to an imprinting defect of 11p15" . . . "Silver-Russell syndrome due to 11p15 microduplication" . . . "Combined immunodeficiency due to partial RAG1 deficiency" . . . "Familial cerebral saccular aneurysm" . . . "Usher syndrome type 1" . . . "Usher syndrome type 2" . . . "Usher syndrome type 3" . . . "Autosomal recessive spondylocostal dysostosis" . . . "Beta-thalassemia major" . . . "Beta-thalassemia intermedia" . . . "Dominant beta-thalassemia" . . . "Delta-beta-thalassemia" . . . "Hemoglobin C-beta-thalassemia syndrome" . . . "Hemoglobin E-beta-thalassemia syndrome" . . . "Transient familial neonatal hyperbilirubinemia" . . . "Beta-thalassemia-X-linked thrombocytopenia syndrome" . . . "Alpha-thalassemia-myelodysplastic syndrome" . . . "Autosomal dominant hyper-IgE syndrome" . . . "Hermansky-Pudlak syndrome with pulmonary fibrosis" . . . "Hermansky-Pudlak syndrome without pulmonary fibrosis" . . . "Hermansky-Pudlak syndrome type 7" . . . "Hermansky-Pudlak syndrome type 8" . . . "Autosomal dominant generalized dystrophic epidermolysis bullosa" . . . "Johanson-Blizzard syndrome" . . . "Isolated growth hormone deficiency type IA" . . . "Isolated growth hormone deficiency type IB" . . . "Isolated growth hormone deficiency type II" . . . "Non-acquired combined pituitary hormone deficiency-sensorineural hearing loss-spine abnormalities syndrome" . . . "Joubert syndrome with oculorenal defect" . . . "Kabuki syndrome" . . . "Sanjad-Sakati syndrome" . . . "Sickle cell anemia" . . . "KBG syndrome" . . . "Autosomal dominant keratitis" . . . "NON RARE IN EUROPE: Isolated keratoconus" . . . "Non-epidermolytic palmoplantar keratoderma" . . . "Duane retraction syndrome" . . . "Keratosis follicularis spinulosa decalvans" . . . "Haim-Munk syndrome" . . . "Isolated cloverleaf skull syndrome" . . . "Isolated Klippel-Feil syndrome" . . . "Familial partial lipodystrophy, Dunnigan type" . . . "Dubin-Johnson syndrome" . . . "Schilbach-Rott syndrome" . . . "Dubowitz syndrome" . . . "Lacrimoauriculodentodigital syndrome" . . . "Laurence-Moon syndrome" . . . "Laurin-Sandrow syndrome" . . . "Early-onset parkinsonism-intellectual disability syndrome" . . . "Legg-Calv\u00E9-Perthes disease" . . . "AApoAII amyloidosis" . . . "Lennox-Gastaut syndrome" . . . "Severe X-linked mitochondrial encephalomyopathy" . . . "15q11q13 microduplication syndrome" . . . "Infantile dystonia-parkinsonism" . . . "SLC35A1-CDG" . . . "Familial hypercholanemia" . . . "Combined immunodeficiency due to CD27 deficiency" . . . "Atypical hypotonia-cystinuria syndrome" . . . "Chuvash erythrocytosis" . . . "Immune dysregulation-inflammatory bowel disease-arthritis-recurrent infections syndrome" . . . "Familial clubfoot due to 17q23.1q23.2 microduplication" . . . "Beckwith-Wiedemann syndrome due to NSD1 mutation" . . . "NON RARE IN EUROPE: Alzheimer disease" . . . "Isolated thyrotropin-releasing hormone deficiency" . . . "Familial congenital mirror movements" . . . "Glaucoma secondary to spherophakia/ectopia lentis and megalocornea" . . . "1q44 microdeletion syndrome" . . . "Leukonychia totalis" . . . "Choreoacanthocytosis" . . . "Pyruvate dehydrogenase E3 deficiency" . . . "Encephalocraniocutaneous lipomatosis" . . . "Multiple symmetric lipomatosis" . . . "Dyggve-Melchior-Clausen disease" . . . "Argininosuccinic aciduria" . . . "Classic progressive supranuclear palsy syndrome" . . . "Progressive supranuclear palsy-parkinsonism syndrome" . . . "Progressive supranuclear palsy-pure akinesia with gait freezing syndrome" . . . "Progressive supranuclear palsy-corticobasal syndrome" . . . "Progressive supranuclear palsy-progressive non-fluent aphasia syndrome" . . . "Nijmegen breakage syndrome-like disorder" . . . "Laryngo-onycho-cutaneous syndrome" . . . "L\u00E9ri-Weill dyschondrosteosis" . . . "Dyschromatosis universalis hereditaria" . . . "46,XY complete gonadal dysgenesis" . . . "Dimethylglycine dehydrogenase deficiency" . . . "Acute fatty liver of pregnancy" . . . "NON RARE IN EUROPE: Diabetes mellitus type 1" . . . "NON RARE IN EUROPE: Essential hypertension" . . . "Hand-foot-genital syndrome" . . . "46,XX gonadal dysgenesis" . . . "Isolated split hand-split foot malformation" . . . "HELLP syndrome" . . . "De novo thrombotic microangiopathy after kidney transplantation" . . . "Biliary atresia with splenic malformation syndrome" . . . "Dominant hypophosphatemia with nephrolithiasis or osteoporosis" . . . "RFT1-CDG" . . . "Primary ciliary dyskinesia" . . . "Mucocutaneous venous malformations" . . . "Mandibuloacral dysplasia" . . . "Nager syndrome" . . . "Van den Ende-Gupta syndrome" . . . "Marden-Walker syndrome" . . . "Shprintzen-Goldberg syndrome" . . . "MASA syndrome" . . . "Postaxial acrofacial dysostosis" . . . "Matthew-Wood syndrome" . . . "Progressive cerebello-cerebral atrophy" . . . "Hyperphosphatasia-intellectual disability syndrome" . . . "Generalized pustular psoriasis" . . . "McKusick-Kaufman syndrome" . . . "Autosomal dominant secondary polycythemia" . . . "Primary ciliary dyskinesia-retinitis pigmentosa syndrome" . . . "Acute neonatal citrullinemia type I" . . . "Adult-onset citrullinemia type I" . . . "Citrullinemia type II" . . . "Neonatal intrahepatic cholestasis due to citrin deficiency" . . . "Juvenile primary lateral sclerosis" . . . "Perinatal lethal hypophosphatasia" . . . "Prenatal benign hypophosphatasia" . . . "Infantile hypophosphatasia" . . . "Childhood-onset hypophosphatasia" . . . "Adult hypophosphatasia" . . . "Odontohypophosphatasia" . . . "Retinal vasculopathy with cerebral leukoencephalopathy and systemic manifestations" . . . "Multiple endocrine neoplasia type 2A" . . . "Multiple endocrine neoplasia type 2B" . . . "M\u00FCllerian aplasia and hyperandrogenism" . . . "FTH1-related iron overload" . . . "Juvenile cataract-microcornea-renal glucosuria syndrome" . . . "MUTYH-related attenuated familial adenomatous polyposis" . . . "APC-related attenuated familial adenomatous polyposis" . . . "Autosomal recessive ataxia due to PEX10 deficiency" . . . "Ectodermal dysplasia-syndactyly syndrome" . . . "Occult macular dystrophy" . . . "NLRP12-associated hereditary periodic fever syndrome" . . . "Megalencephalic leukoencephalopathy with subcortical cysts" . . . "Juvenile Huntington disease" . . . "Isolated delta-storage pool disease" . . . "Familial hypodysfibrinogenemia" . . . "Melnick-Needles syndrome" . . . "Autosomal recessive hypohidrotic ectodermal dysplasia" . . . "Meningioma" . . . "Syndactyly type 8" . . . "Metachondromatosis" . . . "Fumaric aciduria" . . . "Acrogeria" . . . "Metaphyseal chondrodysplasia, Spahr type" . . . "Metaphyseal dysplasia-maxillary hypoplasia-brachydacty syndrome" . . . "Multiple benign circumferential skin creases on limbs" . . . "Corpus callosum agenesis-abnormal genitalia syndrome" . . . "Isolated aniridia" . . . "Polymicrogyria with optic nerve hypoplasia" . . . "AICA-ribosiduria" . . . "Autosomal recessive Stickler syndrome" . . . "2q32q33 microdeletion syndrome" . . . "SATB2-associated syndrome due to a chromosomal rearrangement" . . . "6q25 microdeletion syndrome" . . . "7q31 microdeletion syndrome" . . . "8p11.2 deletion syndrome" . . . "8p23.1 microdeletion syndrome" . . . "Micro syndrome" . . . "Familial osteochondritis dissecans" . . . "Familial hyperaldosteronism type III" . . . "Microphthalmia-retinitis pigmentosa-foveoschisis-optic disc drusen syndrome" . . . "Autosomal dominant spastic ataxia type 1" . . . "Parietal foramina with clavicular hypoplasia" . . . "Pigmented paravenous retinochoroidal atrophy" . . . "Autosomal recessive primary microcephaly" . . . "Ataxia-telangiectasia-like disorder" . . . "Sickle cell-beta-thalassemia disease syndrome" . . . "Sickle cell-hemoglobin C disease syndrome" . . . "Sickle cell-hemoglobin D disease syndrome" . . . "Sickle cell-hemoglobin E disease syndrome" . . . "Hereditary persistence of fetal hemoglobin-sickle cell disease syndrome" . . . "CK syndrome" . . . "Localized junctional epidermolysis bullosa" . . . "Autosomal dominant primary microcephaly" . . . "46,XY partial gonadal dysgenesis" . . . "Hyperzincemia and hypercalprotectinemia" . . . "Gliosarcoma" . . . "Giant cell glioblastoma" . . . "Anaplastic astrocytoma" . . . "Protoplasmic astrocytoma" . . . "Fibrillary astrocytoma" . . . "Gemistocytic astrocytoma" . . . "Pilomyxoid astrocytoma" . . . "Oligodendroglioma" . . . "Anaplastic oligodendroglioma" . . . "Ependymoma" . . . "Oligoastrocytoma" . . . "Anaplastic oligoastrocytoma" . . . "Angiocentric glioma" . . . "Medulloblastoma with extensive nodularity" . . . "Desmoplastic/nodular medulloblastoma" . . . "Choroid plexus carcinoma" . . . "Autosomal recessive chorioretinopathy-microcephaly syndrome" . . . "Constitutional mismatch repair deficiency syndrome" . . . "Melanoma and neural system tumor syndrome" . . . "Pontocerebellar hypoplasia type 2" . . . "Microcephaly-lymphedema-chorioretinopathy syndrome" . . . "Isolated microphthalmia-anophthalmia-coloboma" . . . "Autosomal recessive intermediate Charcot-Marie-Tooth disease type B" . . . "Autosomal recessive spastic ataxia-optic atrophy-dysarthria syndrome" . . . "Plectin-related limb-girdle muscular dystrophy R17" . . . "Temple syndrome due to paternal 14q32.2 microdeletion" . . . "Kagami-Ogata syndrome due to maternal 14q32.2 microdeletion" . . . "Temple syndrome due to paternal 14q32.2 hypomethylation" . . . "Kagami-Ogata syndrome due to maternal 14q32.2 hypermethylation" . . . "Complete hydatidiform mole" . . . "Partial hydatidiform mole" . . . "Genetic hyperferritinemia without iron overload" . . . "Lethal infantile mitochondrial myopathy" . . . "Mitochondrial myopathy with reversible cytochrome C oxidase deficiency" . . . "Mitochondrial DNA depletion syndrome, myopathic form" . . . "Spinocerebellar ataxia with epilepsy" . . . "Autosomal recessive progressive external ophthalmoplegia" . . . "Autosomal dominant progressive external ophthalmoplegia" . . . "Deafness-encephaloneuropathy-obesity-valvulopathy syndrome" . . . "Renal tubulopathy-encephalopathy-liver failure syndrome" . . . "Isolated cytochrome C oxidase deficiency" . . . "Isolated ATP synthase deficiency" . . . "Combined oxidative phosphorylation defect type 2" . . . "Combined oxidative phosphorylation defect type 4" . . . "Combined oxidative phosphorylation defect type 7" . . . "Adult-onset autosomal recessive sideroblastic anemia" . . . "Pyruvate dehydrogenase E1-beta deficiency" . . . "Pyruvate dehydrogenase E3-binding protein deficiency" . . . "Mitochondrial DNA-associated Leigh syndrome" . . . "Navajo neurohepatopathy" . . . "Mitochondrial DNA depletion syndrome, encephalomyopathic form with renal tubulopathy" . . . "Leigh syndrome with leukodystrophy" . . . "Leigh syndrome with nephrotic syndrome" . . . "Ear-patella-short stature syndrome" . . . "Microphthalmia with linear skin defects syndrome" . . . "Early-onset generalized limb-onset dystonia" . . . "Lethal intrauterine growth restriction-cortical malformation-congenital contractures syndrome" . . . "Moyamoya disease" . . . "Mulibrey nanism" . . . "Epidermolysis bullosa simplex with muscular dystrophy" . . . "Classic mycosis fungoides" . . . "Ataxia-pancytopenia syndrome" . . . "Myeloperoxidase deficiency" . . . "Myhre syndrome" . . . "Laminin subunit alpha 2-related congenital muscular dystrophy" . . . "Spinal muscular atrophy-progressive myoclonic epilepsy syndrome" . . . "Infantile myofibromatosis" . . . "Tubular aggregate myopathy" . . . "Myopathy and diabetes mellitus" . . . "X-linked myopathy with excessive autophagy" . . . "Mitochondrial myopathy and sideroblastic anemia" . . . "Glutaryl-CoA dehydrogenase deficiency" . . . "Autosomal recessive sideroblastic anemia" . . . "Familial visceral myopathy" . . . "Isolated complex I deficiency" . . . "Hereditary diffuse gastric cancer" . . . "FOXG1 syndrome due to 14q12 microdeletion" . . . "15q14 microdeletion syndrome" . . . "Proximal 16p11.2 microdeletion syndrome" . . . "Distal 16p11.2 microdeletion syndrome" . . . "14q11.2 microduplication syndrome" . . . "16q24.3 microdeletion syndrome" . . . "Distal 17p13.3 microdeletion syndrome" . . . "17q12 microdeletion syndrome" . . . "17q23.1q23.2 microdeletion syndrome" . . . "20p12.3 microdeletion syndrome" . . . "Linear nevus sebaceus syndrome" . . . "21q22.11q22.12 microdeletion syndrome" . . . "Distal 22q11.2 microdeletion syndrome" . . . "Nail-patella-like renal disease" . . . "Xq27.3q28 duplication syndrome" . . . "Nail-patella syndrome" . . . "Mowat-Wilson syndrome due to monosomy 2q22" . . . "Mowat-Wilson syndrome due to a ZEB2 point mutation" . . . "Familial adenomatous polyposis due to 5q22.2 microdeletion" . . . "Alagille syndrome due to 20p12 microdeletion" . . . "Alagille syndrome due to a JAG1 point mutation" . . . "Alagille syndrome due to a NOTCH2 point mutation" . . . "Okihiro syndrome due to 20q13 microdeletion" . . . "Okihiro syndrome due to a point mutation" . . . "Kleefstra syndrome due to a point mutation" . . . "3M syndrome" . . . "Geleophysic dysplasia" . . . "Glycogen storage disease with severe cardiomyopathy due to glycogenin deficiency" . . . "Langer mesomelic dysplasia" . . . "MRCS syndrome" . . . "Infantile spasms-psychomotor retardation-progressive brain atrophy-basal ganglia disease syndrome" . . . "Hyperinsulinism due to HNF4A deficiency" . . . "Hyperinsulinism due to INSR deficiency" . . . "CHST3-related skeletal dysplasia" . . . "Spondyloepiphyseal dysplasia, Maroteaux type" . . . "COG5-CDG" . . . "DPM3-CDG" . . . "COG4-CDG" . . . "COG1-CDG" . . . "Progressive myoclonic epilepsy type 3" . . . "Acute necrotizing encephalopathy of childhood" . . . "Acral peeling skin syndrome" . . . "Peeling skin syndrome type A" . . . "Peeling skin syndrome type B" . . . "Metatropic dysplasia" . . . "Familial multiple meningioma" . . . "Microcephalic osteodysplastic primordial dwarfism types I and III" . . . "Microcephalic osteodysplastic primordial dwarfism type II" . . . "Fibular aplasia-complex brachydactyly syndrome" . . . "Glycogen storage disease due to liver phosphorylase kinase deficiency" . . . "Osteoglosphonic dysplasia" . . . "Hereditary pulmonary alveolar proteinosis" . . . "Parastremmatic dwarfism" . . . "Lenz-Majewski hyperostotic dwarfism" . . . "Keipert syndrome" . . . "Congenital mesoblastic nephroma" . . . "Autosomal dominant limb-girdle muscular dystrophy type 1A" . . . "Pierson syndrome" . . . "Neu-Laxova syndrome" . . . "Short chain acyl-CoA dehydrogenase deficiency" . . . "Very long chain acyl-CoA dehydrogenase deficiency" . . . "Calpain-3-related limb-girdle muscular dystrophy R1" . . . "Hypomyelination neuropathy-arthrogryposis syndrome" . . . "RAS-associated autoimmune leukoproliferative disease" . . . "Spheroid body myopathy" . . . "Classic maple syrup urine disease" . . . "Intermediate maple syrup urine disease" . . . "Intermittent maple syrup urine disease" . . . "Thiamine-responsive maple syrup urine disease" . . . "DYRK1A-related intellectual disability syndrome due to 21q22.13q22.2 microdeletion" . . . "Total spina bifida aperta" . . . "Thoracolumbosacral spina bifida aperta" . . . "Lumbosacral spina bifida aperta" . . . "Cervical spina bifida aperta" . . . "Cervicothoracic spina bifida aperta" . . . "Cyclic neutropenia" . . . "Upper thoracic spina bifida aperta" . . . "Total spina bifida cystica" . . . "Thoracolumbosacral spina bifida cystica" . . . "Lumbosacral spina bifida cystica" . . . "Cervical spina bifida cystica" . . . "Cervicothoracic spina bifida cystica" . . . "Upper thoracic spina bifida cystica" . . . "Occipital encephalocele" . . . "Arnold-Chiari malformation type I" . . . "Isolated megalencephaly" . . . "Isolated focal cortical dysplasia type Ia" . . . "Dysferlin-related limb-girdle muscular dystrophy R2" . . . "Isolated focal cortical dysplasia type IIa" . . . "Isolated focal cortical dysplasia type IIb" . . . "Isolated Dandy-Walker malformation with hydrocephalus" . . . "Isolated Dandy-Walker malformation without hydrocephalus" . . . "Congenital communicating hydrocephalus" . . . "Congenital non-communicating hydrocephalus" . . . "Arthrogryposis-renal dysfunction-cholestasis syndrome" . . . "Knuckle pads-leukonychia-sensorineural deafness-palmoplantar hyperkeratosis syndrome" . . . "Facioscapulohumeral dystrophy" . . . "Noonan syndrome-like disorder with loose anagen hair" . . . "Ochoa syndrome" . . . "Oculocerebrofacial syndrome, Kaufman type" . . . "Oculopharyngeal muscular dystrophy" . . . "Oculodentodigital dysplasia" . . . "Oculofaciocardiodental syndrome" . . . "Oculotrichoanal syndrome" . . . "Odonto-onycho-dermal dysplasia" . . . "Eye defects-arachnodactyly-cardiopathy syndrome" . . . "Blepharophimosis-intellectual disability syndrome, Ohdo type" . . . "Congenital muscular dystrophy, Fukuyama type" . . . "Steinert myotonic dystrophy" . . . "Horizontal gaze palsy with progressive scoliosis" . . . "Opsismodysplasia" . . . "Bernard-Soulier syndrome" . . . "Orofaciodigital syndrome type 1" . . . "Orofaciodigital syndrome type 2" . . . "Orofaciodigital syndrome type 3" . . . "Orofaciodigital syndrome type 4" . . . "Orofaciodigital syndrome type 6" . . . "Autoimmune lymphoproliferative syndrome with recurrent viral infections" . . . "Myostatin-related muscle hypertrophy" . . . "Preeclampsia" . . . "Heritable pulmonary arterial hypertension" . . . "Drug- or toxin-induced pulmonary arterial hypertension" . . . "Pulmonary arterial hypertension associated with connective tissue disease" . . . "Behavioral variant of frontotemporal dementia" . . . "Frontotemporal dementia with motor neuron disease" . . . "Severe combined immunodeficiency due to DCLRE1C deficiency" . . . "Bile acid CoA ligase deficiency and defective amidation" . . . "Malignant epithelial tumor of salivary glands" . . . "Multiple endocrine neoplasia type 4" . . . "Spinocerebellar ataxia type 32" . . . "Spinocerebellar ataxia type 35" . . . "Spinocerebellar ataxia type 36" . . . "Mucopolysaccharidosis type 6, rapidly progressing" . . . "Mucopolysaccharidosis type 6, slowly progressing" . . . "Non-syndromic male infertility due to sperm motility disorder" . . . "Machado-Joseph disease type 1" . . . "Machado-Joseph disease type 2" . . . "Machado-Joseph disease type 3" . . . "NON RARE IN EUROPE: Familial dysalbuminemic hyperthyroxinemia" . . . "Hemihyperplasia-multiple lipomatosis syndrome" . . . "Progressive osseous heteroplasia" . . . "Familial multinodular goiter" . . . "Osteocraniostenosis" . . . "Hyperbiliverdinemia" . . . "Ogden syndrome" . . . "Lower motor neuron syndrome with late-adult onset" . . . "Hyperinsulinism due to UCP2 deficiency" . . . "Autosomal dominant hyperinsulinism due to SUR1 deficiency" . . . "Autosomal dominant hyperinsulinism due to Kir6.2 deficiency" . . . "Diazoxide-resistant focal hyperinsulinism due to SUR1 deficiency" . . . "Diazoxide-resistant focal hyperinsulinism due to Kir6.2 deficiency" . . . "Sporadic pheochromocytoma/secreting paraganglioma" . . . "Symptomatic form of Coffin-Lowry syndrome in female carriers" . . . "T-B+ severe combined immunodeficiency due to gamma chain deficiency" . . . "Nasu-Hakola disease" . . . "Bruck syndrome" . . . "Multicentric carpo-tarsal osteolysis with or without nephropathy" . . . "Severe combined immunodeficiency due to adenosine deaminase deficiency" . . . "Osteopathia striata-cranial sclerosis syndrome" . . . "Autosomal dominant osteopetrosis type 1" . . . "Osteopetrosis with renal tubular acidosis" . . . "Osteoporosis-pseudoglioma syndrome" . . . "Lateral meningocele syndrome" . . . "Endosteal hyperostosis, Worth type" . . . "Otodental syndrome" . . . "Otofaciocervical syndrome" . . . "Pachydermoperiostosis" . . . "Mitochondrial DNA depletion syndrome, hepatocerebral form due to DGUOK deficiency" . . . "Hereditary neutrophilia" . . . "NON RARE IN EUROPE: Age-related macular degeneration" . . . "ALG11-CDG" . . . "NON RARE IN EUROPE: Paget disease of bone" . . . "Complement component 3 deficiency" . . . "Severe combined immunodeficiency due to LCK deficiency" . . . "Methylmalonic aciduria due to transcobalamin receptor defect" . . . "Septopreoptic holoprosencephaly" . . . "Juvenile Paget disease" . . . "Microform holoprosencephaly" . . . "Pelizaeus-Merzbacher disease, connatal form" . . . "Pelizaeus-Merzbacher disease, classic form" . . . "Pelizaeus-Merzbacher disease, transitional form" . . . "Pelizaeus-Merzbacher disease in female carriers" . . . "Null syndrome" . . . "Pelizaeus-Merzbacher-like disease due to GJC2 mutation" . . . "Pelizaeus-Merzbacher-like disease due to HSPD1 mutation" . . . "Pelizaeus-Merzbacher-like disease due to AIMP1 mutation" . . . "X-linked sideroblastic anemia and spinocerebellar ataxia" . . . "Distal monosomy 12p" . . . "Alpha-dystroglycan-related limb-girdle muscular dystrophy R16" . . . "PLIN1-related familial partial lipodystrophy" . . . "Autosomal semi-dominant severe lipodystrophic laminopathy" . . . "Recessive intellectual disability-motor dysfunction-multiple joint contractures syndrome" . . . "Familial Alzheimer-like prion disease" . . . "Familial steroid-resistant nephrotic syndrome with sensorineural deafness" . . . "Fatal infantile hypertonic myofibrillar myopathy" . . . "Warsaw breakage syndrome" . . . "Nestor-Guillermo progeria syndrome" . . . "Chondrodysplasia with joint dislocations, gPAPP type" . . . "Hereditary sensorimotor neuropathy with hyperelastic skin" . . . "Partial pancreatic agenesis" . . . "Hemoglobinopathy Toms River" . . . "Progressive myoclonic epilepsy type 6" . . . "Familial progressive hyper- and hypopigmentation" . . . "Multiple congenital anomalies-hypotonia-seizures syndrome" . . . "Occipital pachygyria and polymicrogyria" . . . "Acrodysostosis with multiple hormone resistance" . . . "Autosomal recessive nail dysplasia" . . . "Hermansky-Pudlak syndrome type 9" . . . "Megaconial congenital muscular dystrophy" . . . "Moyamoya angiopathy-short stature-facial dysmorphism-hypergonadotropic hypogonadism syndrome" . . . "Severe intellectual disability and progressive spastic paraplegia" . . . "Bullous diffuse cutaneous mastocytosis" . . . "Pseudoxanthomatous diffuse cutaneous mastocytosis" . . . "Papilloma of choroid plexus" . . . "Wolf-Hirschhorn syndrome" . . . "Syndromic recessive X-linked ichthyosis" . . . "Self-improving collodion baby" . . . "Acral self-healing collodion baby" . . . "Annular epidermolytic ichthyosis" . . . "Congenital reticular ichthyosiform erythroderma" . . . "Keratosis linearis-ichthyosis congenita-sclerosing keratoderma syndrome" . . . "Monosomy 5p" . . . "Inherited Creutzfeldt-Jakob disease" . . . "Autosomal recessive spastic paraplegia type 11" . . . "Young-onset Parkinson disease" . . . "Stiff skin syndrome" . . . "Wrinkly skin syndrome" . . . "PEHO syndrome" . . . "Tyrosinemia type 2" . . . "NON RARE IN EUROPE: Rheumatoid arthritis" . . . "Larsen-like syndrome, B3GAT3 type" . . . "Craniosynostosis-dental anomalies" . . . "Facial dysmorphism-developmental delay-behavioral abnormalities syndrome due to 10p11.21p12.31 microdeletion" . . . "Familial benign chronic pemphigus" . . . "Autosomal dominant Charcot-Marie-Tooth disease type 2O" . . . "Familial retinal arterial macroaneurysm" . . . "Autosomal recessive cerebellar ataxia-psychomotor delay syndrome" . . . "Autosomal recessive cerebellar ataxia-epilepsy-intellectual disability syndrome due to WWOX deficiency" . . . "Adult-onset autosomal recessive cerebellar ataxia" . . . "Childhood-onset autosomal recessive slowly progressive spinocerebellar ataxia" . . . "Pontocerebellar hypoplasia type 7" . . . "Pleuropulmonary blastoma familial tumor susceptibility syndrome" . . . "Pentosuria" . . . "Glycerol kinase deficiency, juvenile form" . . . "Glycerol kinase deficiency, adult form" . . . "Phosphoserine aminotransferase deficiency, infantile/juvenile form" . . . "Glycogen storage disease due to lactate dehydrogenase M-subunit deficiency" . . . "Glycogen storage disease due to lactate dehydrogenase H-subunit deficiency" . . . "Ocular albinism" . . . "Camptodactyly-arthropathy-coxa-vara-pericarditis syndrome" . . . "Marfan syndrome type 1" . . . "Marfan syndrome type 2" . . . "Neonatal Marfan syndrome" . . . "Aneurysm-osteoarthritis syndrome" . . . "Perlman syndrome" . . . "Alopecia-intellectual disability syndrome" . . . "Fuhrmann syndrome" . . . "Perrault syndrome" . . . "Persistent M\u00FCllerian duct syndrome" . . . "Peutz-Jeghers syndrome" . . . "Vascular Ehlers-Danlos syndrome" . . . "Phakomatosis pigmentokeratotica" . . . "Phocomelia, Schinzel type" . . . "Classical Ehlers-Danlos syndrome" . . . "Phosphoenolpyruvate carboxykinase deficiency" . . . "Sitosterolemia" . . . "Piebaldism" . . . "TARP syndrome" . . . "Hereditary elliptocytosis" . . . "Hypocalcemic vitamin D-dependent rickets" . . . "Autosomal recessive hypophosphatemic rickets" . . . "Early-onset epileptic encephalopathy and intellectual disability due to GRIN2A mutation" . . . "Hypermethioninemia encephalopathy due to adenosine kinase deficiency" . . . "Developmental delay due to methylmalonate semialdehyde dehydrogenase deficiency" . . . "Familial vesicoureteral reflux" . . . "Early-onset myopathy with fatal cardiomyopathy" . . . "Myosclerosis" . . . "Isolated congenital adermatoglyphia" . . . "Congenital cataract microcornea with corneal opacity" . . . "Combined malonic and methylmalonic acidemia" . . . "12q15q21.1 microdeletion syndrome" . . . "BAP1-related tumor predisposition syndrome" . . . "Inherited isolated adrenal insufficiency due to partial CYP11A1 deficiency" . . . "Mitochondrial membrane protein-associated neurodegeneration" . . . "Exfoliative ichthyosis" . . . "Hereditary arterial and articular multiple calcification syndrome" . . . "Pitt-Hopkins syndrome" . . . "Pityriasis rubra pilaris" . . . "Glutathione synthetase deficiency with 5-oxoprolinuria" . . . "Glutathione synthetase deficiency without 5-oxoprolinuria" . . . "Neonatal glycine encephalopathy" . . . "Infantile glycine encephalopathy" . . . "Atypical glycine encephalopathy" . . . "Hypermethioninemia due to glycine N-methyltransferase deficiency" . . . "Vitamin B12-unresponsive methylmalonic acidemia type mut0" . . . "Brachyolmia-amelogenesis imperfecta syndrome" . . . "Ellis Van Creveld syndrome" . . . "Neuralgic amyotrophy" . . . "Familial spontaneous pneumothorax" . . . "Hereditary pheochromocytoma-paraganglioma" . . . "Multiple myeloma" . . . "Kindler epidermolysis bullosa" . . . "Orofaciodigital syndrome type 5" . . . "Isolated polycystic liver disease" . . . "Familial clubfoot due to 5q31 microdeletion" . . . "Familial clubfoot due to PITX1 point mutation" . . . "Skin fragility-woolly hair-palmoplantar keratoderma syndrome" . . . "Infantile-onset ascending hereditary spastic paralysis" . . . "Malignant migrating focal seizures of infancy" . . . "Tetrahydrobiopterin-responsive hyperphenylalaninemia/phenylketonuria" . . . "Epithelial recurrent erosion dystrophy" . . . "Congenital hereditary endothelial dystrophy type II" . . . "PYCR1-related De Barsy syndrome" . . . "Blepharophimosis-intellectual disability syndrome, MKB type" . . . "MITF-related melanoma and renal cell carcinoma predisposition syndrome" . . . "Congenital dyserythropoietic anemia type IV" . . . "3MC syndrome" . . . "Hypoplastic pancreas-intestinal atresia-hypoplastic gallbladder syndrome" . . . "Familial isolated arrhythmogenic ventricular dysplasia, left dominant form" . . . "Familial isolated arrhythmogenic ventricular dysplasia, biventricular form" . . . "Familial isolated arrhythmogenic ventricular dysplasia, right dominant form" . . . "Lethal occipital encephalocele-skeletal dysplasia syndrome" . . . "EDICT syndrome" . . . "1p21.3 microdeletion syndrome" . . . "Childhood encephalopathy due to thiamine pyrophosphokinase deficiency" . . . "Hypoinsulinemic hypoglycemia and body hemihypertrophy" . . . "Deficiency in anterior pituitary function-variable immunodeficiency syndrome" . . . "Microcephaly-capillary malformation syndrome" . . . "Neonatal inflammatory skin and bowel disease" . . . "Renal-hepatic-pancreatic dysplasia" . . . "Triphalangeal thumb-polysyndactyly syndrome" . . . "Zygodactyly type 3" . . . "Synpolydactyly type 1" . . . "Synpolydactyly type 2" . . . "Congenital vertical talus, unilateral" . . . "Congenital vertical talus, bilateral" . . . "Macrodactyly of fingers, unilateral" . . . "Macrodactyly of toes, unilateral" . . . "Musculocontractural Ehlers-Danlos syndrome" . . . "Guttmacher syndrome" . . . "Progeroid syndrome, Petty type" . . . "Prolactinoma" . . . "Properdin deficiency" . . . "Proteus-like syndrome" . . . "Ollier disease" . . . "Prune belly syndrome" . . . "Peroxisomal acyl-CoA oxidase deficiency" . . . "Mitochondrial neurogastrointestinal encephalomyopathy" . . . "Autosomal recessive multiple pterygium syndrome" . . . "Baraitser-Winter cerebrofrontofacial syndrome" . . . "Mevalonic aciduria" . . . "Familial male-limited precocious puberty" . . . "Kyphoscoliotic Ehlers-Danlos syndrome due to FKBP22 deficiency" . . . "Connective tissue disorder due to lysyl hydroxylase-3 deficiency" . . . "Transient infantile hypertriglyceridemia and hepatosteatosis" . . . "Severe congenital hypochromic anemia with ringed sideroblasts" . . . "Immune thrombocytopenia" . . . "Congenital cataract-hearing loss-severe developmental delay syndrome" . . . "Charcot-Marie-Tooth disease type 2P" . . . "Persistent polyclonal B-cell lymphocytosis" . . . "Nephrotic syndrome-epidermolysis bullosa-sensorineural deafness syndrome" . . . "Autosomal systemic lupus erythematosus" . . . "PLCG2-associated antibody deficiency and immune dysregulation" . . . "Progeroid and marfanoid aspect-lipodystrophy syndrome" . . . "Multiple congenital anomalies-hypotonia-seizures syndrome type 2" . . . "Pseudohypoaldosteronism type 2D" . . . "Pseudohypoaldosteronism type 2E" . . . "DDOST-CDG" . . . "Autosomal recessive infantile hypercalcemia" . . . "Cortical dysgenesis with pontocerebellar hypoplasia due to TUBB3 mutation" . . . "Polymicrogyria due to TUBB2B mutation" . . . "Oligodontia-cancer predisposition syndrome" . . . "Pyle disease" . . . "Juvenile amyotrophic lateral sclerosis" . . . "Pyridoxine-dependent epilepsy" . . . "Familial dilated cardiomyopathy with conduction defect due to LMNA mutation" . . . "Primary cutaneous anaplastic large cell lymphoma" . . . "Hairy cell leukemia variant" . . . "ALK-positive anaplastic large cell lymphoma" . . . "Bifunctional enzyme deficiency" . . . "Ramon syndrome" . . . "RAPADILINO syndrome" . . . "Caudal regression sequence" . . . "Epidermodysplasia verruciformis" . . . "NPHP3-related Meckel-like syndrome" . . . "Intellectual disability-cataracts-calcified pinnae-myopathy syndrome" . . . "Blepharophimosis-intellectual disability syndrome, SBBYS type" . . . "Nicolaides-Baraitser syndrome" . . . "Monoamine oxidase A deficiency" . . . "X-linked intellectual disability, Snyder type" . . . "Interstitial lung disease-nephrotic syndrome-epidermolysis bullosa syndrome" . . . "Autosomal recessive spastic paraplegia type 48" . . . "Congenital hereditary facial paralysis-variable hearing loss syndrome" . . . "Frontonasal dysplasia-severe microphthalmia-severe facial clefting syndrome" . . . "Porencephaly-microcephaly-bilateral congenital cataract syndrome" . . . "FADD-related immunodeficiency" . . . "Primary microcephaly-epilepsy-permanent neonatal diabetes syndrome" . . . "Sodium channelopathy-related small fiber neuropathy" . . . "X-linked complicated spastic paraplegia type 1" . . . "Familial normophosphatemic tumoral calcinosis" . . . "Familial hyperphosphatemic tumoral calcinosis/Hyperphosphatemic hyperostosis syndrome" . . . "Kufor-Rakeb syndrome" . . . "Primary dystonia, DYT21 type" . . . "Benign familial infantile epilepsy" . . . "Costello syndrome" . . . "X-linked intellectual disability-psychosis-macroorchidism syndrome" . . . "Juvenile myoclonic epilepsy" . . . "Methylcobalamin deficiency type cblDv1" . . . "Sulfite oxidase deficiency due to molybdenum cofactor deficiency type A" . . . "Sulfite oxidase deficiency due to molybdenum cofactor deficiency type B" . . . "Sulfite oxidase deficiency due to molybdenum cofactor deficiency type C" . . . "Autism-epilepsy syndrome due to branched chain ketoacid dehydrogenase kinase deficiency" . . . "Methylmalonic acidemia due to methylmalonyl-CoA epimerase deficiency" . . . "Vitamin B12-responsive methylmalonic acidemia, type cblDv2" . . . "Erythrocyte galactose epimerase deficiency" . . . "Generalized galactose epimerase deficiency" . . . "Glycogen storage disease due to acid maltase deficiency, infantile onset" . . . "Glycogen storage disease due to glycogen branching enzyme deficiency, progressive hepatic form" . . . "Glycogen storage disease due to glycogen branching enzyme deficiency, non progressive hepatic form" . . . "Glycogen storage disease due to glycogen branching enzyme deficiency, fatal perinatal neuromuscular form" . . . "Glycogen storage disease due to glycogen branching enzyme deficiency, congenital neuromuscular form" . . . "Glycogen storage disease due to glycogen branching enzyme deficiency, childhood combined hepatic and myopathic form" . . . "Glycogen storage disease due to glycogen branching enzyme deficiency, childhood neuromuscular form" . . . "Autosomal dominant vitreoretinochoroidopathy" . . . "Glycogen storage disease due to glycogen branching enzyme deficiency, adult neuromuscular form" . . . "Revesz syndrome" . . . "Progressive myoclonic epilepsy type 1" . . . "Familial lipoprotein lipase deficiency" . . . "Familial apolipoprotein C-II deficiency" . . . "Sandhoff disease, infantile form" . . . "Sandhoff disease, juvenile form" . . . "Sandhoff disease, adult form" . . . "Tay-Sachs disease, B variant, infantile form" . . . "Tay-Sachs disease, B variant, juvenile form" . . . "Tay-Sachs disease, B variant, adult form" . . . "Tay-Sachs disease, B1 variant" . . . "GM2 gangliosidosis, AB variant" . . . "Primary hypomagnesemia with secondary hypocalcemia" . . . "Atypical Gaucher disease due to saposin C deficiency" . . . "Metachromatic leukodystrophy, late infantile form" . . . "Hereditary central diabetes insipidus" . . . "Metachromatic leukodystrophy, juvenile form" . . . "Metachromatic leukodystrophy, adult form" . . . "Alpha-mannosidosis, infantile form" . . . "Alpha-mannosidosis, adult form" . . . "Mucopolysaccharidosis type 4A" . . . "Mucopolysaccharidosis type 4B" . . . "Free sialic acid storage disease, infantile form" . . . "Intermediate severe Salla disease" . . . "Salla disease" . . . "Atypical Rett syndrome" . . . "Rhizomelic chondrodysplasia punctata type 1" . . . "Rhizomelic chondrodysplasia punctata type 2" . . . "Meacham syndrome" . . . "Rhizomelic chondrodysplasia punctata type 3" . . . "Cirrhosis-dystonia-polycythemia-hypermanganesemia syndrome" . . . "Hereditary orotic aciduria" . . . "Richieri Costa-Pereira syndrome" . . . "Roberts syndrome" . . . "Familial primary hypomagnesemia with hypercalciuria and nephrocalcinosis without severe ocular involvement" . . . "Autosomal dominant Robinow syndrome" . . . "Dermatofibrosarcoma protuberans" . . . "Rotor syndrome" . . . "Tangier disease" . . . "Roussy-L\u00E9vy syndrome" . . . "Saccharopinuria" . . . "Sarcosinemia" . . . "Autosomal dominant epidermolytic ichthyosis" . . . "Early-onset spastic ataxia-myoclonic epilepsy-neuropathy syndrome" . . . "Jawad syndrome" . . . "Hereditary diffuse leukoencephalopathy with axonal spheroids and pigmented glia" . . . "Coats plus syndrome" . . . "Familial cutaneous telangiectasia and oropharyngeal cancer predisposition syndrome" . . . "Infantile cerebellar-retinal degeneration" . . . "FGFR2-related bent bone dysplasia" . . . "12p12.1 microdeletion syndrome" . . . "Developmental and speech delay due to SOX5 deficiency" . . . "Ulnar-mammary syndrome" . . . "Lamellar ichthyosis" . . . "Gastric adenocarcinoma and proximal polyposis of the stomach" . . . "High bone mass osteogenesis imperfecta" . . . "Leukoencephalopathy-thalamus and brainstem anomalies-high lactate syndrome" . . . "Chronic infantile diarrhea due to guanylate cyclase 2C overactivity" . . . "Intestinal obstruction in the newborn due to guanylate cyclase 2C deficiency" . . . "Hereditary sensory and autonomic neuropathy type 6" . . . "Short stature-onychodysplasia-facial dysmorphism-hypotrichosis syndrome" . . . "Autosomal dominant aplasia and myelodysplasia" . . . "Autosomal dominant cerebellar ataxia-deafness-narcolepsy syndrome" . . . "Young adult-onset distal hereditary motor neuropathy" . . . "Schneckenbecken dysplasia" . . . "Craniofacial dysplasia-osteopenia syndrome" . . . "Chudley-McCullough syndrome" . . . "Autosomal recessive spastic ataxia with leukoencephalopathy" . . . "CLN11 disease" . . . "ATP13A2-related juvenile neuronal ceroid lipofuscinosis" . . . "Mitochondrial hypertrophic cardiomyopathy with lactic acidosis due to MTO1 deficiency" . . . "Non-progressive cerebellar ataxia with intellectual disability" . . . "Variant ABeta2M amyloidosis" . . . "Severe neonatal hypotonia-seizures-encephalopathy syndrome due to 5q31.3 microdeletion" . . . "Segmental progressive overgrowth syndrome with fibroadipose hyperplasia" . . . "TMEM165-CDG" . . . "Cerebrofacioarticular syndrome" . . . "Combined immunodeficiency due to STK4 deficiency" . . . "Lethal arteriopathy syndrome due to fibulin-4 deficiency" . . . "Atypical dentin dysplasia due to SMOC2 deficiency" . . . "Familial isolated pituitary adenoma" . . . "Silent pituitary adenoma" . . . "Null pituitary adenoma" . . . "SHOX-related short stature" . . . "Short stature due to partial GHR deficiency" . . . "Short stature due to GHSR deficiency" . . . "Malignant peripheral nerve sheath tumor" . . . "Severe Canavan disease" . . . "Mild Canavan disease" . . . "Primary hypereosinophilic syndrome" . . . "X-linked non progressive cerebellar ataxia" . . . "Sclerosteosis" . . . "Classic congenital adrenal hyperplasia due to 21-hydroxylase deficiency, salt wasting form" . . . "Classic congenital adrenal hyperplasia due to 21-hydroxylase deficiency, simple virilizing form" . . . "Senior-Loken syndrome" . . . "Septo-optic dysplasia spectrum" . . . "S\u00E9zary syndrome" . . . "SHORT syndrome" . . . "Sialuria" . . . "Progressive symmetric erythrokeratodermia" . . . "Infantile convulsions and choreoathetosis" . . . "Severe combined immunodeficiency due to DNA-PKcs deficiency" . . . "Combined immunodeficiency due to ORAI1 deficiency" . . . "Combined immunodeficiency due to STIM1 deficiency" . . . "Pancytopenia due to IKZF1 mutations" . . . "X-linked immunodeficiency with magnesium defect, Epstein-Barr virus infection and neoplasia" . . . "X-linked spasticity-intellectual disability-epilepsy syndrome" . . . "Erythrokeratodermia variabilis" . . . "Pulmonary venoocclusive disease" . . . "Congenital myopathy with internal nuclei and atypical cores" . . . "Wiedemann-Steiner syndrome" . . . "Familial cortical myoclonus" . . . "Diencephalic-mesencephalic junction dysplasia" . . . "Autosomal recessive spastic paraplegia type 53" . . . "Clear cell renal carcinoma" . . . "Papillary renal cell carcinoma" . . . "Chromophobe renal cell carcinoma" . . . "MiT family translocation renal cell carcinoma" . . . "Autosomal recessive myogenic arthrogryposis multiplex congenita" . . . "Carney complex-trismus-pseudocamptodactyly syndrome" . . . "Supravalvular aortic stenosis" . . . "Inherited cancer-predisposing syndrome due to biallelic BRCA2 mutations" . . . "Inherited acute myeloid leukemia" . . . "Acute myeloid leukemia with CEBPA somatic mutations" . . . "Familial papillary or follicular thyroid carcinoma" . . . "Combined oxidative phosphorylation defect type 8" . . . "Combined oxidative phosphorylation defect type 9" . . . "Combined oxidative phosphorylation defect type 13" . . . "Combined oxidative phosphorylation defect type 14" . . . "Combined oxidative phosphorylation defect type 15" . . . "Mendelian susceptibility to mycobacterial diseases due to complete IFNgammaR2 deficiency" . . . "Mendelian susceptibility to mycobacterial diseases due to complete IL12RB1 deficiency" . . . "Mendelian susceptibility to mycobacterial diseases due to complete IL12B deficiency" . . . "Mendelian susceptibility to mycobacterial diseases due to complete ISG15 deficiency" . . . "Autosomal recessive mendelian susceptibility to mycobacterial diseases due to partial IFNgammaR1 deficiency" . . . "Autosomal recessive mendelian susceptibility to mycobacterial diseases due to partial IFNgammaR2 deficiency" . . . "Autosomal dominant mendelian susceptibility to mycobacterial diseases due to partial IFNgammaR1 deficiency" . . . "Autosomal dominant mendelian susceptibility to mycobacterial diseases due to partial IFNgammaR2 deficiency" . . . "Mendelian susceptibility to mycobacterial diseases due to partial STAT1 deficiency" . . . "Mendelian susceptibility to mycobacterial diseases due to partial IRF8 deficiency" . . . "X-linked mendelian susceptibility to mycobacterial diseases due to IKBKG deficiency" . . . "X-linked mendelian susceptibility to mycobacterial diseases due to CYBB deficiency" . . . "Amyloidosis cutis dyschromia" . . . "Retinal macular dystrophy type 2" . . . "PGM1-CDG" . . . "Constitutional megaloblastic anemia with severe neurologic disease" . . . "Alazami syndrome" . . . "Microcephalic primordial dwarfism, Dauber type" . . . "Encephalopathy-hypertrophic cardiomyopathy-renal tubular disease syndrome" . . . "NON RARE IN EUROPE: Lactase non-persistence in adulthood" . . . "NON RARE IN EUROPE: Partial color blindness, protan type" . . . "NON RARE IN EUROPE: Partial color blindness, deutan type" . . . "NON RARE IN EUROPE: Parkinson disease" . . . "Hereditary hyperekplexia" . . . "Skeletal Ewing sarcoma" . . . "Oxoglutaric aciduria" . . . "Dehydrated hereditary stomatocytosis" . . . "Autosomal dominant spastic paraplegia type 41" . . . "MT-ATP6-related mitochondrial spastic paraplegia" . . . "Autosomal dominant spastic paraplegia type 36" . . . "Autosomal recessive spastic paraplegia type 43" . . . "Autosomal recessive spastic paraplegia type 55" . . . "Autosomal recessive spastic paraplegia type 54" . . . "Hereditary sensory and autonomic neuropathy due to TECPR2 mutation" . . . "Autosomal recessive spastic paraplegia type 46" . . . "Autosomal recessive spastic paraplegia type 45" . . . "Overhydrated hereditary stomatocytosis" . . . "Autosomal recessive spastic paraplegia type 44" . . . "Spastic paraplegia-optic atrophy-neuropathy syndrome" . . . "Autosomal recessive spastic paraplegia type 56" . . . "Stormorken-Sjaastad-Langslet syndrome" . . . "Sturge-Weber syndrome" . . . "St\u00FCve-Wiedemann syndrome" . . . "Isolated succinate-CoQ reductase deficiency" . . . "Apparent mineralocorticoid excess" . . . "Multiple osteochondromas" . . . "Deafness-enamel hypoplasia-nail defects syndrome" . . . "Deafness-lymphedema-leukemia syndrome" . . . "Multiple synostoses syndrome" . . . "Cardiospondylocarpofacial syndrome" . . . "NON RARE IN EUROPE: FG syndrome phenotypic spectrum" . . . "Autosomal recessive congenital cerebellar ataxia due to MGLUR1 deficiency" . . . "Early-onset Lafora body disease" . . . "T-cell immunodeficiency with epidermodysplasia verruciformis" . . . "Multiple paragangliomas associated with polycythemia" . . . "Sinoatrial node dysfunction and deafness" . . . "Sweet syndrome" . . . "X-linked intellectual disability-cardiomegaly-congestive heart failure syndrome" . . . "ALG13-CDG" . . . "Autosomal recessive axonal neuropathy with neuromyotonia" . . . "Hypertrophic cardiomyopathy and renal tubular disease due to mitochondrial DNA mutation" . . . "Autoinflammation-PLCG2-associated antibody deficiency-immune dysregulation" . . . "Combined oxidative phosphorylation defect type 11" . . . "Hypopigmentation-punctate palmoplantar keratoderma syndrome" . . . "Pontocerebellar hypoplasia type 8" . . . "Hyperinsulinism due to HNF1A deficiency" . . . "Benign Samaritan congenital myopathy" . . . "Autosomal dominant intermediate Charcot-Marie-Tooth disease with neuropathic pain" . . . "Familial dyskinesia and facial myokymia" . . . "X-linked cleft palate and ankyloglossia" . . . "Classic multiminicore myopathy" . . . "Autosomal dominant Charcot-Marie-Tooth disease type 2 due to KIF5A mutation" . . . "ABetaL34V amyloidosis" . . . "ABeta amyloidosis, Iowa type" . . . "ABeta amyloidosis, Italian type" . . . "ABetaA21G amyloidosis" . . . "ABeta amyloidosis, Arctic type" . . . "SRD5A3-CDG" . . . "Proteasome-associated autoinflammatory syndrome" . . . "Fabry disease" . . . "Proximal symphalangism" . . . "Cleft lip/palate-ectodermal dysplasia syndrome" . . . "Leydig cell hypoplasia due to LHB deficiency" . . . "Classic congenital lipoid adrenal hyperplasia due to STAR deficency" . . . "Non-classic congenital lipoid adrenal hyperplasia due to STAR deficency" . . . "Filippi syndrome" . . . "Cenani-Lenz syndrome" . . . "Congenital factor II deficiency" . . . "Autoimmune lymphoproliferative syndrome" . . . "Familial lambdoid synostosis" . . . "Congenital radioulnar synostosis" . . . "Congenital factor V deficiency" . . . "Synovial sarcoma" . . . "Spondylocarpotarsal synostosis" . . . "Congenital factor VII deficiency" . . . "Catecholaminergic polymorphic ventricular tachycardia" . . . "Takayasu arteritis" . . . "Congenital factor X deficiency" . . . "Autoinflammatory syndrome with pyogenic bacterial infection and amylopectinosis" . . . "Congenital muscular dystrophy with intellectual disability and severe epilepsy" . . . "Tall stature-scoliosis-macrodactyly of the great toes syndrome" . . . "Developmental delay with autism spectrum disorder and gait instability" . . . "Autosomal dominant neovascular inflammatory vitreoretinopathy" . . . "Cerebral sinovenous thrombosis" . . . "Intellectual disability-craniofacial dysmorphism-cryptorchidism syndrome" . . . "Microcephalic primordial dwarfism due to ZNF335 deficiency" . . . "X-linked central congenital hypothyroidism with late-onset testicular enlargement" . . . "Congenital chronic diarrhea with protein-losing enteropathy" . . . "Severe early-onset obesity-insulin resistance syndrome due to SH2B1 deficiency" . . . "Autosomal dominant Charcot-Marie-Tooth disease type 2Q" . . . "Beta-propeller protein-associated neurodegeneration" . . . "Fatty acid hydroxylase-associated neurodegeneration" . . . "Adult-onset multiple mitochondrial DNA deletion syndrome due to DGUOK deficiency" . . . "Thrombocythemia with distal limb defects" . . . "Adult-onset chronic progressive external ophthalmoplegia with mitochondrial myopathy" . . . "Distal arthrogryposis type 5D" . . . "Autosomal dominant focal dystonia, DYT25 type" . . . "Acute megakaryoblastic leukemia without Down syndrome" . . . "Spastic paraplegia-Paget disease of bone syndrome" . . . "Adult-onset distal myopathy due to VCP mutation" . . . "Lipoprotein glomerulopathy" . . . "Tumor necrosis factor receptor 1 associated periodic syndrome" . . . "5p13 microduplication syndrome" . . . "Immunoglobulin-mediated membranoproliferative glomerulonephritis" . . . "C3 glomerulopathy" . . . "C3 glomerulonephritis" . . . "Intermittent hydrarthrosis" . . . "Generalized juvenile polyposis/juvenile polyposis coli" . . . "Congenital factor XI deficiency" . . . "Lymphedema-distichiasis syndrome" . . . "Hemoglobin Lepore-beta-thalassemia syndrome" . . . "Hemoglobin M disease" . . . "DNM1L-related encephalopathy due to mitochondrial and peroxisomal fission defect" . . . "Congenital cataract-progressive muscular hypotonia-hearing loss-developmental delay syndrome" . . . "Tetraamelia-multiple malformations syndrome" . . . "Tetralogy of Fallot" . . . "Metaphyseal chondrodysplasia, Jansen type" . . . "Dravet syndrome" . . . "Congenital factor XII deficiency" . . . "Lethal multiple pterygium syndrome" . . . "Autosomal agammaglobulinemia" . . . "Autosomal recessive severe congenital neutropenia due to G6PC3 deficiency" . . . "Immunodeficiency due to MASP-2 deficiency" . . . "Immunodeficiency due to ficolin3 deficiency" . . . "Severe combined immunodeficiency due to complete RAG1/2 deficiency" . . . "Susceptibility to infection due to TYK2 deficiency" . . . "Essential thrombocythemia" . . . "Congenital amegakaryocytic thrombocytopenia" . . . "Congenital factor XIII deficiency" . . . "Thrombocytopenia-absent radius syndrome" . . . "Waldenstr\u00F6m macroglobulinemia" . . . "Hoyeraal-Hreidarsson syndrome" . . . "NON RARE IN EUROPE: Non-alcoholic fatty liver disease" . . . "Tibial aplasia-ectrodactyly syndrome" . . . "Congenital intrinsic factor deficiency" . . . "Hypoplastic tibiae-postaxial polydactyly syndrome" . . . "Reticular dysgenesis" . . . "Trichothiodystrophy" . . . "Primary Fanconi renotubular syndrome" . . . "Toriello-Carey syndrome" . . . "Toriello-Lacassie-Droste syndrome" . . . "Farber disease" . . . "Pediatric hepatocellular carcinoma" . . . "Arterial tortuosity syndrome" . . . "Neuroectodermal melanolysosomal disease" . . . "Familial atrial fibrillation" . . . "Tricho-dento-osseous syndrome" . . . "5-oxoprolinase deficiency" . . . "Gamma-glutamyl transpeptidase deficiency" . . . "Glutamate-cysteine ligase deficiency" . . . "Trichomegaly-retina pigmentary degeneration-dwarfism syndrome" . . . "Isolated trigonocephaly" . . . "Trismus-pseudocamptodactyly syndrome" . . . "Fibrodysplasia ossificans progressiva" . . . "Truncus arteriosus" . . . "Tuberculosis" . . . "Isovaleric acidemia" . . . "VACTERL with hydrocephalus" . . . "NON RARE IN EUROPE: Berger disease" . . . "Hyperostosis corticalis generalisata" . . . "Naxos disease" . . . "Familial Mediterranean fever" . . . "NON RARE IN EUROPE: Vitiligo" . . . "Vogt-Koyanagi-Harada disease" . . . "Hyperimmunoglobulinemia D with periodic fever" . . . "Weaver syndrome" . . . "Weill-Marchesani syndrome" . . . "Telethonin-related limb-girdle muscular dystrophy R7" . . . "FKRP-related limb-girdle muscular dystrophy R9" . . . "DNAJB6-related limb-girdle muscular dystrophy D1" . . . "Infantile spasms syndrome" . . . "Congenital muscular dystrophy with integrin alpha-7 deficiency" . . . "Familial primary hypomagnesemia with normocalciuria and normocalcemia" . . . "Autosomal dominant primary hypomagnesemia with hypocalciuria" . . . "Autoimmune polyendocrinopathy type 1" . . . "Intellectual disability-developmental delay-contractures syndrome" . . . "Wiedemann-Rautenstrauch syndrome" . . . "Glycogen storage disease due to LAMP-2 deficiency" . . . "Immunodeficiency by defective expression of MHC class I" . . . "Wilson-Turner syndrome" . . . "Wolfram syndrome" . . . "Woodhouse-Sakati syndrome" . . . "Yunis-Varon syndrome" . . . "Zimmermann-Laband syndrome" . . . "CHIME syndrome" . . . "Frasier syndrome" . . . "Fructose-1,6-bisphosphatase deficiency" . . . "Fucosidosis" . . . "NON RARE IN EUROPE: Trimethylaminuria" . . . "Infantile neuroaxonal dystrophy" . . . "T-B+ severe combined immunodeficiency due to JAK3 deficiency" . . . "Isolated scaphocephaly" . . . "Isolated plagiocephaly" . . . "Isolated brachycephaly" . . . "Desmosterolosis" . . . "Hemolytic anemia due to pyrimidine 5' nucleotidase deficiency" . . . "Congenital sucrase-isomaltase deficiency" . . . "X-linked dominant chondrodysplasia punctata" . . . "Galactosialidosis" . . . "MEGDEL syndrome" . . . "Congenital ichthyosis-intellectual disability-spastic quadriplegia syndrome" . . . "Spectrin-associated autosomal recessive cerebellar ataxia" . . . "Progressive external ophthalmoplegia-myopathy-emaciation syndrome" . . . "DNA2-related mitochondrial DNA deletion syndrome" . . . "ISPD-related limb-girdle muscular dystrophy R20" . . . "Autism spectrum disorder due to AUTS2 deficiency" . . . "Intellectual disability-obesity-brain malformations-facial dysmorphism syndrome" . . . "Infantile hypertrophic cardiomyopathy due to MRPL44 deficiency" . . . "Bainbridge-Ropers syndrome" . . . "Familial infantile myoclonic epilepsy" . . . "Focal epilepsy-intellectual disability-cerebro-cerebellar malformation" . . . "Progressive myoclonic epilepsy with dystonia" . . . "Autosomal recessive cerebellar ataxia with late-onset spasticity" . . . "Brain dopamine-serotonin vesicular transport disease" . . . "Early-onset progressive neurodegeneration-blindness-ataxia-spasticity syndrome" . . . "Corneal intraepithelial dyskeratosis-palmoplantar hyperkeratosis-laryngeal dyskeratosis syndrome" . . . "Neurodevelopmental disorder-craniofacial dysmorphism-cardiac defect-skeletal anomalies syndrome due to 9q21.3 microdeletion" . . . "Autosomal dominant intermediate Charcot-Marie-Tooth disease type F" . . . "X-linked Charcot-Marie-Tooth disease type 6" . . . "Cobblestone lissencephaly without muscular or ocular involvement" . . . "CLN13 disease" . . . "Facial dysmorphism-immunodeficiency-livedo-short stature syndrome" . . . "Progressive retinal dystrophy due to retinol transport defect" . . . "Attenuated Ch\u00E9diak-Higashi syndrome" . . . "Minimal pigment oculocutaneous albinism type 1" . . . "Temperature-sensitive oculocutaneous albinism type 1" . . . "Oculocutaneous albinism type 7" . . . "Epileptic encephalopathy with global cerebral demyelination" . . . "Familial primary localized cutaneous amyloidosis" . . . "NON RARE IN EUROPE: Primary adult open-angle glaucoma" . . . "Rubinstein-Taybi syndrome due to CREBBP mutations" . . . "Rubinstein-Taybi syndrome due to 16p13.3 microdeletion" . . . "Rubinstein-Taybi syndrome due to EP300 haploinsufficiency" . . . "Roifman syndrome" . . . "Pyruvate carboxylase deficiency, infantile type" . . . "Pyruvate carboxylase deficiency, severe neonatal type" . . . "Pyruvate carboxylase deficiency, benign type" . . . "Congenital myasthenic syndromes with glycosylation defect" . . . "Gamma-sarcoglycan-related limb-girdle muscular dystrophy R5" . . . "Nanophthalmos" . . . "ALDH18A1-related De Barsy syndrome" . . . "Primary lateral sclerosis" . . . "SLC35A2-CDG" . . . "D,L-2-hydroxyglutaric aciduria" . . . "ANK3-related intellectual disability-sleep disturbance syndrome" . . . "Gerstmann-Straussler-Scheinker syndrome" . . . "Hemolytic uremic syndrome with DGKE deficiency" . . . "3-hydroxy-3-methylglutaryl-CoA synthase deficiency" . . . "Hereditary retinoblastoma" . . . "Non-hereditary retinoblastoma" . . . "Amyotrophic lateral sclerosis type 4" . . . "L-Arginine:glycine amidinotransferase deficiency" . . . "Autosomal recessive cutis laxa type 2B" . . . "Glutaric acidemia type 3" . . . "Autosomal recessive cutis laxa type 2, classic type" . . . "Aromatic L-amino acid decarboxylase deficiency" . . . "Glucose-galactose malabsorption" . . . "Severe combined immunodeficiency due to CARD11 deficiency" . . . "Combined immunodeficiency due to IL21R deficiency" . . . "Morning glory disc anomaly" . . . "NON RARE IN EUROPE: Gilbert syndrome" . . . "Imerslund-Gr\u00E4sbeck syndrome" . . . "Hyperinsulinism-hyperammonemia syndrome" . . . "Gitelman syndrome" . . . "Combined deficiency of factor V and factor VIII" . . . "Propionic acidemia" . . . "Familial glucocorticoid deficiency" . . . "NON RARE IN EUROPE: Glucose-6-phosphate-dehydrogenase deficiency" . . . "High myopia-sensorineural deafness syndrome" . . . "Severe neurodegenerative syndrome with lipodystrophy" . . . "Fetal akinesia-cerebral and retinal hemorrhage syndrome" . . . "Hypomyelination with brain stem and spinal cord involvement and leg spasticity" . . . "Temtamy preaxial brachydactyly syndrome" . . . "Multiple mitochondrial dysfunctions syndrome type 3" . . . "Autosomal recessive congenital cerebellar ataxia due to GRID2 deficiency" . . . "THOC6-related developmental delay-microcephaly-facial dysmorphism syndrome" . . . "BICD2-related autosomal dominant childhood-onset proximal spinal muscular atrophy" . . . "Non-seminomatous germ cell tumor of testis" . . . "Hypohidrosis-enamel hypoplasia-palmoplantar keratoderma-intellectual disability syndrome" . . . "Intellectual disability-strabismus syndrome" . . . "Mitochondrial DNA depletion syndrome, hepatocerebrorenal form" . . . "Leukoencephalopathy with mild cerebellar ataxia and white matter edema" . . . "Acute encephalopathy with biphasic seizures and late reduced diffusion" . . . "Bleeding disorder due to P2Y12 defect" . . . "CTCF-related neurodevelopmental disorder" . . . "LMNA-related cardiocutaneous progeria syndrome" . . . "GMPPB-related limb-girdle muscular dystrophy R19" . . . "Mandibular hypoplasia-deafness-progeroid features-lipodystrophy syndrome" . . . "X-linked parkinsonism-spasticity syndrome" . . . "Acroosteolysis-keloid-like lesions-premature aging syndrome" . . . "Childhood-onset autosomal recessive myopathy with external ophthalmoplegia" . . . "Distal monosomy 1q" . . . "Severe intellectual disability-poor language-strabismus-grimacing face-long fingers syndrome" . . . "Hyperuricemia-pulmonary hypertension-renal failure-alkalosis syndrome" . . . "Neurofibromatosis type 1 due to NF1 mutation or intragenic deletion" . . . "Spinocerebellar ataxia type 37" . . . "Alexander disease type I" . . . "Alexander disease type II" . . . "X-linked dyserythropoietic anemia with abnormal platelets and neutropenia" . . . "COL4A1-related familial vascular leukoencephalopathy" . . . "Hereditary sensory and autonomic neuropathy type 1" . . . "Generalized epilepsy with febrile seizures-plus" . . . "17q21.31 microdeletion syndrome" . . . "Koolen-De Vries syndrome due to a point mutation" . . . "Autosomal recessive cerebral atrophy" . . . "Noonan syndrome-like disorder with juvenile myelomonocytic leukemia" . . . "Charcot-Marie-Tooth disease type 4B3" . . . "Familial benign flecked retina" . . . "Ichthyosis-short stature-brachydactyly-microspherophakia syndrome" . . . "Non-immune hydrops fetalis" . . . "X-linked intellectual disability due to GRIA3 mutations" . . . "ALK-positive large B-cell lymphoma" . . . "Severe early-childhood-onset retinal dystrophy" . . . "Infantile epileptic-dyskinetic encephalopathy" . . . "Hypocomplementemic urticarial vasculitis" . . . "Stevens-Johnson syndrome" . . . "Glycogen storage disease due to glycogen debranching enzyme deficiency" . . . "Myoclonus-dystonia syndrome" . . . "Glycogen storage disease due to muscle glycogen phosphorylase deficiency" . . . "Intellectual disability-seizures-hypophosphatasia-ophthalmic-skeletal anomalies syndrome" . . . "TRAPPC11-related limb-girdle muscular dystrophy R18" . . . "Intellectual disability-hyperkinetic movement-truncal ataxia syndrome" . . . "Congenital neutropenia-myelofibrosis-nephromegaly syndrome" . . . "Congenital sideroblastic anemia-B-cell immunodeficiency-periodic fever-developmental delay syndrome" . . . "Autosomal recessive intermediate Charcot-Marie-Tooth disease type C" . . . "Obesity due to SIM1 deficiency" . . . "2p21 microdeletion syndrome without cystinuria" . . . "Developmental delay-facial dysmorphism syndrome due to MED13L deficiency" . . . "Mitochondrial DNA depletion syndrome, encephalomyopathic form with variable craniofacial anomalies" . . . "Combined oxidative phosphorylation defect type 17" . . . "Pontocerebellar hypoplasia type 9" . . . "Primary hyperaldosteronism-seizures-neurological abnormalities syndrome" . . . "Severe motor and intellectual disabilities-sensorineural deafness-dystonia syndrome" . . . "CADDS" . . . "Methylmalonic acidemia with homocystinuria, type cblJ" . . . "Methylmalonic acidemia with homocystinuria, type cblX" . . . "Microcornea-myopic chorioretinal atrophy-telecanthus syndrome" . . . "Severe dermatitis-multiple allergies-metabolic wasting syndrome" . . . "Diffuse palmoplantar keratoderma with painful fissures" . . . "Glycogen storage disease due to liver glycogen phosphorylase deficiency" . . . "Acrocallosal syndrome" . . . "Focal palmoplantar keratoderma with joint keratoses" . . . "Ataxia-intellectual disability-oculomotor apraxia-cerebellar cysts syndrome" . . . "Acute myeloid leukemia with t(8;16)(p11;p13) translocation" . . . "Acute infantile liver failure-multisystemic involvement syndrome" . . . "Oculocutaneous albinism type 6" . . . "Primary dystonia, DYT17 type" . . . "Ataxia-telangiectasia variant" . . . "Extraskeletal Ewing sarcoma" . . . "Peripheral primitive neuroectodermal tumor" . . . "Small cell carcinoma of the ovary" . . . "Immune dysregulation-polyendocrinopathy-enteropathy-X-linked syndrome" . . . "STT3A-CDG" . . . "STT3B-CDG" . . . "SSR4-CDG" . . . "XYLT1-CDG" . . . "GM3 synthase deficiency" . . . "Autism spectrum disorder-epilepsy-arthrogryposis syndrome" . . . "Congenital muscular dystrophy with cerebellar involvement" . . . "Congenital muscular dystrophy with intellectual disability" . . . "Congenital muscular dystrophy without intellectual disability" . . . "Muscle-eye-brain disease with bilateral multicystic leucodystrophy" . . . "Hypotonia-speech impairment-severe cognitive delay syndrome" . . . "Multicentric osteolysis-nodulosis-arthropathy spectrum" . . . "Glycogen storage disease due to muscle phosphofructokinase deficiency" . . . "Simpson-Golabi-Behmel syndrome" . . . "Andersen-Tawil syndrome" . . . "Episodic ataxia type 1" . . . "Gordon syndrome" . . . "Gorlin syndrome" . . . "Chronic granulomatous disease" . . . "Acrodermatitis enteropathica" . . . "Greig cephalopolysyndactyly syndrome" . . . "Guanidinoacetate methyltransferase deficiency" . . . "Huriez syndrome" . . . "NON RARE IN EUROPE: Hidradenitis suppurativa" . . . "Dihydropyrimidinuria" . . . "Hirschsprung disease" . . . "Langerhans cell histiocytosis" . . . "Omenn syndrome" . . . "Uveal melanoma" . . . "Severe intellectual disability-short stature-behavioral abnormalities-facial dysmorphism syndrome" . . . "Susceptibility to viral and mycobacterial infections due to STAT1 deficiency" . . . "Infantile-onset mesial temporal lobe epilepsy with severe cognitive regression" . . . "East Texas bleeding disorder" . . . "X-linked osteoporosis with fractures" . . . "Fatal post-viral neurodegenerative disorder" . . . "Growth and developmental delay-hypotonia-vision impairment-lactic acidosis syndrome" . . . "SURF1-related Charcot-Marie-Tooth disease type 4" . . . "Growth retardation-mild developmental delay-chronic hepatitis syndrome" . . . "Intellectual disability-severe speech delay-mild dysmorphism syndrome" . . . "Congenital microcephaly-severe encephalopathy-progressive cerebral atrophy syndrome" . . . "Familial episodic pain syndrome with predominantly upper body involvement" . . . "Familial episodic pain syndrome with predominantly lower limb involvement" . . . "Hereditary sensory and autonomic neuropathy type 7" . . . "Primary microcephaly-mild intellectual disability-young-onset diabetes syndrome" . . . "Atypical juvenile parkinsonism" . . . "HSD10 disease, infantile type" . . . "HSD10 disease, neonatal type" . . . "Frontorhiny" . . . "Autoimmune enteropathy and endocrinopathy-susceptibility to chronic infections syndrome" . . . "Adult-onset myasthenia gravis" . . . "Feingold syndrome type 1" . . . "Feingold syndrome type 2" . . . "Homozygous familial hypercholesterolemia" . . . "Short stature-optic atrophy-Pelger-Hu\u00EBt anomaly syndrome" . . . "Holt-Oram syndrome" . . . "46,XX testicular disorder of sex development" . . . "Multiple acyl-CoA dehydrogenase deficiency, severe neonatal type" . . . "Multiple acyl-CoA dehydrogenase deficiency, mild type" . . . "Classic homocystinuria" . . . "Homocystinuria due to methylene tetrahydrofolate reductase deficiency" . . . "Silver-Russell syndrome due to a point mutation" . . . "Severe neonatal lactic acidosis due to NFS1-ISD11 complex deficiency" . . . "Activated PI3K-delta syndrome" . . . "PrP systemic amyloidosis" . . . "Macrocephaly-developmental delay syndrome" . . . "Obesity due to CEP19 deficiency" . . . "Foveal hypoplasia-optic nerve decussation defect-anterior segment dysgenesis syndrome" . . . "Short stature-auditory canal atresia-mandibular hypoplasia-skeletal anomalies syndrome" . . . "Familial hyperprolactinemia" . . . "Hereditary isolated aplastic anemia" . . . "Intellectual disability-coarse face-macrocephaly-cerebellar hypotrophy syndrome" . . . "Joubert syndrome with Jeune asphyxiating thoracic dystrophy" . . . "COASY protein-associated neurodegeneration" . . . "Autosomal dominant Charcot-Marie-Tooth disease type 2U" . . . "Peripheral neuropathy-myopathy-hoarseness-hearing loss syndrome" . . . "Periodic paralysis with later-onset distal motor neuropathy" . . . "Periodic paralysis with transient compartment-like syndrome" . . . "Retinal dystrophy with inner retinal dysfunction and ganglion cell anomalies" . . . "Severe combined immunodeficiency due to IKK2 deficiency" . . . "Ferro-cerebro-cutaneous syndrome" . . . "Sacral agenesis-abnormal ossification of the vertebral bodies-persistent notochordal canal syndrome" . . . "Severe intellectual disability-progressive postnatal microcephaly-midline stereotypic hand movements syndrome" . . . "Polyglucosan body myopathy type 1" . . . "MAN1B1-CDG" . . . "Autosomal spastic paraplegia type 58" . . . "Microcephaly-thin corpus callosum-intellectual disability syndrome" . . . "TCR-alpha-beta-positive T-cell deficiency" . . . "Combined immunodeficiency due to MALT1 deficiency" . . . "Charcot-Marie-Tooth disease type 2R" . . . "Giant cell arteritis" . . . "MAGEL2-related Prader-Willi-like syndrome" . . . "SIM1-related Prader-Willi-like syndrome" . . . "Hereditary cryohydrocytosis with normal stomatin" . . . "Focal facial dermal dysplasia type IV" . . . "Alpha-B crystallin-related late-onset myopathy" . . . "KLHL9-related early-onset distal myopathy" . . . "Distal anoctaminopathy" . . . "Distal nebulin myopathy" . . . "Male infertility with azoospermia or oligozoospermia due to single gene mutation" . . . "Male infertility with teratozoospermia due to single gene mutation" . . . "Huntington disease" . . . "NON RARE IN EUROPE: Psoriatic arthritis" . . . "Pancytopenia-developmental delay syndrome" . . . "Proximal myopathy with extrapyramidal signs" . . . "Optic atrophy-intellectual disability syndrome" . . . "Autosomal recessive spastic paraplegia type 61" . . . "Autosomal recessive spastic paraplegia type 62" . . . "Autosomal recessive spastic paraplegia type 59" . . . "Autosomal recessive spastic paraplegia type 60" . . . "Autosomal recessive spastic paraplegia type 63" . . . "Autosomal recessive spastic paraplegia type 64" . . . "Autosomal recessive spastic paraplegia type 66" . . . "Autosomal recessive spastic paraplegia type 67" . . . "Autosomal recessive spastic paraplegia type 69" . . . "Autosomal recessive spastic paraplegia type 70" . . . "Autosomal recessive spastic paraplegia type 71" . . . "Autosomal spastic paraplegia type 72" . . . "Lipoic acid synthetase deficiency" . . . "Lipoyl transferase 1 deficiency" . . . "Childhood-onset spasticity with hyperglycinemia" . . . "Multiple mitochondrial dysfunctions syndrome type 1" . . . "Multiple mitochondrial dysfunctions syndrome type 2" . . . "Huntington disease-like syndrome due to C9ORF72 expansions" . . . "AXIN2-related attenuated familial adenomatous polyposis" . . . "Fibrolamellar hepatocellular carcinoma" . . . "Moyamoya disease with early-onset achalasia" . . . "Hyperammonemic encephalopathy due to carbonic anhydrase VA deficiency" . . . "Partial corpus callosum agenesis-cerebellar vermis hypoplasia with posterior fossa cysts syndrome" . . . "Autosomal dominant Charcot-Marie-Tooth disease type 2 with giant axons" . . . "MEND syndrome" . . . "Autosomal recessive spondylometaphyseal dysplasia, M\u00E9garban\u00E9 type" . . . "1p31p32 microdeletion syndrome" . . . "Karyomegalic interstitial nephritis" . . . "Autosomal dominant focal non-epidermolytic palmoplantar keratoderma with plantar blistering" . . . "Acute myeloid leukemia with t(6;9)(p23;q34)" . . . "Acute myeloid leukemia with t(9;11)(p22;q23)" . . . "Acute myeloid leukemia with inv(3)(q21q26.2) or t(3;3)(q21;q26.2)" . . . "Megakaryoblastic acute myeloid leukemia with t(1;22)(p13;q13)" . . . "Acute myeloid leukemia with NPM1 somatic mutations" . . . "Autosomal recessive distal renal tubular acidosis" . . . "Familial bicuspid aortic valve" . . . "Progressive myoclonic epilepsy type 5" . . . "Infantile cerebral and cerebellar atrophy with postnatal progressive microcephaly" . . . "Familial hyperaldosteronism type I" . . . "Diffuse cerebral and cerebellar atrophy-intractable seizures-progressive microcephaly syndrome" . . . "Intellectual disability-facial dysmorphism syndrome due to SETD5 haploinsufficiency" . . . "Tatton-Brown-Rahman syndrome" . . . "ADNP syndrome" . . . "FBLN1-related developmental delay-central nervous system anomaly-syndactyly syndrome" . . . "Alacrimia-choreoathetosis-liver dysfunction syndrome" . . . "Multisystemic smooth muscle dysfunction syndrome" . . . "Female infertility due to zona pellucida defect" . . . "Severe intellectual disability-progressive spastic diplegia syndrome" . . . "Global developmental delay-lung cysts-overgrowth-Wilms tumor syndrome" . . . "Autosomal recessive cerebellar ataxia-epilepsy-intellectual disability syndrome due to TUD deficiency" . . . "Autosomal recessive cerebellar ataxia-epilepsy-intellectual disability syndrome due to RUBCN deficiency" . . . "Chondromyxoid fibroma" . . . "Clear cell papillary renal cell carcinoma" . . . "Spinal muscular atrophy with respiratory distress type 2" . . . "DITRA" . . . "Vasculitis due to ADA2 deficiency" . . . "Familial atypical multiple mole melanoma syndrome" . . . "Familial hyperaldosteronism type II" . . . "NON RARE IN EUROPE: Heterozygous familial hypercholesterolemia" . . . "Acromesomelic dysplasia, Maroteaux type" . . . "Pontocerebellar hypoplasia type 10" . . . "Angelman syndrome due to a point mutation" . . . "Angelman syndrome due to imprinting defect in 15q11-q13" . . . "NON RARE IN EUROPE: Melanoma" . . . "Mild phosphoribosylpyrophosphate synthetase superactivity" . . . "Severe phosphoribosylpyrophosphate synthetase superactivity" . . . "Wolfram-like syndrome" . . . "Hereditary late-onset Parkinson disease" . . . "Infantile nephropathic cystinosis" . . . "Juvenile nephropathic cystinosis" . . . "Ocular cystinosis" . . . "Maternal riboflavin deficiency" . . . "Familial isolated trichomegaly" . . . "NON RARE IN EUROPE: Metabolic syndrome" . . . "Early-onset epileptic encephalopathy-cortical blindness-intellectual disability-facial dysmorphism syndrome" . . . "Facial dysmorphism-lens dislocation-anterior segment abnormalities-spontaneous filtering blebs syndrome" . . . "Autosomal recessive cerebellar ataxia due to STUB1 deficiency" . . . "PRKAR1B-related neurodegenerative dementia with intermediate filaments" . . . "AHDC1-related intellectual disability-obstructive sleep apnea-mild dysmorphism syndrome" . . . "Epidermolysis bullosa simplex due to BP230 deficiency" . . . "Epidermolysis bullosa simplex due to exophilin 5 deficiency" . . . "Primary failure of tooth eruption" . . . "Dysbetalipoproteinemia" . . . "NON RARE IN EUROPE: Hyperlipoproteinemia type 4" . . . "Gyrate atrophy of choroid and retina" . . . "Hyperornithinemia-hyperammonemia-homocitrullinuria syndrome" . . . "Bietti crystalline dystrophy" . . . "Neonatal severe primary hyperparathyroidism" . . . "Hyperprolinemia type 1" . . . "Dyschromatosis symmetrica hereditaria" . . . "Malan overgrowth syndrome" . . . "Glycogen storage disease due to acid maltase deficiency, late-onset" . . . "Cranio-cervical dystonia with laryngeal and upper-limb involvement" . . . "Adult-onset cervical dystonia, DYT23 type" . . . "Temple-Baraitser syndrome" . . . "Bleeding disorder due to CalDAG-GEFI deficiency" . . . "Severe combined immunodeficiency due to CTPS1 deficiency" . . . "Postaxial polydactyly-anterior pituitary anomalies-facial dysmorphism syndrome" . . . "Transient myeloproliferative syndrome" . . . "Iminoglycinuria" . . . "Woolly hair-palmoplantar keratoderma syndrome" . . . "Autosomal recessive severe congenital neutropenia due to CXCR2 deficiency" . . . "Autosomal recessive severe congenital neutropenia due to CSF3R deficiency" . . . "Combined oxidative phosphorylation defect type 20" . . . "Combined oxidative phosphorylation defect type 21" . . . "RIDDLE syndrome" . . . "Hereditary clear cell renal cell carcinoma" . . . "Spinocerebellar ataxia type 40" . . . "Spinocerebellar ataxia type 38" . . . "Microcephaly-short stature-intellectual disability-facial dysmorphism syndrome" . . . "Autosomal recessive severe congenital neutropenia due to JAGN1 deficiency" . . . "Nail and teeth abnormalities-marginal palmoplantar keratoderma-oral hyperpigmentation syndrome" . . . "Mucolipidosis type III alpha/beta" . . . "Mucolipidosis type III gamma" . . . "X-linked intellectual disability-limb spasticity-retinal dystrophy-diabetes insipidus syndrome" . . . "Microcephaly-complex motor and sensory axonal neuropathy syndrome" . . . "Malignant hyperthermia of anesthesia" . . . "Progressive myoclonic epilepsy type 8" . . . "Colobomatous microphthalmia-rhizomelic dysplasia syndrome" . . . "Congenital myopathy with myasthenic-like onset" . . . "TOR1AIP1-related limb-girdle muscular dystrophy" . . . "Familial hyperthyroidism due to mutations in TSH receptor" . . . "STING-associated vasculopathy with onset in infancy" . . . "Apolipoprotein A-I deficiency" . . . "Tietz syndrome" . . . "NON RARE IN EUROPE: Familial hypobetalipoproteinemia" . . . "Familial hypoaldosteronism" . . . "Autosomal dominant hypocalcemia" . . . "Hypochondroplasia" . . . "Medium chain acyl-CoA dehydrogenase deficiency" . . . "Combined immunodeficiency due to OX40 deficiency" . . . "Hereditary myopathy with lactic acidosis due to ISCU deficiency" . . . "Primary immunodeficiency with post-measles-mumps-rubella vaccine viral infection" . . . "Scapuloperoneal spinal muscular atrophy" . . . "X-linked scapuloperoneal muscular dystrophy" . . . "Autosomal recessive spastic paraplegia type 57" . . . "Progressive encephalopathy with leukodystrophy due to DECR deficiency" . . . "Normosmic congenital hypogonadotropic hypogonadism" . . . "Orofaciodigital syndrome type 14" . . . "Autosomal dominant Charcot-Marie-Tooth disease type 2Y" . . . "Progressive myoclonic epilepsy type 7" . . . "Keppen-Lubinsky syndrome" . . . "CIDEC-related familial partial lipodystrophy" . . . "LIPE-related familial partial lipodystrophy" . . . "Short stature-advanced bone age-early-onset osteoarthritis syndrome" . . . "Autosomal dominant Charcot-Marie-Tooth disease type 2 due to TFG mutation" . . . "Lethal neonatal spasticity-epileptic encephalopathy syndrome" . . . "Colobomatous optic disc-macular atrophy-chorioretinopathy syndrome" . . . "COG2-CDG" . . . "X-linked microcephaly-growth retardation-prognathism-cryptorchidism syndrome" . . . "Progeroid features-hepatocellular carcinoma predisposition syndrome" . . . "Chronic atrial and intestinal dysrhythmia syndrome" . . . "Autosomal recessive intermediate Charcot-Marie-Tooth disease type D" . . . "Intrauterine growth restriction-short stature-early adult-onset diabetes syndrome" . . . "Intellectual disability-expressive aphasia-facial dysmorphism syndrome" . . . "Autoimmune lymphoproliferative syndrome due to CTLA4 haploinsuffiency" . . . "Periodic fever-infantile enterocolitis-autoinflammatory syndrome" . . . "Thrombomodulin-related bleeding disorder" . . . "Cataract-growth hormone deficiency-sensory neuropathy-sensorineural hearing loss-skeletal dysplasia syndrome" . . . "Microcephalic primordial dwarfism-insulin resistance syndrome" . . . "Familial atrial tachyarrhythmia-infra-Hisian cardiac conduction disease" . . . "Retinitis pigmentosa-juvenile cataract-short stature-intellectual disability syndrome" . . . "Combined immunodeficiency-enteropathy spectrum" . . . "Non-progressive predominantly posterior cavitating leukoencephalopathy with peripheral neuropathy" . . . "Pseudoxanthoma elasticum-like skin manifestations with retinitis pigmentosa" . . . "Autosomal recessive primary immunodeficiency with defective spontaneous natural killer cell cytotoxicity" . . . "MYH7-related late-onset scapuloperoneal muscular dystrophy" . . . "Ketoacidosis due to monocarboxylate transporter-1 deficiency" . . . "RARS-related autosomal recessive hypomyelinating leukodystrophy" . . . "Steel syndrome" . . . "PCNA-related progressive neurodegenerative photosensitivity syndrome" . . . "STAT3-related early-onset multisystem autoimmune disease" . . . "Fatty acyl-CoA reductase 1 deficiency" . . . "Severe autosomal recessive macrothrombocytopenia" . . . "PURA-related severe neonatal hypotonia-seizures-encephalopathy syndrome due to a point mutation" . . . "GCGR-related hyperglucagonemia" . . . "Early-onset myopathy-areflexia-respiratory distress-dysphagia syndrome" . . . "KCNQ2-related epileptic encephalopathy" . . . "PDE4D haploinsufficiency syndrome" . . . "Fatal congenital hypertrophic cardiomyopathy due to glycogen storage disease" . . . "Lethal fetal cerebrorenogenitourinary agenesis/hypoplasia syndrome" . . . "Autosomal dominant myopia-midfacial retrusion-sensorineural hearing loss-rhizomelic dysplasia syndrome" . . . "Interstitial lung disease due to SP-C deficiency" . . . "Interstitial lung disease due to ABCA3 deficiency" . . . "Severe early-onset pulmonary alveolar proteinosis due to MARS deficiency" . . . "Familial colorectal cancer Type X" . . . "Ribose-5-P isomerase deficiency" . . . "Isolated sedoheptulokinase deficiency" . . . "L-ferritin deficiency" . . . "Early-onset posterior subcapsular cataract" . . . "Early-onset lamellar cataract" . . . "Non-specific early-onset epileptic encephalopathy" . . . "Sporadic porphyria cutanea tarda" . . . "Familial porphyria cutanea tarda" . . . "Charcot-Marie-Tooth disease type 2S" . . . "46,XY disorder of sex development due to testicular 17,20-desmolase deficiency" . . . "NDE1-related microhydranencephaly" . . . "NUT midline carcinoma" . . . "X-linked erythropoietic protoporphyria" . . . "Postural orthostatic tachycardia syndrome due to NET deficiency" . . . "PGM3-CDG" . . . "DNAJB2-related Charcot-Marie-Tooth disease type 2" . . . "Ventriculomegaly-cystic kidney disease" . . . "Mandibulofacial dysostosis with alopecia" . . . "Combined oxidative phosphorylation defect type 23" . . . "46,XX ovarian dysgenesis-short stature syndrome" . . . "Lethal fetal brain malformation-duodenal atresia-bilateral renal hypoplasia syndrome" . . . "Cerebellar-facial-dental syndrome" . . . "Cognitive impairment-coarse facies-heart defects-obesity-pulmonary involvement-short stature-skeletal dysplasia syndrome" . . . "Autoimmune interstitial lung disease-arthritis syndrome" . . . "Autosomal dominant spastic paraplegia type 73" . . . "Peeling skin-leukonychia-acral punctate keratoses-cheilitis-knuckle pads syndrome" . . . "Combined oxidative phosphorylation defect type 24" . . . "Autoimmune hemolytic anemia-autoimmune thrombocytopenia-primary immunodeficiency syndrome" . . . "Marie Unna hereditary hypotrichosis" . . . "Combined immunodeficiency due to LRBA deficiency" . . . "3-methylglutaconic aciduria type 7" . . . "Juvenile-onset diabetes mellitus-central and peripheral neurodegeneration syndrome" . . . "Limb-girdle muscular dystrophy due to POMK deficiency" . . . "NIK deficiency" . . . "DOCK2 deficiency" . . . "Susceptibility to localized juvenile periodontitis" . . . "Autosomal dominant spastic paraplegia type 9A" . . . "Autosomal dominant spastic paraplegia type 9B" . . . "Autosomal recessive spastic paraplegia type 9B" . . . "Mitochondrial pyruvate carrier deficiency" . . . "Hemochromatosis type 5" . . . "Lipoyl transferase 2 deficiency" . . . "Polymerase proofreading-related adenomatous polyposis" . . . "Hypomyelination-cerebellar atrophy-hypoplasia of the corpus callosum syndrome" . . . "Tremor-ataxia-central hypomyelination syndrome" . . . "Combined oxidative phosphorylation defect type 25" . . . "Pigmentation defects-palmoplantar keratoderma-skin carcinoma syndrome" . . . "Autosomal dominant Charcot-Marie-Tooth disease type 2V" . . . "Klippel-Feil anomaly-myopathy-facial dysmorphism syndrome" . . . "Progressive scapulohumeroperoneal distal myopathy" . . . "19p13.3 microduplication syndrome" . . . "Spastic tetraplegia-thin corpus callosum-progressive postnatal microcephaly syndrome" . . . "Paroxysmal nocturnal hemoglobinuria" . . . "CAD-CDG" . . . "Autosomal recessive brachyolmia" . . . "Progressive autosomal recessive ataxia-deafness syndrome" . . . "Isolated focal non-epidermolytic palmoplantar keratoderma" . . . "Regressive spondylometaphyseal dysplasia" . . . "Gastrointestinal stromal tumor" . . . "NON RARE IN EUROPE: Primary bile acid malabsorption" . . . "Symptomatic form of fragile X syndrome in female carrier" . . . "Neonatal adrenoleukodystrophy" . . . "Familial congenital nasolacrimal duct obstruction" . . . "X-linked lissencephaly with abnormal genitalia" . . . "Neurodevelopmental disorder-craniofacial dysmorphism-cardiac defect-skeletal anomalies syndrome due to a point mutation" . . . "Congenital insensitivity to pain with severe intellectual disability" . . . "Autosomal recessive cerebellar ataxia due to CWF19L1 deficiency" . . . "Polyendocrine-polyneuropathy syndrome" . . . "Congenital fibrosis of extraocular muscles" . . . "Miyoshi myopathy" . . . "Kuru" . . . "Pleomorphic salivary gland adenoma" . . . "NTHL1-related attenuated familial adenomatous polyposis" . . . "Superficial epidermolytic ichthyosis" . . . "Infantile multisystem neurologic-endocrine-pancreatic disease" . . . "Hereditary sensory neuropathy-deafness-dementia syndrome" . . . "X-linked myotubular myopathy-abnormal genitalia syndrome" . . . "Hereditary neuroendocrine tumor of small intestine" . . . "Polyglucosan body myopathy type 2" . . . "Autosomal dominant mitochondrial myopathy with exercise intolerance" . . . "Predisposition to invasive fungal disease due to CARD9 deficiency" . . . "Neonatal encephalomyopathy-cardiomyopathy-respiratory distress syndrome" . . . "Autosomal dominant intellectual disability-craniofacial anomalies-cardiac defects syndrome" . . . "Progressive essential tremor-speech impairment-facial dysmorphism-intellectual disability-abnormal behavior syndrome" . . . "Syndromic sensorineural deafness due to combined oxidative phosphorylation defect" . . . "X-linked intellectual disability-short stature-overweight syndrome" . . . "Clear cell sarcoma of kidney" . . . "X-linked intellectual disability-hypotonia-movement disorder syndrome" . . . "Progressive myoclonic epilepsy type 9" . . . "Intellectual disability-macrocephaly-hypotonia-behavioral abnormalities syndrome" . . . "Microcephaly-corpus callosum hypoplasia-intellectual disability-facial dysmorphism syndrome" . . . "Microcephaly-intellectual disability-sensorineural hearing loss-epilepsy-abnormal muscle tone syndrome" . . . "Megalencephaly-severe kyphoscoliosis-overgrowth syndrome" . . . "ITPA-related lethal infantile neurological disorder with cataract and cardiac involvement" . . . "Complex lethal osteochondrodysplasia" . . . "Progressive spondyloepimetaphyseal dysplasia-short stature-short fourth metatarsals-intellectual disability syndrome" . . . "Multiple mitochondrial dysfunctions syndrome type 4" . . . "Macrocephaly-intellectual disability-neurodevelopmental disorder-small thorax syndrome" . . . "Harlequin ichthyosis" . . . "NON RARE IN EUROPE: Specific language impairment" . . . "Spinocerebellar ataxia type 41" . . . "Spinocerebellar ataxia type 42" . . . "Ataxia-oculomotor apraxia type 4" . . . "Spondyloepiphyseal dysplasia, Stanescu type" . . . "Autosomal recessive spastic paraplegia type 75" . . . "Craniofacial dysplasia-short stature-ectodermal anomalies-intellectual disability syndrome" . . . "X-linked intellectual disability-cerebellar hypoplasia-spondylo-epiphyseal dysplasia syndrome" . . . "C1 inhibitor deficiency" . . . "Adenosine monophosphate deaminase deficiency" . . . "Lathosterolosis" . . . "Recessive X-linked ichthyosis" . . . "NON RARE IN EUROPE: Autosomal dominant ichthyosis vulgaris" . . . "Paroxysmal extreme pain disorder" . . . "Spastic paraplegia-severe developmental delay-epilepsy syndrome" . . . "Short stature-brachydactyly-obesity-global developmental delay syndrome" . . . "NON RARE IN EUROPE: Infantile capillary hemangioma" . . . "Intellectual disability syndrome due to a DYRK1A point mutation" . . . "BENTA disease" . . . "NEK9-related lethal skeletal dysplasia" . . . "Neonatal alloimmune neutropenia" . . . "Primary dystonia, DYT27 type" . . . "COG6-CGD" . . . "Fever-associated acute infantile liver failure syndrome" . . . "Basel-Vanagaite-Smirin-Yosef syndrome" . . . "Familial gastric type 1 neuroendocrine tumor" . . . "Familial cavitary optic disc anomaly" . . . "Incontinentia pigmenti" . . . "Hereditary persistence of fetal hemoglobin-beta-thalassemia syndrome" . . . "Symptomatic form of hemochromatosis type 1" . . . "Fetal encasement syndrome" . . . "Congenital plasminogen activator inhibitor type 1 deficiency" . . . "Class I glucose-6-phosphate dehydrogenase deficiency" . . . "Char syndrome" . . . "Exercise-induced malignant hyperthermia" . . . "Severe intellectual disability-corpus callosum agenesis-facial dysmorphism-cerebellar ataxia syndrome" . . . "TMEM199-CDG" . . . "Martinique crinkled retinal pigment epitheliopathy" . . . "Autosomal recessive spastic paraplegia type 77" . . . "Familial patent arterial duct" . . . "Autosomal dominant Charcot-Marie-Tooth disease type 2Z" . . . "Autosomal recessive Charcot-Marie-Tooth disease type 2X" . . . "Neonatal severe cardiopulmonary failure due to mitochondrial methylation defect" . . . "Macrocephaly-intellectual disability-left ventricular non compaction syndrome" . . . "Acute infantile liver failure-cerebellar ataxia-peripheral sensory motor neuropathy syndrome" . . . "LIMS2-related limb-girdle muscular dystrophy" . . . "Autosomal dominant thrombocytopenia with platelet secretion defect" . . . "Childhood-onset progressive contractures-limb-girdle weakness-muscle dystrophy syndrome" . . . "Seizures-scoliosis-macrocephaly syndrome" . . . "VPS11-related autosomal recessive hypomyelinating leukodystrophy" . . . "Facial dysmorphism-developmental delay-behavioral abnormalities syndrome due to WAC point mutation" . . . "SMARCA4-deficient sarcoma of thorax" . . . "Fatal familial insomnia" . . . "Tubulinopathy-associated dysgyria" . . . "Severe hypotonia-psychomotor developmental delay-strabismus-cardiac septal defect syndrome" . . . "Intellectual disability-epilepsy-extrapyramidal syndrome" . . . "Microcephalic cortical malformations-short stature due to RTTN deficiency" . . . "Cryptogenic multifocal ulcerous stenosing enteritis" . . . "Chronic enteropathy associated with SLCO2A1 gene" . . . "Autosomal recessive spastic paraplegia type 74" . . . "Isolated generalized anhidrosis with normal sweat glands" . . . "Colobomatous macrophthalmia-microcornea syndrome" . . . "White-Sutton syndrome" . . . "CCDC115-CDG" . . . "SLC39A8-CDG" . . . "Rhizomelic chondrodysplasia punctata type 5" . . . "Severe primary trimethylaminuria" . . . "Hereditary fructose intolerance" . . . "Adenylosuccinate lyase deficiency" . . . "Hereditary papillary renal cell carcinoma" . . . "Familial cold urticaria" . . . "Lysinuric protein intolerance" . . . "Jeune syndrome" . . . "Joubert syndrome" . . . "BVES-related limb-girdle muscular dystrophy" . . . "Autosomal dominant distal axonal motor neuropathy-myofibrillar myopathy syndrome" . . . "Erythrokeratodermia-cardiomyopathy syndrome" . . . "Hereditary pediatric Beh\u00E7et-like disease" . . . "Combined immunodeficiency due to TFRC deficiency" . . . "Autosomal dominant preaxial polydactyly-upperback hypertrichosis syndrome" . . . "Micrognathia-recurrent infections-behavioral abnormalities-mild intellectual disability syndrome" . . . "PMP2-related Charcot-Marie-Tooth disease type 1" . . . "Congenital generalized hypercontractile muscle stiffness syndrome" . . . "IL21-related infantile inflammatory bowel disease" . . . "Postnatal microcephaly-infantile hypotonia-spastic diplegia-dysarthria-intellectual disability syndrome" . . . "Combined oxidative phosphorylation defect type 26" . . . "Pediatric multiple sclerosis" . . . "Nodular fasciitis" . . . "Pontine autosomal dominant microangiopathy with leukoencephalopathy" . . . "Combined oxidative phosphorylation defect type 27" . . . "Cytosolic phospholipase-A2 alpha deficiency associated bleeding disorder" . . . "Progressive microcephaly-seizures-cortical blindness-developmental delay syndrome" . . . "PMP22-RAI1 contiguous gene duplication syndrome" . . . "Kosaki overgrowth syndrome" . . . "Autosomal recessive mendelian susceptibility to mycobacterial diseases due to complete RORgamma receptor deficiency" . . . "Palatal anomalies-widely spaced teeth-facial dysmorphism-developmental delay syndrome" . . . "KID syndrome" . . . "Combined oxidative phosphorylation defect type 29" . . . "Combined oxidative phosphorylation defect type 30" . . . "Lethal left ventricular non-compaction-seizures-hypotonia-cataract-developmental delay syndrome" . . . "Hereditary sensory and autonomic neuropathy type 8" . . . "Kallmann syndrome" . . . "X-linked agammaglobulinemia" . . . "Progressive familial intrahepatic cholestasis type 5" . . . "Progressive familial intrahepatic cholestasis type 4" . . . "MYO5B-related progressive familial intrahepatic cholestasis" . . . "Lethal hydranencephaly-diaphragmatic hernia syndrome" . . . "MSH3-related attenuated familial adenomatous polyposis" . . . "High grade B-cell lymphoma with MYC and/ or BCL2 and/or BCL6 rearrangement" . . . "Isolated neonatal sclerosing cholangitis" . . . "POGLUT1-related limb-girdle muscular dystrophy R21" . . . "Hereditary thrombocytopenia with early-onset myelofibrosis" . . . "Recurrent metabolic encephalomyopathic crises-rhabdomyolysis-cardiac arrhythmia-intellectual disability syndrome" . . . "X-linked female restricted facial dysmorphism-short stature-choanal atresia-intellectual disability" . . . "Global developmental delay-visual anomalies-progressive cerebellar atrophy-truncal hypotonia syndrome" . . . "X-linked intellectual disability-global development delay-facial dysmorphism-sacral caudal remnant syndrome" . . . "Kearns-Sayre syndrome" . . . "PYCR2-related microcephaly-progressive leukoencephalopathy" . . . "Familial Chilblain lupus" . . . "USP18 deficiency" . . . "Familial schizencephaly" . . . "Kennedy disease" . . . "HTRA1-related autosomal dominant cerebral small vessel disease" . . . "Adenylosuccinate synthetase-like 1-related distal myopathy" . . . "X-linked keloid scarring-reduced joint mobility-increased optic cup-to-disc ratio syndrome" . . . "Congenital high-molecular-weight kininogen deficiency" . . . "Congenital cataracts-facial dysmorphism-neuropathy syndrome" . . . "Acquired schizencephaly" . . . "CLCN4-related X-linked intellectual disability syndrome" . . . "EMILIN-1-related connective tissue disease" . . . "MFF-related encephalopathy due to mitochondrial and peroxisomal fission defect" . . . "Kniest dysplasia" . . . "Monosomy 22q13.3" . . . "Prenatal-onset spinal muscular atrophy with congenital bone fractures" . . . "Congenital muscular dystrophy-respiratory failure-skin abnormalities-joint hyperlaxity syndrome" . . . "Autosomal dominant severe congenital neutropenia" . . . "Macrothrombocytopenia-lymphedema-developmental delay-facial dysmorphism-camptodactyly syndrome" . . . "Autosomal dominant Charcot-Marie-Tooth disease type 2 due to DGAT2 mutation" . . . "Pierpont syndrome" . . . "Microcephaly-congenital cataract-psoriasiform dermatitis syndrome" . . . "Aceruloplasminemia" . . . "Female infertility due to oocyte meiotic arrest" . . . "Familial progressive retinal dystrophy-iris coloboma-congenital cataract syndrome" . . . "Split-foot malformation-mesoaxial polydactyly syndrome" . . . "Osteofibrous dysplasia" . . . "Autosomal dominant Charcot-Marie-Tooth disease type 2W" . . . "SIX2-related frontonasal dysplasia" . . . "Autosomal recessive spastic paraplegia type 76" . . . "Global developmental delay-neuro-ophthalmological abnormalities-seizures-intellectual disability syndrome" . . . "Transketolase deficiency" . . . "Severe growth deficiency-strabismus-extensive dermal melanocytosis-intellectual disability syndrome" . . . "TBCK-related intellectual disability syndrome" . . . "Early-onset epilepsy-intellectual disability-brain anomalies syndrome" . . . "TELO2-related intellectual disability-neurodevelopmental disorder" . . . "DDX41-related hematologic malignancy predisposition syndrome" . . . "Distal myopathy, Tateyama type" . . . "Congenital bilateral absence of vas deferens" . . . "Vibratory urticaria" . . . "Achromatopsia" . . . "RERE-related neurodevelopmental syndrome" . . . "MIRAGE syndrome" . . . "Retinitis pigmentosa-hearing loss-premature aging-short stature-facial dysmorphism syndrome" . . . "DIAPH1-related sensorineural hearing loss-thrombocytopenia syndrome" . . . "Infantile-onset generalized dyskinesia with orofacial involvement" . . . "Childhood-onset benign chorea with striatal involvement" . . . "Squamous cell carcinoma of the hypopharynx" . . . "Squamous cell carcinoma of the larynx" . . . "Keratoderma hereditarium mutilans" . . . "Charcot-Marie-Tooth disease type 2T" . . . "9q33.3q34.11 microdeletion syndrome" . . . "C11ORF73-related autosomal recessive hypomyelinating leukodystrophy" . . . "Early-onset progressive diffuse brain atrophy-microcephaly-muscle weakness-optic atrophy syndrome" . . . "Kyphosis-lateral tongue atrophy-myofibrillar myopathy syndrome" . . . "Kyphoscoliosis-lateral tongue atrophy-hereditary spastic paraplegia syndrome" . . . "EVEN-plus syndrome" . . . "Early-onset progressive encephalopathy-spastic ataxia-distal spinal muscular atrophy syndrome" . . . "Ocular anomalies-axonal neuropathy-developmental delay syndrome" . . . "MME-related autosomal dominant Charcot Marie Tooth disease type 2" . . . "Spinocerebellar ataxia type 43" . . . "Childhood-onset basal ganglia degeneration syndrome" . . . "Menstrual cycle-dependent periodic fever" . . . "Thiamine-responsive megaloblastic anemia syndrome" . . . "Aquagenic palmoplantar keratoderma" . . . "LRP5-related primary osteoporosis" . . . "Mirror-image polydactyly" . . . "Short rib-polydactyly syndrome type 5" . . . "MYBPC1-related autosomal recessive non-lethal arthrogryposis multiplex congenita syndrome" . . . "16p13.2 microdeletion syndrome" . . . "Infantile-onset periodic fever-panniculitis-dermatosis syndrome" . . . "Tall stature-intellectual disability-renal anomalies syndrome" . . . "Multinucleated neurons-anhydramnios-renal dysplasia-cerebellar hypoplasia-hydranencephaly syndrome" . . . "Early-onset progressive encephalopathy-hearing loss-pons hypoplasia-brain atrophy syndrome" . . . "Brain malformations-musculoskeletal abnormalities-facial dysmorphism-intellectual disability syndrome" . . . "Microcephaly-corpus callosum and cerebellar vermis hypoplasia-facial dysmorphism-intellectual disability syndrom" . . . "SIN3A-related intellectual disability syndrome due to a point mutation" . . . "Childhood-onset motor and cognitive regression syndrome with extrapyramidal movement disorder" . . . "X-linked external auditory canal atresia-dilated internal auditory canal-facial dysmorphism syndrome" . . . "Squamous cell carcinoma of the nasal cavity and paranasal sinuses" . . . "Squamous cell carcinoma of the oropharynx" . . . "Squamous cell carcinoma of salivary glands" . . . "Polyhydramnios-megalencephaly-symptomatic epilepsy syndrome" . . . "Severe neurodevelopmental disorder with feeding difficulties-stereotypic hand movement-bilateral cataract" . . . "Osteosclerotic metaphyseal dysplasia" . . . "Noonan syndrome with multiple lentigines" . . . "Lafora disease" . . . "Squamous cell carcinoma of the oral cavity" . . . "Squamous cell carcinoma of the lip" . . . "Mitochondrial myopathy-cerebellar ataxia-pigmentary retinopathy syndrome" . . . "Metopic ridging-ptosis-facial dysmorphism syndrome" . . . "STAG1-related intellectual disability-facial dysmorphism-gastroesophageal reflux syndrome" . . . "Alkaline ceramidase 3 deficiency" . . . "Pleural mesothelioma" . . . "Trichorhinophalangeal syndrome type 2" . . . "Larsen syndrome" . . . "Cerebellar ataxia with neuropathy and bilateral vestibular areflexia syndrome" . . . "Severe combined immunodeficiency due to LAT deficiency" . . . "Combined immunodeficiency due to Moesin deficiency" . . . "3-methylglutaconic aciduria type 8" . . . "3-methylglutaconic aciduria type 9" . . . "Combined immunodeficiency due to GINS1 deficiency" . . . "Early-onset seizures-distal limb anomalies-facial dysmorphism-global developmental delay syndrome" . . . "Psychomotor regression-oculomotor apraxia-movement disorder-nephropathy syndrome" . . . "Mucopolysaccharidosis-like syndrome with congenital heart defects and hematopoietic disorders" . . . "CDKL5-deficiency disorder" . . . "Graham Little-Piccardi-Lassueur syndrome" . . . "Stromme syndrome" . . . "Familial steroid-resistant nephrotic syndrome with adrenal insufficiency" . . . "Autosomal recessive complex spastic paraplegia due to Kennedy pathway dysfunction" . . . "Gabriele-de Vries syndrome" . . . "MEPAN syndrome" . . . "Craniolenticulosutural dysplasia" . . . "Cleft lip and palate-craniofacial dysmorphism-congenital heart defect-hearing loss syndrome" . . . "8q24.3 microdeletion syndrome" . . . "Intellectual disability-cardiac anomalies-short stature-joint laxity syndrome" . . . "Oral-facial-digital syndrome with short stature and brachymesophalangy" . . . "Intrauterine growth restriction-congenital multiple caf\u00E9-au-lait macules-increased sister chromatid exchange syndrome" . . . "Hyperphenylalaninemia due to DNAJC12 deficiency" . . . "Intermediate epidermolysis bullosa simplex with cardiomyopathy" . . . "Skeletal dysplasia-T-cell immunodeficiency-developmental delay syndrome" . . . "Congenital progressive bone marrow failure-B-cell immunodeficiency-skeletal dysplasia syndrome" . . . "Leprechaunism" . . . "Striate palmoplantar keratoderma" . . . "Keratolytic winter erythema" . . . "Sch\u00F6pf-Schulz-Passarge syndrome" . . . "Blomstrand lethal chondrodysplasia" . . . "Familial short QT syndrome" . . . "Lesch-Nyhan syndrome" . . . "Ethylmalonic encephalopathy" . . . "Chronic lymphoproliferative disorder of natural killer cells" . . . "Formiminoglutamic aciduria" . . . "Autosomal recessive epidermolytic ichthyosis" . . . "Congenital cerebellar ataxia due to RNU12 mutation" . . . "Autosomal recessive spastic paraplegia type 78" . . . "Intellectual disability-seizures-abnormal gait-facial dysmorphism syndrome" . . . "Generalized arterial calcification of infancy" . . . "WHIM syndrome" . . . "Autosomal recessive anterior segment dysgenesis" . . . "Aicardi-Gouti\u00E8res syndrome" . . . "Potocki-Shaffer syndrome" . . . "Corpus callosum agenesis-intellectual disability-coloboma-micrognathia syndrome" . . . "Acute promyelocytic leukemia" . . . "Xq25 microduplication syndrome" . . . "Proximal myopathy with focal depletion of mitochondria" . . . "Spastic paraplegia-intellectual disability-nystagmus-obesity syndrome" . . . "NON RARE IN EUROPE: Non rare obesity" . . . "Dystonia-parkinsonism-hypermanganesemia syndrome" . . . "Autosomal recessive axonal Charcot-Marie-Tooth disease due to copper metabolism defect" . . . "Autosomal dominant Charcot-Marie-Tooth disease type 2DD" . . . "PLAA-associated neurodevelopmental disorder" . . . "Congenital cataract-severe neonatal hepatopathy-global developmental delay syndrome" . . . "Congenital vertebral-cardiac-renal anomalies syndrome" . . . "Microcephaly-facial dysmorphism-ocular anomalies-multiple congenital anomalies syndrome" . . . "LAMA5-related multisystemic syndrome" . . . "Chronic myeloid leukemia" . . . "Infantile hypotonia-oculomotor anomalies-hyperkinetic movements-developmental delay syndrome" . . . "Mohr-Tranebjaerg syndrome" . . . "Hereditary leiomyomatosis and renal cell cancer" . . . "Mantle cell lymphoma" . . . "MALT lymphoma" . . . "Retinitis punctata albescens" . . . "Branchiootic syndrome" . . . "Inclusion body myopathy with Paget disease of bone and frontotemporal dementia" . . . "Li-Fraumeni syndrome" . . . "X-linked creatine transporter deficiency" . . . "Pseudo-von Willebrand disease" . . . "Myelodysplastic syndrome" . . . "Liddle syndrome" . . . "Severe myopia-generalized joint laxity-short stature syndrome" . . . "Diaphragmatic hernia-short bowel-asplenia syndrome" . . . "NKX6-2-related autosomal recessive hypomyelinating leukodystrophy" . . . "Non-specific syndromic intellectual disability" . . . "Hydrops-lactic acidosis-sideroblastic anemia-multisystemic failure syndrome" . . . "Hypohidrosis-electrolyte imbalance-lacrimal gland dysfunction-ichthyosis-xerostomia syndrome" . . . "Congenital generalized lipodystrophy" . . . "Isolated follicle stimulating hormone deficiency" . . . "Duane retraction syndrome with congenital deafness" . . . "Neurodevelopmental delay-seizures-ophthalmic anomalies-osteopenia-cerebellar atrophy syndrome" . . . "NON RARE IN EUROPE: Exfoliation syndrome" . . . "Letrozole toxicity" . . . "17q24.2 microdeletion syndrome" . . . "Intellectual disability-autism-speech apraxia-craniofacial dysmorphism syndrome" . . . "Male infertility due to acephalic spermatozoa" . . . "Immune dysregulation-inflammatory bowel disease-arthritis-recurrent infections-lymphopenia syndrome" . . . "Inflammatory bowel disease-recurrent sinopulmonary infections syndrome" . . . "Caroli disease" . . . "RELA fusion-positive ependymoma" . . . "KRT1-related diffuse nonepidermolytic keratoderma" . . . "Familial apolipoprotein A5 deficiency" . . . "Mixed phenotype acute leukemia" . . . "Lipoid proteinosis" . . . "Miller-Dieker syndrome" . . . "Muenke syndrome" . . . "Brody myopathy" . . . "X-linked dystonia-parkinsonism" . . . "Oculocerebrorenal syndrome of Lowe" . . . "Goldmann-Favre syndrome" . . . "Familial lipase maturation factor 1 deficiency" . . . "Familial GPIHBP1 deficiency" . . . "Paroxysmal dystonic choreathetosis with episodic ataxia and spasticity" . . . "B3GALT6-related spondylodysplastic Ehlers-Danlos syndrome" . . . "Myopathic Ehlers-Danlos syndrome" . . . "Classical-like Ehlers-Danlos syndrome type 2" . . . "Congenital chloride diarrhea" . . . "Congenital lactase deficiency" . . . "Congenital cornea plana" . . . "GRACILE syndrome" . . . "Arthrogryposis-anterior horn cell disease syndrome" . . . "Gnathodiaphyseal dysplasia" . . . "Hyaline body myopathy" . . . "Systemic lupus erythematosus" . . . "PLG-related hereditary angioedema with normal C1Inh" . . . "Palmoplantar keratoderma-hereditary motor and sensory neuropathy syndrome" . . . "X-linked lymphoproliferative disease due to SH2D1A deficiency" . . . "X-linked lymphoproliferative disease due to XIAP deficiency" . . . "Combined immunodeficiency due to CD70 deficiency" . . . "Combined immunodeficiency due to ITK deficiency" . . . "Lymphangioleiomyomatosis" . . . "Albers-Sch\u00F6nberg osteopetrosis" . . . "Familial hemophagocytic lymphohistiocytosis" . . . "Growth delay-intellectual disability-hepatopathy syndrome" . . . "Combined immunodeficiency due to CARMIL2 deficiency" . . . "GNB5-related intellectual disability-cardiac arrhythmia syndrome" . . . "Leukoencephalopathy with calcifications and cysts" . . . "Auditory neuropathy-optic atrophy syndrome" . . . "Left ventricular noncompaction" . . . "Isolated hyperchlorhidrosis" . . . "Optic atrophy-ataxia-peripheral neuropathy-global developmental delay syndrome" . . . "Burkitt lymphoma" . . . "SYNGAP1-related developmental and epileptic encephalopathy" . . . "PRUNE1-related neurological syndrome" . . . "Atypical hemolytic uremic syndrome with complement gene abnormality" . . . "Global developmental delay-alopecia-macrocephaly-facial dysmorphism-structural brain anomalies syndrome" . . . "RNF13-related severe early-onset epileptic encephalopathy" . . . "Congenital myopathy with reduced type 2 muscle fibers" . . . "Atypical Fanconi syndrome-neonatal hyperinsulinism syndrome" . . . "Craniopharyngioma" . . . "Follicular lymphoma" . . . "X-linked recessive ocular albinism" . . . "MELAS" . . . "MERRF" . . . "MODY" . . . "NAD(P)HX dehydratase deficiency" . . . "NAD(P)HX epimerase deficiency" . . . "FLNA-related X-linked myxomatous valvular dysplasia" . . . "TNP03-related limb-girdle muscular dystrophy D2" . . . "HNRNPDL-related limb-girdle muscular dystrophy D3" . . . "NON RARE IN EUROPE: Celiac disease" . . . "Hypotrichosis simplex" . . . "Pancreatic agenesis-holoprosencephaly syndrome" . . . "Early-onset calcifying leukoencephalopathy-skeletal dysplasia" . . . "Oculocerebrodental syndrome" . . . "Spastic ataxia-dysarthria due to glutaminase deficiency" . . . "Neonatal epileptic encephalopathy due to glutaminase deficiency" . . . "Chondrosarcoma" . . . "Marinesco-Sj\u00F6gren syndrome" . . . "Marshall syndrome" . . . "FOXG1 syndrome" . . . "Marshall-Smith syndrome" . . . "Heme oxygenase-1 deficiency" . . . "Congenital limbs-face contractures-hypotonia-developmental delay syndrome" . . . "Autosomal recessive extra-oral halitosis" . . . "Anterior maxillary protrusion-strabismus-intellectual disability syndrome" . . . "TMEM94-associated congenital heart defect-facial dysmorphism-developmental delay syndrome" . . . "McCune-Albright syndrome" . . . "Atelosteogenesis type II" . . . "Atelosteogenesis type III" . . . "Isolated anencephaly" . . . "Isolated exencephaly" . . . "Syndromic congenital sodium diarrhea" . . . "Meckel syndrome" . . . "Triglyceride deposit cardiomyovasculopathy" . . . "Combined oxidative phosphorylation defect type 39" . . . "Infantile inflammatory bowel disease with neurological involvement" . . . "Craniosynostosis-microretrognathia-severe intellectual disability syndrome" . . . "Menkes disease" . . . "CEBPE-associated autoinflammation-immunodeficiency-neutrophil dysfunction syndrome" . . . "Complement hyperactivation-angiopathic thrombosis-protein-losing enteropathy syndrome" . . . "Congenital autosomal recessive small-platelet thrombocytopenia" . . . "Resistance to thyroid hormone due to a mutation in thyroid hormone receptor alpha" . . . "Resistance to thyroid hormone due to a mutation in thyroid hormone receptor beta" . . . "Acute mast cell leukemia" . . . "Chronic mast cell leukemia" . . . "B-cell immunodeficiency-limb anomaly-urogenital malformation syndrome" . . . "Idiopathic steroid-resistant nephrotic syndrome" . . . "22q11.2 deletion syndrome" . . . "Microphthalmia, Lenz type" . . . "Microcystic stromal tumor" . . . "Multiple mitochondrial dysfunctions syndrome type 5" . . . "Multiple mitochondrial dysfunctions syndrome type 6" . . . "Familial or sporadic hemiplegic migraine" . . . "Alkaptonuria" . . . "Galactose mutarotase deficiency" . . . "QRSL1-related combined oxidative phosphorylation defect" . . . "Moebius syndrome" . . . "Posterior-predominant lissencephaly-broad flat pons and medulla-midline crossing defects syndrome" . . . "Blepharophimosis-ptosis-epicanthus inversus syndrome plus" . . . "Blepharophimosis-ptosis-epicanthus inversus syndrome type 1" . . . "Blepharophimosis-ptosis-epicanthus inversus syndrome type 2" . . . "Brachydactyly type B1" . . . "Infantile-onset pulmonary alveolar proteinosis-hypogammaglobulinemia" . . . "RFVT2-related riboflavin transporter deficiency" . . . "RFVT3-related riboflavin transporter deficiency" . . . "Microcephaly-micromelia syndrome" . . . "Microcephaly-short stature-limb abnormalities syndrome" . . . "WARS2-related combined oxidative phosphorylation defect" . . . "Immunodeficiency by defective expression of MHC class II" . . . "Monilethrix" . . . "Predisposition to severe viral infection due to IRF7 deficiency" . . . "Autosomal recessive mendelian susceptibility to mycobacterial diseases due to partial JAK1 deficiency" . . . "Cathepsin A-related arteriopathy-strokes-leukoencephalopathy" . . . "Muckle-Wells syndrome" . . . "SATB2-associated syndrome due to a pathogenic variant" . . . "NLRC4-related familial cold autoinflammatory syndrome" . . . "Mucolipidosis type II" . . . "Mazabraud syndrome" . . . "Mucolipidosis type IV" . . . "Glycogen storage disease due to aldolase A deficiency" . . . "Classic hairy cell leukemia" . . . "Lethal brain and heart developmental defects" . . . "QRICH1-related intellectual disability-chondrodysplasia syndrome" . . . "Mucopolysaccharidosis type 7" . . . "Multiple sulfatase deficiency" . . . "Sporadic fatal insomnia" . . . "Cystic fibrosis" . . . "Muir-Torre syndrome" . . . "Muscle-eye-brain disease" . . . "Spondylometaphyseal dysplasia-corneal dystrophy syndrome" . . . "Short stature-skeletal dysplasia-retinal degeneration-intellectual disability-sensorineural hearing loss syndrome" . . . "PUM1-associated developmental disability-ataxia-seizure syndrome" . . . "Spinocerebellar ataxia type 46" . . . "Spinocerebellar ataxia type 45" . . . "GRIN2B-related developmental delay, intellectual disability and autism spectrum disorder" . . . "Linear hypopigmentation and craniofacial asymmetry with acral, ocular and brain anomalies" . . . "Dystonia 28" . . . "Choanal atresia-athelia-hypothyroidism-delayed puberty-short stature syndrome" . . . "PHIP-related behavioral problems-intellectual disability-obesity-dysmorphic features syndrome" . . . "Laing early-onset distal myopathy" . . . "Sorsby pseudoinflammatory fundus dystrophy" . . . "GNAO1-related developmental delay-seizures-movement disorder spectrum" . . . "TRAF7-associated heart defect-digital anomalies-facial dysmorphism-motor and speech delay syndrome" . . . "Menke-Hennekam syndrome" . . . "Neonatal ichthyosis-sclerosing cholangitis syndrome" . . . "McLeod neuroacanthocytosis syndrome" . . . "Timothy syndrome type 1" . . . "Antley-Bixler syndrome without genital anomaly or disorder of steroidogenesis" . . . "X-linked centronuclear myopathy" . . . "IRF2BPL-related regressive neurodevelopmental disorder-dystonia-seizures syndrome" . . . "Euthyroid dysprealbuminemic hyperthyroxinemia" . . . "Central core disease" . . . "STXBP1-related encephalopathy" . . . "Hypomyelination of early myelinating structures" . . . "Hereditary angioedema with normal C1Inh not related to F12 or PLG variant" . . . "Allan-Herndon-Dudley syndrome" . . . "Long chain 3-hydroxyacyl-CoA dehydrogenase deficiency" . . . "Enlarged parietal foramina" . . . "Pulmonary alveolar microlithiasis" . . . "Loeys-Dietz syndrome" . . . "Idiopathic bronchiectasis" . . . "Megalencephaly-capillary malformation-polymicrogyria syndrome" . . . "NRXN1-related severe neurodevelopmental disorder-motor stereotypies-chronic constipation-sleep-wake cycle disturbance" . . . "CCNK-related neurodevelopmental disorder-severe intellectual disability-facial dysmorphism syndrome" . . . "Vocal cord and pharyngeal distal myopathy" . . . "GNE myopathy" . . . "KLHL7-related Bohring-Opitz-like syndrome" . . . "Distal myopathy, Welander type" . . . "Proximal myotonic myopathy" . . . "Tibial muscular dystrophy" . . . "Alpha-1-antitrypsin deficiency" . . . "Bethlem myopathy" . . . "Thomsen and Becker disease" . . . "Familial atrial myxoma" . . . "Familial melanoma" . . . "NON RARE IN EUROPE: Primary ovarian failure" . . . "Hereditary methemoglobinemia" . . . "Familial multiple nevi flammei" . . . "Large congenital melanocytic nevus" . . . "Nance-Horan syndrome" . . . "Diastrophic dwarfism" . . . "Short stature due to growth hormone qualitative anomaly" . . . "Alpha-sarcoglycan-related limb-girdle muscular dystrophy R3" . . . "Craniorachischisis" . . . "Distal myopathy with posterior leg and anterior hand involvement" . . . "Short stature due to isolated growth hormone deficiency with X-linked hypogammaglobulinemia" . . . "Laron syndrome" . . . "Isolated oxycephaly" . . . "Angel-shaped phalango-epiphyseal dysplasia" . . . "Acrocapitofemoral dysplasia" . . . "Netherton syndrome" . . . "Neuroblastoma" . . . "Neurofibromatosis type 2" . . . "Neurofibromatosis-Noonan syndrome" . . . "Hereditary neuropathy with liability to pressure palsies" . . . "Childhood absence epilepsy" . . . "Hereditary sensory and autonomic neuropathy type 4" . . . "Giant axonal neuropathy" . . . "NARP syndrome" . . . "NON RARE IN EUROPE: Non rare thrombophilia" . . . "Ovarian hyperstimulation syndrome" . . . "NON RARE IN EUROPE: Recurrent acute pancreatitis" . . . "Dejerine-Sottas syndrome" . . . "Hereditary motor and sensory neuropathy type 5" . . . "Hereditary sensory and autonomic neuropathy type 5" . . . "Spinocerebellar ataxia with axonal neuropathy type 2" . . . "Nevus comedonicus syndrome" . . . "Becker nevus syndrome" . . . "Nijmegen breakage syndrome" . . . "Noonan syndrome" . . . "Norrie disease" . . . "Alstr\u00F6m syndrome" . . . "NON RARE IN EUROPE: Idiopathic infantile nystagmus" . . . "Carvajal syndrome" . . . "Timothy syndrome" . . . "Biotin-thiamine-responsive basal ganglia disease" . . . "Lhermitte-Duclos disease" . . . "Beta-ureidopropionase deficiency" . . . "Permanent neonatal diabetes mellitus-pancreatic and cerebellar agenesis syndrome" . . . "Multiple endocrine neoplasia type 1" . . . "Nephroblastoma" . . . "Monomelic amyotrophy" . . . "Genetic steroid-resistant nephrotic syndrome" . . . "Autosomal dominant multiple pterygium syndrome" . . . "Multiple self-healing squamous epithelioma" . . . "Carpenter syndrome" . . . "Mutilating palmoplantar keratoderma with periorificial keratotic plaques" . . . "Leber congenital amaurosis" . . . "Ondine syndrome" . . . "Mitochondrial DNA-related progressive external ophthalmoplegia" . . . "Ornithine transcarbamylase deficiency" . . . "Obesity due to congenital leptin deficiency" . . . "Goldberg-Shprintzen megacolon syndrome" . . . "CEDNIK syndrome" . . . "Dilated cardiomyopathy with ataxia" . . . "Diaphanospondylodysostosis" . . . "Osteogenesis imperfecta" . . . "Autosomal recessive malignant osteopetrosis" . . . "Osteosarcoma" . . . "Autosomal dominant optic atrophy and cataract" . . . "B-cell chronic lymphocytic leukemia" . . . "Hyaluronidase deficiency" . . . "Late-onset retinal degeneration" . . . "Thrombocytopenia with congenital dyserythropoietic anemia" . . . "X-linked intellectual disability with isolated growth hormone deficiency" . . . "3-methylglutaconic aciduria type 1" . . . "3-methylglutaconic aciduria type 3" . . . "Pallister-Hall syndrome" . . . "Hereditary chronic pancreatitis" . . . "Papillon-Lef\u00E8vre syndrome" . . . "Hypokalemic periodic paralysis" . . . "Hyperkalemic periodic paralysis" . . . "Paramyotonia congenita of Von Eulenburg" . . . "Congenital membranous nephropathy due to fetomaternal anti-neutral endopeptidase alloimmunization" . . . "Familial renal glucosuria" . . . "Pure hair and nail ectodermal dysplasia" . . . "Limb-mammary syndrome" . . . "Naegeli-Franceschetti-Jadassohn syndrome" . . . "Anhidrotic ectodermal dysplasia-immunodeficiency-osteopetrosis-lymphedema syndrome" . . . "Pyogenic arthritis-pyoderma gangrenosum-acne syndrome" . . . "NON RARE IN EUROPE: Immunoglobulin A deficiency" . . . "Low phospholipid-associated cholelithiasis" . . . "Intrahepatic cholestasis of pregnancy" . . . "Tyrosinemia type 3" . . . "Hypotrichosis-lymphedema-telangiectasia-renal defect syndrome" . . . "Bosley-Salih-Alorainy syndrome" . . . "Athabaskan brainstem dysgenesis syndrome" . . . "3-methylcrotonyl-CoA carboxylase deficiency" . . . "Alopecia universalis" . . . "Bullous pemphigoid" . . . "Congenital lactic acidosis, Saguenay-Lac-Saint-Jean type" . . . "Leigh syndrome with cardiomyopathy" . . . "Cholangiocarcinoma" . . . "Small cell lung cancer" . . . "Infant acute respiratory distress syndrome" . . . "Immunodeficiency due to interleukin-1 receptor-associated kinase-4 deficiency" . . . "Dopa-responsive dystonia due to sepiapterin reductase deficiency" . . . "Sensory ataxic neuropathy-dysarthria-ophthalmoparesis syndrome" . . . "Pendred syndrome" . . . "NON RARE IN EUROPE: Patent arterial duct" . . . "Peters anomaly" . . . "Peters plus syndrome" . . . "Hyperinsulinism due to short chain 3-hydroxylacyl-CoA dehydrogenase deficiency" . . . "Split hand-split foot-deafness syndrome" . . . "Rh deficiency syndrome" . . . "Classic glucose transporter type 1 deficiency syndrome" . . . "Congenital brain dysgenesis due to glutamine synthetase deficiency" . . . "Radio-ulnar synostosis-amegakaryocytic thrombocytopenia syndrome" . . . "Familial platelet disorder with associated myeloid malignancy" . . . "Hemolytic anemia due to glucophosphate isomerase deficiency" . . . "Glycogen storage disease due to phosphoglycerate kinase 1 deficiency" . . . "Familial thrombocytosis" . . . "Hemolytic anemia due to diphosphoglycerate mutase deficiency" . . . "Rapid-onset dystonia-parkinsonism" . . . "Benign paroxysmal torticollis of infancy" . . . "Obesity due to pro-opiomelanocortin deficiency" . . . "Obesity due to prohormone convertase I deficiency" . . . "Obesity due to melanocortin 4 receptor deficiency" . . . "Glycogen storage disease due to muscle phosphorylase kinase deficiency" . . . "Isolated Pierre Robin syndrome" . . . "Chylomicron retention disease" . . . "Gray platelet syndrome" . . . "Hypoplasminogenemia" . . . "Continuous spikes and waves during sleep" . . . "Alpers-Huttenlocher syndrome" . . . "Polycythemia vera" . . . "Autosomal dominant polycystic kidney disease" . . . "Autosomal recessive polycystic kidney disease" . . . "HANAC syndrome" . . . "Growth delay due to insulin-like growth factor type 1 deficiency" . . . "Growth delay due to insulin-like growth factor I resistance" . . . "Alpha delta granule deficiency" . . . "Porokeratosis of Mibelli" . . . "Hutchinson-Gilford progeria syndrome" . . . "Familial mitral valve prolapse" . . . "Prolidase deficiency" . . . "Severe hereditary thrombophilia due to congenital protein S deficiency" . . . "Proteus syndrome" . . . "Severe hereditary thrombophilia due to congenital protein C deficiency" . . . "Mitochondrial trifunctional protein deficiency" . . . "Autoimmune pulmonary alveolar proteinosis" . . . "Congenital prekallikrein deficiency" . . . "Pseudoachondroplasia" . . . "NON RARE IN EUROPE: Pseudoarylsulfatase A deficiency" . . . "Wolman disease" . . . "Cholesteryl ester storage disease" . . . "Familial isolated restrictive cardiomyopathy" . . . "46,XY disorder of sex development due to 17-beta-hydroxysteroid dehydrogenase 3 deficiency" . . . "Retinal arterial tortuosity" . . . "North Carolina macular dystrophy" . . . "Bradyopsia" . . . "Familial drusen" . . . "Central areolar choroidal dystrophy" . . . "Oguchi disease" . . . "Primary immunodeficiency with natural-killer cell deficiency and adrenal insufficiency" . . . "Periodontal Ehlers-Danlos syndrome" . . . "46,XY disorder of sex development due to 5-alpha-reductase 2 deficiency" . . . "B4GALT7-related spondylodysplastic Ehlers-Danlos syndrome" . . . "X-linked Ehlers-Danlos syndrome" . . . "X-linked sideroblastic anemia" . . . "Acquired idiopathic sideroblastic anemia" . . . "Congenital muscular dystrophy, Ullrich type" . . . "6q terminal deletion syndrome" . . . "MORM syndrome" . . . "Pseudoxanthoma elasticum" . . . "Purine nucleoside phosphorylase deficiency" . . . "Pycnodysostosis" . . . "Hemolytic anemia due to red cell pyruvate kinase deficiency" . . . "Rabson-Mendenhall syndrome" . . . "NON RARE IN EUROPE: Ulcerative colitis" . . . "Trichorhinophalangeal syndrome type 1 and 3" . . . "Gaucher disease type 1" . . . "Gaucher disease type 2" . . . "Gaucher disease type 3" . . . "Niemann-Pick disease type A" . . . "Niemann-Pick disease type B" . . . "Odontoleukodystrophy" . . . "Majeed syndrome" . . . "Anophthalmia/microphthalmia-esophageal atresia syndrome" . . . "Infantile Refsum disease" . . . "Monosomy 9q22.3" . . . "Refsum disease" . . . "Hereditary hemorrhagic telangiectasia" . . . "Lujan-Fryns syndrome" . . . "X-linked non-syndromic intellectual disability" . . . "Rett syndrome" . . . "Reynolds syndrome" . . . "Axenfeld-Rieger syndrome" . . . "Estrogen resistance syndrome" . . . "Generalized glucocorticoid resistance syndrome" . . . "Juvenile polyposis of infancy" . . . "PPARG-related familial partial lipodystrophy" . . . "Familial partial lipodystrophy, K\u00F6bberling type" . . . "AKT2-related familial partial lipodystrophy" . . . "Acquired partial lipodystrophy" . . . "Hereditary inclusion body myopathy-joint contractures-ophthalmoplegia syndrome" . . . "Grange syndrome" . . . "Congenital bile acid synthesis defect type 4" . . . "Pyridoxal phosphate-responsive seizures" . . . "Atrophoderma vermiculata" . . . "Hyperprolinemia type 2" . . . "Thyrotoxic periodic paralysis" . . . "Myxofibrosarcoma" . . . "Eiken syndrome" . . . "Developmental malformations-deafness-dystonia syndrome" . . . "Mandibulofacial dysostosis-microcephaly syndrome" . . . "Neonatal diabetes-congenital hypothyroidism-congenital glaucoma-hepatic fibrosis-polycystic kidneys syndrome" . . . "Hepatic veno-occlusive disease-immunodeficiency syndrome" . . . "DEND syndrome" . . . "Generalized epilepsy-paroxysmal dyskinesia syndrome" . . . "Dowling-Degos disease" . . . "Familial progressive hyperpigmentation" . . . "Acrokeratosis verruciformis of Hopf" . . . "Disseminated superficial actinic porokeratosis" . . . "2-aminoadipic 2-oxoadipic aciduria" . . . "Hydroxykynureninuria" . . . "2-methylbutyryl-CoA dehydrogenase deficiency" . . . "Isobutyryl-CoA dehydrogenase deficiency" . . . "Retinitis pigmentosa" . . . "Hemochromatosis type 2" . . . "Hypoxanthine guanine phosphoribosyltransferase partial deficiency" . . . "Crigler-Najjar syndrome type 1" . . . "Crigler-Najjar syndrome type 2" . . . "Galactokinase deficiency" . . . "Classic galactosemia" . . . "Glycogen storage disease due to liver and muscle phosphorylase kinase deficiency" . . . "Biotinidase deficiency" . . . "Holocarboxylase synthetase deficiency" . . . "Pyruvate dehydrogenase E1-alpha deficiency" . . . "Pyruvate dehydrogenase E2 deficiency" . . . "Pyruvate dehydrogenase phosphatase deficiency" . . . "Mild phenylketonuria" . . . "Classic phenylketonuria" . . . "GM1 gangliosidosis type 1" . . . "GM1 gangliosidosis type 2" . . . "GM1 gangliosidosis type 3" . . . "Glycogen storage disease due to glucose-6-phosphatase deficiency type Ia" . . . "Glycogen storage disease due to glucose-6-phosphatase deficiency type Ib" . . . "Sanfilippo syndrome type A" . . . "Sanfilippo syndrome type B" . . . "Sanfilippo syndrome type C" . . . "Sanfilippo syndrome type D" . . . "Hereditary coproporphyria" . . . "Acute intermittent porphyria" . . . "Congenital erythropoietic porphyria" . . . "Autosomal erythropoietic protoporphyria" . . . "Alpha-N-acetylgalactosaminidase deficiency type 1" . . . "Alpha-N-acetylgalactosaminidase deficiency type 2" . . . "Alpha-N-acetylgalactosaminidase deficiency type 3" . . . "Methylmalonic acidemia with homocystinuria, type cblC" . . . "Methylmalonic acidemia with homocystinuria, type cblD" . . . "Methylmalonic acidemia with homocystinuria type cblF" . . . "Fish-eye disease" . . . "Familial LCAT deficiency" . . . "Hyperinsulinism due to glucokinase deficiency" . . . "X-linked retinoschisis" . . . "Congenital bile acid synthesis defect type 1" . . . "Congenital bile acid synthesis defect type 3" . . . "Congenital bile acid synthesis defect type 2" . . . "Progressive familial intrahepatic cholestasis type 2" . . . "Progressive familial intrahepatic cholestasis type 3" . . . "Progressive familial intrahepatic cholestasis type 1" . . . "Vitamin B12-responsive methylmalonic acidemia type cblA" . . . "Vitamin B12-responsive methylmalonic acidemia type cblB" . . . "Vitamin B12-unresponsive methylmalonic acidemia type mut-" . . . "L-2-hydroxyglutaric aciduria" . . . "D-2-hydroxyglutaric aciduria" . . . "PMM2-CDG" . . . "MPI-CDG" . . . "ALG6-CDG" . . . "ALG3-CDG" . . . "DPM1-CDG" . . . "MPDU1-CDG" . . . "ALG12-CDG" . . . "ALG8-CDG" . . . "ALG2-CDG" . . . "ALG1-CDG" . . . "ALG9-CDG" . . . "MGAT2-CDG" . . . "MOGS-CDG" . . . "B4GALT1-CDG" . . . "COG7-CDG" . . . "Brachytelephalangic chondrodysplasia punctata" . . . "3-phosphoserine phosphatase deficiency, infantile/juvenile form" . . . "3-phosphoglycerate dehydrogenase deficiency, infantile/juvenile form" . . . "Congenital non-bullous ichthyosiform erythroderma" . . . "Keratoderma hereditarium mutilans with ichthyosis" . . . "Autosomal dominant generalized epidermolysis bullosa simplex, severe form" . . . "Epidermolysis bullosa simplex with mottled pigmentation" . . . "Autosomal dominant generalized epidermolysis bullosa simplex, intermediate form" . . . "Localized epidermolysis bullosa simplex" . . . "PLEC-related intermediate epidermolysis bullosa simplex without extracutaneous involvement" . . . "Intermediate generalized junctional epidermolysis bullosa" . . . "Junctional epidermolysis bullosa with pyloric atresia" . . . "Severe generalized junctional epidermolysis bullosa" . . . "Late-onset junctional epidermolysis bullosa" . . . "Autosomal recessive generalized dystrophic epidermolysis bullosa, severe form" . . . "Recessive dystrophic epidermolysis bullosa inversa" . . . "Localized dystrophic epidermolysis bullosa, pretibial form" . . . "Self-improving dystrophic epidermolysis bullosa" . . . "Woolly hair nevus" . . . "Oculocutaneous albinism type 1A" . . . "Oculocutaneous albinism type 2" . . . "Oculocutaneous albinism type 3" . . . "Oculocutaneous albinism type 1B" . . . "Oculocutaneous albinism type 4" . . . "Pseudohypoparathyroidism type 1A" . . . "Pseudohypoparathyroidism type 1C" . . . "Pseudopseudohypoparathyroidism" . . . "Milroy disease" . . . "Cutaneous mastocytoma" . . . "Porphyria variegata" . . . "Atypical Werner syndrome" . . . "Griscelli syndrome type 1" . . . "Griscelli syndrome type 2" . . . "Griscelli syndrome type 3" . . . "Phakomatosis cesioflammea" . . . "Phakomatosis cesiomarmorata" . . . "X-linked congenital generalized hypertrichosis" . . . "Autosomal dominant deafness-onychodystrophy syndrome" . . . "Saethre-Chotzen syndrome" . . . "DOORS syndrome" . . . "Punctate palmoplantar keratoderma type 1" . . . "Ichthyosis hystrix of Curth-Macklin" . . . "Cholesterol-ester transfer protein deficiency" . . . "Autosomal recessive hyperinsulinism due to SUR1 deficiency" . . . "Autosomal recessive hyperinsulinism due to Kir6.2 deficiency" . . . "Mild hyperphenylalaninemia" . . . "Gardner syndrome" . . . "Sarcoidosis" . . . "Schinzel-Giedion syndrome" . . . "Congenital alpha2-antiplasmin deficiency" . . . "3C syndrome" . . . "Schwartz-Jampel syndrome" . . . "NON RARE IN EUROPE: Multiple sclerosis" . . . "Amyotrophic lateral sclerosis" . . . "Tuberous sclerosis complex" . . . "Scott syndrome" . . . "Seckel syndrome" . . . "Shwachman-Diamond syndrome" . . . "Sialidosis type 1" . . . "Sj\u00F6gren-Larsson syndrome" . . . "Smith-Lemli-Opitz syndrome" . . . "Smith-Magenis syndrome" . . . "Sneddon syndrome" . . . "Sotos syndrome" . . . "Hereditary spherocytosis" . . . "Primary myelofibrosis" . . . "NON RARE IN EUROPE: Ankylosing spondylitis" . . . "Stargardt disease" . . . "Hereditary thrombophilia due to congenital antithrombin deficiency" . . . "Succinyl-CoA:3-oxoacid CoA transferase deficiency" . . . "Proximal spinal muscular atrophy type 1" . . . "Proximal spinal muscular atrophy type 2" . . . "Proximal spinal muscular atrophy type 3" . . . "Proximal spinal muscular atrophy type 4" . . . "Glomuvenous malformation" . . . "Congenital primary aphakia" . . . "Microtia" . . . "Narcolepsy type 2" . . . "Desmoplastic small round cell tumor" . . . "CAMOS syndrome" . . . "Megalencephaly-polymicrogyria-postaxial polydactyly-hydrocephalus syndrome" . . . "Enteric anendocrinosis" . . . "Leukoencephalopathy-spondyloepimetaphyseal dysplasia syndrome" . . . "Hypercoagulability syndrome due to glycosylphosphatidylinositol deficiency" . . . "Microcytic anemia with liver iron overload" . . . "Congenital nephrotic syndrome, Finnish type" . . . "Antley-Bixler syndrome" . . . "Syndromic diarrhea" . . . "Senior-Boichis syndrome" . . . "Fibronectin glomerulopathy" . . . "Syringocystadenoma papilliferum" . . . "Desmin-related myopathy with Mallory body-like inclusions" . . . "Sebocystomatosis" . . . "Testicular seminomatous germ cell tumor" . . . "Alpha-thalassemia-X-linked intellectual disability syndrome" . . . "Glanzmann thrombasthenia" . . . "Fanconi anemia" . . . "Familial encephalopathy with neuroserpin inclusion bodies" . . . "Palmoplantar keratoderma-XX sex reversal-predisposition to squamous cell carcinoma syndrome" . . . "Bothnia retinal dystrophy" . . . "Cystic leukoencephalopathy without megalencephaly" . . . "NON RARE IN EUROPE: Aldosterone-producing adenoma" . . . "Neurogenic scapuloperoneal syndrome, Kaeser type" . . . "Hypomyelination-congenital cataract syndrome" . . . "Camptodactyly-tall stature-scoliosis-hearing loss syndrome" . . . "Severe achondroplasia-developmental delay-acanthosis nigricans syndrome" . . . "Platyspondylic dysplasia, Torrance type" . . . "Spondylometaphyseal dysplasia-cone-rod dystrophy syndrome" . . . "Familial digital arthropathy-brachydactyly" . . . "Microcephalic osteodysplastic dysplasia, Saul-Wilson type" . . . "IMAGe syndrome" . . . "Infantile osteopetrosis with neuroaxonal dysplasia" . . . "Diaphyseal medullary stenosis-bone malignancy syndrome" . . . "Endosteal sclerosis-cerebellar hypoplasia syndrome" . . . "Singleton-Merten dysplasia" . . . "Idiopathic juvenile osteoporosis" . . . "Spondylo-ocular syndrome" . . . "Familial expansile osteolysis" . . . "Dysspondyloenchondromatosis" . . . "Paris-Trousseau thrombocytopenia" . . . "Ischiovertebral syndrome" . . . "Genitopatellar syndrome" . . . "Keutel syndrome" . . . "Fetal Gaucher disease" . . . "X-linked intellectual disability, Cantagrel type" . . . "Christianson syndrome" . . . "Syndromic X-linked intellectual disability due to JARID1C mutation" . . . "MEHMO syndrome" . . . "BRESEK syndrome" . . . "X-linked intellectual disability, Siderius type" . . . "X-linked intellectual disability, Stocco Dos Santos type" . . . "X-linked intellectual disability, Cabezas type" . . . "X-linked epilepsy-learning disabilities-behavior disorders syndrome" . . . "HSD10 disease, atypical type" . . . "X-linked thrombocytopenia with normal platelets" . . . "X-linked intellectual disability-hypotonia-facial dysmorphism-aggressive behavior syndrome" . . . "Fried syndrome" . . . "Fetal and neonatal alloimmune thrombocytopenia" . . . "Rheumatoid factor-negative polyarticular juvenile idiopathic arthritis" . . . "Oligoarticular juvenile idiopathic arthritis" . . . "Systemic-onset juvenile idiopathic arthritis" . . . "Short stature-pituitary and cerebellar defects-small sella turcica syndrome" . . . "AA amyloidosis" . . . "ATTRV30M amyloidosis" . . . "AGel amyloidosis" . . . "ATTRV122I amyloidosis" . . . "X-linked reticulate pigmentary disorder" . . . "NON RARE IN EUROPE: Tourette syndrome" . . . "Townes-Brocks syndrome" . . . "Transcobalamin deficiency" . . . "Congenitally uncorrected transposition of the great arteries" . . . "Treacher-Collins syndrome" . . . "NON RARE IN EUROPE: Hereditary essential tremor" . . . "DPAGT1-CDG" . . . "X-linked severe congenital neutropenia" . . . "Familial multiple trichoepithelioma" . . . "POMT1-related limb-girdle muscular dystrophy R11" . . . "Helicoid peripapillary chorioretinal degeneration" . . . "Benign adult familial myoclonic epilepsy" . . . "Aplasia of lacrimal and salivary glands" . . . "Congenital analbuminemia" . . . "Hemolytic anemia due to adenylate kinase deficiency" . . . "Alport syndrome-intellectual disability-midface hypoplasia-elliptocytosis syndrome" . . . "Atrichia with papular lesions" . . . "Familial avascular necrosis of femoral head" . . . "Chronic neutrophilic leukemia" . . . "Chronic myeloproliferative disease, unclassifiable" . . . "Juvenile myelomonocytic leukemia" . . . "Refractory anemia with excess blasts" . . . "Myelodysplastic syndrome associated with isolated del(5q) chromosome abnormality" . . . "Acute myeloid leukaemia with myelodysplasia-related features" . . . "Acute basophilic leukemia" . . . "T-cell large granular lymphocyte leukemia" . . . "Subcutaneous panniculitis-like T-cell lymphoma" . . . "Triose phosphate-isomerase deficiency" . . . "Epilepsy with myoclonic absences" . . . "Dermatopathia pigmentosa reticularis" . . . "Hereditary palmoplantar keratoderma, Gamborg-Nielsen type" . . . "Triple A syndrome" . . . "Familial abdominal aortic aneurysm" . . . "Familial progressive cardiac conduction defect" . . . "Desmoid tumor" . . . "Mal de Meleda" . . . "Apert syndrome" . . . "Tyrosinemia type 1" . . . "Autosomal recessive non-syndromic intellectual disability" . . . "S-adenosylhomocysteine hydrolase deficiency" . . . "Familial acute necrotizing encephalopathy" . . . "Isolated congenital anosmia" . . . "Ichthyosis-prematurity syndrome" . . . "Posterior column ataxia-retinitis pigmentosa syndrome" . . . "Tritanopia" . . . "Terminal osseous dysplasia-pigmentary defects syndrome" . . . "Anterior segment developmental anomaly" . . . "Vacuolar myopathy with sarcoplasmic reticulum protein aggregates" . . . "Hypomyelination-hypogonadotropic hypogonadism-hypodontia syndrome" . . . "Neurodegeneration due to 3-hydroxyisobutyryl-CoA hydrolase deficiency" . . . "Channelopathy-associated congenital insensitivity to pain" . . . "Autosomal recessive ataxia, Beauce type" . . . "VACTERL/VATER association" . . . "Van der Woude syndrome" . . . "X-linked Alport syndrome" . . . "Autosomal dominant Alport syndrome" . . . "Autosomal recessive Alport syndrome" . . . "Autosomal dominant polycystic kidney disease type 1 with tuberous sclerosis" . . . "Pseudohypoaldosteronism type 2B" . . . "Pseudohypoaldosteronism type 2C" . . . "MUC1-related autosomal dominant tubulointerstitial kidney disease" . . . "UMOD-related autosomal dominant tubulointerstitial kidney disease" . . . "Idiopathic aplastic anemia" . . . "Familial exudative vitreoretinopathy" . . . "Von Hippel-Lindau disease" . . . "WAGR syndrome" . . . "Waardenburg syndrome type 1" . . . "Waardenburg syndrome type 2" . . . "Waardenburg syndrome type 3" . . . "Waardenburg-Shah syndrome" . . . "Autosomal recessive generalized epidermolysis bullosa simplex" . . . "Autosomal recessive generalized dystrophic epidermolysis bullosa, intermediate form" . . . "Dystrophic epidermolysis bullosa pruriginosa" . . . "Lissencephaly syndrome, Norman-Roberts type" . . . "Wagner disease" . . . "X-linked hypophosphatemia" . . . "Autosomal dominant hypophosphatemic rickets" . . . "Infantile Bartter syndrome with sensorineural deafness" . . . "Walker-Warburg syndrome" . . . "X-linked cone dysfunction syndrome with myopia" . . . "Parkinson-dementia complex of Guam" . . . "Primary immunodeficiency syndrome due to LAMTOR2 deficiency" . . . "Deafness with labyrinthine aplasia, microtia, and microdontia" . . . "Primary erythromelalgia" . . . "Hemolytic anemia due to glutathione reductase deficiency" . . . "Non-spherocytic hemolytic anemia due to hexokinase deficiency" . . . "Hemoglobin D disease" . . . "Primary familial polycythemia" . . . "Familial pseudohyperkalemia" . . . "Hereditary folate malabsorption" . . . "Retinopathy of prematurity" . . . "Granulomatosis with polyangiitis" . . . "Hereditary motor and sensory neuropathy, Okinawa type" . . . "Severe early-onset axonal neuropathy due to MFN2 deficiency" . . . "Hereditary motor and sensory neuropathy type 6" . . . "Mandibuloacral dysplasia with type A lipodystrophy" . . . "Mandibuloacral dysplasia with type B lipodystrophy" . . . "Werner syndrome" . . . "Parkes Weber syndrome" . . . "Klippel-Tr\u00E9naunay syndrome" . . . "Cockayne syndrome type 1" . . . "Cockayne syndrome type 2" . . . "Cockayne syndrome type 3" . . . "Blau syndrome" . . . "Xeroderma pigmentosum variant" . . . "Autosomal dominant cutis laxa" . . . "Autosomal recessive cutis laxa type 1" . . . "Brittle cornea syndrome" . . . "Hypotrichosis simplex of the scalp" . . . "Telangiectasia macularis eruptiva perstans" . . . "Williams syndrome" . . . "Wilson disease" . . . "X-linked non-syndromic sensorineural deafness type DFN" . . . "Autosomal dominant non-syndromic sensorineural deafness type DFNA" . . . "Autosomal recessive non-syndromic sensorineural deafness type DFNB" . . . "Mitochondrial non-syndromic sensorineural deafness" . . . "Jervell and Lange-Nielsen syndrome" . . . "Otopalatodigital syndrome type 1" . . . "Otopalatodigital syndrome type 2" . . . "Stickler syndrome type 1" . . . "Stickler syndrome type 2" . . . "Charcot-Marie-Tooth disease type 1E" . . . "Hypothyroidism due to TSH receptor mutations" . . . "Isolated thyroid-stimulating hormone deficiency" . . . "Non-acquired panhypopituitarism" . . . "Wiskott-Aldrich syndrome" . . . "Congenital adrenal hyperplasia due to 3-beta-hydroxysteroid dehydrogenase deficiency" . . . "Congenital adrenal hyperplasia due to 17-alpha-hydroxylase deficiency" . . . "Congenital adrenal hyperplasia due to 11-beta-hydroxylase deficiency" . . . "46,XY disorder of sex development due to isolated 17,20-lyase deficiency" . . . "Partial androgen insensitivity syndrome" . . . "NON RARE IN EUROPE: Wolff-Parkinson-White syndrome" . . . "Fragile X syndrome" . . . "Cerebrotendinous xanthomatosis" . . . "Argininemia" . . . "Xeroderma pigmentosum" . . . "Cardiomyopathy-hypotonia-lactic acidosis syndrome" . . . "DK1-CDG" . . . "Ichthyosis-hypotrichosis syndrome" . . . "Body skin hyperlaxity due to vitamin K-dependent coagulation factor deficiency" . . . "Combined immunodeficiency due to ZAP70 deficiency" . . . "Zellweger syndrome" . . . "TSH-secreting pituitary adenoma" . . . "Germinoma of the central nervous system" . . . "Familial thoracic aortic aneurysm and aortic dissection" . . . "Congenital ptosis" . . . "Pilomatrixoma" . . . "Ring dermoid of cornea" . . . "Rieger anomaly" . . . "Isolated congenital megalocornea" . . . "Isolated congenital sclerocornea" . . . "Persistent hyperplastic primary vitreous" . . . "Snowflake vitreoretinal degeneration" . . . "Aarskog-Scott syndrome" . . . "Aromatase deficiency" . . . "Congenital tufting enteropathy" . . . "Ablepharon macrostomia syndrome" . . . "Abruzzo-Erickson syndrome" . . . "Acatalasemia" . . . "Hyperammonemia due to N-acetylglutamate synthase deficiency" . . . "Idiopathic achalasia" . . . "Renal agenesis, unilateral" . . . "Posterior urethral valve" . . . "HNF1B-related autosomal dominant tubulointerstitial kidney disease" . . . "Autosomal dominant intermediate Charcot-Marie-Tooth disease type E" . . . "Hypocalcemic vitamin D-resistant rickets" . . . "Renal dysplasia, unilateral" . . . "Renal dysplasia, bilateral" . . . "Acheiropodia" . . . "Fragile X-associated tremor/ataxia syndrome" . . . "Pfeiffer syndrome type 1" . . . "Pfeiffer syndrome type 2" . . . "Pfeiffer syndrome type 3" . . . "Crouzon syndrome-acanthosis nigricans syndrome" . . . "Short rib-polydactyly syndrome, Beemer-Langer type" . . . "Short rib-polydactyly syndrome, Majewski type" . . . "Short rib-polydactyly syndrome, Saldino-Noonan type" . . . "Short rib-polydactyly syndrome, Verma-Naumoff type" . . . "Thanatophoric dysplasia type 2" . . . "Polyostotic fibrous dysplasia" . . . "Monostotic fibrous dysplasia" . . . "Mild spondyloepiphyseal dysplasia due to COL2A1 mutation with early-onset osteoarthritis" . . . "Spondyloepimetaphyseal dysplasia, PAPSS2 type" . . . "Spondyloepiphyseal dysplasia, Kimberley type" . . . "Spondyloepiphyseal dysplasia tarda" . . . "Achondrogenesis type 2" . . . "Hypochondrogenesis" . . . "Achondrogenesis type 1B" . . . "Achondrogenesis type 1A" . . . "Autosomal dominant brachyolmia" . . . "Multiple epiphyseal dysplasia type 4" . . . "Multiple epiphyseal dysplasia type 1" . . . "Multiple epiphyseal dysplasia type 5" . . . "Spondylometaphyseal dysplasia, Kozlowski type" . . . "Spondylometaphyseal dysplasia, 'corner fracture' type" . . . "Spondylometaphyseal dysplasia, Schmidt type" . . . "Spondylometaphyseal dysplasia, Sedaghatian type" . . . "Radial hemimelia" . . . "Tibial hemimelia" . . . "Autosomal recessive Kenny-Caffey syndrome" . . . "Autosomal dominant Kenny-Caffey syndrome" . . . "Autosomal dominant omodysplasia" . . . "Autosomal recessive omodysplasia" . . . "Pelviscapular dysplasia" . . . "Postaxial polydactyly type A" . . . "Postaxial polydactyly type B" . . . "Polydactyly of a triphalangeal thumb" . . . "Polysyndactyly" . . . "Polydactyly of a biphalangeal thumb" . . . "Spondyloepimetaphyseal dysplasia congenita, Strudwick type" . . . "Anauxetic dysplasia" . . . "X-linked spondyloepimetaphyseal dysplasia" . . . "Spondyloepimetaphyseal dysplasia, Shohat type" . . . "Spondyloepimetaphyseal dysplasia, Missouri type" . . . "SPONASTRIME dysplasia" . . . "Spondyloepimetaphyseal dysplasia-short limb-abnormal calcification syndrome" . . . "Spondyloepimetaphyseal dysplasia with joint laxity" . . . "Spondyloepimetaphyseal dysplasia with multiple dislocations" . . . "Familial hypocalciuric hypercalcemia type 1" . . . "Brachydactyly type C" . . . "NON RARE IN EUROPE: Brachydactyly type D" . . . "Brachydactyly type E" . . . "Brachydactyly type A1" . . . "Brachydactyly type A2" . . . "Juvenile sialidosis type 2" . . . "Congenital sialidosis type 2" . . . "Syndactyly type 3" . . . "Syndactyly type 4" . . . "Syndactyly type 5" . . . "Brachydactyly-syndactyly, Zhao type" . . . "Hurler syndrome" . . . "Scheie syndrome" . . . "Hurler-Scheie syndrome" . . . "Pediatric systemic lupus erythematosus" . . . "AApoAI amyloidosis" . . . "ALys amyloidosis" . . . "AFib amyloidosis" . . . "Dense deposit disease" . . . "Atypical hemolytic uremic syndrome with anti-factor H antibodies" . . . "Congenital thrombotic thrombocytopenic purpura" . . . "Late-onset nephronophthisis" . . . "Infantile nephronophthisis" . . . "Juvenile nephronophthisis" . . . "OBSOLETE: Alpha-1-antichymotrypsin deficiency" . . . "Primary hyperoxaluria type 1" . . . "Primary hyperoxaluria type 2" . . . "Primary hyperoxaluria type 3" . . . "Xanthinuria type I" . . . "Xanthinuria type II" . . . "Antenatal Bartter syndrome" . . . "Classic Bartter syndrome" . . . "Nephrogenic syndrome of inappropriate antidiuresis" . . . "Autosomal recessive proximal renal tubular acidosis" . . . "Autosomal dominant distal renal tubular acidosis" . . . "Distal renal tubular acidosis with anemia" . . . "Cystinuria type A" . . . "Cystinuria type B" . . . "Hemoglobin H disease" . . . "Dent disease type 1" . . . "Dent disease type 2" . . . "Schwannomatosis" . . . "Lobar holoprosencephaly" . . . "Alobar holoprosencephaly" . . . "Midline interhemispheric variant of holoprosencephaly" . . . "Bladder exstrophy" . . . "FG syndrome type 1" . . . "X-linked intellectual disability, Porteous type" . . . "Hamel cerebro-palato-cardiac syndrome" . . . "X-linked intellectual disability, Golabi-Ito-Hall type" . . . "X-linked intellectual disability, Sutherland-Haan type" . . . "X-linked intellectual disability, Hedera type" . . . "Aspartylglucosaminuria" . . . "12q14 microdeletion syndrome" . . . "Deafness-infertility syndrome" . . . "15q24 microdeletion syndrome" . . . "Spondyloepiphyseal dysplasia congenita" . . . "Partington syndrome" . . . "Hereditary renal hypouricemia" . . . "Pseudohypoparathyroidism type 1B" . . . "Cerebellar ataxia, Cayman type" . . . "Spinocerebellar ataxia with axonal neuropathy type 1" . . . "Recessive mitochondrial ataxia syndrome" . . . "Spinocerebellar ataxia type 7" . . . "Anonychia congenita totalis" . . . "D-glyceric aciduria" . . . "Malonic aciduria" . . . "Acrodysostosis" . . . "Hepatoerythropoietic porphyria" . . . "Lissencephaly due to LIS1 mutation" . . . "Acrofacial dysostosis, Weyers type" . . . "COG8-CDG" . . . "Autosomal recessive spinocerebellar ataxia-blindness-deafness syndrome" . . . "Autosomal recessive cerebellar ataxia-movement disorder syndrome" . . . "Combined pituitary hormone deficiencies, genetic forms" . . . "Pituitary stalk interruption syndrome" . . . "Hajdu-Cheney syndrome" . . . "NON RARE IN EUROPE: Non-classic congenital adrenal hyperplasia due to 21-hydroxylase deficiency" . . . "Congenital adrenal hyperplasia due to cytochrome P450 oxidoreductase deficiency" . . . "X-linked adrenal hypoplasia congenita" . . . "Non-syndromic posterior hypospadias" . . . "Thyroid ectopia" . . . "Athyreosis" . . . "Familial thyroid dyshormonogenesis" . . . "Thyroid hypoplasia" . . . "Acro-renal-ocular syndrome" . . . "Friedreich ataxia" . . . "Kleefstra syndrome due to 9q34 microdeletion" . . . "Temple syndrome due to maternal uniparental disomy of chromosome 14" . . . "Paternal uniparental disomy of chromosome 6" . . . "Cushing disease" . . . "Leydig cell hypoplasia due to complete LH resistance" . . . "Leydig cell hypoplasia due to partial LH resistance" . . . "Kagami-Ogata syndrome due to paternal uniparental disomy of chromosome 14" . . . "Acromegaly" . . . "Acromegaloid facial appearance syndrome" . . . "Hypertrichosis-acromegaloid facial appearance syndrome" . . . "Acromesomelic dysplasia, Hunter-Thompson type" . . . "Acromicric dysplasia" . . . "Ataxia with vitamin E deficiency" . . . "Hereditary sensory and autonomic neuropathy type 2" . . . "Glycogen storage disease due to phosphoglycerate mutase deficiency" . . . "Rippling muscle disease" . . . "Reducing body myopathy" . . . "Zebra body myopathy" . . . "Rigid spine syndrome" . . . "Pontocerebellar hypoplasia type 3" . . . "Insulinoma" . . . "Carney-Stratakis syndrome" . . . "Bohring-Opitz syndrome" . . . "Hereditary continuous muscle fiber activity" . . . "Melanoma of soft tissue" . . . "ABri amyloidosis" . . . "ADan amyloidosis" . . . "Renal hypoplasia, bilateral" . . . "Unilateral multicystic dysplastic kidney" . . . "Bilateral multicystic dysplastic kidney" . . . "Renal tubular dysgenesis of genetic origin" . . . "Adams-Oliver syndrome" . . . "Right sided atrial isomerism" . . . "NON RARE IN EUROPE: Benign familial hematuria" . . . "17q11 microdeletion syndrome" . . . "Adenine phosphoribosyltransferase deficiency" . . . "ADULT syndrome" . . . "Familial paroxysmal ataxia" . . . "Testicular regression syndrome" . . . "Hereditary combined deficiency of vitamin K-dependent clotting factors" . . . "Rare isolated myopia" . . . "Autosomal dominant optic atrophy, classic form" . . . "Autosomal recessive isolated optic atrophy" . . . "Prader-Willi syndrome due to maternal uniparental disomy of chromosome 15" . . . "Spinocerebellar ataxia type 1" . . . "Spinocerebellar ataxia type 2" . . . "Spinocerebellar ataxia type 6" . . . "Spinocerebellar ataxia type 17" . . . "Spinocerebellar ataxia type 8" . . . "Spinocerebellar ataxia type 10" . . . "Spinocerebellar ataxia type 12" . . . "Spinocerebellar ataxia type 14" . . . "Spinocerebellar ataxia type 27" . . . "Spinocerebellar ataxia type 4" . . . "Spinocerebellar ataxia type 5" . . . "Spinocerebellar ataxia type 11" . . . "Spinocerebellar ataxia type 13" . . . "Spinocerebellar ataxia type 15/16" . . . "Spinocerebellar ataxia type 18" . . . "Spinocerebellar ataxia type 19/22" . . . "Spinocerebellar ataxia type 21" . . . "Autosomal dominant nocturnal frontal lobe epilepsy" . . . "Alpha-thalassemia-intellectual disability syndrome linked to chromosome 16" . . . "Angelman syndrome due to maternal 15q11q13 deletion" . . . "Angelman syndrome due to paternal uniparental disomy of chromosome 15" . . . "Primary dystonia, DYT4 type" . . . "Primary dystonia, DYT6 type" . . . "Primary dystonia, DYT13 type" . . . "Autosomal dominant dopa-responsive dystonia" . . . "Paroxysmal kinesigenic dyskinesia" . . . "Paroxysmal non-kinesigenic dyskinesia" . . . "Paroxysmal exertion-induced dyskinesia" . . . "Hypohidrotic ectodermal dysplasia with immunodeficiency" . . . "Landau-Kleffner syndrome" . . . "Familial focal epilepsy with variable foci" . . . "Chronic myelomonocytic leukemia" . . . "Atypical chronic myeloid leukemia" . . . "Refractory anemia" . . . "Acute myeloid leukemia with abnormal bone marrow eosinophils inv(16)(p13q22) or t(16;16)(p13;q22)" . . . "Acute myeloid leukemia with 11q23 abnormalities" . . . "Acute myeloid leukemia with minimal differentiation" . . . "Acute myeloblastic leukemia without maturation" . . . "Acute myeloblastic leukemia with maturation" . . . "Acute undifferentiated leukemia" . . . "Primary mediastinal large B-cell lymphoma" . . . "Intravascular large B-cell lymphoma" . . . "Lymphomatoid papulosis" . . . "Classic Hodgkin lymphoma, nodular sclerosis type" . . . "Systemic mastocytosis with associated hematologic neoplasm" . . . "Aggressive systemic mastocytosis" . . . "Autosomal dominant Emery-Dreifuss muscular dystrophy" . . . "Autosomal recessive Emery-Dreifuss muscular dystrophy" . . . "Charcot-Marie-Tooth disease type 2B1" . . . "X-linked Emery-Dreifuss muscular dystrophy" . . . "Southeast Asian ovalocytosis" . . . "Congenital dyserythropoietic anemia type I" . . . "Congenital dyserythropoietic anemia type III" . . . "Congenital dyserythropoietic anemia type II" . . . "Familial afibrinogenemia" . . . "Familial dysfibrinogenemia" . . . "Bleeding diathesis due to glycoprotein VI deficiency" . . . "Bilateral perisylvian polymicrogyria" . . . "Early-onset X-linked optic atrophy" . . . "Periventricular nodular heterotopia" . . . "Becker muscular dystrophy" . . . "Duchenne muscular dystrophy" . . . "Oculopharyngodistal myopathy" . . . "Amish nemaline myopathy" . . . "Congenital myopathy with excess of thin filaments" . . . "Congenital multicore myopathy with external ophthalmoplegia" . . . "Neutral lipid storage disease with ichthyosis" . . . "Neutral lipid storage myopathy" . . . "Desminopathy" . . . "Distal myotilinopathy" . . . "Late-onset distal myopathy, Markesbery-Griggs type" . . . "Postsynaptic congenital myasthenic syndromes" . . . "Presynaptic congenital myasthenic syndromes" . . . "Synaptic congenital myasthenic syndromes" . . . "Acute inflammatory demyelinating polyradiculoneuropathy" . . . "Spinal muscular atrophy with respiratory distress type 1" . . . "Multiple system atrophy, parkinsonian type" . . . "Huntington disease-like 2" . . . "Colobomatous microphthalmia" . . . "Coloboma of choroid and retina" . . . "Coloboma of eye lens" . . . "Coloboma of iris" . . . "Coloboma of macula" . . . "Coloboma of eyelid" . . . "Coloboma of optic disc" . . . "Complete cryptophthalmia" . . . "Meesmann corneal dystrophy" . . . "Epithelial basement membrane dystrophy" . . . "Gelatinous drop-like corneal dystrophy" . . . "Thiel-Behnke corneal dystrophy" . . . "Reis-B\u00FCcklers corneal dystrophy" . . . "Granular corneal dystrophy type I" . . . "Granular corneal dystrophy type II" . . . "Lattice corneal dystrophy type I" . . . "Schnyder corneal dystrophy" . . . "Macular corneal dystrophy" . . . "Fleck corneal dystrophy" . . . "Posterior polymorphous corneal dystrophy" . . . "Fuchs endothelial corneal dystrophy" . . . "Congenital hereditary endothelial dystrophy type I" . . . "Congenital glaucoma" . . . "Juvenile glaucoma" . . . "Axenfeld anomaly" . . . "Pulverulent cataract" . . . "Early-onset sutural cataract" . . . "Early-onset anterior polar cataract" . . . "Cerulean cataract" . . . "Coralliform cataract" . . . "Early-onset nuclear cataract" . . . "Early-onset posterior polar cataract" . . . "Total early-onset cataract" . . . "Autosomal recessive spastic ataxia of Charlevoix-Saguenay" . . . "Adult-onset foveomacular vitelliform dystrophy" . . . "Butterfly-shaped pigment dystrophy" . . . "Reticular dystrophy of the retinal pigment epithelium" . . . "Multifocal pattern dystrophy simulating fundus flavimaculatus" . . . "Spastic paraplegia type 7" . . . "X-linked Charcot-Marie-Tooth disease type 5" . . . "Spastic paraplegia type 2" . . . "Adult-onset autosomal dominant leukodystrophy" . . . "Congenitally uncorrected transposition of the great arteries with coarctation" . . . "Complete atrioventricular septal defect with ventricular hypoplasia" . . . "Complete atrioventricular septal defect-tetralogy of Fallot" . . . "Agnathia-holoprosencephaly-situs inversus syndrome" . . . "Atrial septal defect, ostium secundum type" . . . "Atrial septal defect, sinus venosus type" . . . "Atrial septal defect, ostium primum type" . . . "Lymphedema-posterior choanal atresia syndrome" . . . "Familial medullary thyroid carcinoma" . . . "Complete androgen insensitivity syndrome" . . . "Fetal akinesia deformation sequence" . . . "Metaphyseal chondromatosis with D-2-hydroxyglutaric aciduria" . . . "Primary dystonia, DYT2 type" . . . "Leber plus disease" . . . "Pituitary gigantism" . . . "Isolated sulfite oxidase deficiency" . . . "Myotonia fluctuans" . . . "Myotonia permanens" . . . "Acetazolamide-responsive myotonia" . . . "King-Denborough syndrome" . . . "Amish lethal microcephaly" . . . "Kostmann syndrome" . . . "Alveolar rhabdomyosarcoma" . . . "Embryonal rhabdomyosarcoma" . . . "Bifid uvula" . . . "Cleft velum" . . . "Dentin dysplasia type I" . . . "Dentin dysplasia type II" . . . "Subcortical band heterotopia" . . . "Oligodontia" . . . "Hemimegalencephaly" . . . "Haddad syndrome" . . . "Oculootodental syndrome" . . . "PEHO-like syndrome" . . . "Familial porencephaly" . . . "Neuronal intestinal pseudoobstruction" . . . "LIG4 syndrome" . . . "Turcot syndrome with polyposis" . . . "Familial gestational hyperthyroidism" . . . "Resistance to thyrotropin-releasing hormone syndrome" . . . "Leukocyte adhesion deficiency type I" . . . "Leukocyte adhesion deficiency type II" . . . "Leukocyte adhesion deficiency type III" . . . "Genetic recurrent myoglobinuria" . . . "Glycogen storage disease due to muscle beta-enolase deficiency" . . . "Ravine syndrome" . . . "Ovarioleukodystrophy" . . . "Cree leukoencephalopathy" . . . "Precursor B-cell acute lymphoblastic leukemia" . . . "Precursor T-cell acute lymphoblastic leukemia" . . . "Familial isolated hyperparathyroidism" . . . "Hyperparathyroidism-jaw tumor syndrome" . . . "Isolated permanent neonatal diabetes mellitus" . . . "Transient neonatal diabetes mellitus" . . . "Acute megakaryoblastic leukemia in Down syndrome" . . . "Mendelian susceptibility to mycobacterial diseases due to complete IFNgammaR1 deficiency" . . . "Acyl-CoA dehydrogenase 9 deficiency" . . . "Gynandroblastoma" . . . "Maligant granulosa cell tumor of the ovary" . . . "Malignant Sertoli-Leydig cell tumor of the ovary" . . . "Autosomal dominant Charcot-Marie-Tooth disease type 2B" . . . "Autosomal dominant Charcot-Marie-Tooth disease type 2C" . . . "Autosomal dominant Charcot-Marie-Tooth disease type 2D" . . . "Autosomal dominant Charcot-Marie-Tooth disease type 2E" . . . "Autosomal dominant Charcot-Marie-Tooth disease type 2F" . . . "Autosomal dominant Charcot-Marie-Tooth disease type 2I" . . . "Autosomal dominant Charcot-Marie-Tooth disease type 2J" . . . "Autosomal dominant Charcot-Marie-Tooth disease type 2K" . . . "Autosomal dominant Charcot-Marie-Tooth disease type 2L" . . . "Autosomal dominant Charcot-Marie-Tooth disease type 2A1" . . . "Autosomal dominant Charcot-Marie-Tooth disease type 2A2" . . . "Charcot-Marie-Tooth disease type 4A" . . . "Charcot-Marie-Tooth disease type 4C" . . . "Charcot-Marie-Tooth disease type 4D" . . . "Charcot-Marie-Tooth disease type 4E" . . . "Charcot-Marie-Tooth disease type 4F" . . . "Charcot-Marie-Tooth disease type 4G" . . . "Charcot-Marie-Tooth disease type 4H" . . . "Charcot-Marie-Tooth disease type 4B1" . . . "Charcot-Marie-Tooth disease type 4B2" . . . "Benign recurrent intrahepatic cholestasis type 1" . . . "Benign recurrent intrahepatic cholestasis type 2" . . . "Atypical teratoid rhabdoid tumor" . . . "Myxoid/round cell liposarcoma" . . . "Dedifferentiated liposarcoma" . . . "Well-differentiated liposarcoma" . . . "Squamous cell carcinoma of the esophagus" . . . "Intermediate DEND syndrome" . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .